教育研究活動データベース

日本語に切り替えるswitch to english

森田 智視

モリタ サトシ

医学部附属病院 先端医療研究開発機構 教授

森田 智視
list
    Last Updated :2025/04/24

    基本情報

    学部兼担

    • 医学部

    学位

    • 博士(保健学)(東京大学)

    使用言語

    • 日本語
    • 英語

    ID,URL

    researchmap URL

    list
      Last Updated :2025/04/24

      研究

      研究テーマ・研究概要

      • 研究テーマ

        ベイズ流統計手法
        臨床試験デザイン
        臨床試験におけるアダプティブディシジョンメイキング
      • 研究概要

        医学統計学とバイオインフォマティックスを通じて早期臨床開発から臨床研究までを連動的にサポートするための研究活動を行っています。医学統計ではベイズ流統計に基づいた新規臨床試験デザイン開発を行います。ゲノム情報などのバイオマーカーデータを新治療法開発(効果予測因子探索など)に活用するためのバイオインフォマティックス研究にも積極的に取り組みます。また、患者quality of lifeをはじめとするpatient-reported outcomesの評価法とデータ解析法に関する研究も行います。医学研究者とのコラボレーションの中で議論した問題点の解決を大きなモティベーションとしてこれらの研究活動を積極的に推進しています。

      研究分野

      • その他, その他

      論文

      • HER2陽性進行・再発乳癌に対するHP療法にタキサン併用とエリブリン併用を比較する第III相JBCRG-M06試験
        佐治 重衡; 山下 年成; 高野 利実; 内藤 陽一; 常泉 道子; 吉村 章代; 高橋 將人; 鶴谷 純司; 岩谷 胤生; 北田 正博; 多田 寛; 森 菜採子; 斎藤 毅; 岩朝 勤; 荒木 和浩; 坂井 和子; 長谷川 広季; 内田 洋平; 森田 智視; 増田 慎三
        日本乳癌学会総会プログラム抄録集, 2024年07月
      • Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO-HBP-005): Clinical Study Group of Osaka University, Hepato-Biliary-Pancreatic Group.
        Shogo Kobayashi; Akira Tomokuni; Yutaka Takeda; Hiroshi Wada; Yoshiteru Katsura; Kazuhiko Hashimoto; Yoshito Tomimaru; Tadafumi Asaoka; Terumasa Yamada; Masanori Tsujie; Takehiro Noda; Satoshi Morita; Hiroaki Nagano; Masaki Mori; Yuichiro Doki; Hidetoshi Eguchi
        Hepatology research : the official journal of the Japan Society of Hepatology, 2024年01月27日, 査読有り
      • 消化器癌治療における日本からのエビデンスの発信 Oncologic ResectionやRCTの結果からみえてきたもの 直腸前方切除術における下腸間膜動脈の切離部位の検討 HTLT(High-tie vs low-tie)study(無作為比較試験)
        藤井 正一; 石部 敦士; 大田 貢由; 野原 京子; 針原 康; 國崎 主税; 大庭 真梨; 森田 智視; 遠藤 格; 小西 敏郎
        日本消化器外科学会総会, 2013年07月
      • Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.
        Feiqian Wang; Kazushi Numata; Masahiro Okada; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
        Quantitative imaging in medicine and surgery, 2021年06月
      • The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
        Feiqian Wang; Kazushi Numata; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Hiroyuki Fukuda; Masahiro Okada; Litao Ruan; Wen Luo; Norihiro Koizumi; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
        Abdominal radiology (New York), 2021年06月
      • A fast-filament eruption observed in the Halpha spectral line. I. Imaging spectroscopy diagnostic
        Denis P. Cabezas; Kiyoshi Ichimoto; Ayumi Asai; Satoru UeNo; Satoshi Morita; Ken-ichi Otsuji; Kazunari Shibata
        Astronomy & Astrophysics, 2024年08月05日
      • 関節型若年性特発性関節炎(JIA)に対するmethotrexate療法による有効性と副作用に関する薬理遺伝学的検討
        柳町 昌克; 成戸 拓也; 原 拓磨; 岸 崇之; 菊地 雅子; 原 良紀; 宮前 多佳子; 今川 智之; 森 雅亮; 金子 徹治; 森田 智視; 横田 俊平
        臨床薬理, 2009年11月
      • Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers.
        Yurina Maeshima; Tatsuki R Kataoka; Alexis Vandenbon; Masahiro Hirata; Yasuhide Takeuchi; Yutaka Suzuki; Yukiko Fukui; Masahiro Kawashima; Masahiro Takada; Yumiko Ibi; Hironori Haga; Satoshi Morita; Masakazu Toi; Shinpei Kawaoka; Kosuke Kawaguchi
        EBioMedicine, 2024年09月
      • Iron and iodine deficiencies among under-2 children, adolescent girls, and pregnant women of Bangladesh: association with common diseases.
        M. Harun-Or-Rashid; Uh Farida Khatun; Yoshitoku Yoshida; Satoshi Morita; Nuruddin Chowdhury; Junichi Sakamoto
        Nagoya journal of medical science, 2009年
      • Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06)
        Misato Masuyama; Norikazu Masuda; Hidetoshi Kawaguchi; Yutaka Yamamoto; Shigehira Saji; Takahiro Nakayama; Kenjiro Aogi; Keisei Anan; Shoichiro Ohtani; Nobuaki Sato; Toshimi Takano; Eriko Tokunaga; Seigo Nakamura; Yoshie Hasegawa; Masaya Hattori; Tomomi Fujisawa; Satoshi Morita; Miki Yamaguchi; Toshinari Yamashita; Daisuke Yotsumoto; Masakazu Toi; Shinji Ohno
        Cancer Medicine, 2023年08月
      • Associations between Sleep-Disordered Breathing and Serum Uric Acid and Their Sex Differences: The Nagahama Study.
        Hironobu Sunadome; Kimihiko Murase; Yasuharu Tabara; Takeshi Matsumoto; Takuma Minami; Osamu Kanai; Tadao Nagasaki; Naomi Takahashi; Satoshi Hamada; Kiminobu Tanizawa; Jumpei Togawa; Sayaka Uiji; Tomoko Wakamura; Naoko Komenami; Kazuya Setoh; Takahisa Kawaguchi; Satoshi Morita; Yoshimitsu Takahashi; Takeo Nakayama; Toyohiro Hirai; Susumu Sato; Fumihiko Matsuda; Kazuo Chin
        Nutrients, 2023年09月30日, 査読有り
      • Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19) (International Journal of Clinical Oncology, (2021), 26, 7, (1229-1236), 10.1007/s10147-021-01920-0)
        Kenjiro Aogi; Kenichi Watanabe; Masahiro Kitada; Takafumi Sangai; Shoichiro Ohtani; Tomoyuki Aruga; Hidetoshi Kawagichi; Tomomi Fujisawa; Shigeto Maeda; Takashi Morimoto; Nobuaki Sato; Shintaro Takao; Satoshi Morita; Norikazu Masuda; Masakazu Toi; Shinji Ohno
        International Journal of Clinical Oncology, 2021年07月01日
      • Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
        Kenjiro Aogi; Kenichi Watanabe; Masahiro Kitada; Takashi Sangai; Shoichiro Ohtani; Tomoyuki Aruga; Hidetoshi Kawagichi; Tomomi Fujisawa; Shigeto Maeda; Takashi Morimoto; Nobuaki Sato; Shintaro Takao; Satoshi Morita; Norikazu Masuda; Masakazu Toi; Shinji Ohno
        International Journal of Clinical Oncology, 2021年07月01日
      • Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study (Breast Cancer, 10.1007/s12282-017-0798-4)
        Masaya Hattori; Hiroshi Ishiguro; Norikazu Masuda; Akiyo Yoshimura; Shoichiro Ohtani; Hiroyuki Yasojima; Satoshi Morita; Shinji Ohno; Hiroji Iwata
        Breast Cancer, 2018年01月01日
      • Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
        Don Pietro Saldajeno; Shinpei Kawaoka; Norikazu Masuda; Sunao Tanaka; Hiroko Bando; Tomomi Nishimura; Takayuki Kadoya; Takashi Yamanaka; Shigeru Imoto; Ravindranath M Velaga; Nobuko Tamura; Tomoyuki Aruga; Kazushi Ikeda; Yukiko Fukui; Yurina Maeshima; Masahiro Takada; Eiji Suzuki; Takayuki Ueno; Seishi Ogawa; Hironori Haga; Shinji Ohno; Satoshi Morita; Kosuke Kawaguchi; Masakazu Toi
        British journal of cancer, 2024年01月18日
      • Comprehensive data of 4502 patients newly diagnosed with colorectal liver metastasis between 2015 and 2017, and prognostic data of 2427 patients newly diagnosed with colorectal liver metastasis in 2013 and 2014: Third report of a nationwide survey in Japan.
        Katsunori Sakamoto; Toru Beppu; Goro Honda; Kenjiro Kotake; Masakazu Yamamoto; Keiichi Takahashi; Itaru Endo; Kiyoshi Hasegawa; Michio Itabashi; Yojiro Hashiguchi; Yoshihito Kotera; Shin Kobayashi; Tatsuro Yamaguchi; Soichiro Natsume; Ken Tabuchi; Hirotoshi Kobayashi; Kensei Yamaguchi; Kimitaka Tani; Satoshi Morita; Masaru Miyazaki; Kenichi Sugihara
        Journal of hepato-biliary-pancreatic sciences, 2023年05月
      • Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic Cancer
        Satoshi Kobayashi; Makoto Ueno; Hiroki Hara; Kuniyasu Irie; Yoshihiro Goda; Satoshi Moriya; Shun Tezuka; Masao Tanaka; Takuji Okusaka; Shinichi Ohkawa; Manabu Morimoto
        ONCOLOGY, 2016年, 査読有り
      • 乳癌免疫療法の課題と展望 免疫療法としてのCDK4/6阻害薬 腸内細菌叢と循環免疫プロファイルの観点から
        河口 浩介; 前島 佑里奈; 藤本 優里; 石黒 洋; 山神 和彦; 高原 祥子; 諏訪 裕文; 鳥井 雅恵; 永井 成勲; 相良 安昭; 辻 和香子; 山城 大泰; 古武 剛; 片岡 正子; 福井 由紀子; 中村 有輝; 田中 直; Li Wei; 森田 智視; 戸井 雅和
        日本乳癌学会総会プログラム抄録集, 2023年06月
      • Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis.
        Ayane Yamaguchi; Kosuke Kawaguchi; Kana Kawanishi; Yurina Maeshima; Akiyoshi Nakakura; Tatsuki R Kataoka; Sachiko Takahara; Shunsaku Nakagawa; Atsushi Yonezawa; Masahiro Takada; Masahiro Kawashima; Nobuko Kawaguchi-Sakita; Takeshi Kotake; Eiji Suzuki; Hanako Shimizu; Masae Torii; Satoshi Morita; Hiroshi Ishiguro; Masakazu Toi
        Breast cancer research and treatment, 2023年12月21日
      • Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents
        Kuniyasu Irie; Manabu Morimoto; Kazushi Numata; Masaaki Kondo; Satoshi Moriya; Yu Shimoyama; Akito Nozaki; Yoshihiro Goda; Satoshi Kobayashi; Makoto Ueno; Shinichi Ohkawa; Katsuaki Tanaka; Shin Maeda
        ABDOMINAL IMAGING, 2015年08月, 査読有り
      • Fucosylated Fraction of Alpha-fetoprotein as a Serological Marker of Early Hepatocellular Carcinoma
        Satoshi Moriya; Manabu Morimoto; Kazushi Numata; Akito Nozaki; Yu Shimoyama; Masaaki Kondo; Masayuki Nakano; Shin Maeda; Katsuaki Tanaka
        ANTICANCER RESEARCH, 2013年03月, 査読有り
      • Inflammation-based Prognostic Score for Hepatocellular Carcinoma Patients on Sorafenib Treatment
        Manabu Morimoto; Kazushi Numata; Satoshi Moriya; Masaaki Kondo; Akito Nozaki; Yu Morioka; Shin Maeda; Katsuaki Tanaka
        ANTICANCER RESEARCH, 2012年02月, 査読有り
      • Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.
        Daisuke Nishizaki; Koya Hida; Atsuhiko Sumii; Ryosuke Okamura; Yoshiharu Sakai; Tsuyoshi Konishi; Takashi Akiyoshi; Satoshi Maruyama; Masazumi Okajima; Yasuyuki Miyakura; Seiichiro Yamamoto; Satoshi Morita; Masahiko Watanabe
        Diseases of the colon and rectum, 2022年08月01日
      • Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.
        Makoto Chuma; Hidenori Toyoda; Juntaro Matsuzaki; Yoshimasa Saito; Takashi Kumada; Toshifumi Tada; Yuji Kaneoka; Atsuyuki Maeda; Hideki Yokoo; Koji Ogawa; Toshiya Kamiyama; Akinobu Taketomi; Yoshihiro Matsuno; Keiichi Yazawa; Kazuhisa Takeda; Chikara Kunisaki; Katsuaki Ogushi; Satoshi Moriya; Koji Hara; Akito Nozaki; Masaaki Kondo; Hiroyuki Fukuda; Kazushi Numata; Katsuaki Tanaka; Shin Maeda; Naoya Sakamoto
        Hepatology research : the official journal of the Japan Society of Hepatology, 2019年07月, 査読有り
      • EGFR遺伝子変異陽性NSCLC症例に対するゲフィチニブ治療の第II相試験統合解析(I-CAMP study group)
        杉尾 賢二; 平島 智徳; 樋田 豊明; 萩原 弘一; 砂長 則明; 井上 彰; 朝比奈 肇; 森田 智視; 光冨 徹哉; 福岡 正博; 貫和 敏博; 安元 公正
        日本呼吸器学会雑誌, 2009年05月
      • Sleep disordered breathing and haemoglobin A1c levels within or over normal range and ageing or sex differences: the Nagahama study.
        Takeshi Matsumoto; Kimihiko Murase; Yasuharu Tabara; Takuma Minami; Osamu Kanai; Hirofumi Takeyama; Hironobu Sunadome; Tadao Nagasaki; Naomi Takahashi; Yoshinari Nakatsuka; Satoshi Hamada; Tomohiro Handa; Kiminobu Tanizawa; Isuzu Nakamoto; Tomoko Wakamura; Naoko Komenami; Kazuya Setoh; Takahisa Kawaguchi; Takanobu Tsutsumi; Satoshi Morita; Yoshimitsu Takahashi; Takeo Nakayama; Susumu Sato; Toyohiro Hirai; Fumihiko Matsuda; Kazuo Chin
        Journal of sleep research, 2022年11月27日
      • Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.
        Satoru Iwasa; Zi-Xian Wang; Kei Muro; Satoshi Morita; Young Suk Park; Dongsheng Zhang; Yasuhide Yamada; Junichi Sakamoto; Tae Won Kim
        Cancer communications (London, England), 2023年04月
      • Early drop in serum lactate dehydrogenase concentrations as a predictor of tumor response to ongoing anti-epidermal growth factor receptor antibody treatment
        Shigeyoshi Iwamoto; Hiromichi Maeda; Satoshi Morita; Tsuyoshi Sano; Shunichiro Komatsu; Takashi Arikawa; Seiji Ishiguro; Junichi Sakamoto; Hideyuki Mishima
        Annals of Cancer Research and Therapy, 2017年, 査読有り
      • Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)
        Nobuyuki Katakami; Takashi Nishimura; Yu Hidaka; Akito Hata; Kazumi Nishino; Masahide Mori; Tomonori Hirashima; Naoto Takase; Toshihiko Kaneda; Hisashi Ohnishi; Satoshi Morita; Yukimasa Hatachi
        Lung Cancer, 2023年05月
      • TNBCにおける時系列的なサイトカインプロファイルと治療効果およびHRDの相関性(Time-series cytokine profiles correlate with treatment responses and HRD in TNBC)
        河口 浩介; Saldajeno Don Pietro; 河岡 慎平; 田中 直; 坂東 裕子; 西村 友美; 角舎 学行; 山中 隆司; 井本 滋; Velaga Ravi; 前島 佑里奈; 高田 正泰; 上野 貴之; 石黒 洋; 小川 誠司; 羽賀 博典; 大野 真司; 森田 智視; 増田 慎三; 戸井 雅和
        日本乳癌学会総会プログラム抄録集, 2022年06月
      • Proposal of a novel H category‐based classification of colorectal liver metastases based on a Japanese nationwide survey
        Toru Beppu; Katsunori Imai; Goro Honda; Katsunori Sakamoto; Shin Kobayashi; Itaru Endo; Kiyoshi Hasegawa; Kenjiro Kotake; Michio Itabashi; Yojiro Hashiguchi; Yoshihito Kotera; Tatsuro Yamaguchi; Ken Tabuchi; Hirotoshi Kobayashi; Kensei Yamaguchi; Satoshi Morita; Ken Kikuchi; Masaru Miyazaki; Kenichi Sugihara; Masakazu Yamamoto; Keiichi Takahashi
        Journal of Hepato-Biliary-Pancreatic Sciences, 2021年03月16日
      • A randomized phase II trial comparing docetaxel plus cyclophosphamide with epirubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy for hormone receptor-negative breast cancer. Kanagawa breast oncology group (KBOG) 1101 study
        T. Ishikawa; D. Shimizu; M. Tanabe; M. S. Oba; T. Sasaki; S. Morita; K. Kida; S. Nawata; M. Mogami; T. Doi; K. Tsugawa; H. Ogata; Y. Kosaka; N. Sengoku; Y. Saito; Y. Suzuki; A. Suto; T. Chishima; Y. Ichikawa; I. Endo; Y. Tokuda
        CANCER RESEARCH, 2013年12月
      • Individualized Treatment Strategies for HER2-Negative Breast Cancer Subtypes
        T. Ishikawa; D. Shimizu; A. Yamada; T. Sasaki; S. Morita; M. Tanabe; K. Kawachi; A. Nozawa; T. Chishima; M. Kimura; Y. Ichikawa; I. Endo
        CANCER RESEARCH, 2011年12月
      • Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer
        Masahiro Takada; Michio Yoshimura; Takeshi Kotake; Kosuke Kawaguchi; Ryuji Uozumi; Masako Kataoka; Hironori Kato; Hiroshi Yoshibayashi; Hirofumi Suwa; Wakako Tsuji; Hiroyasu Yamashiro; Eiji Suzuki; Masae Torii; Yosuke Yamada; Tatsuki Kataoka; Hiroshi Ishiguro; Satoshi Morita; Masakazu Toi
        Scientific Reports, 2022年12月27日
      • 局所進行胃癌に対する術前補助化学療法+D2切除の予後予測マーカー検索 COMPASS試験バイオマーカー研究
        大島 貴; 吉川 貴己; 宮城 洋平; 森田 智視; 田邉 和照; 西川 和宏; 伊藤 友一; 青山 徹; 林 勉; 尾形 高士; 利野 靖; 益田 宗孝; 横瀬 智之; 坂本 純一
        日本消化器外科学会雑誌, 2017年10月
      • 局所進行胃癌に対するNeoaduvant chemotherapyの効果予測バイオマーカー検索(COMPASS試験バイオマーカー研究)
        大島 貴; 吉川 貴己; 宮城 洋平; 森田 智視; 田邊 和照; 西川 和宏; 伊藤 友一; 青山 徹; 横瀬 智之; 坂本 純一
        日本消化器外科学会雑誌, 2016年11月
      • A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
        Masaru Matsumura; Kiyoshi Hasegawa; Masaru Oba; Kensei Yamaguchi; Hiroyuki Uetake; Takayuki Yoshino; Satoshi Morita; Keiichi Takahashi; Michiaki Unno; Yasuhiro Shimada; Kei Muro; Nobuhisa Matsuhashi; Masaki Mori; Hideo Baba; Mitsuo Shimada; Yoshihiro Mise; Yoshikuni Kawaguchi; Tatsuo Kagimura; Kiyoshi Ishigure; Akio Saiura; Kenichi Sugihara; Norihiro Kokudo
        Langenbeck's archives of surgery, 2022年06月
      • もやもや病同胞家系におけるRNF213遺伝子14576多型の量的効果の検討
        宮武 聡子; 東保 肇; 大場 ちひろ; 土井 宏; 三宅 紀子; 田栗 正隆; 森田 智視; 松本 直通
        臨床神経学, 2013年12月
      • Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
        Keiko Imamura; Yuishin Izumi; Makiko Nagai; Kazutoshi Nishiyama; Yasuhiro Watanabe; Ritsuko Hanajima; Naohiro Egawa; Takashi Ayaki; Ryosuke Oki; Koji Fujita; Ryuji Uozumi; Akiko Morinaga; Tomoko Hirohashi; Yosuke Fujii; Takuya Yamamoto; Harutsugu Tatebe; Takahiko Tokuda; Naoto Takahashi; Satoshi Morita; Ryosuke Takahashi; Haruhisa Inoue
        eClinicalMedicine, 2022年10月
      • Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
        Nobuyuki Katakami; Toshihide Yokoyama; Satoshi Morita; Tatsuro Okamoto; Yoshiko Urata; Yoshihiro Hattori; Yasuo Iwamoto; Yuki Sato; Norihiko Ikeda; Toshiaki Takahashi; Haruko Daga; Tetsuya Oguri; Yasuhito Fujisaka; Kazumi Nishino; Shunichi Sugawara; Toshiyuki Kozuki; Masahide Oki; Nobuyuki Yamamoto; Kazuhiko Nakagawa
        International journal of clinical oncology, 2022年11月21日
      • First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study.
        Shinya Yamamoto; Kazutaka Narui; Takashi Ishikawa; Shoko Adachi; Kazuhiro Shimada; Daisuke Shimizu; Akimitsu Yamada; Sadatoshi Sugae; Mikiko Tanabe; Mari Oba; Satoshi Morita; Takako Doi; Satoshi Hasegawa; Tomoyuki Morita; Ayako Kito; Takashi Chishima; Yasushi Ichikawa; Itaru Endo
        Anticancer research, 2021年03月
      • RETROSPECTIVE STUDY REGARDING THE EFFICACY OF 2ND OR HIGHER LINE CHEMOTHERAPY OF PATIENTS IN ADVANCED OR RECURRENT GASTRIC CANCER (ARGC) AFTER THE FAILURE OF S-1 OR S-1 COMBINATION CHEMOTHERAPY (S plus alpha)
        K. Kobayashi; A. Tsuji; Y. Hata; S. Morita; T. Horimi
        ANNALS OF ONCOLOGY, 2010年10月
      • Retrospective study of the patients with unresectable gastric cancer (UNGC) who underwent a gastrectomy after receiving S-1 or S-1 combination chemotherapy (S-1+alpha)
        K. Kobayashi; A. Tsuji; Y. Hata; S. Morita; T. Horimi
        JOURNAL OF CLINICAL ONCOLOGY, 2009年05月
      • A phase II study of 5-FU (CVI) and low-dose consecutive CDDP (LFP) therapy in advanced gallbladder carcinoma.
        K Kobayashi; A Tsuji; S Morita; Y Shima; T Horimi; T Shirasaka; T Kanematsu
        JOURNAL OF CLINICAL ONCOLOGY, 2005年06月
      • Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.
        Tsuyoshi Shimamura; Nobuhisa Akamatsu; Masato Fujiyoshi; Atushi Kawaguchi; Satoshi Morita; Seiji Kawasaki; Shinji Uemoto; Norihiro Kokudo; Kiyoshi Hasegawa; Hideki Ohdan; Hiroto Egawa; Hiroyuki Furukawa; Satoru Todo
        Transplant international : official journal of the European Society for Organ Transplantation, 2019年04月
      • Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
        Sotaro Sadahiro; Kazuhiro Sakamoto; Takashi Tsuchiya; Takao Takahashi; Hiroki Ohge; Toshihiko Sato; Ken Kondo; Yutaka Ogata; Hideo Baba; Michio Itabashi; Masataka Ikeda; Madoka Hamada; Kiyoshi Maeda; Hiroyuki Masuko; Keiichi Takahashi; Junichi Sakamoto; Mitsuo Kusano; Ichinosuke Hyodo; Masataka Taguri; Satoshi Morita
        BMC cancer, 2022年02月15日
      • Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer.
        Junzo Hamanishi; Masaki Mandai; Takafumi Ikeda; Manabu Minami; Atsushi Kawaguchi; Noriomi Matsumura; Kaoru Abiko; Tsukasa Baba; Ken Yamaguchi; Akihiko Ueda; Masashi Kanai; Yukiko Mori; Shigemi Matsumoto; Toshinori Murayama; Shunsuke Chikuma; Satoshi Morita; Masayuki Yokode; Akira Shimizu; Tasuku Honjo; Ikuo Konishi
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • Multimodal telemonitoring for weight reduction in sleep apnea patients: A randomized controlled trial.
        Kimihiko Murase; Takuma Minami; Satoshi Hamada; David Gozal; Naomi Takahashi; Yoshinari Nakatsuka; Hirofumi Takeyama; Kiminobu Tanizawa; Daisuke Endo; Toshiki Akahoshi; Yasutaka Moritsuchi; Toru Tsuda; Yoshiro Toyama; Motoharu Ohi; Yasuhiro Tomita; Koji Narui; Naho Matsuyama; Tetsuro Ohdaira; Takatoshi Kasai; Tomomasa Tsuboi; Yasuhiro Gon; Yoshihiro Yamashiro; Shinichi Ando; Hiroyuki Yoshimine; Yoshifumi Takata; Akiomi Yoshihisa; Koichiro Tatsumi; Shin-Ichi Momomura; Tomohiro Kuroda; Satoshi Morita; Takeo Nakayama; Toyohiro Hirai; Kazuo Chin
        Chest, 2022年08月20日
      • Markers of cardiovascular disease risk in sleep-disordered breathing with or without comorbidities: the Nagahama study.
        Yoshinari Nakatsuka; Kimihiko Murase; Takeshi Matsumoto; Yasuharu Tabara; Isuzu Nakamoto; Takuma Minami; Naomi Takahashi; Hirofumi Takeyama; Osamu Kanai; Satoshi Hamada; Kiminobu Tanizawa; Tomohiro Handa; Tomoko Wakamura; Naoko Komenami; Satoshi Morita; Takeo Nakayama; Toyohiro Hirai; Fumihiko Matsuda; Kazuo Chin
        Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021年12月01日
      • 食道癌化学放射線療法後遺残・再発に対するsalvage PDTの新展開 化学放射線療法後の局所遺残再発食道癌に対するタラポルフィンナトリウムと半導体レーザーを用いた光線力学的療法の長期成績
        山本 佳宣; 堀松 高博; 矢野 友規; 多田 春江; 玉置 将司; 石原 立; 片岡 洋望; 森田 智視; 小野 裕之; 武藤 学
        日本レーザー医学会誌, 2021年09月
      • Lazaroid (U74500A) prevents vascular and myocardial dysfunction after 24-hour heart preservation - A study based on cross-circulated blood-perfused rabbit hearts
        T Nishida; S Morita; K Miyamoto; M Masuda; R Tominaga; Y Kawachi; H Yasui
        CIRCULATION, 1996年11月, 査読有り
      • Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
        Yutaka Yamamoto; Hiroji Iwata; Naruto Taira; Norikazu Masuda; Masato Takahashi; Tetsuhiro Yoshinami; Takayuki Ueno; Tatsuya Toyama; Takashi Yamanaka; Toshimi Takano; Masahiro Kashiwaba; Koichiro Tsugawa; Yoshie Hasegawa; Kenji Tamura; Hiroshi Tada; Fumikata Hara; Tomomi Fujisawa; Naoki Niikura; Shigehira Saji; Satoshi Morita; Masakazu Toi; Shinji Ohno
        Cancer science, 2022年06月26日
      • Predictive factors for structural remission using abatacept: Results from the ABROAD study.
        Kosaku Murakami; Masahiro Sekiguchi; Shintaro Hirata; Takao Fujii; Kiyoshi Matsui; Satoshi Morita; Koichiro Ohmura; Yutaka Kawahito; Norihiro Nishimoto; Tsuneyo Mimori; Hajime Sano
        Modern rheumatology, 2019年05月, 査読有り
      • Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
        Koya Hida; Daisuke Nishizaki; Atsuhiko Sumii; Ryosuke Okamura; Yoshiharu Sakai; Tsuyoshi Konishi; Tomonori Akagi; Tomohiro Yamaguchi; Takashi Akiyoshi; Meiki Fukuda; Seiichiro Yamamoto; Shigeki Arizono; Mamoru Uemura; Hirotoshi Hasegawa; Kenji Kawada; Satoshi Morita; Masahiko Watanabe
        Annals of surgical oncology, 2021年10月
      • ゲフィチニブを用いた化学療法の効果を比較した第III相試験WJTOG3405の全生存期間に関する最終解析(Final overall survival results of WJTOG3405, a phase III trial comparing gefitinib with chemotherapy)
        Yoshioka Hiroshige; Shimokawa Mototsugu; Seto Takashi; Morita Satoshi; Yatabe Yasushi; Okamoto Isamu; Tsurutani Junji; Satouchi Miyako; Hirashima Tomonori; Atagi Shinji; Shibata Kazuhiko; Saito Hiroshi; Toyooka Shinichi; Yamamoto Nobuyuki; Nakagawa Kazuhiko; Mitsudomi Tetsuya
        肺癌, 2019年11月
      • The impact of age on outcomes of elderly ED patients ventilated due to community acquired pneumonia
        Toru Hifumi; Ippei Jinbo; Ichiro Okada; Nobuaki Kiriu; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Kenya Kawakita; Satoshi Morita; Yasuhiro Kuroda
        AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015年02月, 査読有り
      • 第2相における適応的デザインの適用例
        森田 智視
        計量生物学, 2008年07月01日
      • Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial
        Yutaka Kuroda; Takeyuki Tanaka; Takaki Miyagawa; Hidetoshi Hamada; Hiroyasu Abe; Toshiko Ito-Ihara; Ryuta Asada; Yusuke Fujimoto; Daisuke Takahashi; Tomonori Tetsunaga; Ayumi Kaneuji; Michiaki Takagi; Yutaka Inaba; Satoshi Morita; Nobuhiko Sugano; Sakae Tanaka; Shuichi Matsuda; Haruhiko Akiyama; Tsuyoshi Asano; Juji Ito; Hirofumi Oshima; Taizo Kaneko; Yoko Fukasawa; Hyonmin Choe; Shusuke Ueda; Kayoko Enomoto; Harue Tada; Akiko Kuroda; Yasuhiko Tabata; Yaichiro Okuzu; Toshiyuki Kawai; Koji Goto; Manabu Nankaku; Masaki Takao; Wataru Ando; Kazuki Yamada; Michio Yamamoto; Takashi Sakai; Yasuhiro Ishidou; Shigeru Yamada; Hidetsugu Ohara; Hiroshi Fujita; Hirotsugu Ohashi; Hirokazu Iida; Takashi Nakamura
        Regenerative Medicine, 2021年06月02日
      • [Evaluation of the safety and efficacy of endoscopic treatment for early gastric cancers in patients aged over 80 years].
        Setoyama T; Miyamoto SI; Nikaido M; Horimatsu T; Matsumoto S; Ezoe Y; Morita S; Aoyama I; Kawanami C; Kusaka T; Chiba T; Muto M; Seno H
        Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2018年, 査読有り
      • Evaluation of respiratory rate monitoring performance using a home oxygen monitoring device among patients with interstitial lung disease and chronic obstructive pulmonary disease.
        Satoshi Hamada; Tomohiro Handa; Naoya Tanabe; Susumu Sato; Kiminobu Tanizawa; Atsuyasu Sato; Satoshi Morita; Kazuo Chin; Toyohiro Hirai
        Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2022年
      • The efficacy and safety of FOLFIRI plus BEV/mXELIRI+BEV by UGT1A1 polymorphisms in metastatic colorectal cancer AXEPT trial
        Hiroshi Matsuoka; Yoshinori Kagawa; Mitsuyoshi Ota; Akitaka Makiyama; Kohei Akiyoshi; Tadamichi Denda; Chu Matsuda; Yasuhide Yamada; Satoshi Morita; Junichi Sakamoto; Kei Muro; Masato Nakamura; Masahito Kotaka; Tmohiro Nishina; Taichi Yabuno; Takanori Matsui; Satoru Iwasa; Tae Won Kim; Rui-Hua Xu; Young Suk Park
        ANNALS OF ONCOLOGY, 2019年10月, 査読有り
      • Impact of the prior chemotherapy with two different fluoropyrimidines on the efficacy of CapeIRI or FOLFIRI in metastatic colorectal cancer: An exploratory analysis of the phase III AXEPT trial.
        Tae Won Kim; Kei Muro; Rui-hua Xu; Young Suk Park; Wei Wang; Sae-Won Han; Mitsuyoshi Ota; Joong Bae Ahn; Yanhong Deng; Kohei Akiyoshi; Sang Hee Cho; Yi Ba; Tadamichi Denda; Keun-Wook Lee; Tao Zhang; Chu Matsuda; Yasuhide Yamada; Satoshi Morita; Satoru Iwasa; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2019年02月, 査読有り
      • Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
        Rui-Hua Xu; Kei Muro; Satoshi Morita; Satoru Iwasa; Sae Won Han; Wei Wang; Masahito Kotaka; Masato Nakamura; Joong Bae Ahn; Yan-Hong Deng; Takeshi Kato; Sang-Hee Cho; Yi Ba; Hiroshi Matsuoka; Keun-Wook Lee; Tao Zhang; Yasuhide Yamada; Junichi Sakamoto; Young Suk Park; Tae Won Kim
        LANCET ONCOLOGY, 2018年05月, 査読有り
      • S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): A randomized, open-label, phase III, noninferiority trial
        Y. Yamada; T. Denda; M. Gamoh; I. Iwanaga; S. Yuki; H. Shimodaira; M. Nakamura; T. Yamaguchi; H. Ohori; K. Kobayashi; M. Tsuda; Y. Kobayashi; Y. Miyamoto; M. Kotake; K. Shimada; A. Sato; S. Morita; S. Takahashi; Y. Komatsu; C. Ishioka
        Annals of Oncology, 2018年03月01日, 査読有り
      • A multinational, randomized, phase III trial of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab as second-line therapy for metastatic colorectal cancer: Safety analysis of Asian XELIRI project (AXEPT)
        Masato Nakamura; Tae Won Kim; Rui-hua Xu; Young Suk Park; Yong Sang Hong; Tao Zhang; Takeshi Kato; Sang Hee Cho; Wei Wang; Hiroshi Matsuoka; Sae-Won Han; Yanhong Deng; Akitaka Makiyama; Keun-Wook Lee; Yi Ba; Mitsuyoshi Ota; Satoru Iwasa; Satoshi Morita; Yasuhide Yamada; Kei Muro
        JOURNAL OF CLINICAL ONCOLOGY, 2017年02月, 査読有り
      • International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).
        Kazuhiro Yoshida; Itaru Yasufuku; Masanori Terashima; Sun Young Rha; Jae Moon Bae; Guoxin Li; Hitoshi Katai; Masahiko Watanabe; Yasuyuki Seto; Sung Hoon Noh; Han- Kwang Yang; Jiafu Ji; Hideo Baba; Yuko Kitagawa; Satoshi Morita; Masahiko Nishiyama; Yasuhiro Kodera
        Annals of gastroenterological surgery, 2022年03月
      • 大腸がん治療の最前線 進行・再発大腸がんの治療戦略 SOFT study:切除不能大腸癌に対するmFOLFOX6+Bev療法とSOX+Bev療法との第III相試験
        吉田 元樹; 山田 康秀; 高張 大亮; 松本 寛; 辻 晃仁; 有岡 仁; 嶋田 顕; 傅田 忠道; 森田 智視; 高橋 慶一; 室 圭; 島田 安博; 杉原 健一
        日本癌治療学会誌, 2013年09月
      • 進行再発大腸癌に対するirinotecan-based regimensの血液毒性予測nomogram開発
        市川 度; 上原 圭介; 南村 圭亮; 田中 千弘; 瀧井 康公; 兵頭 一之介; 藤田 健一; 中村 将人; 辻 晃仁; 高橋 威洋; 森田 智視; 安藤 雄一; 杉山 徹; 大橋 靖雄; 坂田 優; UGT1A1観察研究グループ
        日本癌治療学会誌, 2013年09月
      • Multi-institutional phase II study on the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy for lung tumors.
        Yukinori Matsuo; Masahiro Hiraoka; Katsuyuki Karasawa; Masaki Kokubo; Takashi Sakamoto; Nobutaka Mukumoto; Mitsuhiro Nakamura; Satoshi Morita; Takashi Mizowaki
        Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022年05月02日
      • Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
        Shigehira Saji; Naruto Taira; Masahiro Kitada; Toshimi Takano; Masahiro Takada; Tohru Ohtake; Tatsuya Toyama; Yuichiro Kikawa; Yoshie Hasegawa; Tomomi Fujisawa; Masahiro Kashiwaba; Takanori Ishida; Rikiya Nakamura; Yutaka Yamamoto; Uhi Toh; Hiroji Iwata; Norikazu Masuda; Satoshi Morita; Shinji Ohno; Masakazu Toi
        The Lancet. Oncology, 2022年05月
      • Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
        Takayuki Ueno; Shigehisa Kitano; Norikazu Masuda; Daiki Ikarashi; Makiko Yamashita; Tomohiro Chiba; Takayuki Kadoya; Hiroko Bando; Takashi Yamanaka; Shoichiro Ohtani; Shigenori Nagai; Takahiro Nakayama; Masato Takahashi; Shigehira Saji; Kenjiro Aogi; Ravi Velaga; Kosuke Kawaguchi; Satoshi Morita; Hironori Haga; Shinji Ohno; Masakazu Toi
        BMC medicine, 2022年04月25日
      • No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation
        Kojiro Taura; Tsuyoshi Shimamura; Nobuhisa Akamatsu; Koji Umeshita; Masato Fujiyoshi; Hiroyasu Abe; Satoshi Morita; Shinji Uemoto; Susumu Eguchi; Hiroyuki Furukawa; Yasutsugu Takada; Hiroto Egawa; Hideki Ohdan; Etsuro Hatano
        Journal of Hepato-Biliary-Pancreatic Sciences, 2022年03月22日
      • Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
        Yoon-Koo Kang; Satoshi Morita; Taroh Satoh; Min-Hee Ryu; Yee Chao; Ken Kato; Hyun Cheol Chung; Jen-Shi Chen; Kei Muro; Won Ki Kang; Kun-Huei Yeh; Takaki Yoshikawa; Sang Cheul Oh; Li-Yuan Bai; Takao Tamura; Keun-Wook Lee; Yasuo Hamamoto; Jong Gwang Kim; Keisho Chin; Do-Youn Oh; Keiko Minashi; Jae Yong Cho; Masahiro Tsuda; Hiroki Sameshima; Li-Tzong Chen; Narikazu Boku
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022年01月
      • EGFR-TKI増悪後のEGFR T790M陽性進行肺腺癌に対するオシメルチニブ+/-ベバシズマブの第2相試験(WJOG8715L)
        赤松 弘朗; 戸井 之裕; 林 秀敏; 藤本 大智; 寺岡 俊輔; 森田 智視; 中川 和彦; 山本 信之
        和歌山医学, 2021年03月
      • Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC Trial.
        James Chih-Hsin Yang; Tony S K Mok; Shun Lu; Kazuhiko Nakagawa; Nobuyuki Yamamoto; Yuan-Kai Shi; Li Zhang; Ross A Soo; Satoshi Morita; Tomohide Tamura
        JTO clinical and research reports, 2021年03月
      • Night-time frequency of urination as a manifestation of sleep-disordered breathing: the Nagahama study
        Satoshi Hamada; Yasuharu Tabara; Kimihiko Murase; Takeshi Matsumoto; Kazuya Setoh; Tomoko Wakamura; Takahisa Kawaguchi; Shinji Kosugi; Takeo Nakayama; Toyohiro Hirai; Fumihiko Matsuda; Kazuo Chin; Yoshimitsu Takahashi; Takuma Minami; Naomi Takahashi; Hirofumi Takeyama; Satoshi Morita; Tomohiro Handa; Naoko Komenami
        Sleep Medicine, 2021年01月
      • EGFR-TKI増悪後のEGFR T790M陽性進行肺腺癌に対するオシメルチニブ+/-ベバシズマブの第2相試験(WJOG8715L)
        赤松 弘朗; 戸井 之裕; 林 秀敏; 藤本 大智; 立原 素子; 古屋 直樹; 大谷 咲子; 清水 淳市; 片上 信之; 東 公一; 三浦 奈保子; 西野 和美; 原 聡志; 寺岡 俊輔; 森田 智視; 中川 和彦; 山本 信之
        肺癌, 2020年10月
      • 非小細胞性肺癌に対するアファチニブの治療効果のEGFRエクソン19欠失変異のサブタイプ別検討
        徳留 なほみ; 洪 泰浩; 赤松 弘朗; 藤本 大智; 岡本 勇; 中川 和彦; 森田 智視; 山本 信之
        和歌山医学, 2019年03月
      • Impact of UGT1A1 genotype on the efficacy and safety of irinotecan‐based chemotherapy in metastatic colorectal cancer
        Satoru Iwasa; Kei Muro; Satoshi Morita; Young Suk Park; Masato Nakamura; Masahito Kotaka; Tomohiro Nishina; Hiroshi Matsuoka; Joong Bae Ahn; Keun‐Wook Lee; Yong Sang Hong; Sae Won Han; Sang‐Hee Cho; Dong‐Sheng Zhang; Wei‐Jia Fang; Li Bai; Xiang‐Lin Yuan; Ying Yuan; Yasuhide Yamada; Junichi Sakamoto; Tae Won Kim
        Cancer Science, 2021年11月
      • Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).
        Eriko Tokunaga; Norikazu Masuda; Naohito Yamamoto; Hiroji Iwata; Hiroko Bando; Tomoyuki Aruga; Shoichiro Ohtani; Tomomi Fujisawa; Toshimi Takano; Kenichi Inoue; Nobuyasu Suganuma; Masahiro Takada; Kenjiro Aogi; Kenichi Sakurai; Hideo Shigematsu; Katsumasa Kuroi; Hironori Haga; Shinji Ohno; Satoshi Morita; Masakazu Toi
        Cancers, 2021年08月09日
      • Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer.
        Masanori Terashima; Kazumasa Fujitani; Masahiko Ando; Kentaro Sakamaki; Ryohei Kawabata; Yuichi Ito; Takaki Yoshikawa; Masato Kondo; Yasuhiro Kodera; Masahide Kaji; Yoshio Oka; Hiroshi Imamura; Junji Kawada; Akinori Takagane; Hideaki Shimada; Yutaka Tanizawa; Takeharu Yamanaka; Satoshi Morita; Motoki Ninomiya; Kazuhiro Yoshida
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021年01月
      • Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.
        Hiroyasu Yamashiro; Hiroji Iwata; Norikazu Masuda; Naohito Yamamoto; Reiki Nishimura; Shoichiro Ohtani; Nobuaki Sato; Masato Takahashi; Takako Kamio; Kosuke Yamazaki; Tsuyoshi Saito; Makoto Kato; Tecchuu Lee; Katsumasa Kuroi; Toshimi Takano; Shinji Yasuno; Satoshi Morita; Shinji Ohno; Masakazu Toi
        Breast cancer (Tokyo, Japan), 2020年07月
      • Predicting the efficacy of nivolumab combined with radiation therapy by longitudinal liquid biopsy with artificial intelligence for patients with metastatic breast cancer (translational research of the KBCRN-B-002 trial).
        Kosuke Kawaguchi; Masahiro Takada; Takeshi Kotake; Michio Yoshimura; Ryuji Uozumi; Masako Kataoka; Takahiko Koyama; Reitaro Tokumasu; Hironori Kato; Hiroshi Yoshibayashi; Hirofumi Suwa; Wakako Tsuji; Hiroyasu Yamashiro; Tatsuki R Kataoka; Hiroshi Ishiguro; Laxmi Parida; Satoshi Morita; Masakazu Toi
        Journal of Clinical Oncology, 2020年05月20日
      • Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.
        Takayuki Ueno; Norikazu Masuda; Nobuaki Sato; Shoichiro Ohtani; Jun Yamamura; Nobuki Matsunami; Masahiro Kashiwaba; Toshimi Takano; Masato Takahashi; Koji Kaneko; Shinji Ohno; Satoshi Morita; Masakazu Toi
        Japanese journal of clinical oncology, 2020年01月24日
      • Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
        Atsuo Takashima; Kohei Shitara; Kazumasa Fujitani; Keisuke Koeda; Hiroki Hara; Norisuke Nakayama; Shuichi Hironaka; Kazuhiro Nishikawa; Yutaka Kimura; Kenji Amagai; Hirofumi Fujii; Kei Muro; Taito Esaki; Yasuhiro Choda; Toshimi Takano; Keisho Chin; Atsushi Sato; Masahiro Goto; Norimasa Fukushima; Takuo Hara; Nozomu Machida; Manabu Ohta; Narikazu Boku; Masashi Shimura; Satoshi Morita; Wasaburo Koizumi
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019年01月
      • Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.
        Haruyasu Murakami; Hiroshi Nokihara; Hidetoshi Hayashi; Takashi Seto; Keunchil Park; Koichi Azuma; Chun-Ming Tsai; James Chih-Hsin Yang; Makoto Nishio; Sang-We Kim; Katsuyuki Kiura; Akira Inoue; Koji Takeda; Jin-Hyoung Kang; Tomoki Nakagawa; Kentaro Takeda; Rio Akazawa; Yuichiro Kaneko; Masashi Shimazaki; Satoshi Morita; Masahiro Fukuoka; Kazuhiko Nakagawa
        Cancer science, 2018年09月
      • Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
        Shoichiro Ohtani; Takahiro Nakayama; Tetsuhiro Yoshinami; Ken-Ichi Watanabe; Fumikata Hara; Yasuaki Sagara; Hidetoshi Kawaguchi; Kenji Higaki; Nobuki Matsunami; Yoshie Hasegawa; Masato Takahashi; Makiko Mizutani; Takashi Morimoto; Masako Sato; Mitsuya Itoh; Satoshi Morita; Norikazu Masuda
        Breast cancer (Tokyo, Japan), 2018年07月
      • Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study.
        Nobuaki Sato; Norikazu Masuda; Takashi Morimoto; Takayuki Ueno; Chizuko Kanbayashi; Koji Kaneko; Hiroyuki Yasojima; Shigehira Saji; Hironobu Sasano; Satoshi Morita; Shinji Ohno; Masakazu Toi
        Cancer medicine, 2018年06月14日
      • Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment
        Masaya Okada; Jun Imagawa; Hideo Tanaka; Hirohisa Nakamae; Masayuki Hino; Kazunori Murai; Yoji Ishida; Takashi Kumagai; Seiichi Sato; Kazuteru Ohashi; Hisashi Sakamaki; Hisashi Wakita; Nobuhiko Uoshima; Yasunori Nakagawa; Yosuke Minami; Masahiro Ogasawara; Tomoharu Takeoka; Hiroshi Akasaka; Takahiko Utsumi; Naokuni Uike; Tsutomu Sato; Sachiko Ando; Kensuke Usuki; Syuichi Mizuta; Satoshi Hashino; Tetsuhiko Nomura; Masato Shikami; Hisashi Fukutani; Yokiko Ohe; Hiroshi Kosugi; Hirohiko Shibayama; Yasuhiro Maeda; Toshihiro Fukushima; Hirohito Yamazaki; Kazuo Tsubaki; Toshimasa Kukita; Yoko Adachi; Toshiki Nataduka; Hiroto Sakoda; Hisayuki Yokoyama; Takahiro Okamoto; Yukari Shirasugi; Yasushi Onishi; Masaharu Nohgawa; Satoshi Yoshihara; Satoshi Morita; Junichi Sakamoto; Shinya Kimura
        Clinical Lymphoma, Myeloma and Leukemia, 2018年05月
      • 胃癌補助化学療法の開発戦略
        吉川 貴己; 桑原 寛; 青山 徹; 三箇山 洋; 林 勉; 尾形 高士; 長 晴彦; 円谷 彰; 森田 智視; 坂本 純一
        日本外科系連合学会誌, 2012年08月30日
      • 進行乳癌に対するwPTX+BV導入療法後のホルモン維持療法の有用性 JBCRG BOOSTER試験
        大谷 彰一郎; 佐治 重衡; 長谷川 善枝; 藤澤 知巳; 柏葉 匡寛; 石田 孝宣; 山本 豊; 石川 孝; 永井 成勲; 芳林 浩史; 松本 光史; 相良 安昭; 北田 正博; 高野 利美; 高田 正泰; 増田 慎三; 平 成人; 森田 智視; 大野 真司; 戸井 雅和
        日本乳癌学会総会プログラム抄録集, 2020年10月
      • Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study.
        Hidetoshi Kawaguchi; Norikazu Masuda; Takahiro Nakayama; Kenjiro Aogi; Keisei Anan; Yoshinori Ito; Shoichiro Ohtani; Nobuaki Sato; Shigehira Saji; Toshimi Takano; Eriko Tokunaga; Seigo Nakamura; Yoshie Hasegawa; Masaya Hattori; Tomomi Fujisawa; Satoshi Morita; Miki Yamaguchi; Hiroko Yamashita; Toshinari Yamashita; Yutaka Yamamoto; Daisuke Yotsumoto; Masakazu Toi; Shinji Ohno
        Breast cancer (Tokyo, Japan), 2020年05月
      • TEMPORAL EVOLUTION AND SPATIAL DISTRIBUTION OF WHITE-LIGHT FLARE KERNELS IN A SOLAR FLARE
        T. Kawate; T. T. Ishii; Y. Nakatani; K. Ichimoto; A. Asai; S. Morita; S. Masuda
        ASTROPHYSICAL JOURNAL, 2016年12月, 査読有り
      • Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer
        Sumiyuki Nishida; Soyoko Morimoto; Yusuke Oji; Satoshi Morita; Toshiaki Shirakata; Takayuki Enomoto; Akihiro Tsuboi; Yutaka Ueda; Kiyoshi Yoshino; Alzaaqi Shouq; Mizuki Kanegae; Satoshi Ohno; Fumihiro Fujiki; Hiroko Nakajima; Yoshiki Nakae; Jun Nakata; Naoki Hosen; Atsushi Kumanogoh; Yoshihiro Oka; Tadashi Kimura; Haruo Sugiyama
        Journal of Immunotherapy, 2022年01月, 査読有り
      • A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).
        Ippei Fukada; Yoshinori Ito; Naoto Kondo; Shoichiro Ohtani; Masaya Hattori; Eriko Tokunaga; Nobuki Matsunami; Kohjiro Mashino; Taijiro Kosaka; Masahiko Tanabe; Daisuke Yotsumoto; Kosho Yamanouchi; Masataka Sawaki; Masahiro Kashiwaba; Hidetaka Kawabata; Katsumasa Kuroi; Satoshi Morita; Shinji Ohno; Masakazu Toi; Norikazu Masuda
        Breast cancer research and treatment, 2021年09月23日
      • Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214
        Norikazu Masuda; Tetsuhiro Yoshinami; Masahiko Ikeda; Makiko Mizutani; Miki Yamaguchi; Yoshifumi Komoike; Tsutomu Takashima; Katsuhide Yoshidome; Junji Tsurutani; Mitsuhiko Iwamoto; Fumie Fujisawa; Hiroyuki Yasojima; Jun Yamamura; Hirotaka Morishima; Fuminori Aki; Tomomi Yamada; Satoshi Morita; Takahiro Nakayama
        CANCERS, 2021年09月
      • Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC.
        Yasuto Yoneshima; Satoshi Morita; Masahiko Ando; Atsushi Nakamura; Shunichiro Iwasawa; Hiroshige Yoshioka; Yasuhiro Goto; Masafumi Takeshita; Toshiyuki Harada; Katsuya Hirano; Tetsuya Oguri; Masashi Kondo; Satoru Miura; Yukio Hosomi; Terufumi Kato; Toshio Kubo; Junji Kishimoto; Nobuyuki Yamamoto; Yoichi Nakanishi; Isamu Okamoto
        Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021年09月
      • Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial
        Tadamichi Denda; Atsuo Takashima; Makio Gamoh; Ichiro Iwanaga; Yoshito Komatsu; Masanobu Takahashi; Masato Nakamura; Hisatsugu Ohori; Akiko Sakashita; Masahiro Tsuda; Yoshimitsu Kobayashi; Hideo Baba; Masanori Kotake; Chikashi Ishioka; Yasuhide Yamada; Atsushi Sato; Satoshi Yuki; Satoshi Morita; Shin Takahashi; Tatsuro Yamaguchi; Ken Shimada
        European Journal of Cancer, 2021年09月
      • Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.
        Norikazu Masuda; Tetsuhiro Yoshinami; Masahiko Ikeda; Makiko Mizutani; Miki Yamaguchi; Yoshifumi Komoike; Tsutomu Takashima; Katsuhide Yoshidome; Junji Tsurutani; Mitsuhiko Iwamoto; Fumie Fujisawa; Hiroyuki Yasojima; Jun Yamamura; Hirotaka Morishima; Fuminori Aki; Tomomi Yamada; Satoshi Morita; Takahiro Nakayama
        Cancers, 2021年08月31日
      • Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.
        Yosuke Kawashima; Tatsuro Fukuhara; Haruhiro Saito; Naoki Furuya; Kana Watanabe; Shunichi Sugawara; Shunichiro Iwasawa; Yoshio Tsunezuka; Ou Yamaguchi; Morihito Okada; Kozo Yoshimori; Ichiro Nakachi; Masahiro Seike; Koichi Azuma; Futoshi Kurimoto; Yukari Tsubata; Yuka Fujita; Hiromi Nagashima; Gyo Asai; Satoshi Watanabe; Masaki Miyazaki; Koichi Hagiwara; Toshihiro Nukiwa; Satoshi Morita; Kunihiko Kobayashi; Makoto Maemondo
        The Lancet. Respiratory medicine, 2021年08月26日
      • Association of Sleep Disordered Breathing and Blood Pressure with Albuminuria: The Nagahama Study.
        Kimihiko Murase; Takeshi Matsumoto; Yasuharu Tabara; Adrienne Ohler; David Gozal; Takuma Minami; Osamu Kanai; Hirofumi Takeyama; Naomi Takahashi; Satoshi Hamada; Kiminobu Tanizawa; Tomoko Wakamura; Naoko Komenami; Kazuya Setoh; Takahisa Kawaguchi; Takanobu Tsutsumi; Satoshi Morita; Yoshimitsu Takahashi; Takeo Nakayama; Motoko Yanagita; Toyohiro Hirai; Fumihiko Matsuda; Kazuo Chin
        Annals of the American Thoracic Society, 2021年08月04日
      • Correction to: Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.
        Koshiro Morino; Satoru Seo; Tomoaki Yoh; Ken Fukumitsu; Takamichi Ishii; Kojiro Taura; Satoshi Morita; Toshimi Kaido; Shinji Uemoto
        Annals of surgical oncology, 2021年06月21日
      • Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.
        Shin Takahashi; Yasuhiro Sakamoto; Tadamichi Denda; Atsuo Takashima; Yoshito Komatsu; Masato Nakamura; Hisatsugu Ohori; Tatsuro Yamaguchi; Yoshimitsu Kobayashi; Hideo Baba; Masanori Kotake; Kenji Amagai; Hitoshi Kondo; Ken Shimada; Atsushi Sato; Satoshi Yuki; Akira Okita; Kota Ouchi; Keigo Komine; Mika Watanabe; Satoshi Morita; Chikashi Ishioka
        Cancer science, 2021年04月
      • Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
        Norikazu Masuda; Hiroko Bando; Takashi Yamanaka; Takayuki Kadoya; Masato Takahashi; Shigenori E. Nagai; Shoichiro Ohtani; Tomoyuki Aruga; Eiji Suzuki; Yuichiro Kikawa; Hiroyuki Yasojima; Hiroi Kasai; Hiroshi Ishiguro; Hidetaka Kawabata; Satoshi Morita; Hironori Haga; Tatsuki R. Kataoka; Ryuji Uozumi; Shinji Ohno; Masakazu Toi
        Breast Cancer Research and Treatment, 2021年03月25日
      • Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
        Kazumasa Fujitani; Kohei Shitara; Atsuo Takashima; Keisuke Koeda; Hiroki Hara; Norisuke Nakayama; Shuichi Hironaka; Kazuhiro Nishikawa; Yutaka Kimura; Kenji Amagai; Hisashi Hosaka; Yoshito Komatsu; Ken Shimada; Ryohei Kawabata; Hideki Ohdan; Yasuhiro Kodera; Masato Nakamura; Takako Eguchi Nakajima; Yoshinori Miyata; Toshikazu Moriwaki; Tetsuya Kusumoto; Kazuo Nishikawa; Kazuhiro Ogata; Masashi Shimura; Satoshi Morita; Wasaburo Koizumi
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021年03月
      • Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I Study.
        Akira Ono; Haruyasu Murakami; Takashi Seto; Toshio Shimizu; Sawori Watanabe; Shigeru Takeshita; Kentaro Takeda; Junko Toyoshima; Itsuro Nagase; Erkut Bahceci; Maiko Morishita; Satoshi Morita; Masahiro Fukuoka; Kazuhiko Nakagawa
        Drugs in R&D, 2021年03月
      • Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial.
        Hiroaki Akamatsu; Yukihiro Toi; Hidetoshi Hayashi; Daichi Fujimoto; Motoko Tachihara; Naoki Furuya; Sakiko Otani; Junichi Shimizu; Nobuyuki Katakami; Koichi Azuma; Naoko Miura; Kazumi Nishino; Satoshi Hara; Shunsuke Teraoka; Satoshi Morita; Kazuhiko Nakagawa; Nobuyuki Yamamoto
        JAMA oncology, 2021年03月01日
      • Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
        Kazumasa Fujitani; Kohei Shitara; Atsuo Takashima; Keisuke Koeda; Hiroki Hara; Norisuke Nakayama; Shuichi Hironaka; Kazuhiro Nishikawa; Yutaka Kimura; Kenji Amagai; Hisashi Hosaka; Yoshito Komatsu; Ken Shimada; Ryohei Kawabata; Hideki Ohdan; Yasuhiro Kodera; Masato Nakamura; Takako Eguchi Nakajima; Yoshinori Miyata; Toshikazu Moriwaki; Tetsuya Kusumoto; Kazuo Nishikawa; Kazuhiro Ogata; Masashi Shimura; Satoshi Morita; Wasaburo Koizumi
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021年03月
      • A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
        Yuji Minegishi; Ou Yamaguchi; Shunichi Sugawara; Shoichi Kuyama; Satoshi Watanabe; Kazuhiro Usui; Masahide Mori; Osamu Hataji; Toshihiro Nukiwa; Satoshi Morita; Kunihiko Kobayashi; Akihiko Gemma
        BMC cancer, 2021年03月01日
      • Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
        Toshinari Yamashita; Hidetoshi Kawaguchi; Norikazu Masuda; Masahiro Kitada; Kazutaka Narui; Masaya Hattori; Tetsuhiro Yoshinami; Nobuki Matsunami; Kazuhiro Yanagihara; Teru Kawasoe; Takeshi Nagashima; Hiroko Bando; Hiroshi Yano; Yoshie Hasegawa; Rikiya Nakamura; Masahiro Kashiwaba; Satoshi Morita; Shinji Ohno; Masakazu Toi
        Investigational new drugs, 2021年02月
      • Disagreement between patient- and physician-reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
        Akira Ooki; Satoshi Morita; Akihito Tsuji; Shigeyoshi Iwamoto; Hiroki Hara; Hiroaki Tanioka; Hironaga Satake; Masato Kataoka; Masahito Kotaka; Yoshinori Kagawa; Masato Nakamura; Tatsushi Shingai; Masashi Ishikawa; Yasuhiro Miyake; Takeshi Suto; Yojiro Hashiguchi; Taichi Yabuno; Masahiko Ando; Junichi Sakamoto; Kensei Yamaguchi
        Cancer medicine, 2020年12月
      • Long-term outcome of liver resection for colorectal metastases in the presence of extrahepatic disease: A multi-institutional Japanese study.
        Yu Sawada; Kota Sahara; Itaru Endo; Katsunori Sakamoto; Goro Honda; Toru Beppu; Kenjiro Kotake; Masakazu Yamamoto; Keiichi Takahashi; Kiyoshi Hasegawa; Michio Itabashi; Yojiro Hashiguchi; Yoshihito Kotera; Shin Kobayashi; Tatsuro Yamaguchi; Ken Tabuchi; Hirotoshi Kobayashi; Kensei Yamaguchi; Satoshi Morita; Soichiro Natsume; Masaru Miyazaki; Kenichi Sugihara
        Journal of hepato-biliary-pancreatic sciences, 2020年11月
      • Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsy.
        Kazutaka Narui; Takashi Ishikawa; Mari S Oba; Yoshie Hasegawa; Hiroshi Kaise; Takahiko Kawate; Akimitsu Yamada; Kimito Yamada; Yasuhiro Suzuki; Naoki Niikura; Norio Kohno; Takeo Kimoto; Sadatoshi Sugae; Yoshimasa Kosaka; Masaru Miyashita; Takuho Okamura; Daisuke Shimizu; Hirokazu Tanino; Mikiko Tanabe; Satoshi Morita; Itaru Endo; Yutaka Tokuda
        Surgical oncology, 2020年10月06日
      • EGFR-TKI増悪後のEGFR T790M陽性進行肺腺癌に対するオシメルチニブ+/-ベバシズマブの第2相試験(WJOG8715L)
        赤松 弘朗; 戸井 之裕; 林 秀敏; 藤本 大智; 立原 素子; 古屋 直樹; 大谷 咲子; 清水 淳市; 片上 信之; 東 公一; 三浦 奈保子; 西野 和美; 原 聡志; 寺岡 俊輔; 森田 智視; 中川 和彦; 山本 信之
        肺癌, 2020年10月
      • 食道癌DCF療法における成分栄養剤の口腔粘膜炎抑制の検討 EPOC2試験:JFMC49-1601-C5
        中島 雄一郎; 田中 善宏; 竹内 裕也; 大辻 英吾; 永野 浩昭; 松原 久裕; 馬場 秀夫; 江見 泰徳; 沖 英次; 上野 尚雄; 富塚 健; 森田 智視; 前原 喜彦; 北川 雄光; 吉田 和弘
        日本癌治療学会学術集会抄録集, 2020年10月
      • Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy.
        Yusuke Okuma; Ryo Ko; Takehito Shukuya; Kazunari Tateishi; Hisao Imai; Shunichiro Iwasawa; Eisaku Miyauchi; Tetsuya Kojima; Yuka Fujita; Toshihiko Hino; Shinsuke Yamanda; Toshiro Suzuki; Aya Fukuizumi; Tomohiro Sakakibara; Toshiyuki Harada; Satoshi Morita; Kunihiko Kobayashi; Toshihiro Nukiwa; Kazuhisa Takahashi
        Lung cancer (Amsterdam, Netherlands), 2020年10月
      • A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
        Kaoru Tanaka; Satoshi Morita; Masahiko Ando; Takuma Yokoyama; Atsushi Nakamura; Hiroshige Yoshioka; Takashi Ishiguro; Satoru Miura; Ryo Toyozawa; Tetsuya Oguri; Haruko Daga; Ryo Ko; Akihiro Bessho; Motoko Tachihara; Yasuo Iwamoto; Katsuya Hirano; Yoichi Nakanishi; Kazuhiko Nakagawa; Nobuyuki Yamamoto; Isamu Okamoto
        Cancer, 2020年08月15日
      • 動脈硬化リスク因子が睡眠時無呼吸症候群と動脈硬化の関連性に及ぼす影響についての検討 ながはまスタディ
        中塚 賀也; 村瀬 公彦; 濱田 哲; 武山 博文; 松本 健; 高橋 順美; 谷澤 公伸; 半田 知宏; 田原 康玄; 平井 豊博; 森田 智視; 中山 健夫; 松田 文彦; 陳 和夫
        日本呼吸器学会誌, 2020年08月
      • 下部進行直腸癌に対する予防的側方郭清-あり vs なし-【なし】術前短径5mm以上の側方リンパ節に郭清の意義がある
        肥田 侯矢; 西崎 大輔; 住井 敦彦; 有薗 茂樹; 小西 毅; 赤木 智徳; 山口 智弘; 秋吉 高志; 福田 明輝; 岡村 亮輔; 森田 智視; 山本 聖一郎; 坂井 義治; 渡邊 昌彦
        日本外科学会定期学術集会抄録集, 2020年08月
      • Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment-free remission.
        Takashi Kumagai; Chiaki Nakaseko; Kaichi Nishiwaki; Chikashi Yoshida; Kazuteru Ohashi; Naoki Takezako; Hina Takano; Yasuji Kouzai; Tadashi Murase; Kosei Matsue; Satoshi Morita; Junichi Sakamoto; Hisashi Wakita; Hisashi Sakamaki; Koiti Inokuchi
        Cancer science, 2020年08月
      • Sleep disordered breathing and metabolic comorbidities across sex and menopausal status in East Asians: the Nagahama Study.
        Takeshi Matsumoto; Kimihiko Murase; Yasuharu Tabara; Takuma Minami; Osamu Kanai; Hirofumi Takeyama; Naomi Takahashi; Satoshi Hamada; Kiminobu Tanizawa; Tomoko Wakamura; Naoko Komenami; Kazuya Setoh; Takahisa Kawaguchi; Takanobu Tsutsumi; Satoshi Morita; Yoshimitsu Takahashi; Takeo Nakayama; Toyohiro Hirai; Fumihiko Matsuda; Kazuo Chin
        The European respiratory journal, 2020年08月
      • Comprehensive data of 3525 patients newly diagnosed with colorectal liver metastasis between 2013 and 2014: 2nd report of a nationwide survey in Japan.
        Katsunori Sakamoto; Goro Honda; Toru Beppu; Kenjiro Kotake; Masakazu Yamamoto; Keiichi Takahashi; Itaru Endo; Kiyoshi Hasegawa; Michio Itabashi; Yojiro Hashiguchi; Yoshihito Kotera; Shin Kobayashi; Tatsuro Yamaguchi; Ken Tabuchi; Hirotoshi Kobayashi; Kensei Yamaguchi; Satoshi Morita; Masaru Miyazaki; Kenichi Sugihara
        Journal of hepato-biliary-pancreatic sciences, 2020年08月
      • Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial.
        Takashi Oshima; Takaki Yoshikawa; Yohei Miyagi; Satoshi Morita; Michio Yamamoto; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takanori Matsui; Yutaka Kimura; Tomoyuki Yokose; Yukihiko Hiroshima; Toru Aoyama; Tsutomu Hayashi; Takashi Ogata; Haruhiko Cho; Yasushi Rino; Munetaka Masuda; Akira Tsuburaya; Junichi Sakamoto
        Oncotarget, 2020年07月28日
      • Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study
        Yutaka Yamamoto; Hiroyasu Yamashiro; Uhi Toh; Naoto Kondo; Rikiya Nakamura; Masahiro Kashiwaba; Masato Takahashi; Koichiro Tsugawa; Takashi Ishikawa; Takahiro Nakayama; Shoichiro Ohtani; Toshimi Takano; Tomomi Fujisawa; Tatsuya Toyama; Hidetoshi Kawaguchi; Kojiro Mashino; Yuichi Tanino; Satoshi Morita; Masakazu Toi; Shinji Ohno
        Breast Cancer, 2020年07月26日
      • Erratum: Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD) (Trials (2020) 21 1 (391))
        Toshinari Yamashita; Norikazu Masuda; Shigehira Saji; Kazuhiro Araki; Yoshinori Ito; Toshimi Takano; Masato Takahashi; Junji Tsurutani; Kei Koizumi; Masahiro Kitada; Yasuyuki Kojima; Yasuaki Sagara; Hiroshi Tada; Tsutomu Iwasa; Takayuki Kadoya; Tsuguo Iwatani; Hiroki Hasegawa; Satoshi Morita; Shinji Ohno
        Trials, 2020年06月08日, 査読有り
      • Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey.
        Shin Kobayashi; Toru Beppu; Goro Honda; Masakazu Yamamoto; Keiichi Takahashi; Itaru Endo; Kiyoshi Hasegawa; Kenjiro Kotake; Michio Itabashi; Yojiro Hashiguchi; Yoshihito Kotera; Katsunori Sakamoto; Tatsuro Yamaguchi; Satoshi Morita; Ken Tabuchi; Masaru Miyazaki; Kenichi Sugihara
        Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2020年06月
      • Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial
        Kazuhiro Nishikawa; Kenta Murotani; Kazumasa Fujitani; Hitoshi Inagaki; Yusuke Akamaru; Shinya Tokunaga; Masakazu Takagi; Shigeyuki Tamura; Naotoshi Sugimoto; Tadashi Shigematsu; Takaki Yoshikawa; Tohru Ishiguro; Masato Nakamura; Hiroko Hasegawa; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto; Toshimasa Tsujinaka
        European Journal of Cancer, 2020年06月, 査読有り
      • A semiparametric Bayesian approach to population finding with time‐to‐event and toxicity data in a randomized clinical trial
        Satoshi Morita; Peter Müller; Hiroyasu Abe
        Biometrics, 2020年05月07日
      • Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.
        Terumasa Hayashi; Shoichi Maruyama; Masaomi Nangaku; Ichiei Narita; Hideki Hirakata; Kenichiro Tanabe; Satoshi Morita; Yoshiharu Tsubakihara; Enyu Imai; Tadao Akizawa
        Clinical journal of the American Society of Nephrology : CJASN, 2020年05月07日
      • Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).
        Toshinari Yamashita; Norikazu Masuda; Shigehira Saji; Kazuhiro Araki; Yoshinori Ito; Toshimi Takano; Masato Takahashi; Junji Tsurutani; Kei Koizumi; Masahiro Kitada; Yasuyuki Kojima; Yasuaki Sagara; Hiroshi Tada; Tsutomu Iwasa; Takayuki Kadoya; Tsuguo Iwatani; Hiroki Hasegawa; Satoshi Morita; Shinji Ohno
        Trials, 2020年05月07日, 査読有り
      • Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
        Nozomi Ishigooka; Takao Fujii; Hiroyasu Abe; Kosaku Murakami; Ran Nakashima; Motomu Hashimoto; Hajime Yoshifuji; Masao Tanaka; Hiromu Ito; Koichiro Ohmura; Satoshi Morita; Tsuneyo Mimori
        Modern Rheumatology, 2020年05月03日
      • Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
        Kazunari Tateishi; Ryo Ko; Takehito Shukuya; Yusuke Okuma; Satoshi Watanabe; Shoichi Kuyama; Kyoko Murase; Yoko Tsukita; Hironori Ashinuma; Taku Nakagawa; Kazutsugu Uematsu; Mika Nakao; Yoshiaki Mori; Kyoichi Kaira; Atsuto Mouri; Takao Miyabayashi; Hiroyuki Sakashita; Yoko Matsumoto; Tomoyuki Tanigawa; Tomonobu Koizumi; Satoshi Morita; Kunihiko Kobayashi; Toshihiro Nukiwa; Kazuhisa Takahashi
        The oncologist, 2020年04月
      • Patient-reported symptom burden as a prognostic factor in treatment with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
        Akira Ooki; Satoshi Morita; Shigeyoshi Iwamoto; Hiroki Hara; Hiroaki Tanioka; Hironaga Satake; Masato Kataoka; Masahito Kotaka; Yoshinori Kagawa; Masato Nakamura; Tatsushi Shingai; Masashi Ishikawa; Yasuhiro Miyake; Takeshi Suto; Yojiro Hashiguchi; Taichi Yabuno; Junichi Sakamoto; Akihito Tsuji; Masahiko Ando; Kensei Yamaguchi
        Cancer medicine, 2020年03月
      • A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management
        Kimihiko Murase; Kiminobu Tanizawa; Takuma Minami; Takeshi Matsumoto; Ryo Tachikawa; Naomi Takahashi; Toru Tsuda; Yoshiro Toyama; Motoharu Ohi; Toshiki Akahoshi; Yasuhiro Tomita; Koji Narui; Hiroshi Nakamura; Tetsuro Ohdaira; Hiroyuki Yoshimine; Tomomasa Tsuboi; Yoshihiro Yamashiro; Shinichi Ando; Takatoshi Kasai; Hideo Kita; Koichiro Tatsumi; Naoto Burioka; Keisuke Tomii; Yasuhiro Kondoh; Hirofumi Takeyama; Tomohiro Handa; Satoshi Hamada; Toru Oga; Takeo Nakayama; Tetsuo Sakamaki; Satoshi Morita; Tomohiro Kuroda; Toyohiro Hirai; Kazuo Chin
        ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020年03月, 査読有り
      • A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management.
        Kimihiko Murase; Kiminobu Tanizawa; Takuma Minami; Takeshi Matsumoto; Ryo Tachikawa; Naomi Takahashi; Toru Tsuda; Yoshiro Toyama; Motoharu Ohi; Toshiki Akahoshi; Yasuhiro Tomita; Koji Narui; Hiroshi Nakamura; Tetsuro Ohdaira; Hiroyuki Yoshimine; Tomomasa Tsuboi; Yoshihiro Yamashiro; Shinichi Ando; Takatoshi Kasai; Hideo Kita; Koichiro Tatsumi; Naoto Burioka; Keisuke Tomii; Yasuhiro Kondoh; Hirofumi Takeyama; Tomohiro Handa; Satoshi Hamada; Toru Oga; Takeo Nakayama; Tetsuo Sakamaki; Satoshi Morita; Tomohiro Kuroda; Toyohiro Hirai; Kazuo Chin
        Annals of the American Thoracic Society, 2020年03月, 査読有り
      • S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial.
        Eiji Sunami; Tetsuya Kusumoto; Mitsuyoshi Ota; Yoshiyuki Sakamoto; Kazuhiro Yoshida; Naohiro Tomita; Atsuyuki Maeda; Jin Teshima; Michio Okabe; Chihiro Tanaka; Junichiro Yamauchi; Michio Itabashi; Kenjiro Kotake; Keiichi Takahashi; Hideo Baba; Narikazu Boku; Keisuke Aiba; Megumi Ishiguro; Satoshi Morita; Naruhito Takenaka; Ryota Okude; Kenichi Sugihara
        Clinical colorectal cancer, 2020年03月, 査読有り
      • A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
        Ishiguro H; Masuda N; Sato N; Higaki K; Morimoto T; Yanagita Y; Mizutani M; Ohtani S; Kaneko k; Fujisawa T; Takahashi M; Kadoya T; Matsunami M; Yamamoto Y; Ohno S; Takano T; Morita S; , Tanaka-Mizuno S; Toi M
        Breast Cancer Res and Treat, 2020年03月, 査読有り
      • Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis
        Isao Murakami; Kosaku Murakami; Motomu Hashimoto; Masao Tanaka; Hiromu Ito; Takao Fujii; Mie Torii; Kaori Ikeda; Akiko Kuwabara; Kiyoshi Tanaka; Akiko Yoshida; Shuji Akizuki; Ran Nakashima; Hajime Yoshifuji; Koichiro Ohmura; Takashi Usui; Satoshi Morita; Tsuneyo Mimori
        PLOS ONE, 2020年02月13日
      • A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
        Norikazu Masuda; Shoichiro Ohtani; Toshimi Takano; Kenichi Inoue; Eiji Suzuki; Rikiya Nakamura; Hiroko Bando; Yoshinori Ito; Kazushige Ishida; Takashi Yamanaka; Katsumasa Kuroi; Hiroyuki Yasojima; Hiroi Kasai; Tsuyoshi Takasuka; Takaki Sakurai; Tatsuki R. Kataoka; Satoshi Morita; Shinji Ohno; Masakazu Toi
        Breast Cancer Research and Treatment, 2020年02月01日
      • A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel plus carboplatin plus trastuzumab plus pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
        Norikazu Masuda; Shoichiro Ohtani; Toshimi Takano; Kenichi Inoue; Eiji Suzuki; Rikiya Nakamura; Hiroko Bando; Yoshinori Ito; Kazushige Ishida; Takashi Yamanaka; Katsumasa Kuroi; Hiroyuki Yasojima; Hiroi Kasai; Tsuyoshi Takasuka; Takaki Sakurai; Tatsuki R. Kataoka; Satoshi Morita; Shinji Ohno; Masakazu Toi
        BREAST CANCER RESEARCH AND TREATMENT, 2020年02月
      • Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.
        Koshiro Morino; Satoru Seo; Tomoaki Yoh; Ken Fukumitsu; Takamichi Ishii; Kojiro Taura; Satoshi Morita; Toshimi Kaido; Shinji Uemoto
        Annals of surgical oncology, 2020年01月14日, 査読有り
      • Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.
        Yukio Hosomi; Satoshi Morita; Shunichi Sugawara; Terufumi Kato; Tatsuro Fukuhara; Akihiko Gemma; Kazuhisa Takahashi; Yuka Fujita; Toshiyuki Harada; Koichi Minato; Kei Takamura; Koichi Hagiwara; Kunihiko Kobayashi; Toshihiro Nukiwa; Akira Inoue
        Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020年01月10日
      • Impact of sex and histology on the therapeutic effects of fluoropyrimidines and oxaliplatin plus bevacizumab for patients with metastatic colorectal cancer in the SOFT trial
        Yasuhide Yamada; Kei Muro; Keiichi Takahashi; Hideo Baba; Yoshito Komatsu; Taroh Satoh; Masahiro Goto; Hideyuki Mishima; Masahiko Watanabe; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Naruhito Takenaka; Tadashi Hirooka; Kenichi Sugihara
        Global Health & Medicine, 2020年, 査読有り
      • A randomized controlled trial of telemedicine for long-term sleep apnea continuous positive airway pressure management
        Kimihiko Murase; Kiminobu Tanizawa; Takuma Minami; Takeshi Matsumoto; Ryo Tachikawa; Naomi Takahashi; Toru Tsuda; Yoshiro Toyama; Motoharu Ohi; Toshiki Akahoshi; Yasuhiro Tomita; Koji Narui; Hiroshi Nakamura; Tetsuro Ohdaira; Hiroyuki Yoshimine; Tomomasa Tsuboi; Yoshihiro Yamashiro; Shinichi Ando; Takatoshi Kasai; Hideo Kita; Koichiro Tatsumi; Naoto Burioka; Keisuke Tomii; Yasuhiro Kondoh; Hirofumi Takeyama; Tomohiro Handa; Satoshi Hamada; Toru Oga; Takeo Nakayama; Tetsuo Sakamaki; Satoshi Morita; Tomohiro Kuroda; Toyohiro Hirai; Kazuo Chin
        Annals of the American Thoracic Society, 2020年, 査読有り
      • Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.
        Hanako Ohashi Ikeda; Yuki Muraoka; Masayuki Hata; Eriko Sumi; Takafumi Ikeda; Takayuki Nakagawa; Hiroyasu Abe; Harue Tada; Satoshi Morita; Akira Kakizuka; Nagahisa Yoshimura; Akitaka Tsujikawa
        PloS one, 2020年, 査読有り
      • Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer.
        H Yoshioka; M Shimokawa; T Seto; S Morita; Y Yatabe; I Okamoto; J Tsurutani; M Satouchi; T Hirashima; S Atagi; K Shibata; H Saito; S Toyooka; N Yamamoto; K Nakagawa; T Mitsudomi
        Annals of oncology : official journal of the European Society for Medical Oncology, 2019年12月01日
      • Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.
        Kazutaka Narui; Takashi Ishikawa; Daisuke Shimizu; Akimitsu Yamada; Mikiko Tanabe; Takeshi Sasaki; Mari S Oba; Satoshi Morita; Shuichi Nawata; Kumiko Kida; Masatoshi Mogaki; Takako Doi; Koichiro Tsugawa; Haruki Ogata; Tomohiko Ota; Yoshimasa Kosaka; Norihiko Sengoku; Masaru Kuranami; Naoki Niikura; Yuki Saito; Yasuhiro Suzuki; Akihiko Suto; Hitoshi Arioka; Takashi Chishima; Yasushi Ichikawa; Itaru Endo; Yutaka Tokuda
        Breast (Edinburgh, Scotland), 2019年10月
      • 胃癌周術期治療Up to Date 局所進行胃癌に対するバイオマーカーを用いた術前・術後補助化学療法の個別化治療
        大島 貴; 吉川 貴己; 森田 智視; 円谷 彰; 吉田 和弘; 木村 弥生; 利野 靖; 益田 宗孝; 宮城 洋平; 坂本 純一
        日本癌治療学会学術集会抄録集, 2019年10月
      • Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.
        Trotta L; Kabeya Y; Buyse M; Doffagne E; Venet D; Desmet L; Burzykowski T; Tsuburaya A; Yoshida K; Miyashita Y; Morita S; Sakamoto J; Praveen P; Oba K
        Clinical trials (London, England), 2019年10月, 査読有り
      • Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study.
        Nobuaki Sato; Norikazu Masuda; Takashi Morimoto; Takayuki Ueno; Chizuko Kanbayashi; Koji Kaneko; Hiroyuki Yasojima; Shigehira Saji; Hironobu Sasano; Satoshi Morita; Shinji Ohno; Masakazu Toi
        Cancer medicine, 2019年09月
      • Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
        Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
        Medicine, 2019年08月, 査読有り
      • A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group.
        Shogo Kobayashi; Hiroaki Nagano; Akira Tomokuni; Kunihito Gotoh; Daisuke Sakai; Etsuro Hatano; Satoru Seo; Hiroaki Terajima; Yoichiro Uchida; Tetsuo Ajiki; Hironaga Satake; Keiko Kamei; Taiji Tohyama; Tetsuro Hirose; Iwao Ikai; Satoshi Morita; Tatsuya Ioka
        Annals of surgery, 2019年08月, 査読有り
      • Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L).
        Hiroaki Akamatsu; Shunsuke Teraoka; Satoshi Morita; Nobuyuki Katakami; Motoko Tachihara; Haruko Daga; Nobuyuki Yamamoto; Kazuhiko Nakagawa
        Clinical lung cancer, 2019年07月
      • Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.
        Iwaki K; Yagi S; Morita S; Hamaguchi Y; Masano Y; Yamamoto G; Ogawa E; Nagai K; Kamo N; Hata K; Taura K; Okajima H; Kaido T; Uemoto S
        Transplantation proceedings, 2019年07月, 査読有り
      • Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study).
        Hiroaki Akamatsu; Yasuhiro Koh; Isamu Okamoto; Daichi Fujimoto; Akihiro Bessho; Koichi Azuma; Satoshi Morita; Nobuyuki Yamamoto; Kazuhiko Nakagawa
        Lung cancer (Amsterdam, Netherlands), 2019年05月
      • A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.
        Kazuhiro Nishikawa; Kenta Murotani; Kazumasa Fujitani; Hitoshi Inagaki; Yusuke Akamaru; Shinya Tokunaga; Masakazu Takagi; Shigeyuki Tamura; Naotoshi Sugimoto; Tadashi Shigematsu; Takaki Yoshikawa; Tohru Ishiguro; Masato Nakamura; Hiroko Hasegawa; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto; Toshimasa Tsujinaka
        Cancer chemotherapy and pharmacology, 2019年05月, 査読有り
      • Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
        Sugawara S; Nakagawa K; Yamamoto N; Nokihara H; Ohe Y; Nishio M; Takahashi T; Goto K; Maemondo M; Ichinose Y; Seto T; Sakai H; Gemma A; Imamura F; Shingyoji M; Saka H; Inoue A; Takeda K; Okamoto I; Kiura K; Morita S; Tamura T
        International journal of clinical oncology, 2019年05月, 査読有り
      • Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
        Saito Haruhiro; Fukuhara Tatsuro; Furuya Naoki; Watanabe Kana; Sugawara Shunichi; Iwasawa Shunichiro; Tsunezuka Yoshio; Yamaguchi Ou; Okada Morihito; Yoshimori Kozo; Nakachi Ichiro; Gemma Akihiko; Azuma Koichi; Kurimoto Futoshi; Tsubata Yukari; Fujita Yuka; Nagashima Hiromi; Asai Gyo; Watanabe Satoshi; Miyazaki Masaki; Hagiwara Koichi; Nukiwa Toshihiro; Morita Satoshi; Kobayashi Kunihiko; Maemondo Makoto
        LANCET ONCOLOGY, 2019年05月, 査読有り
      • Stage IV胃癌におけるConversion Therapyに関する国際共同観察研究(CONVO-GC-1)
        吉田 和弘; 寺島 雅典; 片井 均; 渡邊 昌彦; 瀬戸 泰之; 馬場 秀夫; 北川 雄光; 森田 智視; 西山 正彦
        日本胃癌学会総会記事, 2019年02月
      • Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.
        Iwamura S; Kaido T; Morita S; Miyachi Y; Yao S; Shirai H; Kobayashi A; Hamaguchi Y; Kamo N; Yagi S; Uemoto S
        Hepatology research : the official journal of the Japan Society of Hepatology, 2019年01月, 査読有り
      • A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.
        Tsuboi A; Hashimoto N; Fujiki F; Morimoto S; Kagawa N; Nakajima H; Hosen N; Nishida S; Nakata J; Morita S; Sakamoto J; Oji Y; Oka Y; Sugiyama H
        Cancer immunology, immunotherapy : CII, 2018年11月, 査読有り
      • Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
        Ryo Ko; Takehito Shukuya; Yusuke Okuma; Kazunari Tateishi; Hisao Imai; Shunichiro Iwasawa; Eisaku Miyauchi; Akiko Fujiwara; Tomohide Sugiyama; Keisuke Azuma; Keiko Muraki; Masahiro Yamasaki; Hisashi Tanaka; Yuta Takashima; Sayo Soda; Osamu Ishimoto; Nobuyuki Koyama; Satoshi Morita; Kunihiko Kobayashi; Toshihiro Nukiwa; Kazuhisa Takahashi
        The oncologist, 2018年10月
      • 胆道癌術後の大量肝切除状態におけるGEMまたはS-1療法の第I/II相試験(KHBO1003/1208)
        小林 省吾; 永野 浩昭; 波多野 悦朗; 瀬尾 智; 寺嶋 宏明; 味木 徹夫; 佐竹 悠良; 亀井 敬子; 藤山 泰二; 廣瀬 哲朗; 猪飼 伊和夫; 竹村 茂一; 柳本 泰明; 森田 智視; 井岡 達也
        日本癌治療学会学術集会抄録集, 2018年10月
      • Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial.
        Toshimi Kaido; Masahiro Shinoda; Yukihiro Inomata; Takahito Yagi; Nobuhisa Akamatsu; Yasutsugu Takada; Hideki Ohdan; Tsuyoshi Shimamura; Yasuhiro Ogura; Susumu Eguchi; Hidetoshi Eguchi; Satoshi Ogata; Tomoharu Yoshizumi; Toshihiko Ikegami; Michio Yamamoto; Satoshi Morita; Shinji Uemoto
        Nutrition (Burbank, Los Angeles County, Calif.), 2018年10月, 査読有り
      • Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
        Suzuki E; Sugimoto M; Kawaguchi K; Pu F; Uozumi R; Yamaguchi A; Nishie M; Tsuda M; Kotake T; Morita S; Toi M
        Breast cancer (Tokyo, Japan), 2018年10月, 査読有り
      • Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study
        Tamami Yoshida; Motomu Hashimoto; Rie Kawahara; Hiroko Yamamoto; Masao Tanaka; Hiromu Ito; Izuru Masuda; Kiminori Hosoda; Wataru Yamamoto; Ryuji Uozumi; Satoshi Morita; Yasutomo Fujii; Tsuneyo Mimori; Kazuko Nin
        Rheumatology International, 2018年09月
      • A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.
        Shigeyoshi Iwamoto; Akira Ooki; Satoshi Morita; Hiroki Hara; Hiroaki Tanioka; Hironaga Satake; Masato Kataoka; Masahito Kotaka; Yoshinori Kagawa; Masato Nakamura; Tatsushi Shingai; Masashi Ishikawa; Yasuhiro Miyake; Takeshi Sudo; Yojiro Hashiguchi; Taichi Yabuno; Junichi Sakamoto; Akihito Tsuji; Masahiko Ando; Kensei Yamaguchi
        Cancer medicine, 2018年09月
      • 局所進行胃癌に対する術前補助化学療法の効果予測マーカー検索 COMPASS試験バイオマーカー研究(Search for predictive biomarkers of response to neoadjuvant chemotherapy in locally advanced gastric cancer)
        大島 貴; 吉川 貴己; 森田 智視; 宮城 洋一; 田邊 和照; 西川 和宏; 伊藤 友一; 青山 徹; 利野 靖; 益田 宗孝; 坂本 純一
        日本癌学会総会記事, 2018年09月
      • A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study
        Yutaka Yamamoto; Hiroji Iwata; Takayuki Ueno; Naruto Taira; Masahiro Kashiwaba; Masato Takahashi; Hiroshi Tada; Koichiro Tsugawa; Tatsuya Toyama; Naoki Niikura; Fumikata Hara; Tomomi Fujisawa; Tetsuhiro Yoshinami; Shigehira Saji; Toshimi Takano; Norikazu Masuda; Satoshi Morita; Masakazu Toi; Shinji Ohno
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018年09月, 査読有り
      • A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.
        Kazuhiro Nishikawa; Akira Tsuburaya; Takaki Yoshikawa; Masazumi Takahashi; Kazuaki Tanabe; Kensei Yamaguchi; Shigefumi Yoshino; Tsutomu Namikawa; Toru Aoyama; Yasushi Rino; Junji Kawada; Akihito Tsuji; Koichi Taira; Yutaka Kimura; Yasuhiro Kodera; Yoshinori Hirashima; Hiroshi Yabusaki; Naoki Hirabayashi; Kazumasa Fujitani; Yumi Miyashita; Satoshi Morita; Junichi Sakamoto
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018年09月, 査読有り
      • Prevalence and factors associated with sarcopeniain patients with rheumatoid arthritis
        Mie Torii; Motomu Hashimoto; Akiko Hanai; Takao Fujii; Moritoshi Furu; Hiromu Ito; Ryuji Uozumi; Masahide Hamaguchi; Chikashi, Terao; Wataru Yamamoto; Miyabi Uda; Kazuko nin; Satoshi Morita; Hidenori Arai; Tsuneyo Mimori
        Modern Rheumatology, 2018年09月, 査読有り
      • ASP8273 tolerability and antitumor activity in tyrosine kinase inhibitor-naïve Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
        Koichi Azuma; Makoto Nishio; Hidetoshi Hayashi; Katsuyuki Kiura; Miyako Satouchi; Shunichi Sugawara; Toyoaki Hida; Yasuo Iwamoto; Akira Inoue; Koji Takeda; Satoshi Ikeda; Tomoki Nakagawa; Kentaro Takeda; Seitaro Asahina; Kanji Komatsu; Satoshi Morita; Masahiro Fukuoka; Kazuhiko Nakagawa
        Cancer science, 2018年08月
      • Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial
        N. Masuda; M. Toi; N. Yamamoto; H. Iwata; K. Kuroi; H. Bando; S. Ohtani; T. Takano; K. Inoue; Y. Yanagita; H. Kasai; S. Morita; T. Sakurai; S. Ohno
        Breast Cancer, 2018年07月01日, 査読有り
      • WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.
        Yusuke Oji; Masayoshi Inoue; Yoshito Takeda; Naoki Hosen; Yasushi Shintani; Manabu Kawakami; Takuya Harada; Yui Murakami; Miki Iwai; Mari Fukuda; Sumiyuki Nishida; Jun Nakata; Yoshiki Nakae; Satoshi Takashima; Toshiaki Shirakata; Hiroko Nakajima; Kana Hasegawa; Hiroshi Kida; Takashi Kijima; Soyoko Morimoto; Fumihiro Fujiki; Akihiro Tsuboi; Eiichi Morii; Satoshi Morita; Junichi Sakamoto; Atsushi Kumanogoh; Yoshihiro Oka; Meinoshin Okumura; Haruo Sugiyama
        International journal of cancer, 2018年06月01日, 査読有り
      • Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis.
        Sakura Iizumi; Atsuo Takashima; Kentaro Sakamaki; Satoshi Morita; Narikazu Boku
        Cancer chemotherapy and pharmacology, 2018年06月, 査読有り
      • Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.
        Tetsuya Kusumoto; Eiji Sunami; Mitsuyoshi Ota; Kazuhiro Yoshida; Yoshiyuki Sakamoto; Naohiro Tomita; Atsuyuki Maeda; Izumi Mochizuki; Michio Okabe; Katsuyuki Kunieda; Junichiro Yamauchi; Michio Itabashi; Kenjiro Kotake; Keiichi Takahashi; Hideo Baba; Narikazu Boku; Keisuke Aiba; Megumi Ishiguro; Satoshi Morita; Kenichi Sugihara
        Clinical colorectal cancer, 2018年06月, 査読有り
      • The Relationship Between Cephalogram Analysis and Oxygen Desaturation Index During Sleep in Patients Submitted for Mandibular Setback Surgery
        Dahy Khaled Gamal; Takahashi Katsu; Saito Kazuyuki; Kakeno Azumi; Kiso Honoka; Isobe Yu; Mishima Sayaka; Asai Keita; Moussa Abd-Elmateen; Shahat Badawy; Rezk Ibrahim; Oga Toru; Morita Satoshi; Chin Kazuo; Bessho Kazuhisa
        JOURNAL OF CRANIOFACIAL SURGERY, 2018年06月, 査読有り
      • A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells.
        三上 芳喜
        Cancer Med, 2018年06月, 査読有り
      • Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)
        Takayoshi Tachibana; Kanto Study Group for Cell Therapy (KSGCT); Junya Kanda; Shinichiro Machida; Takeshi Saito; Masatsugu Tanaka; Yuho Najima; Satoshi Koyama; Takuya Miyazaki; Eri Yamamoto; Masahiro Takeuchi; Satoshi Morita; Yoshinobu Kanda; Heiwa Kanamori; Shinichiro Okamoto
        International Journal of Hematology, 2018年05月01日, 査読有り
      • Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy.
        Yuka Ito; Takashi Tsuda; Hiroko Minatogawa; Sayaka Kano; Kentaro Sakamaki; Masahiko Ando; Koichiro Tsugawa; Yasuyuki Kojima; Naoki Furuya; Kunihiro Matsuzaki; Mamoru Fukuda; Sadatoshi Sugae; Ichiro Ohta; Hitoshi Arioka; Yutaka Tokuda; Kazutaka Narui; Ayako Tsuboya; Takashi Suda; Satoshi Morita; Narikazu Boku; Takeharu Yamanaka; Takako Eguchi Nakajima
        Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018年04月01日, 査読有り
      • A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial
        Naoto Takahashi; Mitsuro Kanda; Takaki Yoshikawa; Nobuhiro Takiguchi; Kazumasa Fujitani; Katsufumi Miyamoto; Yuichi Ito; Osamu Takayama; Motohiro Imano; Norio Mitsumori; Junichi Sakamoto; Satoshi Morita; Yasuhiro Kodera
        Gastric Cancer, 2018年03月13日, 査読有り
      • Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study.
        Yuho Najima; Chikashi Yoshida; Noriyoshi Iriyama; Shin Fujisawa; Hisashi Wakita; Shigeru Chiba; Shinichiro Okamoto; Kimihiro Kawakami; Naoki Takezako; Takashi Kumagai; Kazuma Ohyashiki; Jun Taguchi; Shingo Yano; Tadahiko Igarashi; Yasuji Kouzai; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki; Koiti Inokuchi
        Leukemia research, 2018年03月
      • Effects of Ezetimibe-Statin Combination Therapy on Coronary Atherosclerosis in Acute Coronary Syndrome
        Kiyoshi Hibi; Shinjo Sonoda; Masanori Kawasaki; Yutaka Otsuji; Toyoaki Murohara; Hideki Ishii; Katsuhiko Sato; Ryoji Koshida; Yukio Ozaki; Masataka Sata; Yoshihiro Morino; Tadashi Miyamoto; Tetsuya Amano; Satoshi Morita; Ken Kozuma; Kazuo Kimura; Hisayoshi Fujiwara
        CIRCULATION JOURNAL, 2018年03月
      • 局所進行胃癌に対する術前補助化学療法の予後予測マーカー検索 COMPASS試験バイオマーカー研究(A biomarker analysis to predict the outcomes of patients with gastric cancer who received NAC)
        大島 貴; 吉川 貴己; 宮城 洋平; 森田 智視; 田邊 和照; 西川 和宏; 伊藤 友一; 青山 徹; 林 勉; 利野 靖; 益田 宗孝; 横瀬 智之; 坂本 純一
        日本胃癌学会総会記事, 2018年03月
      • Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort
        Isamu Okamoto; Satoshi Morita; Naoki Tashiro; Fumio Imamura; Akira Inoue; Takashi Seto; Nobuyuki Yamamoto; Yuichiro Ohe; Kazuhiko Nakagawa; Masahiro Fukuoka
        Lung Cancer, 2018年03月01日, 査読有り
      • 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化 多施設共同無作為化比較試験
        村瀬 公彦; 谷澤 公伸; 津田 徹; 大井 元晴; 赤星 俊樹; 成井 浩司; 名嘉村 博; 大平 徹郎; 吉嶺 裕之; 坪井 知正; 山城 義広; 安藤 眞一; 葛西 隆敏; 北 英夫; 巽 浩一郎; 鰤岡 直人; 富井 啓介; 近藤 康博; 小賀 徹; 酒巻 哲夫; 森田 智視; 平井 豊博; 黒田 知宏; 陳 和夫; 厚生労働科学研究遠隔モニタリング研究班
        日本呼吸器学会誌, 2018年03月, 査読有り
      • Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study.
        Sumiyuki Nishida; Takeshi Ishikawa; Shinichi Egawa; Shigeo Koido; Hiroaki Yanagimoto; Jun Ishii; Yoshihide Kanno; Satoshi Kokura; Hiroaki Yasuda; Mari Saito Oba; Maho Sato; Soyoko Morimoto; Fumihiro Fujiki; Hidetoshi Eguchi; Hiroaki Nagano; Atsushi Kumanogoh; Michiaki Unno; Masanori Kon; Hideaki Shimada; Kei Ito; Sadamu Homma; Yoshihiro Oka; Satoshi Morita; Haruo Sugiyama
        Cancer immunology research, 2018年03月, 査読有り
      • Comprehensive data of 3,820 patients newly diagnosed with colorectal liver metastasis between 2005 and 2007: report of a nationwide survey in Japan.
        Katsunori Sakamoto; Goro Honda; Toru Beppu; Kenjiro Kotake; Masakazu Yamamoto; Keiichi Takahashi; Itaru Endo; Kiyoshi Hasegawa; Michio Itabashi; Yojiro Hashiguchi; Yoshihito Kotera; Shin Kobayashi; Tatsuro Yamaguchi; Satoshi Morita; Masaru Miyazaki; Kenichi Sugihara
        Journal of hepato-biliary-pancreatic sciences, 2018年02月
      • Neoadjuvant palbociclib on ER+ breast cancer (N007): Clinical response and EndoPredict's value
        Louis W.C. Chow; Satoshi Morita; Christopher Y.C. Chow; Wai-Kuen Ng; Masakazu Toi
        Endocrine-Related Cancer, 2018年02月01日, 査読有り
      • A survival analysis of a prospective multicenter observational study of surgical palliation in patients treated for malignant gastric outlet obstruction caused by incurable advanced gastric cancer
        Terashima Masanori; Fujitani Kazumasa; Ando Masahiko; Sakamaki Kentaro; Kawabata Ryohei; Ito Yuichi; Yoshikawa Takaki; Kondo Masato; Kodera Yasuhiro; Kaji Masahide; Oka Yoshio; Imamura Hiroshi; Kawada Junji; Takagane Akinori; Shimada Hideaki; Tanizawa Yutaka; Yamanaka Takeharu; Morita Satoshi; Ninomiya Motoki; Yoshida Kazuhiro
        JOURNAL OF CLINICAL ONCOLOGY, 2018年02月01日
      • Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study
        Hidetoshi Kawaguchi; Norikazu Masuda; Takahiro Nakayama; Kenjiro Aogi; Keisei Anan; Yoshinori Ito; Shoichiro Ohtani; Nobuaki Sato; Shigehira Saji; Toshimi Takano; Eriko Tokunaga; Seigo Nakamura; Yoshie Hasegawa; Masaya Hattori; Tomomi Fujisawa; Satoshi Morita; Miki Yamaguchi; Hiroko Yamashita; Toshinari Yamashita; Yutaka Yamamoto; Daisuke Yotsumoto; Masakazu Toi; Shinji Ohno
        Current Medical Research and Opinion, 2018年01月02日, 査読有り
      • Rationale and design of the TRUSTY study: a randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy
        Takayuki Yoshino; Eiji Oki; Hiroaki Nozawa; Takako Eguchi-Nakajima; Hiroya Taniguchi; Satoshi Morita; Naruhito Takenaka; Daisuke Ozawa; Kuniaki Shirao
        ESMO Open, 2018年
      • Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations.
        Satoshi Oizumi; Shunichi Sugawara; Koichi Minato; Toshiyuki Harada; Akira Inoue; Yuka Fujita; Makoto Maemondo; Satoshi Watanabe; Kazuhiko Ito; Akihiko Gemma; Yoshiki Demura; Shinichi Fukumoto; Hiroshi Isobe; Ichiro Kinoshita; Satoshi Morita; Kunihiko Kobayashi; Koichi Hagiwara; Keisuke Aiba; Toshihiro Nukiwa
        ESMO open, 2018年
      • A randomized, open-label, phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic Breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: The Japan Breast cancer research group-M05 PRECIOUS study
        Yutaka Yamamoto; Hiroji Iwata; Takayuki Ueno; Naruto Taira; Masahiro Kashiwaba; Masato Takahashi; Hiroshi Tada; Koichiro Tsugawa; Tatsuya Toyama; Naoki Niikura; Fumikata Hara; Tomomi Fujisawa; Tetsuhiro Yoshinami; Shigehira Saji; Toshimi Takano; Norikazu Masuda; Satoshi Morita; Masakazu Toi; Shinji Ohno
        Japanese Journal of Clinical Oncology, 2018年, 査読有り
      • The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
        Kazuhiro Nishikawa; Toru Aoyama; Mari S. Oba; Takaki Yoshikawa; Chu Matsuda; Yoshinori Munemoto; Nobuhiro Takiguchi; Kazuaki Tanabe; Naoki Nagata; Motohiro Imano; Mitsuru Oshiro; Ryoji Fukushima; Masato Kataoka; Satoshi Morita; Akira Tsuburaya; Hideyuki Mishima; Toru Kono; Junichi Sakamoto
        Journal of Cancer, 2018年, 査読有り
      • The efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the kanto CML study group
        Noriyoshi Iriyama; Kazuteru Ohashi; Satoshi Hashino; Shinya Kimura; Chiaki Nakaseko; Hina Takano; Masayuki Hino; Michihiro Uchiyama; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki; Koiti Inokuchi
        Internal Medicine, 2018年, 査読有り
      • Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
        Masatoshi Kudo; Ann-Lii Cheng; Joong-Won Park; Jae Hyung Park; Po-Chin Liang; Hisashi Hidaka; Namiki Izumi; Jeong Heo; Youn Jae Lee; I-Shyan Sheen; Chang-Fang Chiu; Hitoshi Arioka; Satoshi Morita; Yasuaki Arai
        The Lancet Gastroenterology and Hepatology, 2018年01月01日, 査読有り
      • Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation
        Takashi Kumagai; Chiaki Nakaseko; Kaichi Nishiwaki; Chikashi Yoshida; Kazuteru Ohashi; Naoki Takezako; Hina Takano; Yasuji Kouzai; Tadashi Murase; Kosei Matsue; Satoshi Morita; Junichi Sakamoto; Hisashi Wakita; Hisashi Sakamaki; Koiti Inokuchi; the Kanto CML and Shimousa Hematology Study Groups
        Cancer Science, 2018年01月01日, 査読有り
      • Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
        Yamashiro H; Sawaki M; Masuda N; Okumura Y; Takano T; Tokunaga E; Saito T; Sagara Y; Yamazaki K; Kawaguchi Y; Lee T; Ozaki S; Yamagami K; Yamamoto N; Kuroi K; Suwa H; Ohtani S; Ito T; Yasuno S; Morita S; Ohno S; Toi M
        Breast cancer : basic and clinical research, 2018年, 査読有り
      • Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial).
        Okuno K; Aoyama T; Oba K; Yokoyama N; Matsuhashi N; Kunieda K; Nishimura Y; Akamatsu H; Kobatake T; Morita S; Yoshikawa T; Sakamoto J; Saji S
        Cancer chemotherapy and pharmacology, 2018年01月, 査読有り
      • Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study
        Hattori M; Ishiguro H; Masuda N; Yoshimura A; Ohtani S; Yasojima H; Morita S; Ohno S; Iwata H
        Breast Cancer, 2018年01月, 査読有り
      • Infiltration of PD-1-positive cells in combination with tumor site PD-l1 expression is a positive prognostic factor in cutaneous angiosarcoma
        Yuki Honda; Atsushi Otsuka; Sachiko Ono; Yosuke Yamamoto; Judith A. Seidel; Satoshi Morita; Masahiro Hirata; Tatsuki R. Kataoka; Tatsuya Takenouchi; Kazuyasu Fujii; Takuro Kanekura; Yuko Okubo; Kenzo Takahashi; Teruki Yanagi; Daichi Hoshina; Hiroo Hata; Riichiro Abe; Taku Fujimura; Takeru Funakoshi; Koji Yoshino; Mamiko Masuzawa; Yasuyuki Amoh; Ryota Tanaka; Yasuhiro Fujisawa; Tetsuya Honda; Kenji Kabashima
        OncoImmunology, 2017年12月23日, 査読有り
      • Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial
        Fumihiro Asano; Takashi Ishida; Naofumi Shinagawa; Noriaki Sukoh; Masaki Anzai; Kenya Kanazawa; Akifumi Tsuzuku; Satoshi Morita
        BMC PULMONARY MEDICINE, 2017年12月, 査読有り
      • Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)
        Hiroaki Tanaka; Mitsuro Kanda; Satoshi Morita; Masataka Taguri; Kazuhiro Nishikawa; Mitsuo Shimada; Kazuya Muguruma; Keisuke Koeda; Masazumi Takahashi; Mikihito Nakamori; Hiroyuki Konno; Akihito Tsuji; Yoshinori Hosoya; Tetsuhiko Shirasaka; Susumu Yamamitsu; Michio Sowa; Masaki Kitajima; Masazumi Okajima; Michiya Kobayashi; Junichi Sakamoto; Shigetoyo Saji; Kosei Hirakawa
        INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017年12月, 査読有り
      • Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
        H. Nokihara; S. Lu; T. S. K. Mok; K. Nakagawa; N. Yamamoto; Y. K. Shi; L. Zhang; R. A. Soo; J. C. Yang; S. Sugawara; M. Nishio; T. Takahashi; K. Goto; J. Chang; M. Maemondo; Y. Ichinose; Y. Cheng; W. T. Lim; S. Morita; T. Tamura
        ANNALS OF ONCOLOGY, 2017年11月, 査読有り
      • 進行胃癌に対する術前補助化学療法の予後予測マーカー検索(COMPASS試験biomarker研究)
        大島 貴; 吉川 貴己; 宮城 洋平; 森田 智視; 田邊 和照; 西川 和宏; 伊藤 友一; 青山 徹; 林 勉; 尾形 高士; 長 晴彦; 横瀬 智之; 利野 靖; 益田 宗孝; 坂本 純一
        日本癌治療学会学術集会抄録集, 2017年10月
      • Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy
        Masayuki Shiseki; Chikashi Yoshida; Naoki Takezako; Akira Ohwada; Takashi Kumagai; Kaichi Nishiwaki; Akira Horikoshi; Tetsuya Fukuda; Hina Takano; Yasuji Kouzai; Junji Tanaka; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki; Koiti Inokuchi
        International Journal of Clinical Oncology, 2017年10月01日, 査読有り
      • Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.
        Kiminori Kimura; Akemi Ikoma; Maki Shibakawa; Shinji Shimoda; Kenichi Harada; Masanao Saio; Jun Imamura; Yosuke Osawa; Masamichi Kimura; Koji Nishikawa; Takuji Okusaka; Satoshi Morita; Kazuaki Inoue; Tatsuya Kanto; Koji Todaka; Yoichi Nakanishi; Michinori Kohara; Masashi Mizokami
        EBioMedicine, 2017年09月, 査読有り
      • Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry -
        Yugo Yamashita; Ryuji Uozumi; Yasuhiro Hamatani; Masahiro Esato; Yeong-Hwa Chun; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Hisashi Ogawa; Mitsuru Abe; Satoshi Morita; Masaharu Akao
        CIRCULATION JOURNAL, 2017年09月, 査読有り
      • Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
        Tetsuhiro Kikuchi; Asuka Morizane; Daisuke Doi; Hiroaki Magotani; Hirotaka Onoe; Takuya Hayashi; Hiroshi Mizuma; Sayuki Takara; Ryosuke Takahashi; Haruhisa Inoue; Satoshi Morita; Michio Yamamoto; Keisuke Okita; Masato Nakagawa; Malin Parmar; Jun Takahashi
        Nature, 2017年08月30日, 査読有り
      • Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study
        Maki Tanioka; Satoshi Yamaguchi; Muneaki Shimada; Shoji Nagao; Kazuhiro Takehara; Masato Nishimura; Satoshi Morita; Shunichi Negoro; Kiyoshi Fujiwara; Junzo Kigawa
        Medical Oncology, 2017年08月01日, 査読有り
      • Abstract 5706: Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may be contribute to the identification and the immunological classification of breast cancer patients by blood test
        Eiji Suzuki; Kosuke Kawaguchi; Masahiro Sugimoto; Fengling Pu; Ryuji Uozumi; Ayane Yamaguchi; Mariko Nishie; Moe Tsuda; Takeshi Kotake; Satoshi Morita; Masakazu Toi
        Clinical Research (Excluding Clinical Trials), 2017年07月01日
      • Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies
        Shuichiro Nakabo; Motomu Hashimoto; Shinji Ito; Moritoshi Furu; Hiromu Ito; Takao Fujii; Hajime Yoshifuji; Yoshitaka Imura; Ran Nakashima; Kosaku Murakami; Nobuo Kuramoto; Masao Tanaka; Junko Satoh; Akihito Ishigami; Satoshi Morita; Tsuneyo Mimori; Koichiro Ohmura
        Rheumatology (United Kingdom), 2017年07月01日, 査読有り
      • Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
        Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
        Clinical lung cancer, 2017年07月, 査読有り
      • Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach
        Hiromasa Inoue; Takahide Nagase; Satoshi Morita; Atsushi Yoshida; Tatsunori Jinnai; Masakazu Ichinose
        International Journal of COPD, 2017年06月20日, 査読有り
      • Clinical characteristics of influenza-associated pneumonia of adults: Clinical features and factors contributing to severity and mortality
        Takashi Ishiguro; Naho Kagiyama; Ryuji Uozumi; Kyuto Odashima; Yotaro Takaku; Kazuyoshi Kurashima; Satoshi Morita; Noboru Takayanagi
        Yale Journal of Biology and Medicine, 2017年06月01日, 査読有り
      • Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: A multicentre, prospective, observational study in Japan
        Wataru Fukuda; Tadamasa Hanyu; Masaki Katayama; Shinichi Mizuki; Akitomo Okada; Masayuki Miyata; Yuichi Handa; Masatoshi Hayashi; Yoshinobu Koyama; Kaoru Arii; Toshiyuki Kitaori; Hiroyuki Hagiyama; Yoshinori Urushidani; Takahito Yamasaki; Yoshihiko Ikeno; Tsuyoshi Suzuki; Atsushi Omoto; Toshifumi Sugitani; Satoshi Morita; Shigeko Inokuma
        Annals of the Rheumatic Diseases, 2017年06月01日, 査読有り
      • Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer: A Large, Multicenter, Propensity Score Matched Cohort Study in Japan.
        Hida K; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Yamamoto M; Nishigori T; Kawada K; Hasegawa S; Morita S; Watanabe M; Japan; Society of; Laparoscopic Colorectal Surgery
        Annals of surgery, 2017年06月, 査読有り
      • Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
        Kohei Shitara; Atsuo Takashima; Kazumasa Fujitani; Keisuke Koeda; Hiroki Hara; Norisuke Nakayama; Shuichi Hironaka; Kazuhiro Nishikawa; Yoichi Makari; Kenji Amagai; Shinya Ueda; Kazuhiro Yoshida; Hideki Shimodaira; Tomohiro Nishina; Masahiro Tsuda; Yukinori Kurokawa; Takao Tamura; Yasutsuna Sasaki; Satoshi Morita; Wasaburo Koizumi
        The lancet. Gastroenterology & hepatology, 2017年04月, 査読有り
      • Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
        Hata A; Katakami N; Hattori Y; Tanaka K; Fujita S; Kotani Y; Nishimura T; Imamura F; Yokota S; Satouchi M; Monden K; Otsuka K; Nishiyama A; Tsubouchi K; Kaneda T; Yoshioka H; Morita S; Negoro S
        Cancer chemotherapy and pharmacology, 2017年04月, 査読有り
      • The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients
        Tanaka S; Ueno T; Ishiguro H; Morita S; Toi M
        NPJ Precis Oncol, 2017年04月, 査読有り
      • A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.
        Tomonori Yano; Hiroi Kasai; Takahiro Horimatsu; Kenichi Yoshimura; Satoshi Teramukai; Satoshi Morita; Harue Tada; Yoshinobu Yamamoto; Hiromi Kataoka; Naomi Kakushima; Ryu Ishihara; Hajime Isomoto; Manabu Muto
        Oncotarget, 2017年03月28日, 査読有り
      • A simulation study of methods for selecting subgroup-specific doses in phase 1 trials
        Satoshi Morita; Peter F. Thall; Kentaro Takeda
        PHARMACEUTICAL STATISTICS, 2017年03月, 査読有り
      • S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomized phase 3: SOFT study
        H. Baba; Y. Yamada; D. Takahari; H. Matsumoto; K. Yoshida; M. Nakamura; M. Yoshida; S. Iwamoto; K. Shimada; Y. Komatsu; Y. Sasaki; T. Satoh; K. Takahashi; H. Mishima; K. Muro; M. Watanabe; Y. Sakata; S. Morita; Y. Shimada; K. Sugihara
        ESMO Open, 2017年03月, 査読有り
      • Meta-analysis of Patient-level Data on Therapeutic Effects of TJ-14 (Hangeshashinto) for Gastroenterological Cancer Chemotherapy-induced Severe Oral Mucositis with the HANGESHA-G and HANGESHA-Cs : protocol paper
        Toru Aoyama; Kazuhiro Nishikawa; Mari Oba; Takaki Yoshikawa; Chu Matsuda; Yoshinori Munemoto; Nobuhiro Takiguchi; Kazuaki Tanabe; Naoki Nagata; Motohiro Imano; Mitsuru Oshiro; Ryoji Fukushima; Masato Kataoka; Satoshi Morita; Akira Tsuburaya; Hideyuki Mishima; Toru Kono; Junichi Sakamoto
        Annals of Cancer Research and Therapy, 2017年, 査読有り
      • Meta-analysis of patient-level data on biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer with the TCOG GI-0801 BIRIP and ECRIN TRICS RCTS: Protocol paper
        Kazuhiro Nishikawa; Wasaburo Koizumi; Akira Tsuburaya; Takeharu Yamanaka; Satoshi Morita; Kazumasa Fujitani; Yusuke Akamaru; Ken Shimada; Hisashi Hosaka; Norisuke Nakayama; Toshimasa Tsujinaka; Junichi Sakamoto
        Annals of Cancer Research and Therapy, 2017年, 査読有り
      • Daikenchuto administration for intestinal hypomotility after open abdominal surgery: A pooled analysis of three randomized controlled trials
        Toru Kono; Mitsuo Shimada; Masaaki Nishi; Yuji Morine; Kozo Yoshikawa; Hidetoshi Katsuno; Koutarou Maeda; Keisuke Koeda; Satoshi Morita; Masahiko Watanabe; Mitsuo Kusano; Junichi Sakamoto; Shigetoyo Saji; Hiroki Sokuoka; Yuya Ohtake; Yasuto Sato; Takashi Kanematsu; Masaki Kitajima
        Annals of Cancer Research and Therapy, 2017年, 査読有り
      • Bayesian population finding with biomarkers in a randomized clinical trial
        Satoshi Morita; Peter Müller
        Biometrics, 2017年, 査読有り
      • Breathing-swallowing discoordination is associated with frequent exacerbations of COPD.
        Shinsuke Nagami; Yoshitaka Oku; Naomi Yagi; Susumu Sato; Ryuji Uozumi; Satoshi Morita; Yoshie Yamagata; Jun Kayashita; Kazuya Tanimura; Atsuyasu Sato; Ryosuke Takahashi; Shigeo Muro
        BMJ open respiratory research, 2017年, 査読有り
      • Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
        Yasuto Yoneshima; Satoshi Morita; Masahiko Ando; Satoru Miura; Hiroshige Yoshioka; Tetsuya Abe; Terufumi Kato; Masashi Kondo; Yukio Hosomi; Katsuyuki Hotta; Nobuyuki Yamamoto; Junji Kishimoto; Yoichi Nakanishi; Isamu Okamoto
        CLINICAL LUNG CANCER, 2017年01月, 査読有り
      • Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102)
        Kazuhiro Nishikawa; Tsunehiro Takahashi; Hiromasa Takaishi; Akira Miki; Hirokazu Noshiro; Takaki Yoshikawa; Yasunori Nishida; Satoru Iwasa; Hiroto Miwa; Toshiki Masuishi; Narikazu Boku; Yasuhide Yamada; Yasuhiro Kodera; Kazuhiro Yoshida; Satoshi Morita; Junichi Sakamoto; Shigetoyo Saji; Yuko Kitagawa
        INTERNATIONAL JOURNAL OF CANCER, 2017年01月, 査読有り
      • Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial
        Yasuhiro Kodera; Naoto Takahashi; Takaki Yoshikawa; Nobuhiro Takiguchi; Kazumasa Fujitani; Yuichi Ito; Katsufumi Miyamoto; Osamu Takayama; Motohiro Imano; Daisuke Kobayashi; Yumi Miyashita; Satoshi Morita; Junichi Sakamoto
        GASTRIC CANCER, 2017年01月, 査読有り
      • Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size.
        Kentaro Sakamaki; Yosuke Kito; Kentaro Yamazaki; Naoki Izawa; Takashi Tsuda; Satoshi Morita; Narikazu Boku
        ESMO open, 2017年, 査読有り
      • A CD57(+) CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients
        Masayuki Hori; Takahiro Yasumi; Saeko Shimodera; Hirofumi Shibata; Eitaro Hiejima; Hirotsugu Oda; Kazushi Izawa; Tomoki Kawai; Masataka Ishimura; Naoko Nakano; Ryutaro Shirakawa; Ryuta Nishikomori; Hidetoshi Takada; Satoshi Morita; Hisanori Horiuchi; Osamu Ohara; Eiichi Ishii; Toshio Heike
        JOURNAL OF CLINICAL IMMUNOLOGY, 2017年01月, 査読有り
      • Clinical trial comparing UFT-PSK combination adjuvant therapy and surgery-alone for stage II rectal cancer
        Okuno K; Aoyama T; Oba K; Yokoyama N; Yoshida K; Kunieda K; Nishimura E; Akamatsu H; Obatake T; Morita S; Yoshikawa T; Saji S
        Annals of Cancer Research and Therapy, 2017年, 査読有り
      • Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer
        Kawaguchi K; Suzuki E; Yamaguchi A; Yamamoto M; Morita S; Toi M
        Breast Cancer, 2017年, 査読有り
      • Transcutaneous oxygen pressure as a surrogate index of lower limb amputation.
        Hiroomi Nishio; Kenji Minakata; Atsushi Kawaguchi; Motoyuki Kumagai; Takafumi Ikeda; Akira Shimizu; Masayuki Yokode; Satoshi Morita; Ryuzo Sakata
        International angiology : a journal of the International Union of Angiology, 2016年12月
      • Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
        Masahito Kotaka; Ruihua Xu; Kei Muro; Young Suk Park; Satoshi Morita; Satoru Iwasa; Hiroyuki Uetake; Tomohiro Nishina; Hiroaki Nozawa; Hiroshi Matsumoto; Kentaro Yamazaki; Sae-Won Han; Wei Wang; Joong Bae Ahn; Yanhong Deng; Sang-Hee Cho; Yi Ba; Keun-Wook Lee; Tao Zhang; Taroh Satoh; Marc E. Buyse; Baek-Yeol Ryoo; Lin Shen; Junichi Sakamoto; Tae Won Kim
        CHINESE JOURNAL OF CANCER, 2016年12月, 査読有り
      • Relationship between overall survival and response or progression-free survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 antibodies
        Takehito Shukuya; Keita Mori; Joseph M. Amann; Erin M. Bertino; Gregory A. Otterson; Peter G. Shields; Satoshi Morita; David P. Carbone
        Journal of Thoracic Oncology, 2016年11月13日, 査読有り
      • Association of pleural effusion with an early molecular response. in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study
        Maki Hagihara; Noriyoshi Iriyama; Chikashi Yoshida; Hisashi Wakita; Shigeru Chiba; Shinichiro Okamoto; Kimihiro Kawakami; Naoki Takezako; Takashi Kumagai; Koiti Inokuchi; Kazuma Ohyashiki; Jun Taguchi; Shingo Yano; Tadahiko Igarashi; Yasuji Kouzai; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki
        ONCOLOGY REPORTS, 2016年11月, 査読有り
      • Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants
        Hiromichi Maeda; Maho Sato; Michiya Kobayashi; Nobuhiro Takiguchi; Takaki Yoshikawa; Shigefumi Yoshino; Kazuhiro Yoshida; Akira Tsuburaya; Junichi Sakamoto; Satoshi Morita
        SUPPORTIVE CARE IN CANCER, 2016年11月, 査読有り
      • Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study
        Masahiro Sekiguchi; Takao Fujii; Kiyoshi Matsui; Kosaku Murakami; Satoshi Morita; Koichiro Ohmura; Yutaka Kawahito; Norihiro Nishimoto; Tsuneyo Mimori; Hajime Sano
        JOURNAL OF RHEUMATOLOGY, 2016年11月, 査読有り
      • 胃 胃がんにおける術前化学療法の適応 術前化学療法の効果予測バイオマーカー探索COMPASS附随研究
        田邊 和照; 吉川 貴己; 大島 貴; 宮城 洋平; 森田 智視; 西川 和宏; 伊藤 友一; 松井 隆則; 木村 豊; 青山 徹; 林 勉; 尾形 高士; 長 晴彦; 円谷 彰; 坂本 純一
        日本癌治療学会学術集会抄録集, 2016年10月
      • 物性調整した食品別の嚥下動態の相違と適切な嚥下調整食選択への応用
        永見 慎輔; 八木 直美; 魚住 龍史; 山縣 誉志江; 田中 信吾; 伊藤 圭子; 平位 知久; 延原 浩; 森田 智視; 高橋 良輔; 栢下 淳; 越久 仁敬
        嚥下医学, 2016年09月
      • 物性調整した食品別の嚥下動態の相違と適切な嚥下調整食選択への応用
        永見 慎輔; 八木 直美; 魚住 龍史; 山縣 誉志江; 延原 浩; 平位 知久; 伊藤 圭子; 田中 信吾; 森田 智視; 高橋 良輔; 栢下 淳; 越久 仁敬
        嚥下医学, 2016年09月
      • Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial
        Shoichi Ohwada; Satoshi Morita
        Pharmaceutical Statistics, 2016年09月01日, 査読有り
      • Risk factors for the severity and mortality of pneumococcal pneumonia: Importance of premorbid patients' performance status
        Takashi Ishiguro; Naho Kagiyama; Ryuji Uozumi; Kyuto Odashima; Kazuyoshi Kurashima; Satoshi Morita; Noboru Takayanagi
        JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016年09月, 査読有り
      • Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)
        Shigefumi Yoshino; Kazuhiro Nishikawa; Satoshi Morita; Tsuyoshi Takahashi; Koichiro Sakata; Jiro Nagao; Hiroshi Nemoto; Nozomu Murakami; Takeru Matsuda; Hiroyasu Hasegawa; Ryoichi Shimizu; Takaki Yoshikawa; Hiroyuki Osanai; Motohiro Imano; Hiroshi Naitoh; Akiyoshi Tanaka; Takashi Tajiri; Akira Gochi; Michinari Suzuki; Junichi Sakamoto; Shigetoyo Saji; Masaaki Oka
        EUROPEAN JOURNAL OF CANCER, 2016年09月, 査読有り
      • Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
        Yoshiko Urata; Nobuyuki Katakami; Satoshi Morita; Reiko Kaji; Hiroshige Yoshioka; Takashi Seto; Miyako Satouchi; Yasuo Iwamoto; Masashi Kanehara; Daichi Fujimoto; Norihiko Ikeda; Haruyasu Murakami; Haruko Daga; Tetsuya Oguri; Isao Goto; Fumio Imamura; Shunichi Sugawara; Hideo Saka; Naoyuki Nogami; Shunichi Negoro; Kazuhiko Nakagawa; Yoichi Nakanishi
        JOURNAL OF CLINICAL ONCOLOGY, 2016年09月, 査読有り
      • Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide
        Yusuke Oji; Naoya Hashimoto; Akihiro Tsuboi; Yui Murakami; Miki Iwai; Naoki Kagawa; Yasuyoshi Chiba; Shuichi Izumoto; Olga Elisseeva; Ryo Ichinohasama; Junichi Sakamoto; Satoshi Morita; Hiroko Nakajima; Satoshi Takashima; Yoshiki Nakae; Jun Nakata; Manabu Kawakami; Sumiyuki Nishida; Naoki Hosen; Fumihiro Fujiki; Soyoko Morimoto; Mayuko Adachi; Masahiro Iwamoto; Yoshihiro Oka; Toshiki Yoshimine; Haruo Sugiyama
        INTERNATIONAL JOURNAL OF CANCER, 2016年09月, 査読有り
      • Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
        Kentaro Yamazaki; M. Nagase; H. Tamagawa; S. Ueda; T. Tamura; K. Murata; T. Eguchi Nakajima; E. Baba; M. Tsuda; T. Moriwaki; T. Esaki; Y. Tsuji; K. Muro; K. Taira; T. Denda; S. Funai; K. Shinozaki; H. Yamashita; N. Sugimoto; T. Okuno; T. Nishina; M. Umeki; T. Kurimoto; T. Takayama; A. Tsuji; M. Yoshida; A. Hosokawa; Y. Shibata; K. Suyama; M. Okabe; K. Suzuki; N. Seki; K. Kawakami; M. Sato; K. Fujikawa; T. Hirashima; T. Shimura; K. Taku; T. Otsuji; F. Tamura; E. Shinozaki; K. Nakashima; H. Hara; T. Tsushima; M. Ando; S. Morita; N. Boku; I. Hyodo
        Annals of Oncology, 2016年08月01日, 査読有り
      • A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head
        Yutaka Kuroda; Ryuta Asada; Kazutaka So; Atsushi Yonezawa; Manabu Nankaku; Kumi Mukai; Toshiko Ito-Ihara; Harue Tada; Michio Yamamoto; Toshinori Murayama; Satoshi Morita; Yasuhiko Tabata; Masayuki Yokode; Akira Shimizu; Shuichi Matsuda; Haruhiko Akiyama
        International Orthopaedics, 2016年08月01日, 査読有り
      • 消化管癌診療におけるバイオマーカーの役割 局所進行胃癌に対する術前補助化学療法の効果予測バイオマーカー検索 COMPASS試験バイオマーカー研究
        大島 貴; 吉川 貴己; 宮城 洋平; 森田 智視; 田邊 和照; 西川 和宏; 伊藤 友一; 青山 徹; 横瀬 智之; 坂本 純一
        日本消化器外科学会総会, 2016年07月
      • Diagnostic criteria that can most accurately differentiate allergic bronchopulmonary mycosis from other eosinophilic lung diseases: A retrospective, single-center study
        Takashi Ishiguro; Noboru Takayanagi; Ryuji Uozumi; Yuri Baba; Eriko Kawate; Yoichi Kobayashi; Yotaro Takaku; Naho Kagiyama; Yoshihiko Shimizu; Satoshi Morita; Yutaka Sugita
        Respiratory Investigation, 2016年07月01日, 査読有り
      • Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy
        Tomoya Yokota; Hiroyuki Tachibana; Tetsuhito Konishi; Takashi Yurikusa; Satoshi Hamauchi; Kensuke Sakai; Masaya Nishikawa; Miho Suzuki; Yayoi Naganawa; Tomoka Hagihara; Hiromi Tsumaki; Tomo Kubo; Maho Sato; Masataka Taguri; Satoshi Morita; Toru Eguchi; Kaoru Kubota; Sadamoto Zenda
        SUPPORTIVE CARE IN CANCER, 2016年07月, 査読有り
      • Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101
        Yuichi Ito; Takaki Yoshikawa; Michitaka Fujiwara; Hiroshi Kojima; Takanori Matsui; Yoshinari Mochizuki; Haruhiko Cho; Toru Aoyama; Seiji Ito; Kazunari Misawa; Hiroshi Nakayama; Yuki Morioka; Akiharu Ishiyama; Chie Tanaka; Satoshi Morita; Junichi Sakamoto; Yasuhiro Kodera
        GASTRIC CANCER, 2016年07月, 査読有り
      • Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)
        Satoshi Matsusaka; Atsushi Nashimoto; Kazuhiro Nishikawa; Akira Miki; Hiroto Miwa; Kazuya Yamaguchi; Takaki Yoshikawa; Atsushi Ochiai; Satoshi Morita; Takeshi Sano; Yasuhiro Kodera; Yoshihiro Kakeji; Junichi Sakamoto; Shigetoyo Saji; Kazuhiro Yoshida
        GASTRIC CANCER, 2016年07月, 査読有り
      • Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer
        Takaki Yoshikawa; Satoshi Morita; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takanori Matsui; Kazumasa Fujitani; Yutaka Kimura; Junya Fujita; Toru Aoyama; Tsutomu Hayashi; Haruhiko Cho; Akira Tsuburaya; Yumi Miyashita; Junichi Sakamoto
        EUROPEAN JOURNAL OF CANCER, 2016年07月, 査読有り
      • 周術期トラスツズマブ治療歴を有する再発乳癌におけるトラスツズマブ投与の観察研究(JBCRG-C02)
        澤木 正孝; 山城 大泰; 増田 慎三; 奥村 恭博; 高野 利実; 徳永 えり子; 齊藤 毅; 相良 安昭; 山崎 弘資; 保野 慎治; 森田 智視; 大野 真司; 戸井 雅和; JBCRG
        日本乳癌学会総会プログラム抄録集, 2016年06月
      • Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum
        Masashi Takano; Kaichiro Yamamoto; Tsutomu Tabata; Yuji Minegishi; Takuma Yokoyama; Eiji Hirata; Takeshi Ikeda; Muneaki Shimada; Kouzo Yamada; Satoshi Morita; Yuichi Ando; Koji Hirata; Masahiro Sugihara; Toru Sugiyama; Yasuo Ohashi; Yuh Sakata
        Asia-Pacific Journal of Clinical Oncology, 2016年06月01日, 査読有り
      • Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
        Koki Nakanishi; Daisuke Kobayashi; Yoshinari Mochizuki; Kiyoshi Ishigure; Seiji Ito; Hiroshi Kojima; Akiharu Ishiyama; Shinichi Fujitake; Toshio Shikano; Satoshi Morita; Yasuhiro Kodera
        INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016年06月, 査読有り
      • Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy.
        Kunihiro Matsuzaki; Yuka Ito; Mamoru Fukuda; Kentaro Sakamaki; Masahiko Ando; Yasuyuki Kojima; Naoki Furuya; Takashi Tsuda; Hiroko Minatogawa; Yasushi Ichikawa; Ichiro Ohta; Saori Takei; Yutaka Tokuda; Kazutaka Narui; Ayako Tsuboya; Takashi Suda; Satoshi Morita; Takeharu Yamanaka; Narikazu Boku; Takako Eguchi Nakajima
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月, 査読有り
      • Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients
        Akira Inoue; Kazushi Yoshida; Satoshi Morita; Fumio Imamura; Takashi Seto; Isamu Okamoto; Kazuhiko Nakagawa; Nobuyuki Yamamoto; Satoshi Muto; Masahiro Fukuoka
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016年05月, 査読有り
      • Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial.
        Ken-ichi Okada; Manabu Kawai; Seiko Hirono; Tsutomu Fujii; Yasuhiro Kodera; Masayuki Sho; Yoshiyuki Nakajima; Sohei Satoi; A-Hon Kwon; Yasuhiro Shimizu; Yoshiyasu Ambo; Naru Kondo; Yoshiaki Murakami; Jiro Ohuchida; Hidetoshi Eguchi; Hiroaki Nagano; Mari S Oba; Satoshi Morita; Junichi Sakamoto; Hiroki Yamaue
        Surgery, 2016年05月, 査読有り
      • Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study)
        Hidetoshi Katsuno; Koutarou Maeda; Masatoshi Ohya; Kazuhiko Yoshioka; Akira Tsunoda; Keiji Koda; Hiroyoshi Matsuoka; Hiroki Ohge; Satoshi Morita; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
        Journal of Gastroenterology, 2016年03月01日, 査読有り
      • Effects of exenatide and liraglutide on 24-hour glucose fluctuations in type 2 diabetes
        Jo Nagakura; Tadashi Yamakawa; Masataka Taguri; Hirohisa Tsuchiya; Erina Shigematsu; Jun Suzuki; Satoshi Morita; Kazuaki Kadonosono; Yasuo Terauchi
        ENDOCRINE JOURNAL, 2016年03月, 査読有り
      • A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey
        Rika Sakai; Masataka Taguri; Kumi Oshima; Takehiko Mori; Hiroatsu Ago; Souichi Adachi; Satoshi Morita; Shuichi Taniguchi; Takahiro Fukuda; Kazuteru Ohashi; Tetsuya Eto; Koichi Miyamura; Koji Iwato; Naoki Kobayashi; Heiwa Kanamori; Yasuo Morishima; Tokiko Nagamura-Inoue; Hisashi Sakamaki; Yoshiko Atsuta; Makoto Murata
        INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016年03月, 査読有り
      • A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey
        R. Sakai; M. Taguri; K. Oshima; T. Mori; H. Ago; S. Adachi; S. Morita; S. Taniguchi; T. Fukuda; K. Ohashi; T. Eto; K. Miyamura; K. Iwato; N. Kobayashi; H. Kanamori; Y. Morishima; T. Nagamura-Inoue; H. Sakamaki; Y. Atsuta; M. Murata
        Int J Hematol, 2016年03月
      • Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study
        Naoko Sueoka-Aragane; Nobuyuki Katakami; Miyako Satouchi; Soichiro Yokota; Keisuke Aoe; Kentaro Iwanaga; Kojiro Otsuka; Satoshi Morita; Shinya Kimura; Shunichi Negoro
        CANCER SCIENCE, 2016年02月, 査読有り
      • Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial)
        Enyu Imai; Shoichi Maruyama; Masaomi Nangaku; Hideki Hirakata; Terumasa Hayashi; Ichiei Narita; Hideki Kono; Eiji Nakatani; Satoshi Morita; Yoshiharu Tsubakihara; Tadao Akizawa
        CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016年02月, 査読有り
      • Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.
        Kou T; Kanai M; Yamamoto M; Xue P; Mori Y; Kudo Y; Kurita A; Uza N; Kodama Y; Asada M; Kawaguchi M; Masui T; Mizumoto M; Yazumi S; Matsumoto S; Takaori K; Morita S; Muto M; Uemoto S; Chiba T
        International journal of clinical oncology, 2016年02月, 査読有り
      • Clinical and Radiographic Comparison of Influenza Virus-associated Pneumonia among Three Viral Subtypes
        Takashi Ishiguro; Noboru Takayanagi; Tetsu Kanauchi; Ryuji Uozumi; Eriko Kawate; Yotaro Takaku; Naho Kagiyama; Yoshihiko Shimizu; Toshiko Hoshi; Satoshi Morita; Yutaka Sugita
        INTERNAL MEDICINE, 2016年, 査読有り
      • The Long-term Clinical Course of Chronic Eosinophilic Pneumonia
        Takashi Ishiguro; Noboru Takayanagi; Ryuji Uozumi; Mami Tada; Naho Kagiyama; Yotaro Takaku; Yoshihiko Shimizu; Yutaka Sugita; Satoshi Morita
        INTERNAL MEDICINE, 2016年, 査読有り
      • Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review.
        Uneno Y; Yokoyama A; Nishikawa Y; Funakoshi T; Ozaki Y; Aoyama I; Baba K; Yamaguchi D; Morita S; Mori Y; Kanai M; Kinoshita H; Inoue T; Sawamoto N; Matsumoto R; Matsumoto S; Muto M
        Internal medicine (Tokyo, Japan), 2016年, 査読有り
      • Prognostic Significance of Preoperative Neutrophil–Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection
        Yusuke Takahashi; Hirotoshi Horio; Tai Hato; Masahiko Harada; Noriyuki Matsutani; Satoshi Morita; Masafumi Kawamura
        Annals of Surgical Oncology, 2015年12月01日, 査読有り
      • Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO)
        Taishi Hata; Michitaka Honda; Michiya Kobayashi; Akihiro Toyokawa; Masahiro Tsuda; Yukihiko Tokunaga; Kozo Takase; Masakazu Miyake; Satoshi Morita; Naoki Nagata; Junichi Sakamoto; Masahiko Gosho; Hideyuki Mishima
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015年12月, 査読有り
      • Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
        Jun Imagawa; Hideo Tanaka; Masaya Okada; Hirohisa Nakamae; Masayuki Hino; Kazunori Murai; Yoji Ishida; Takashi Kumagai; Seiichi Sato; Kazuteru Ohashi; Hisashi Sakamaki; Hisashi Wakita; Nobuhiko Uoshima; Yasunori Nakagawa; Yosuke Minami; Masahiro Ogasawara; Tomoharu Takeoka; Hiroshi Akasaka; Takahiko Utsumi; Naokuni Uike; Tsutomu Sato; Sachiko Ando; Kensuke Usuki; Satoshi Morita; Junichi Sakamoto; Shinya Kimura
        LANCET HAEMATOLOGY, 2015年12月, 査読有り
      • Oral Food Intake Versus Fasting on Postoperative Pancreatic Fistula After Distal Pancreatectomy: A Multi-Institutional Randomized Controlled Trial.
        Tsutomu Fujii; Suguru Yamada; Kenta Murotani; Yukiyasu Okamura; Kiyoshi Ishigure; Mitsuro Kanda; Shin Takeda; Satoshi Morita; Akimasa Nakao; Yasuhiro Kodera
        Medicine, 2015年12月, 査読有り
      • Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)
        Sadahiro, Sotaro; Morita, Satoshi; Sasaki, Kazuaki; Sakamoto, Kazuhiro; Ohge, Hiroki; Takahashi, Takao; Tsuchiya, Takashi; Sato, Toshihiko; Kondo, Ken; Ogata, Yutaka; Masuko, Hiroyuki; Baba, Hideo; Maeda, Kiyoshi; Hamada, Madoka; Itabashi, Michio; Nishimu
        CLINICAL COLORECTAL CANCER, 2015年12月, 査読有り
      • Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
        Junzo Hamanishi; Masaki Mandai; Takafumi Ikeda; Manabu Minami; Atsushi Kawaguchi; Toshinori Murayama; Masashi Kanai; Yukiko Mori; Shigemi Matsumoto; Shunsuke Chikuma; Noriomi Matsumura; Kaoru Abiko; Tsukasa Baba; Ken Yamaguchi; Akihiko Ueda; Yuko Hosoe; Satoshi Morita; Masayuki Yokode; Akira Shimizu; Tasuku Honjo; Ikuo Konishi
        Journal of Clinical Oncology, 2015年12月, 査読有り
      • Influence of Food Intake on the Healing Process of Postoperative Pancreatic Fistula After Pancreatoduodenectomy: A Multi-institutional Randomized Controlled Trial.
        Tsutomu Fujii; Akimasa Nakao; Kenta Murotani; Yukiyasu Okamura; Kiyoshi Ishigure; Tsuyoshi Hatsuno; Mitsuru Sakai; Suguru Yamada; Mitsuro Kanda; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Yasuhiro Kodera
        Annals of surgical oncology, 2015年11月, 査読有り
      • A new approach to collecting biobank and bioinformatics data at Kyoto University Cancer Center
        Muto Manabu; Uneno Yu; Nishikawa Yoshitaka; Mori Yukiko; Kanai Masashi; Mastumoto Shigemi; Kato Genta; Kuroda Tomohiro; Morita Satoshi; Okuno Yasushi
        ANNALS OF ONCOLOGY, 2015年11月, 査読有り
      • Introduction of clinical sequence using a comprehensive cancer gene panel (OncoPrime) to daily clinical practice
        Kanai Masashi; Sakuma Tomohiro; Yanagisawa Koji; Koyanagi Tomoyoshi; Matsumoto Shigemi; Kuroda Tomohiro; Morita Satoshi; Kosugi Shinji; Okuno Yasushi
        ANNALS OF ONCOLOGY, 2015年11月, 査読有り
      • Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
        Taroh Satoh; Kyung Hee Lee; Sun Young Rha; Yasutsuna Sasaki; Se Hoon Park; Yoshito Komatsu; Hirofumi Yasui; Tae-You Kim; Kensei Yamaguchi; Nozomu Fuse; Yasuhide Yamada; Takashi Ura; Si-Young Kim; Masaki Munakata; Soh Saitoh; Kazuto Nishio; Satoshi Morita; Eriko Yamamoto; Qingwei Zhang; Jung-mi Kim; Yeul Hong Kim; Yuh Sakata
        GASTRIC CANCER, 2015年10月, 査読有り
      • Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: Results of the D-first study
        Noriyoshi Iriyama; Shin Fujisawa; Chikashi Yoshida; Hisashi Wakita; Shigeru Chiba; Shinichiro Okamoto; Kimihiro Kawakami; Naoki Takezako; Takashi Kumagai; Koiti Inokuchi; Kazuma Ohyashiki; Jun Taguchi; Shingo Yano; Tadahiko Igarashi; Yasuji Kouzai; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki
        American Journal of Hematology, 2015年09月01日, 査読有り
      • Bayesian response adaptive randomization using longitudinal outcomes
        Tomoyoshi Hatayama; Satoshi Morita; Kentaro Sakamaki
        PHARMACEUTICAL STATISTICS, 2015年09月, 査読有り
      • A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911
        Kazuhiko Yamada; Hiromi Aono; Yukio Hosomi; Hiroaki Okamoto; Terufumi Kato; Yuko Komase; Masanori Nishikawa; Koichi Azuma; Hiroaki Takeoka; Yusuke Okuma; Yoshiro Nakahara; Akira Sato; Mari S. Oba; Satoshi Morita; Hideo Kunitoh; Koshiro Watanabe
        EUROPEAN JOURNAL OF CANCER, 2015年09月, 査読有り
      • Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer
        Yoshito Komatsu; Chikashi Ishioka; Ken Shimada; Yasuhide Yamada; Makio Gamoh; Atsushi Sato; Tatsuro Yamaguchi; Satoshi Yuki; Satoshi Morita; Shin Takahashi; Rei Goto; Minoru Kurihara
        BMC CANCER, 2015年09月, 査読有り
      • Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients
        Bando,H; Masuda,N; Nakamura,R; Kondo,N; Kuroi,K; Akiyoshi,S; Ohtani,S; Toshimi,T; Inoue,K; Yanagida,Y; Ishiguro,H; Shimizu,S; Aogi,K; Amano,S; Ozaki,S; Iguchi-Manaka,A; Kasai,H; Morita,S; Kataoka,T. R; Toi,M
        EUROPEAN JOURNAL OF CANCER, 2015年09月, 査読有り
      • Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy
        Yamashita,T; Masuda,N; Yamamoto,N; Kondo,N; Bando,H; Akiyoshi,S; Ohtani,S; Takano,T; Inoue,K; Fujisawa,T; Ishiguro,H; Nakayama,H; Aogi,K; Amano,S; Ozaki,H; Yasojima,H; Kasai,H; Kataoka,T. R; Morita,S; Toi,M
        EUROPEAN JOURNAL OF CANCER, 2015年09月, 査読有り
      • Gender differences in patients undergoing surgery for acute type A aortic dissection
        Toshihiro Fukui; Minoru Tabata; Satoshi Morita; Shuichiro Takanashi
        Journal of Thoracic and Cardiovascular Surgery, 2015年09月01日, 査読有り
      • Retrospective efficacy and safety analyses of erlotinib, pemetrexed, and docetaxel in EGFR-mutation-negative patients with previously treated advanced non-squamous non-small-cell lung cancer.
        Nishiyama A; Katakami N; Yoshioka H; Iwasaku M; Korogi Y; Hata A; Takeshita J; Otsuka K; Nishino K; Uchida J; Okuyama T; Namba Y; Mori M; Fujita S; Morita S
        Lung cancer (Amsterdam, Netherlands), 2015年09月, 査読有り
      • A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)
        Kazumi Nishino; Fumio Imamura; Toru Kumagai; Nobuyuki Katakami; Akito Hata; Chiyuki Okuda; Yoshiko Urata; Yosihihiro Hattori; Motoko Tachihara; Souichirou Yokota; Takashi Nishimura; Toshihiko Kaneda; Miyako Satouchi; Satoshi Morita; Shunichi Negoro
        LUNG CANCER, 2015年08月, 査読有り
      • Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
        Kozo Yoshikawa; Mitsuo Shimada; Go Wakabayashi; Koichiro Ishida; Takashi Kaiho; Yuko Kitagawa; Junichi Sakamoto; Norio Shiraishi; Keisuke Koeda; Erito Mochiki; Yoshiro Saikawa; Kazuya Yamaguchi; Masayuki Watanabe; Satoshi Morita; Seigo Kitano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
        JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015年08月, 査読有り
      • Detecting overall survival benefit derived from survival postprogression rather than progression-free survival.
        Satoshi Morita; Kentaro Sakamaki; Guosheng Yin
        Journal of the National Cancer Institute, 2015年08月, 査読有り
      • HER2陰性局所進行乳癌に対するアンスラサイクリン-タキサン-エリブリン逐次療法の有用性確認試験(JBCRG-17)
        増田 慎三; 深田 一平; 近藤 直人; 大谷 彰一郎; 服部 正也; 小坂 泰二郎; 田辺 真彦; 増野 浩二郎; 松並 展輝; 澤木 正孝; 柏葉 匡寛; 川端 英孝; 相良 安昭; 黒井 克昌; 森田 智視; 大野 真司; 戸井 雅和; 伊藤 良則
        日本乳癌学会総会プログラム抄録集, 2015年07月
      • pCRの意義を問う HER2陽性乳癌における術前Dual-HER2 blockage療法±ホルモン療法の検討(Neo-LaTH、JBCRG-16試験)
        山本 尚人; 増田 慎三; 近藤 直人; 坂東 裕子; 黒井 克昌; 大野 真司; 宮本 健志; 檜垣 健二; 高野 利実; 井上 賢一; 中村 力也; 清水 哲; 石黒 洋; 青儀 健二郎; 天野 定雄; 山城 大泰; 笠井 宏委; 森田 智視; 桜井 孝規; 戸井 雅和
        日本乳癌学会総会プログラム抄録集, 2015年07月
      • Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212)
        Tomoyuki Otsuka; Masahde Mori; Yukihiro Yano; Junji Uchida; Kazumi Nishino; Reiko Kaji; Akito Hata; Yoshihiro Hattori; Yoshiko Urata; Toshihiko Kaneda; Motoko Tachihara; Fumio Imamura; Nobuyuki Katakami; Shunichi Negoro; Satoshi Morita; Soichiro Yokota
        ANTICANCER RESEARCH, 2015年07月, 査読有り
      • Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
        Chu Matsuda; Yoshinori Munemoto; Hideyuki Mishima; Naoki Nagata; Mitsuru Oshiro; Masato Kataoka; Junichi Sakamoto; Toru Aoyama; Satoshi Morita; Toru Kono
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015年07月, 査読有り
      • A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment
        H. Fujikawa; K. Sakamaki; T. Kawabe; T. Hayashi; T. Aoyama; T. Sato; T. Oshima; Y. Rino; S. Morita; M. Masuda; T. Ogata; H. Cho; T. Yoshikawa
        ANNALS OF SURGICAL ONCOLOGY, 2015年07月, 査読有り
      • A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
        Hata A; Katakami N; Fujita S; Nanjo S; Takeshita J; Tanaka K; Kaneda T; Nishiyama A; Nishimura T; Nakagawa A; Otsuka K; Morita S; Urata Y; Negoro S
        Cancer chemotherapy and pharmacology, 2015年06月, 査読有り
      • Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.
        Hashimoto N; Tsuboi A; Kagawa N; Chiba Y; Izumoto S; Kinoshita M; Kijima N; Oka Y; Morimoto S; Nakajima H; Morita S; Sakamoto J; Nishida S; Hosen N; Oji Y; Arita N; Yoshimine T; Sugiyama H
        Cancer immunology, immunotherapy : CII, 2015年06月, 査読有り
      • Durable tumor remission in patients with platinum-resistant ovarian cancer receiving nivolumab.
        Hamanishi Junzo; Mandai Masaki; Ikeda Takafumi; Minami Manabu; Kawaguchi Atsushi; Matsumura Noriomi; Abiko Kaoru; Baba Tsukasa; Yamaguchi Ken; Ueda Akihiko; Hosoe Yuko; Morita Satoshi; Shimizu Akira; Honjo Tasuku; Konishi Ikuo
        JOURNAL OF CLINICAL ONCOLOGY, 2015年05月20日, 査読有り
      • Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry
        Yasuhiro Hamatani; Hisashi Ogawa; Ryuji Uozumi; Moritake Iguchi; Yugo Yamashita; Masahiro Esato; Yeong-Hwa Chun; Hikari Tsuji; Hiromichi Wada; Koji Hasegawa; Mitsuru Abe; Satoshi Morita; Masaharu Akao
        CIRCULATION JOURNAL, 2015年05月, 査読有り
      • Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
        Yasuhide Miyoshi; Kazumi Noguchi; Masahiro Yanagisawa; Masataka Taguri; Satoshi Morita; Ichiro Ikeda; Kiyoshi Fujinami; Takeshi Miura; Kazuki Kobayashi; Hiroji Uemura
        BMC CANCER, 2015年05月, 査読有り
      • Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial
        Kazuhiro Nishikawa; Kazumasa Fujitani; Hitoshi Inagaki; Yusuke Akamaru; Shinya Tokunaga; Masakazu Takagi; Shigeyuki Tamura; Naotoshi Sugimoto; Tadashi Shigematsu; Takaki Yoshikawa; Tohru Ishiguro; Masato Nakamura; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto; Toshimasa Tsujinaka
        EUROPEAN JOURNAL OF CANCER, 2015年05月, 査読有り
      • Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation.
        Fukuhara T; Maemondo M; Inoue A; Kobayashi K; Sugawara S; Oizumi S; Isobe H; Gemma A; Harada M; Yoshizawa H; Kinoshita I; Fujita Y; Saijo Y; Hagiwara K; Morita S; Nukiwa T
        Lung cancer (Amsterdam, Netherlands), 2015年05月, 査読有り
      • Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group
        Noriyoshi Iriyama; Shin Fujisawa; Chikashi Yoshida; Hisashi Wakita; Shigeru Chiba; Shinichiro Okamoto; Kimihiro Kawakami; Naoki Takezako; Takashi Kumagai; Koiti Inokuchi; Kazuma Ohyashiki; Jun Taguchi; Shingo Yano; Tadahiko Igarashi; Yasuji Kouzai; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki
        American Journal of Hematology, 2015年04月01日, 査読有り
      • Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial
        Kazunari Misawa; Michitaka Fujiwara; Masahiko Ando; Seiji Ito; Yoshinari Mochizuki; Yuichi Ito; Eiji Onishi; Kiyoshi Ishigure; Yuki Morioka; Tsunenobu Takase; Takuya Watanabe; Yoshitaka Yamamura; Satoshi Morita; Yasuhiro Kodera
        GASTRIC CANCER, 2015年04月, 査読有り
      • A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial)
        Wasaburo Koizumi; Satoshi Morita; Yuh Sakata
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015年03月, 査読有り
      • Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis
        Manabu Morimoto; Kazushi Numata; Masaaki Kondo; Satoshi Kobayashi; Shinichi Ohkawa; Hisashi Hidaka; Takahide Nakazawa; Yusuke Okuwaki; Chiaki Okuse; Kotaro Matsunaga; Michihiro Suzuki; Satoshi Morita; Masataka Taguri; Katsuaki Tanaka
        HEPATOLOGY RESEARCH, 2015年03月, 査読有り
      • Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer
        Masatsugu Hamaji; Fengshi Chen; Yukinori Matsuo; Atsushi Kawaguchi; Satoshi Morita; Nami Ueki; Makoto Sonobe; Yasushi Nagata; Masahiro Hiraoka; Hiroshi Date
        ANNALS OF THORACIC SURGERY, 2015年03月, 査読有り
      • Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting.
        Masaaki Kondo; Manabu Morimoto; Tomohiro Ishii; Akito Nozaki; Hiroyuki Fukuda; Kazushi Numata; Satoshi Kobayashi; Shinichi Ohkawa; Hisashi Hidaka; Takahide Nakazawa; Akitaka Shibuya; Chiaki Okuse; Michihiro Suzuki; Kentaro Sakamaki; Satoshi Morita; Shin Maeda; Katsuaki Tanaka
        Journal of digestive diseases, 2015年03月, 査読有り
      • Decreased plasma levels of active glucagon-like peptide-1 in coronary artery disease.
        Eiichi Akiyama; Seigo Sugiyama; Junichi Matsubara; Hirofumi Kurokawa; Masaaki Konishi; Toshimitsu Nozaki; Keisuke Ohba; Kouichirou Fujisue; Hirofumi Maeda; Kenji Sakamoto; Koichi Sugamura; Hitoshi Sumida; Hideaki Jinnouchi; Kentaro Sakamaki; Satoshi Morita; Kazuo Kimura; Satoshi Umemura; Hisao Ogawa
        Journal of the American College of Cardiology, 2015年02月24日, 査読有り
      • A Methylene Blue-assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer A Prospective, Randomized, Controlled Study
        Toru Aoyama; Hirohito Fujikawa; Haruhiko Cho; Takashi Ogata; Junya Shirai; Tsutomu Hayashi; Yasushi Rino; Munetaka Masuda; Mari S. Oba; Satoshi Morita; Takaki Yoshikawa
        AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015年02月, 査読有り
      • A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors
        Hattori Y; Satouchi M; Shimada T; Urata Y; Yoneda T; Mori M; Nishimura T; Sunadome H; Kumagai T; Imamura F; Fujita S; Kaji R; Hata A; Tachihara M; Morita S; Negoro S
        Lung cancer (Amsterdam, Netherlands), 2015年02月, 査読有り
      • A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)
        Masashi Kanai; Etsuro Hatano; Shogo Kobayashi; Yutaka Fujiwara; Shigeru Marubashi; Atsushi Miyamoto; Hisanori Shiomi; Shoji Kubo; Shinichi Ikuta; Hiroaki Yanagimoto; Hiroaki Terajima; Hisashi Ikoma; Daisuke Sakai; Yuzo Kodama; Satoru Seo; Satoshi Morita; Tetsuo Ajiki; Hiroaki Nagano; Tatsuya Ioka
        Cancer Chemotherapy and Pharmacology, 2015年02月, 査読有り
      • Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.
        Yamshiro H; Iwata H; Masuda N; Yamamoto N; Nishimura R; Ohtani S; Sato N; Takahashi M; Kamio T; Yamazaki K; Saito T; Kato M; Lee T; Ohno S; Kuroi K; Takano T; Takada M; Yasuno S; Morita S; Toi M
        Int J Clin Oncol, 2015年02月, 査読有り
      • Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001)
        Mitsuo Shimada; Yuji Morine; Hiroaki Nagano; Etsuro Hatano; Takashi Kaiho; Masaru Miyazaki; Toru Kono; Toshiya Kamiyama; Satoshi Morita; Junichi Sakamoto; Mitsuo Kusano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
        INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015年02月, 査読有り
      • Prognostic model for survival in patients with advanced pancreatic cancer receiving palliative chemotherapy.
        Uneno Yu; Kou Tadayuki; Kanai Masashi; Yamamoto Michio; Xue Peng; Mori Yukiko; Kudo Yasushi; Kurita Akira; Uza Norimitsu; Kodama Yuzo; Asada Masanori; Masui Toshihiko; Yazumi Shujiro; Matsumoto Shigemi; Takaori Kyoichi; Morita Satoshi; Muto Manabu; Chiba Tsutomu
        JOURNAL OF CLINICAL ONCOLOGY, 2015年01月20日, 査読有り
      • Incorporating Historical Data in Bayesian Phase I Trial Design: The Caucasian-to-Asian Toxicity Tolerability Problem
        Kentaro Takeda; Satoshi Morita
        Therapeutic Innovation and Regulatory Science, 2015年01月17日, 査読有り
      • Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: A randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902)
        Hidetoshi Katsuno; Koutarou Maeda; Takashi Kaiho; Katsuyuki Kunieda; Kimihiko Funahashi; Junichi Sakamoto; Toru Kono; Hirotoshi Hasegawa; Yoshiyuki Furukawa; Yoshihiro Imazu; Satoshi Morita; Masahiko Watanabe
        Japanese Journal of Clinical Oncology, 2015年, 査読有り
      • A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer who relapsed after S-1 adjuvant therapy, XP after TS-1 adjuvant failure (XParTS)
        Masazumi Takahashi; Akira Tsuburaya; Kazuhiro Nishikawa; Kazuaki Tanabe; Kensei Yamaguchi; Shigefumi Yoshino; Tsutomu Namikawa; Takaki Yoshikawa; Yasushi Rino; Junji Kawada; Akihito Tsuji; Koichi Taira; Ryohei Kawabata; Yasuhiro Kodera; Yoshinori Hirashima; Hiroshi Yabusaki; Naoki Hirabayashi; Kazumasa Fujitani; Satoshi Morita; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2015年01月, 査読有り
      • The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer
        Masato Nakamura; Yasuhide Yamada; Kei Muro; Keiichi Takahashi; Hideo Baba; Yasutsuna Sasaki; Yoshito Komatsu; Taroh Satoh; Hideyuki Mishima; Masahiko Watanabe; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Kenichi Sugihara
        FUTURE ONCOLOGY, 2015年, 査読有り
      • Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial
        Naoki Sakane; Kazuhiko Kotani; Kaoru Takahashi; Yoshiko Sano; Kokoro Tsuzaki; Kentaro Okazaki; Juichi Sato; Sadao Suzuki; Satoshi Morita; Yoshitake Oshima; Kazuo Izumi; Masayuki Kato; Naoki Ishizuka; Mitsuhiko Noda; Hideshi Kuzuya
        BMJ OPEN, 2015年, 査読有り
      • A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study
        Hirofumi Yasui; Kei Muro; Yasuhiro Shimada; Akihito Tsuji; Shinichi Sameshima; Hideo Baba; Taroh Satoh; Tadamichi Denda; Kenji Ina; Tomohiro Nishina; Kensei Yamaguchi; Taito Esaki; Shinya Tokunaga; Hiroyuki Kuwano; Narikazu Boku; Yoshito Komatsu; Masahiko Watanabe; Ichinosuke Hyodo; Satoshi Morita; Kenichi Sugihara
        JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015年01月, 査読有り
      • Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.
        Kaido T; Morita S; Tanaka S; Ogawa K; Mori A; Hatano E; Uemoto S
        Disease markers, 2015年, 査読有り
      • The Pathological Response to Anthracycline is Associated with Topoisomerase IIα Gene Amplification in the HER2 Breast Cancer Subset.
        Takashi Ishikawa; Takeshi Sasaki; Mikiko Tanabe; Kazutaka Narui; Kumiko Kida; Kazuhiro Shimada; Daisuke Shimizu; Akimitsu Yamada; Satoshi Morita; Mari S Oba; Kae Kawachi; Akinori Nozawa; Yasushi Ichikawa; Kazuaki Takabe; Itaru Endo
        Journal of surgery and science, 2014年12月
      • The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis
        T. Mihara; K. Uchimoto; S. Morita; T. Goto
        ANAESTHESIA, 2014年12月, 査読有り
      • A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study).
        Yasuo Hamamoto; Tatsuro Yamaguchi; Tomohiro Nishina; Kentaro Yamazaki; Takashi Ura; Takako Nakajima; Ayumu Goto; Ken Shimada; Norisuke Nakayama; Junichi Sakamoto; Satoshi Morita; Yasuhide Yamada
        The oncologist, 2014年11月, 査読有り
      • Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis
        Yukinori Matsuo; Fengshi Chen; Masatsugu Hamaji; Atsushi Kawaguchi; Nami Ueki; Yasushi Nagata; Makoto Sonobe; Satoshi Morita; Hiroshi Date; Masahiro Hiraoka
        EUROPEAN JOURNAL OF CANCER, 2014年11月, 査読有り
      • 未治療進行EGFR遺伝子変異陽性肺がんに対するゲフィチニブ治療後のプラチナ併用化学療法の有効性の検討
        宮内 栄作; 井上 彰; 小林 国彦; 前門戸 任; 菅原 俊一; 大泉 聡史; 磯部 宏; 弦間 昭彦; 西條 康夫; 吉澤 弘久; 森田 智視; 萩原 弘一; 貫和 敏博
        肺癌, 2014年10月
      • Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation
        Satoshi Morita; Hideharu Yamamoto; Yasuo Sugitani
        STATISTICS IN MEDICINE, 2014年10月, 査読有り
      • Wilms' tumor gene 1 (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer
        Koido Shigeo; Nishida Sumiyuki; Homma Sadamu; Takeda Yutaka; Komita Hideo; Morita Satoshi; Ito Toshinori; Morimoto Soyoko; Oka Yoshihiro; Yanagisawa Satoru; Toyama Yoichi; Ikegami Masahiro; Nagano Hiroaki; Ohkusa Toshifumi; Tajiri Hisao; Sugiyama Haruo
        CANCER RESEARCH, 2014年10月01日, 査読有り
      • Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial
        Toshio Ogihara; Takao Saruta; Hiromi Rakugi; Ikuo Saito; Kazuaki Shimamoto; Hiroaki Matsuoka; Kazuyuki Shimada; Sadayoshi Ito; Masatsugu Horiuchi; Tsutomu Imaizumi; Shuichi Takishita; Jitsuo Higaki; Shigehiro Katayama; Genjiroh Kimura; Satoshi Umemura; Nobuyuki Ura; Koichi Hayashi; Masato Odawara; Norio Tanahashi; Toshihiko Ishimitsu; Naoki Kashihara; Satoshi Morita; Satoshi Teramukai
        JOURNAL OF HYPERTENSION, 2014年10月, 査読有り
      • Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study.
        Shogo Kobayashi; Hiroaki Nagano; Daisuke Sakai; Hidetoshi Eguchi; Etsuro Hatano; Masashi Kanai; Satoru Seo; Kojiro Taura; Yutaka Fujiwara; Tetsuo Ajiki; Shigekazu Takemura; Shoji Kubo; Hiroaki Yanagimoto; Hideyoshi Toyokawa; Akihito Tsuji; Hiroaki Terajima; Satoshi Morita; Tatsuya Ioka
        Cancer chemotherapy and pharmacology, 2014年10月, 査読有り
      • Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung Injury Mice Model
        Ken Murakami; Masataka Kohno; Masatoshi Kadoya; Hidetake Nagahara; Wataru Fujii; Takahiro Seno; Aihiro Yamamoto; Ryo Oda; Hiroyoshi Fujiwara; Toshikazu Kubo; Satoshi Morita; Hiroshi Nakada; Timothy Hla; Yutaka Kawahito
        PLoS ONE, 2014年09月08日, 査読有り
      • Observational Study of Axilla Treatment for Breast Cancer Patients with 1-3 Positive Micrometastases or Macrometastases in Sentinel Lymph Nodes
        Mari S. Oba; Shigeru Imoto; Uhi Toh; Noriaki Wada; Masaya Kawada; Masahiro Kitada; Norikazu Masuda; Tetsuya Taguchi; Shigeki Minami; Hiromitsu Jinno; Junichi Sakamoto; Satoshi Morita
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014年09月, 査読有り
      • Low Creatinine Clearance is a Risk Factor for D2 Gastrectomy after Neoadjuvant Chemotherapy
        Tsutomu Hayashi; Toru Aoyama; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takashi Ogata; Haruhiko Cho; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto; Takaki Yoshikawa
        ANNALS OF SURGICAL ONCOLOGY, 2014年09月, 査読有り
      • Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs
        Takashi Ogura; Satoshi Morita; Kan Yonemori; Takahiro Nonaka; Tsutomu Urano
        THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014年09月, 査読有り
      • Diagnostic Value of Computed Tomography for Staging of Clinical T1 Gastric Cancer
        H. Fujikawa; T. Yoshikawa; S. Hasegawa; T. Hayashi; T. Aoyama; T. Ogata; H. Cho; T. Oshima; Y. Rino; S. Morita; M. Masuda
        ANNALS OF SURGICAL ONCOLOGY, 2014年09月, 査読有り
      • Optimal Duration of Dual Antiplatelet Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Japanese Patients with Coronary Artery Disease (OPERA): Study Design and Rationale
        Masato Nakamura; Shinsuke Nanto; Atsushi Hirayama; Tadateru Takayama; Masakatsu Nishikawa; Kazuo Kimura; Satoshi Morita; Tadanori Aizawa; Ryuta Asano; Yuji Matsumaru; Chikuma Hamada; Takaaki Isshiki
        CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014年09月, 査読有り
      • Macroscopic Type Is a Prognostic Factor for Recurrence-free Survival After Resection of Gastric GIST
        Hiroshi Miyamoto; Chikara Kunisaki; Yuichi Otsuka; Masazumi Takahashi; Ryo Takagawa; Koichiro Misuta; Kunio Kameda; Hirochika Makino; Goro Matsuda; Naotaka Yamaguchi; Noriyuki Kamiya; Takashi Murakami; Satoshi Morita; Hirotoshi Akiyama; Itaru Endo
        ANTICANCER RESEARCH, 2014年08月, 査読有り
      • Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
        Hiroyuki Fukuda; Kazushi Numata; Satoshi Moriya; Yu Shimoyama; Tomohiro Ishii; Akito Nozaki; Masaaki Kondo; Manabu Morimoto; Shin Maeda; Kentaro Sakamaki; Satoshi Morita; Katsuaki Tanaka
        Radiology, 2014年08月, 査読有り
      • A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer
        N. Masuda; K. Higaki; T. Takano; N. Matsunami; T. Morimoto; S. Ohtani; M. Mizutani; T. Miyamoto; K. Kuroi; S. Ohno; S. Morita; M. Toi
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014年08月, 査読有り
      • Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
        Tsutomu Takashima; Takahiro Nakayama; Katsuhide Yoshidome; Hidemi Kawajiri; Shunji Kamigaki; Junji Tsurutani; Takashi Arai; Toshikazu Ito; Yoshihumi Komoike; Takako Doi; Norikazu Masuda; Keisuke Miyauchi; Yasuo Miyoshi; Junichi Sakamoto; Satoshi Morita; Tetsuya Taguchi
        ANTICANCER RESEARCH, 2014年07月, 査読有り
      • Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
        Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
        The Lancet. Oncology, 2014年07月, 査読有り
      • Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn's disease
        Tomohiko Sasaki; Tomohiko Sasaki; Tomohiko Sasaki; Reiko Kunisaki; Hiroto Kinoshita; Hideaki Kimura; Teruaki Kodera; Akinori Nozawa; Akiho Hanzawa; Naomi Shibata; Hiromi Yonezawa; Eiji Miyajima; Satoshi Morita; Shoichi Fujii; Kazushi Numata; Katsuaki Tanaka; Masanori Tanaka; Shin Maeda
        BMC Research Notes, 2014年06月14日, 査読有り
      • The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
        Manabu Kakizoe; Masahiro Yao; Ukihide Tateishi; Ryogo Minamimoto; Daiki Ueno; Kazuhiro Namura; Kazuhide Makiyama; Narihiko Hayashi; Futoshi Sano; Takeshi Kishida; Kazuki Kobayashi; Sumio Noguchi; Ichiro Ikeda; Yoshiharu Ohgo; Masataka Taguri; Satoshi Morita; Tomio Inoue; Yoshinobu Kubota; Noboru Nakaigawa
        BMC cancer, 2014年06月02日
      • Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
        Masanori Toyoda; Tetsuo Ajiki; Yutaka Fujiwara; Hiroaki Nagano; Shogo Kobayashi; Daisuke Sakai; Etsuro Hatano; Masashi Kanai; Shoji Nakamori; Atsushi Miyamoto; Akihito Tsuji; Satoshi Kaihara; Hisashi Ikoma; Shigekazu Takemura; Hideyoshi Toyokawa; Hiroaki Terajima; Satoshi Morita; Tatsuya Ioka
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014年06月, 査読有り
      • Prognostic factors in stage IB gastric cancer
        Toru Aoyama; Takaki Yoshikawa; Hirohito Fujikawa; Tsutomu Hayashi; Takashi Ogata; Haruhiko Cho; Takanobu Yamada; Shinichi Hasegawa; Kazuhito Tsuchida; Norio Yukawa; Takashi Oshima; Mari S. Oba; Satoshi Morita; Yasushi Rino; Munetaka Masuda
        WORLD JOURNAL OF GASTROENTEROLOGY, 2014年06月, 査読有り
      • Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group.
        Cho H; Yoshikawa T; Oba MS; Hirabayashi N; Shirai J; Aoyama T; Hayashi T; Yamada T; Oba K; Morita S; Sakamoto J; Tsuburaya A
        Annals of surgical oncology, 2014年06月, 査読有り
      • Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study
        Takaki Yoshikawa; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takanori Matsui; Yutaka Kimura; Shinichi Hasegawa; Toru Aoyama; Tsutomu Hayashi; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto
        ANNALS OF SURGICAL ONCOLOGY, 2014年06月, 査読有り
      • A randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment for metastatic colorectal cancer: West Japan Oncology Group study 4407G (WJOG4407G).
        Kentaro Yamazaki; Michitaka Nagase; Hiroshi Tamagawa; Shinya Ueda; Takao Tamura; Kohei Murata; Takashi Tsuda; Eishi Baba; Masahiro Tsuda; Toshikazu Moriwaki; Taito Esaki; Yasushi Tsuji; Kei Muro; Koichi Taira; Tadamichi Denda; Takahiro Tsushima; Masahiko Ando; Satoshi Morita; Narikazu Boku; Ichinosuke Hyodo
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • Two phase III studies comparing 6 months of either mFOLFOX6 or XELOX with 3 months of the same regimen as adjuvant chemotherapy in patients with completely resected stage III colon cancer (ACHIEVE) or high-risk stage II colon cancer (ACHIEVE-2).
        Takayuki Yoshino; Toshiaki Watanabe; Masaki Mori; Atsushi Ohtsu; Tsunekazu Mizushima; Kentaro Yamazaki; Eiji Sunami; Kunlaki Shirao; Atsushi Sato; Satoshi Morita; Takeharu Yamanaka; Axel Gzothey; Daniel J. Sargent; Junichi Sakamoto; Shigetoyo Saji
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • An internally and externally validated nomogram to predict severe neutropenia in Japanese patients (pts) with advanced colorectal cancer (aCRC) treated with irinotecan (IR1)-based regimens.
        Wataru Ichikawa; Keisuke Uehara; Keisuke Minamimura; Chihiro Tanaka; Yasumasa Takii; Hideaki Miyauchi; Sotaro Sadahiro; Ken-ichi Fujita; Toshikazu Moriwaki; Masato Nakamura; Takehiro Takahashi; Akihito Tsuji; Katsunori Shinozaki; Satoshi Morita; Yuichi Ando; Yukihiro Okutani; Masahiro Sugihara; Toru Sugiyama; Yasuo Ohashi; Yuh Sakata
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • First-line gemcitabine versus treatment of physician's choice in patients with metastatic and stage IV breast cancer: A prospective cohort study
        Kazutaka Narui; Takashi Ishikawa; Kazuhiro Shimada; Kumiko Kida; Daisuke Shimizu; Ikuko Ota; Kounosuke Kiuchi; Mikiko Tanabe; Mari Saito Oba; Satoshi Morita; Sadatoshi Sugae; Takako Doi; Satoshi Hasegawa; Tomoyuki Morita; Ayako Kito; Takashi Chishima; Yasushi Ichikawa; Itaru Endo
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial
        Shigehira Saji; Masakazu Toi; Takashi Ishikawa; Takanori Ishida; Shoichiro Ohtani; Masahiro Kashiwaba; Yasuaki Sagara; Shigenori E. Nagai; Yoshie Hasegawa; Tomomi Fujisawa; Norikazu Masuda; Koji Matsumoto; Yutaka Yamamoto; Hiroshi Yoshibayashi; Naruto Taira; Satoshi Morita; Shinji Ohno
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations: NEJ005/TCOG0902.
        Satoshi Oizumi; Shunichi Sugawara; Koichi Minato; Toshiyuki Harada; Akira Inoue; Yuka Fujita; Makoto Maemondo; Hirohisa Yoshizawa; Kazuhiko Ito; Akihiko Gemma; Masaru Nishitsuji; Masao Harada; Hiroshi Isobe; Ichiro Kinoshita; Satoshi Morita; Kunihiko Kobayashi; Koichi Hagiwara; Minoru Kurihara; Toshihiro Nukiwa
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月, 査読有り
      • Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
        Toru Aoyama; Kazuhiro Nishikawa; Nobuhiro Takiguchi; Kazuaki Tanabe; Motohiro Imano; Ryoji Fukushima; Junichi Sakamoto; Mari S. Oba; Satoshi Morita; Toru Kono; Akira Tsuburaya
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014年05月, 査読有り
      • Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)
        M. Takada; H. Ishiguro; S. Nagai; S. Ohtani; H. Kawabata; Y. Yanagita; Y. Hozumi; C. Shimizu; S. Takao; N. Sato; Y. Kosaka; Y. Sagara; H. Iwata; S. Ohno; K. Kuroi; N. Masuda; H. Yamashiro; M. Sugimoto; M. Kondo; Y. Naito; H. Sasano; T. Inamoto; S. Morita; M. Toi
        BREAST CANCER RESEARCH AND TREATMENT, 2014年05月, 査読有り
      • The Tandem Etalon Magnetograph of the Solar Magnetic Activity Research Telescope (SMART) at Hida Observatory
        Shin'ichi Nagata; Satoshi Morita; Kiyoshi Ichimoto; Keisuke Nishida; Yoshikazu Nakatani; Goichi Kimura; Naoki Kaneda; Reizaburou Kitai; Satoru UeNo; Takako T. Ishii
        PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 2014年04月, 査読有り
      • Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease
        Nobuyuki Horita; Naoki Miyazawa; Satoshi Morita; Ryota Kojima; Miyo Inoue; Yoshiaki Ishigatsubo; Takeshi Kaneko
        RESPIRATORY RESEARCH, 2014年04月, 査読有り
      • Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study
        Isamu Okamoto; Kazuko Sakai; Satoshi Morita; Hiroshige Yoshioka; Hiroyasu Kaneda; Koji Takeda; Tomonori Hirashima; Yoshihito Kogure; Tatsuo Kimura; Toshiaki Takahashi; Shinji Atagi; Takashi Seto; Toshiyuki Sawa; Masashi Yamamoto; Miyako Satouchi; Motoyasu Okuno; Seisuke Nagase; Koichi Takayama; Keisuke Tomii; Tadashi Maeda; Satoshi Oizumi; Shinji Fujii; Yusaku Akashi; Kazumi Nishino; Noriyuki Ebi; Kazuhiko Nakagawa; Yoichi Nakanishi; Kazuto Nishio
        ONCOTARGET, 2014年04月, 査読有り
      • Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients
        Nobuyuki Horita; Makiko Yomota; Masahiro Sasaki; Satoshi Morita; Masaharu Shinkai; Yoshiaki Ishigatsubo; Takeshi Kaneko
        CLINICAL RESPIRATORY JOURNAL, 2014年04月, 査読有り
      • The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer
        Jun Watanabe; Kenji Tatsumi; Mitsuyoshi Ota; Yusuke Suwa; Shinsuke Suzuki; Akira Watanabe; Atsushi Ishibe; Kazuteru Watanabe; Hirotoshi Akiyama; Yasushi Ichikawa; Satoshi Morita; Itaru Endo
        INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014年03月, 査読有り
      • Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study
        Toru Aoyama; Takaki Yoshikawa; Satoshi Morita; Junya Shirai; Hirohito Fujikawa; Kenichi Iwasaki; Tsutomu Hayashi; Takashi Ogata; Haruhiko Cho; Norio Yukawa; Takashi Oshima; Yasushi Rino; Munetaka Masuda; Akira Tsuburaya
        BMC CANCER, 2014年03月, 査読有り
      • A prospective randomized controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site infections in open and laparoscopic colorectal surgery
        Masakatsu Numata; Teni Godai; Junya Shirai; Kazuteru Watanabe; Daisuke Inagaki; Shinichi Hasegawa; Tsutomu Sato; Takashi Oshima; Shoichi Fujii; Chikara Kunisaki; Norio Yukawa; Yasushi Rino; Masataka Taguri; Satoshi Morita; Munetaka Masuda
        INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014年03月, 査読有り
      • Short-term results of a randomized study between laparoscopic and open surgery in elderly colorectal cancer patients
        Shoichi Fujii; Atsushi Ishibe; Mitsuyoshi Ota; Shigeru Yamagishi; Kazuteru Watanabe; Jun Watanabe; Amane Kanazawa; Yasushi Ichikawa; Mari Oba; Satoshi Morita; Yojiro Hashiguchi; Chikara Kunisaki; Itaru Endo
        SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2014年02月, 査読有り
      • Wilms Tumor Gene ( WT1) Peptide- based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer
        Sumiyuki Nishida; Shigeo Koido; Yutaka Takeda; Sadamu Homma; Hideo Komita; Akitaka Takahara; Satoshi Morita; Toshinori Ito; Soyoko Morimoto; Kazuma Hara; Akihiro Tsuboi; Yoshihiro Oka; Satoru Yanagisawa; Yoichi Toyama; Masahiro Ikegami; Toru Kitagawa; Hidetoshi Eguchi; Hiroshi Wada; Hiroaki Nagano; Jun Nakata; Yoshiki Nakae; Naoki Hosen; Yusuke Oji; Toshio Tanaka; Ichiro Kawase; Atsushi Kumanogoh; Junichi Sakamoto; Yuichiro Doki; Masaki Mori; Toshifumi Ohkusa; Hisao Tajiri; Haruo Sugiyama
        JOURNAL OF IMMUNOTHERAPY, 2014年02月, 査読有り
      • Small, Moderate, and Large Changes, and the Minimum Clinically Important Difference in the University of California, San Diego Shortness of Breath Questionnaire
        Nobuyuki Horita; Naoki Miyazawa; Satoshi Morita; Ryota Kojima; Naoko Kimura; Takeshi Kaneko; Yoshiaki Ishigatsubo
        COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014年02月, 査読有り
      • Androgen deprivation therapy prevents bladder cancer recurrence
        Koji Izumi; Masataka Taguri; Hiroshi Miyamoto; Yoshinori Hara; Takeshi Kishida; Kimio Chiba; Tetsuo Murai; Kotaro Hirai; Kotaro Suzuki; Kiyoshi Fujinami; Teiichiro Ueki; Koichi Udagawa; Kazuo Kitami; Masatoshi Moriyama; Yasuhide Miyoshi; Futoshi Tsuchiya; Ichiro Ikeda; Kazuki Kobayashi; Maho Sato; Satoshi Morita; Kazumi Noguchi; Hiroji Uemura
        Oncotarget, 2014年, 査読有り
      • Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy
        Jin Oshikawa; Yoshiyuki Toya; Satoshi Morita; Masataka Taguri; Kazushige Hanaoka; Toshio Hasegawa; Kazo Kaizu; Kouju Kamata; Shuzo Kobayashi; Takayasu Ohtake; Takeo Sato; Gen Yasuda; Kenjiro Kimura; Satoshi Umemura
        Clinical and Experimental Hypertension, 2014年, 査読有り
      • Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets
        N. Yamamoto; H. Yamaguchi; K. Ohmura; T. Yokoyama; H. Yoshifuji; N. Yukawa; D. Kawabata; T. Fujii; S. Morita; S. Nagata; T. Mimori
        Lupus, 2014年, 査読有り
      • A Continual Reassessment Method With Cohort Size Adaptation Based on Bayesian Posterior Probabilities in Phase I Dose-Finding Studies
        Tomoyuki Kakizume; Satoshi Morita
        Therapeutic Innovation and Regulatory Science, 2014年, 査読有り
      • Higher level at admission and subsequent decline in hemoglobin in patients with acute pulmonary edema.
        Masaaki Konishi; Yasushi Matsuzawa; Hiroyuki Suzuki; Eiichi Akiyama; Noriaki Iwahashi; Nobuhiko Maejima; Mitsuaki Endo; Kengo Tsukahara; Kiyoshi Hibi; Masami Kosuge; Toshiaki Ebina; Kentaro Sakamaki; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        Circulation journal : official journal of the Japanese Circulation Society, 2014年, 査読有り
      • Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
        Masanori Toyoda; Tetsuo Ajiki; Yutaka Fujiwara; Hiroaki Nagano; Shogo Kobayashi; Daisuke Sakai; Etsuro Hatano; Masashi Kanai; Shoji Nakamori; Atsushi Miyamoto; Akihito Tsuji; Satoshi Kaihara; Hisashi Ikoma; Shigekazu Takemura; Hideyoshi Toyokawa; Hiroaki Terajima; Tatsuya Ioka
        JOURNAL OF CLINICAL ONCOLOGY, 2014年01月, 査読有り
      • A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)
        Yoshihiro Hattori; Miyako Satouchi; Nobuyuki Katakami; Shiro Fujita; Reiko Kaji; Akito Hata; Yoshiko Urata; Temiko Shimada; Junji Uchida; Keisuke Tomii; Satoshi Morita; Shunichi Negoro
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014年01月, 査読有り
      • A Randomized Phase III Trial Exploring the Prognostic Value of Extensive Intraoperative Peritoneal Lavage in Addition to Standard Treatment for Resectable Advanced Gastric Cancer: CCOG 1102 Study
        Kazunari Misawa; Yoshinari Mochizuki; Norifumi Ohashi; Takanori Matsui; Hiroshi Nakayama; Kenji Tsuboi; Mitsuru Sakai; Seiji Ito; Satoshi Morita; Yasuhiro Kodera
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014年01月, 査読有り
      • CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
        Tae Iwasawa; Takashi Ogura; Fumikazu Sakai; Tetsu Kanauchi; Takanobu Komagata; Tomohisa Baba; Toshiyuki Gotoh; Satoshi Morita; Takuya Yazawa; Tomio Inoue
        EUROPEAN JOURNAL OF RADIOLOGY, 2014年01月, 査読有り
      • Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial
        Takaki Yoshikawa; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takanori Matsui; Yutaka Kimura; Naoki Hirabayashi; Shoki Mikata; Makoto Iwahashi; Ryoji Fukushima; Nobuhiro Takiguchi; Isao Miyashiro; Satoshi Morita; Yumi Miyashita; Aakira Tsuburaya; Junichi Sakamoto
        ANNALS OF SURGICAL ONCOLOGY, 2014年01月, 査読有り
      • Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial
        Shuichi Hironaka; Shinya Ueda; Hirofumi Yasui; Tomohiro Nishina; Masahiro Tsuda; Takehiko Tsumura; Naotoshi Sugimoto; Hideki Shimodaira; Shinya Tokunaga; Toshikazu Moriwaki; Taito Esaki; Michitaka Nagase; Kazumasa Fujitani; Kensei Yamaguchi; Takashi Ura; Yasuo Hamamoto; Satoshi Morita; Isamu Okamoto; Narikazu Boku; Ichinosuke Hyodo
        Journal of Clinical Oncology, 2013年12月10日, 査読有り
      • Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
        Toru Kono; Taishi Hata; Satoshi Morita; Yoshinori Munemoto; Takanori Matsui; Hiroshi Kojima; Hiroyoshi Takemoto; Mutsumi Fukunaga; Naoki Nagata; Mitsuo Shimada; Junichi Sakamoto; Hideyuki Mishima
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013年12月, 査読有り
      • A phase II study of pemetrexed in chemotherapy-naïve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003)
        Y. Hattori; M. Iwasaku; M. Satouchi; A. Nishiyama; Y. Korogi; K. Otsuka; S. Fujita; N. Katakami; M. Mori; K. Nishino; S. Morita; S. Negoro
        Japanese Journal of Clinical Oncology, 2013年12月, 査読有り
      • Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial
        Yasuhide Yamada; Daisuke Takahari; Hiroshi Matsumoto; Hideo Baba; Masato Nakamura; Kazuhiro Yoshida; Motoki Yoshida; Shigeyoshi Iwamoto; Ken Shimada; Yoshito Komatsu; Yasutsuna Sasaki; Taroh Satoh; Keiichi Takahashi; Hideyuki Mishima; Kei Muro; Masahiko Watanabe; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Kenichi Sugihara
        LANCET ONCOLOGY, 2013年12月, 査読有り
      • Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.
        Xavier Paoletti; Koji Oba; Yung-Jue Bang; Harry Bleiberg; Narikazu Boku; Olivier Bouché; Paul Catalano; Nozomu Fuse; Stefan Michiels; Markus Moehler; Satoshi Morita; Yasuo Ohashi; Atsushi Ohtsu; Arnaud Roth; Philippe Rougier; Junichi Sakamoto; Daniel Sargent; Mitsuru Sasako; Kohei Shitara; Peter Thuss-Patience; Eric Van Cutsem; Tomasz Burzykowski; Marc Buyse
        Journal of the National Cancer Institute, 2013年11月06日, 査読有り
      • Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.
        Koji Oba; Xavier Paoletti; Steven Alberts; Yung-Jue Bang; Jacqueline Benedetti; Harry Bleiberg; Paul Catalano; Florian Lordick; Stefan Michiels; Satoshi Morita; Yasuo Ohashi; Jean-Pierre Pignon; Philippe Rougier; Mitsuru Sasako; Junichi Sakamoto; Daniel Sargent; Kohei Shitara; Eric Van Cutsem; Marc Buyse; Tomasz Burzykowski
        Journal of the National Cancer Institute, 2013年11月06日, 査読有り
      • Positron emission mammography (PEM): reviewing standardized semiquantitative method
        Yayoi Yamamoto; Youichiro Tasaki; Yukiko Kuwada; Yukihiko Ozawa; Atsushi Katayama; Yoshihide Kanemaki; Katsutoshi Enokido; Seigo Nakamura; Kouichi Kubouchi; Satoshi Morita; Mutsumi Noritake; Yasuo Nakajima; Tomio Inoue
        ANNALS OF NUCLEAR MEDICINE, 2013年11月, 査読有り
      • Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats
        Yukihide Koyama; Tomio Andoh; Yoshinori Kamiya; Satoshi Morita; Tomoyuki Miyazaki; Kazuhiro Uchimoto; Takahiro Mihara; Takahisa Goto
        Anesthesiology, 2013年11月, 査読有り
      • A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment
        K. Nishino; F. Imamura; S. Morita; M. Mori; K. Komuta; T. Kijima; Y. Namba; T. Kumagai; S. Yamamoto; I. Tachibana; Y. Nakazawa; J. Uchida; S. Minami; R. Takahashi; Y. Yano; T. Okuyama; A. Kumanogoh
        Lung Cancer, 2013年11月, 査読有り
      • SNP (-617C > A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women
        Yasuko Okano; Uru Nezu; Yasuaki Enokida; Ming Ta Michael Lee; Hiroko Kinoshita; Alexander Lezhava; Yoshihide Hayashizaki; Satoshi Morita; Masataka Taguri; Yasushi Ichikawa; Takeshi Kaneko; Yutaka Natsumeda; Tomoyuki Yokose; Haruhiko Nakayama; Yohei Miyagi; Toshihisa Ishikawa
        PLOS ONE, 2013年09月, 査読有り
      • Preoperative Chemotherapy Is Effective for Stage III Resectable Non-Small-Cell Lung Cancer: Metaanalysis of 16 Trials
        Nobuyuki Horita; Naoki Miyazawa; Satoshi Morita; Ryota Kojima; Naoko Kimura; Takeshi Kaneko; Yoshiaki Ishigatsubo
        CLINICAL LUNG CANCER, 2013年09月, 査読有り
      • Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes
        Zenko Nagashima; Kengo Tsukahara; Satoshi Morita; Tsutomu Endo; Teruyasu Sugano; Kiyoshi Hibi; Hideo Himeno; Kazuki Fukui; Satoshi Umemura; Kazuo Kimura
        JOURNAL OF CARDIOLOGY, 2013年09月, 査読有り
      • Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C
        Yu Shimoyama; Akito Nozaki; Manabu Morimoto; Satoshi Moriya; Masaaki Kondo; Hiroyuki Fukuda; Kazushi Numata; Eiji Miyajima; Mari S. Oba; Masataka Taguri; Satoshi Morita; Shin Maeda; Katsuaki Tanaka
        HEPATOLOGY RESEARCH, 2013年09月, 査読有り
      • Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer
        Hisato Kawakami; Isamu Okamoto; Hidetoshi Hayashi; Masataka Taguri; Satoshi Morita; Kazuhiko Nakagawa
        European Journal of Cancer, 2013年09月, 査読有り
      • Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection
        Kiyotaka Imoto; Keiji Uchida; Norihisa Karube; Toru Yasutsune; Tonoki Cho; Kazuo Kimura; Munetaka Masuda; Satoshi Morita
        EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013年09月, 査読有り
      • Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms
        Ryonho Koh; Kingo Hirasawa; Sei Yahara; Hiroyuki Oka; Kazuya Sugimori; Manabu Morimoto; Kazushi Numata; Atsushi Kokawa; Takeshi Sasaki; Akinori Nozawa; Masataka Taguri; Satoshi Morita; Shin Maeda; Katsuaki Tanaka
        GASTROINTESTINAL ENDOSCOPY, 2013年09月, 査読有り
      • The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis
        S. Kako; S. Morita; H. Sakamaki; H. Iida; M. Kurokawa; K. Miyamura; H. Kanamori; M. Hara; N. Kobayashi; Y. Morishima; K. Kawa; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda
        Bone Marrow Transplantation, 2013年08月, 査読有り
      • Reevaluation of the Effectiveness of Ramosetron for Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis
        Takahiro Mihara; Kentaro Tojo; Kazuhiro Uchimoto; Satoshi Morita; Takahisa Goto
        ANESTHESIA AND ANALGESIA, 2013年08月, 査読有り
      • Virtual Bronchoscopic Navigation Combined with Ultrathin Bronchoscopy A Randomized Clinical Trial
        Fumihiro Asano; Naofumi Shinagawa; Takashi Ishida; Joe Shindoh; Masaki Anzai; Akifumi Tsuzuku; Satoshi Oizumi; Satoshi Morita
        AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013年08月, 査読有り
      • Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study.
        Shinichi Hasegawa; Chikara Kunisaki; Hidetaka Ono; Takashi Oshima; Shoichi Fujii; Masataka Taguri; Satoshi Morita; Tsutomu Sato; Roppei Yamada; Norio Yukawa; Yasushi Rino; Munetaka Masuda
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013年07月, 査読有り
      • Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study.
        Nobuyuki Horita; Takeshi Kaneko; Masaharu Shinkai; Makiko Yomota; Satoshi Morita; Bruce K Rubin; Yoshiaki Ishigatsubo
        Respiratory care, 2013年07月, 査読有り
      • SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer.
        Yoshida Kazuhiro; Tsuburaya Akira; Kobayashi Michiya; Yoshino Shigefumi; Takahashi Masazumi; Takiguchi Nobuhiro; Tanabe Kazuaki; Takahashi Naoto; Imamura Hiroshi; Tatsumoto Naokuni; Hara Akinori; Nishikawa Kazuhiro; Fukushima Ryoji; Kurita Akira; Kojima Hiroshi; Miyashita Yumi; Oba Koji; Buyse Marc E; Morita Satoshi; Sakamoto Junichi
        JOURNAL OF CLINICAL ONCOLOGY, 2013年06月20日, 査読有り
      • Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study
        Nobuyuki Horita; Naoki Miyazawa; Satoshi Morita; Ryota Kojima; Naoko Kimura; Takeshi Kaneko; Yoshiaki Ishigatsubo
        Respiratory Research, 2013年06月03日, 査読有り
      • Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia
        T. Kawahara; S. Morita; H. Ito; H. Terao; R. Sakata; H. Ishiguro; K. Tanaka; H. Miyamoto; J. Matsuzaki; Y. Kubota; H. Uemura
        BMC Urology, 2013年06月, 査読有り
      • Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer
        Yoshiko Urata; Isamu Okamoto; Masayuki Takeda; Yoshihiro Hattori; Keiko Okuno; Temiko Shimada; Takayasu Kurata; Hiroyasu Kaneda; Masaki Miyazaki; Masaaki Terashima; Kaoru Tanaka; Satoshi Morita; Kazuhiko Nakagawa; Shunichi Negoro; Miyako Satouchi
        CANCER, 2013年06月, 査読有り
      • Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris
        Toshihiro Fukui; Minoru Tabata; Satoshi Morita; Shuichiro Takanashi
        JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013年06月, 査読有り
      • Stereotactic Ablative Body Radiation Therapy for Octogenarians With Non-Small Cell Lung Cancer
        Atsuya Takeda; Naoko Sanuki; Takahisa Eriguchi; Takeshi Kaneko; Satoshi Morita; Hiroshi Handa; Yousuke Aoki; Yohei Oku; Etsuo Kunieda
        INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013年06月, 査読有り
      • SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer.
        Yoshida Kazuhiro; Tsuburaya Akira; Kobayashi Michiya; Yoshino Shigefumi; Takahashi Masazumi; Takiguchi Nobuhiro; Tanabe Kazuaki; Takahashi Naoto; Imamura Hiroshi; Tatsumoto Naokuni; Hara Akinori; Nishikawa Kazuhiro; Fukushima Ryoji; Kurita Akira; Kojima Hiroshi; Miyashita Yumi; Oba Koji; Buyse Marc E; Morita Satoshi; Sakamoto Junichi
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月20日, 査読有り
      • Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction.
        Yasushi Matsuzawa; Masaaki Konishi; Eiichi Akiyama; Hiroyuki Suzuki; Naoki Nakayama; Masayoshi Kiyokuni; Shinichi Sumita; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Mitsuaki Endo; Nobuhiko Maejima; Kenichiro Saka; Katsutaka Hashiba; Kozo Okada; Masataka Taguri; Satoshi Morita; Seigo Sugiyama; Hisao Ogawa; Hironobu Sashika; Satoshi Umemura; Kazuo Kimura
        Journal of the American College of Cardiology, 2013年05月14日, 査読有り
      • Postprogression Survival in Patients With Advanced Non-Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy
        Hidetoshi Hayashi; Isamu Okamoto; Masataka Taguri; Satoshi Morita; Kazuhiko Nakagawa
        CLINICAL LUNG CANCER, 2013年05月, 査読有り
      • Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey
        Tomoo Shiozawa; Jun-ichi Tadokoro; Toshitaka Fujiki; Koji Fujino; Koji Kakihata; Shuji Masatani; Satoshi Morita; Akihiko Gemma; Narikazu Boku
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013年05月, 査読有り
      • Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study
        H. Yoshioka; I. Okamoto; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; S. Atagi; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; Y. Nakanishi; K. Nakagawa
        ANNALS OF ONCOLOGY, 2013年05月, 査読有り
      • Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation
        Yoshinobu Kanda; Junya Kanda; Yoshiko Atsuta; Yoshinobu Maeda; Tatsuo Ichinohe; Kazuteru Ohashi; Takahiro Fukuda; Koichi Miyamura; Hiroatsu Iida; Takehiko Mori; Koji Iwato; Tetsuya Eto; Keisei Kawa; Satoshi Morita; Yasuo Morishima
        BRITISH JOURNAL OF HAEMATOLOGY, 2013年05月, 査読有り
      • Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.
        Koji Oba; Xavier Paoletti; Yung-Jue Bang; Harry Bleiberg; Tomasz Burzykowski; Nozomu Fuse; Stefan Michiels; Satoshi Morita; Yasuo Ohashi; Jean-Pierre Pignon; Philippe Rougier; Junichi Sakamoto; Daniel Sargent; Mitsuru Sasako; Kohei Shitara; Akira Tsuburaya; Eric Van Cutsem; Marc Buyse
        European journal of cancer (Oxford, England : 1990), 2013年05月, 査読有り
      • Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity
        T. Kikuchi; H. Tan; T. Mihara; K. Uchimoto; D. Mitsushima; K. Takase; S. Morita; T. Goto; T. Andoh; Y. Kamiya
        Neuroscience, 2013年05月01日, 査読有り
      • High-Speed Imaging System for Solar-Flare Research at Hida Observatory
        Takako T. Ishii; Tomoko Kawate; Yoshikazu Nakatani; Satoshi Morita; Kiyoshi Ichimoto; Satoshi Masuda
        PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 2013年04月, 査読有り
      • Anemia affects the quality of life of japanese cancer patients
        Izumi Wasada; Hisae Eguchi; Maya Kurita; Shitomi Kudo; Tomoko Shishida; Yaeko Mishima; Yuko Saito; Nobuko Ushiorozawa; Takashi Seto; Kojiro Shimozuma; Satoshi Morita; Mari Saito; Yuki Yokomizo; Kenichi Ishizawa; Yasuo Ohashi; Kenji Eguchi
        Tokai Journal of Experimental and Clinical Medicine, 2013年04月, 査読有り
      • Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study
        Takao Takahashi; Yoshihisa Shibata; Yuichiro Tojima; Kenji Tsuboi; Eiji Sakamoto; Katsuyuki Kunieda; Hiroshi Matsuoka; Kazuyoshi Suzumura; Mikinori Sato; Tatsushi Naganuma; Junichi Sakamoto; Satoshi Morita; Ken Kondo
        International Journal of Clinical Oncology, 2013年04月, 査読有り
      • INTERNAL LIMITING MEMBRANE CONTRAST AFTER STAINING WITH INDOCYANINE GREEN AND BRILLIANT BLUE G DURING MACULAR SURGERY
        Kazuaki Kadonosono; Akira Arakawa; Maiko Inoue; Shin Yamane; Eiichi Uchio; Tadashi Yamakawa; Masataka Taguri; Satoshi Morita; Jamison R. Ridgeley; Yasuo Yanagi
        RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013年04月, 査読有り
      • Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study)
        Ken-Ichi Okada; Manabu Kawai; Katsuhiko Uesaka; Yasuhiro Kodera; Hiroaki Nagano; Yoshiaki Murakami; Satoshi Morita; Junichi Sakamoto; Hiroki Yamaue
        Japanese Journal of Clinical Oncology, 2013年04月, 査読有り
      • The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort
        Tsutomu Hayashi; Takaki Yoshikawa; Kiran Bonam; Henry M. Sue-Ling; Masataka Taguri; Satoshi Morita; Akira Tsuburaya; Jeremy D. Hayden; Heike I. Grabsch
        CANCER, 2013年04月, 査読有り
      • WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
        Takashi Miyatake; Yutaka Ueda; Akiko Morimoto; Takayuki Enomoto; Sumiyuki Nishida; Toshiaki Shirakata; Yoshihiro Oka; Akihiro Tsuboi; Yusuke Oji; Naoki Hosen; Shin-ichi Nakatsuka; Satoshi Morita; Junichi Sakamoto; Haruo Sugiyama; Tadashi Kimura
        JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013年03月, 査読有り
      • Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study
        Manabu Morimoto; Kazushi Numata; Masaaki Kondo; Satoshi Moriya; Satoshi Morita; Shin Maeda; Katsuaki Tanaka
        EUROPEAN JOURNAL OF RADIOLOGY, 2013年03月, 査読有り
      • High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival
        Akimitsu Yamada; Takashi Ishikawa; Ikuko Ota; Mariko Kimura; Daisuke Shimizu; Mikiko Tanabe; Takashi Chishima; Takeshi Sasaki; Yasushi Ichikawa; Satoshi Morita; Koh-ichiro Yoshiura; Kazuaki Takabe; Itaru Endo
        BREAST CANCER RESEARCH AND TREATMENT, 2013年02月, 査読有り
      • A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer.
        Shinichi Hasegawa; Yuji Yamamoto; Masataka Taguri; Satoshi Morita; Tsutomu Sato; Roppei Yamada; Takashi Oshima; Norio Yukawa; Takaki Yoshikawa; Yasushi Rino; Toshio Imada; Munetaka Masuda
        Japanese journal of clinical oncology, 2013年02月, 査読有り
      • Double-Blind, Placebo-Controlled, Randomized Phase II Study of TJ-14 (Hangeshashinto) for Infusional Fluorinated-Pyrimidine-based Colorectal Cancer Chemotherapy-induced Oral Mucositis
        Chu Matsuda; Toru Kono; Yoshinori Munemoto; Naoki Nagata; Masato Kataoka; Mitsuru Oshiro; Satoshi Morita; Junichi Sakamoto; Hideyuki Mishima
        Annals of Cancer Research and Therapy, 2013年, 査読有り
      • Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients
        T. Miyahara; S. Mochinaga; S. Kimura; N. Aragane; T. Yakabe; S. Morita; K. Okudaira; H. Fujito
        Cancer Chemotherapy and Pharmacology, 2013年01月, 査読有り
      • Basal and ischemia-induced transcardiac troponin release into the coronary circulation in patients with suspected coronary artery disease.
        Masaaki Konishi; Seigo Sugiyama; Koichi Sugamura; Toshimitsu Nozaki; Keisuke Ohba; Junichi Matsubara; Kenji Sakamoto; Yasuhiro Nagayoshi; Hitoshi Sumida; Eiichi Akiyama; Yasushi Matsuzawa; Kentaro Sakamaki; Satoshi Morita; Kazuo Kimura; Satoshi Umemura; Hisao Ogawa
        PloS one, 2013年, 査読有り
      • Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment
        Naoki Sakane; Kazuhiko Kotani; Kaoru Takahashi; Yoshiko Sano; Kokoro Tsuzaki; Kentaro Okazaki; Juichi Sato; Sadao Suzuki; Satoshi Morita; Kazuo Izumi; Masayuki Kato; Naoki Ishizuka; Mitsuhiko Noda; Hideshi Kuzuya
        BMC PUBLIC HEALTH, 2013年01月, 査読有り
      • Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
        A. Inoue; K. Kobayashi; M. Maemondo; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa
        Annals of Oncology, 2013年01月, 査読有り
      • Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan
        N. Horita; N. Miyazawa; T. Yoshiyama; T. Sato; M. Yamamoto; K. Tomaru; M. Masuda; K. Tashiro; M. Sasaki; S. Morita; T. Kaneko; Y. Ishigatsubo
        INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013年01月, 査読有り
      • Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and Takotsubo cardiomyopathy.
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Masaomi Gohbara; Yasushi Matsuzawa; Kozo Okada; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        European heart journal. Acute cardiovascular care, 2012年12月, 査読有り
      • Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G > A variant in RNF213 showed varying clinical course and severity
        Satoko Miyatake; Hajime Touho; Noriko Miyake; Chihiro Ohba; Hiroshi Doi; Hirotomo Saitsu; Masataka Taguri; Satoshi Morita; Naomichi Matsumoto
        JOURNAL OF HUMAN GENETICS, 2012年12月, 査読有り
      • Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial
        Kojiro Shimozuma; Yasuo Ohashi; Ayano Takeuchi; Toshihiko Aranishi; Satoshi Morita; Katsumasa Kuroi; Shozo Ohsumi; Haruhiko Makino; Noriyuki Katsumata; Masaru Kuranami; Kimito Suemasu; Toru Watanabe; Frederick H. Hausheer
        SUPPORTIVE CARE IN CANCER, 2012年12月, 査読有り
      • Long-term quality of life of donors after living donor liver transplantation
        Yasutsugu Takada; Yoshimi Suzukamo; Fumitaka Oike; Hiroto Egawa; Satoshi Morita; Shunichi Fukuhara; Shinji Uemoto; Koichi Tanaka
        LIVER TRANSPLANTATION, 2012年11月, 査読有り
      • Influence of Omeprazole and Famotidine on the Antiplatelet Effects of Clopidogrel in Addition to Aspirin in Patients With Acute Coronary Syndromes - A Prospective, Randomized, Multicenter Study
        Hideto Yano; Kengo Tsukahara; Satoshi Morita; Tsutomu Endo; Teruyasu Sugano; Kiyoshi Hibi; Hideo Himeno; Kazuki Fukui; Satoshi Umemura; Kazuo Kimura
        CIRCULATION JOURNAL, 2012年11月, 査読有り
      • A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer
        Kazuhiro Nishikawa; Satoshi Morita; Takanori Matsui; Michiya Kobayashi; Yoji Takeuchi; Ikuo Takahashi; Seiji Sato; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto; Yoshihiro Kakeji; Hideo Baba
        GASTRIC CANCER, 2012年10月, 査読有り
      • Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case
        Takafumi Watanabe; Takaki Yoshikawa; Yoichi Kameda; Toru Aoyama; Tsutomu Hayashi; Takashi Ogata; Haruhiko Cho; Akira Tsuburaya; Satoshi Morita; Yumi Miyashita; Junichi Sakamoto
        SURGERY TODAY, 2012年10月, 査読有り
      • Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting
        Toshihiro Fukui; Minoru Tabata; Satoshi Morita; Shuichiro Takanashi
        JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012年10月, 査読有り
      • Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy
        Takahiro Tsushima; Masataka Taguri; Yoshitaka Honma; Hideaki Takahashi; Shinya Ueda; Tomohiro Nishina; Hiroki Kawai; Shunsuke Kato; Mitsukuni Suenaga; Fumio Tamura; Satoshi Morita; Narikazu Boku
        ONCOLOGIST, 2012年09月, 査読有り
      • Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial
        Takuma Higurashi; Kunihiro Hosono; Hiroki Endo; Hirokazu Takahashi; Hiroshi Iida; Takashi Uchiyama; Akiko Ezuka; Shiori Uchiyama; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Shin Maeda; Satoshi Morita; Yutaka Natsumeda; Hajime Nagase; Atsushi Nakajima
        BMC CANCER, 2012年09月, 査読有り
      • 免疫疾患の臨床 関節リウマチにおけるCTLA4-Ig共刺激シグナル阻害剤のCD8+T細胞への影響
        松谷 隆治; 李 穎; 村上 美帆; 關口 昌弘; 松井 聖; 北野 将康; 大村 浩一郎; 井村 嘉孝; 藤井 隆夫; 黒岩 孝則; 中原 英子; 前田 恵治; 船内 正憲; 村上 孝作; 入交 重雄; 森田 智視; 川人 豊; 三森 経世; 佐野 統; 西本 憲弘
        日本臨床免疫学会会誌, 2012年08月
      • Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: A biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations
        M. Morimoto; K. Numata; A. Nozaki; M. Kondo; S. Moriya; M. Taguri; S. Morita; M. Konno; A. Sugo; E. Miyajima; S. Maeda; K. Tanaka
        International Journal of Clinical Oncology, 2012年08月, 査読有り
      • Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
        Masataka Yoshimoto; Shintaro Takao; Masaru Hirata; Yasushi Okamoto; Sumio Yamashita; Yoshihiro Kawaguchi; Makoto Takami; Hidemi Furusawa; Satoshi Morita; Chigusa Abe; Junichi Sakamoto
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012年08月, 査読有り
      • A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)
        Akira Tsuburaya; Satoshi Morita; Yasuhiro Kodera; Michiya Kobayashi; Kohei Shitara; Kensei Yamaguchi; Takaki Yoshikawa; Kazuhiro Yoshida; Shigefumi Yoshino; Jun-ichi Sakamoto
        BMC CANCER, 2012年07月, 査読有り
      • Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis
        Kohei Shitara; Satoshi Morita; Kazumasa Fujitani; Shigenori Kadowaki; Nobuhiro Takiguchi; Naoki Hirabayashi; Masazumi Takahashi; Masakazu Takagi; Yukihiko Tokunaga; Ryoji Fukushima; Yasuhiro Munakata; Kazuhiro Nishikawa; Akinori Takagane; Takaho Tanaka; Yoshiaki Sekishita; Junichi Sakamoto; Akira Tsuburaya
        GASTRIC CANCER, 2012年07月, 査読有り
      • Laparoscopic or Open Distal Gastrectomy After Neoadjuvant Chemotherapy for Operable Gastric Cancer, a Randomized Phase II Trial (LANDSCOPE Trial)
        Takaki Yoshikawa; Tetsu Fukunaga; Masataka Taguri; Chikara Kunisaki; Shinichi Sakuramoto; Seiji Ito; Satoshi Morita; Akira Tsuburaya
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012年07月, 査読有り
      • Understanding Measurements of Vitality in Patients with Chronic Kidney Disease: Connecting a Quality-of-Life Scale to Daily Activities
        Shunichi Fukuhara; Tadao Akizawa; Satoshi Morita; Yoshiharu Tsubakihara
        PLOS ONE, 2012年07月, 査読有り
      • Clinicopathologic Study of Intrapancreatic Cancer Spread in Carcinoma of the Body and Tail of the Pancreas
        Kazuo Yamamura; Akimasa Nakao; Tsutomu Fujii; Suguru Yamada; Hiroyuki Sugimoto; Hideki Kasuya; Shuji Nomoto; Yasuhiro Kodera; Shigeo Nakamura; Satoshi Morita; Shin Takeda
        PANCREAS, 2012年07月, 査読有り
      • A PHASE I/II STUDY OF TRI-WEEKLY XELIRI PLUS BEVACIZUMAB FOR JAPANESE PATIENTS WITH MCRC AS SECOND-LINE CHEMOTHERAPY (BIX STUDY)
        Tatsuro Yamaguchi; Yasuo Hamamoto; Tomohiro Nishina; Kentaro Yamazaki; Takashi Ura; Nakajima Takako; Ayumu Goto; Ken Shimada; Norisuke Nakayama; Junichi Sakamoto; Satoshi Morita; Yasuhide Yamada
        ANNALS OF ONCOLOGY, 2012年06月, 査読有り
      • Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial
        Satoshi Oizumi; Kunihiko Kobayashi; Akira Inoue; Makoto Maemondo; Shunichi Sugawara; Hirohisa Yoshizawa; Hiroshi Isobe; Masao Harada; Ichiro Kinoshita; Shoji Okinaga; Terufumi Kato; Toshiyuki Harada; Akihiko Gemma; Yasuo Saijo; Yuki Yokomizo; Satoshi Morita; Koichi Hagiwara; Toshihiro Nukiwa
        ONCOLOGIST, 2012年06月, 査読有り
      • Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
        H. Hayashi; I. Okamoto; S. Morita; M. Taguri; K. Nakagawa
        ANNALS OF ONCOLOGY, 2012年06月, 査読有り
      • Effects of Valsartan, an Angiotensin II Receptor Blocker, on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Who Receive an Angiotensin-Converting Enzyme Inhibitor
        Hideto Yano; Kiyoshi Hibi; Naoki Nozawa; Hiroyuki Ozaki; Ikuyoshi Kusama; Toshiaki Ebina; Masami Kosuge; Kengo Tsukahara; Jun Okuda; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        CIRCULATION JOURNAL, 2012年06月, 査読有り
      • Oral S-1 and carboplatin plus bevacizumab with maintenance S-1 and bevacizumab for chemo-naive patients (Pts) with advanced non-squamous non-small cell lung cancer (NSCLC).
        Kaneda Hiroyasu; Urata Yoshiko; Okamoto Isamu; Hattori Yoshihiro; Okuno Keiko; Shimada Temiko; Takeda Masayuki; Kurata Takayasu; Miyazaki Masaki; Terashima Masaaki; Tanaka Kaoru; Kiyota Hidemi; Hayashi Hidetoshi; Kudo Toshihiro; Okabe Takafumi; Azuma Koichi; Morita Satoshi; Nakagawa Kazuhiko; Negoro Shunichi; Satouchi Miyako
        JOURNAL OF CLINICAL ONCOLOGY, 2012年05月20日, 査読有り
      • Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: a matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost
        Shoichi Fujii; Kazuteru Watanabe; Mitsuyoshi Ota; Jun Watanabe; Yasushi Ichikawa; Shigeru Yamagishi; Kenji Tatsumi; Hirokazu Suwa; Chikara Kunisaki; Masataka Taguri; Satoshi Morita; Itaru Endo
        SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012年05月, 査読有り
      • Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis
        Kenzen Kou; Michiko Aihara; Tomoko Matsunaga; Huichin Chen; Masataka Taguri; Satoshi Morita; Hiroyuki Fujita; Yukie Yamaguchi; Takeshi Kambara; Zenro Ikezawa
        ARCHIVES OF DERMATOLOGICAL RESEARCH, 2012年05月, 査読有り
      • A Phase III Trial to Evaluate the Effect of Perioperative Nutrition Enriched with Eicosapentaenoic Acid on Body Weight Loss after Total Gastrectomy for T2T4a Gastric Cancer
        Takaki Yoshikawa; Naoki Hiki; Masataka Taguri; Takeshi Sano; Souya Nunobe; Hideki Taniguchi; Ryoji Fukushima; Haruhiko Cho; Satoshi Morita; Akira Tsuburaya
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012年05月, 査読有り
      • Use of C-11-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma Clinical article
        Yasuyoshi Chiba; Manabu Kinoshita; Yoshiko Okita; Akihito Tsuboi; Kayako Isohashi; Naoki Kagawa; Yasunori Fujimoto; Yusuke Oji; Yoshihiro Oka; Eku Shimosegawa; Satoshi Morita; Jun Hatazawa; Haruo Sugiyama; Naoya Hashimoto; Toshiki Yoshimine
        JOURNAL OF NEUROSURGERY, 2012年04月, 査読有り
      • 併存疾患を有する進行胃癌患者における術後合併症予測
        小野 秀高; 國崎 主税; 長谷川 慎一; 大島 貴; 藤井 正一; 高川 亮; 木村 準; 小坂 隆司; 牧野 洋知; 秋山 浩利; 斉藤 真梨; 森田 智視; 遠藤 格
        日本外科学会雑誌, 2012年03月
      • Homozygous c.14576G > A variant of RNF213 predicts early-onset and severe form of moyamoya disease
        S. Miyatake; N. Miyake; H. Touho; A. Nishimura-Tadaki; Y. Kondo; I. Okada; Y. Tsurusaki; H. Doi; H. Sakai; H. Saitsu; K. Shimojima; T. Yamamoto; M. Higurashi; N. Kawahara; H. Kawauchi; K. Nagasaka; N. Okamoto; T. Mori; S. Koyano; Y. Kuroiwa; M. Taguri; S. Morita; Y. Matsubara; S. Kure; N. Matsumoto
        NEUROLOGY, 2012年03月, 査読有り
      • Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial
        Takuma Higurashi; Hirokazu Takahashi; Hiroki Endo; Kunihiro Hosono; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Takashi Uchiyama; Yasuo Hata; Nobutaka Fujisawa; Shiori Uchiyama; Akiko Ezuka; Hajime Nagase; Takaomi Kessoku; Nobuyuki Matsuhashi; Shoji Yamanaka; Yoshiaki Inayama; Satoshi Morita; Atsushi Nakajima
        BMC CANCER, 2012年03月, 査読有り
      • Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: a prospective cohort study
        Shinju Arata; Junichi Suzuki; Yoshihiro Moriwaki; Noriyuki Suzuki; Masayuki Iwashita; Mitsugi Sugiyama; Satoshi Morita
        EMERGENCY MEDICINE JOURNAL, 2012年03月, 査読有り
      • Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: a case-control study
        Chikara Kunisaki; Hirochika Makino; Takashi Kosaka; Takashi Oshima; Shoichi Fujii; Ryo Takagawa; Jun Kimura; Hidetaka A. Ono; Hirotoshi Akiyama; Masataka Taguri; Satoshi Morita; Itaru Endo
        SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012年03月, 査読有り
      • Adjuvant paclitaxel followed by oral fluoropyrimidines for gastric cancer: Safety data of the factorial phase III SAMIT trial.
        Kobayashi Michiya; Tsuburaya Akira; Yoshida Kazuhiro; Yoshino Shigefumi; Miyashita Yumi; Morita Satoshi; Oba Koji; Buyse Marc E
        JOURNAL OF CLINICAL ONCOLOGY, 2012年02月01日, 査読有り
      • Differences in Negative T Waves Between Takotsubo Cardiomyopathy and Reperfused Anterior Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Noriaki Iwahashi; Kengo Tsukahara; Mitsuaki Endo; Nobuhiko Maejima; Zenko Nagashima; Hiroyuki Suzuki; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        CIRCULATION JOURNAL, 2012年02月, 査読有り
      • Laparoscopic Colorectal Cancer Surgery by a Colon Lifting-up Technique That Decreases the Number of Access Ports: Comparison by Propensity Scoring of Short-term and Long-term Outcomes With Standard Multiport Laparoscopic Surgery
        Shoichi Fujii; Kazuteru Watanabe; Mitsuyoshi Ota; Jun Watanabe; Yasushi Ichikawa; Shigeru Yamagishi; Kenji Tatsumi; Hirokazu Suwa; Chikara Kunisaki; Masataka Taguri; Satoshi Morita; Itaru Endo
        SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2012年02月, 査読有り
      • First simultaneous observation of AN Hα Moreton wave, EUV wave, and filament/prominence oscillations
        A. Asai; T.T. Ishii; H. Isobe; R. Kitai; K. Ichimoto; S. Ueno; S. Nagata; S. Morita; K. Nishida; D. Shiota; A. Oi; M. Akioka; K. Shibata
        Astrophysical Journal Letters, 2012年02月, 査読有り
      • Implications of ST-Segment Elevation in Leads V-5 and V-6 in Patients With Reperfused Inferior Wall Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Noriaki Iwahashi; Satoshi Morita; Mitsuaki Endo; Nobuhiki Maejima; Masaomi Gouhara; Zenkou Nagashima; Satoshi Umemura; Kazuo Kimura
        AMERICAN JOURNAL OF CARDIOLOGY, 2012年02月, 査読有り
      • Chromospheric Anemone Jets Observed with Hinode/SOT and Hida Ca II Spectroheliograph
        S. Morita; K. Shibata; S. Ueno; K. Ichimoto; R. Kitai; K. Otsuji
        HINODE-3: THE 3RD HINODE SCIENCE MEETING, 2012年, 査読有り
      • The Impact of a Negative History of Smoking on Survival in Patients with Non-Small Cell Lung Cancer Detected with Clinic-based Screening Programs
        Hideyuki Nagakura; Masanori Nishikawa; Nobuko Kusano; Mari Saito; Satoshi Morita; Takeshi Kaneko; Yoshiaki Ishigatsubo
        INTERNAL MEDICINE, 2012年, 査読有り
      • Impacts and Predictors of Cytotoxic Anticancer Agents in Different Breast Cancer Subtypes
        Takashi Ishikawa; Daisuke Shimizu; Akimitsu Yamada; Takeshi Sasaki; Satoshi Morita; Mikiko Tanabe; Kae Kawachi; Akinori Nozawa; Takashi Chishima; Mariko Kimura; Yasushi Ichikawa; Itaru Endo
        ONCOLOGY RESEARCH, 2012年, 査読有り
      • Efficacy of Ezetimibe is Associated with Gender and Baseline Lipid Levels in Patients with Type 2 Diabetes
        Erina Shigematsu; Tadashi Yamakawa; Masataka Taguri; Satoshi Morita; Mikiya Tokui; Kazunori Miyamoto; Osamu Funae; Yoji Takatuka; Kazuaki Kadonosono; Hiroshi Shigematsu; Yasuo Terauchi
        JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012年, 査読有り
      • Prior Effective Sample Size in Conditionally Independent Hierarchical Models
        Satoshi Morita; Peter F. Thall; Peter Mueller
        BAYESIAN ANALYSIS, 2012年, 査読有り
      • Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure
        S. Arata; Y. Moriwaki; K. Takayama; M. Morimoto; K. Numata; M. Taguri; S. Morita; H. Imanari; K. Tanaka
        Acta Hepatologica Japonica, 2012年, 査読有り
      • Preservation of the Pyloric Ring Has Little Value in Surgery for Pancreatic Head Cancer: A Comparative Study Comparing Three Surgical Procedures
        Tsutomu Fujii; Mitsuro Kanda; Yasuhiro Kodera; Shunji Nagai; Tevfik T. Sahin; Masamichi Hayashi; Akiyuki Kanzaki; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
        ANNALS OF SURGICAL ONCOLOGY, 2012年01月, 査読有り
      • A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A Randomized Phase II Trial (COMPASS-D Trial)
        Takaki Yoshikawa; Masataka Taguri; Shinichi Sakuramoto; Chikara Kunisaki; Tetsu Fukunaga; Seiji Ito; Haruhiko Cho; Kazuaki Tanabe; Kazuhiro Nishikawa; Takanori Matsui; Satoshi Morita; Akira Tsuburaya
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012年01月, 査読有り
      • Correlation Between Radiographic Classification and Pathological Grade of Portal Vein Wall Invasion in Pancreatic Head Cancer
        Akimasa Nakao; Akiyuki Kanzaki; Tsutomu Fujii; Yasuhiro Kodera; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shigeo Nakamura; Satoshi Morita; Shin Takeda
        ANNALS OF SURGERY, 2012年01月, 査読有り
      • Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children.
        Masakatsu Yanagimachi; Hiroaki Goto; Takako Miyamae; Keisuke Kadota; Tomoyuki Imagawa; Masaaki Mori; Hidenori Sato; Ryu Yanagisawa; Tetsuji Kaneko; Satoshi Morita; Eiichi Ishii; Shumpei Yokota
        J. Clin. Immunol., 2011年12月, 査読有り
      • Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan
        Minoru Kubota; Makoto Hiramatsu; Masato Yamakawa; Shunichi Fukuhara; Satoshi Morita; Manabu Iwasaki; Tadao Akizawa
        CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011年12月, 査読有り
      • Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children
        Masakatsu Yanagimachi; Hiroaki Goto; Takako Miyamae; Keisuke Kadota; Tomoyuki Imagawa; Masaaki Mori; Hidenori Sato; Ryu Yanagisawa; Tetsuji Kaneko; Satoshi Morita; Eiichi Ishii; Shumpei Yokota
        JOURNAL OF CLINICAL IMMUNOLOGY, 2011年12月, 査読有り
      • Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP
        Masaru Ito; Takeshi Kaneko; Hideto Goto; Nobuhiro Yamaguchi; Shin Fujisawa; Shigeru Ono; Satoshi Morita; Naoki Miyazawa; Heiwa Kanamori; Yuji Watanuki; Yoshiaki Ishigatsubo
        JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011年12月, 査読有り
      • Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3
        Xiaoying Wang; Ryogo Akasaka; Chie Takemoto; Satoshi Morita; Machiko Yamaguchi; Takaho Terada; Mikako Shirozu; Shigeyuki Yokoyama; Shilin Chen; Shuyi Si; Yong Xie
        ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY AND CRYSTALLIZATION COMMUNICATIONS, 2011年12月, 査読有り
      • Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection
        Kingo Hirasawa; Atsushi Kokawa; Hiroyuki Oka; Sei Yahara; Takeshi Sasaki; Akinori Nozawa; Manabu Morimoto; Kazushi Numata; Masataka Taguri; Satoshi Morita; Shin Maeda; Katsuaki Tanaka
        GASTROINTESTINAL ENDOSCOPY, 2011年12月, 査読有り
      • Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey
        K. Kawaguchi; H. Ishiguro; S. Morita; S. Nakamura; S. Ohno; N. Masuda; H. Iwata; K. Aogi; K. Kuroi; M. Toi
        BREAST CANCER RESEARCH AND TREATMENT, 2011年11月, 査読有り
      • Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer
        Shingo Kato; Kensuke Kubota; Takeshi Shimamura; Yoshiyasu Shinohara; Noritoshi Kobayashi; Seitaro Watanabe; Masato Yoneda; Masahiko Inamori; Fumio Nakamura; Hitoshi Ishiguro; Noboru Nakaigawa; Yoji Nagashima; Masataka Taguri; Yoshinobu Kubota; Yoshio Goshima; Satoshi Morita; Itaru Endo; Shin Maeda; Atsushi Nakajima; Hitoshi Nakagama
        CANCER SCIENCE, 2011年11月, 査読有り
      • Comparison of Pancreatic Head Resection With Segmental Duodenectomy and Pylorus-Preserving Pancreatoduodenectomy for Benign and Low-Grade Malignant Neoplasms of the Pancreatic Head
        Tsutomu Fujii; Mitsuro Kanda; Yasuhiro Kodera; Shunji Nagai; Tevfik T. Sahin; Akiyuki Kanzaki; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Satoshi Morita; Shin Takeda; Akimasa Nakao
        PANCREAS, 2011年11月, 査読有り
      • Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection
        Akito Hata; Nobuyuki Katakami; Hiroshige Yoshioka; Shiro Fujita; Kei Kunimasa; Shigeki Nanjo; Kyoko Otsuka; Reiko Kaji; Keisuke Tomii; Masahiro Iwasaku; Akihiro Nishiyama; Hidetoshi Hayashi; Satoshi Morita; Tadashi Ishida
        LUNG CANCER, 2011年11月, 査読有り
      • Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study
        Tadao Akizawa; Fumitake Gejyo; Shinichi Nishi; Yasuhiko Iino; Yuzou Watanabe; Masashi Suzuki; Akira Saito; Takashi Akiba; Hideki Hirakata; Shunichi Fukuhara; Satoshi Morita; Michiaki Hiroe; Yoshiyuki Hada; Makoto Suzuki; Makoto Akaishi; Manabu Iwasaki; Yoshiharu Tsubakihara
        THERAPEUTIC APHERESIS AND DIALYSIS, 2011年10月, 査読有り
      • Prognostic Implications of Lymph Node Metastases in Carcinoma of the Body and Tail of the Pancreas
        Tevfik T. Sahin; Tsutomu Fujii; Mitsuro Kanda; Shunji Nagai; Yasuhiro Kodera; Akiyuki Kanzaki; Kazuo Yamamura; Hiroyuki Sugimoto; Hideki Kasuya; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
        PANCREAS, 2011年10月, 査読有り
      • New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis
        Yasunori Sakuma; Junichi Ishitoya; Masanori Komatsu; Osamu Shiono; Mariko Hirama; Yukiko Yamashita; Tetsuji Kaneko; Satoshi Morita; Mamoru Tsukuda
        AURIS NASUS LARYNX, 2011年10月, 査読有り
      • 【腹腔鏡手術vs開腹手術(胃がん)】胃癌に対する腹腔鏡下胃切除術と開腹胃切除術 A Case-Control Study
        國崎 主税; 小坂 隆司; 長谷川 慎一; 大島 貴; 藤井 正一; 高川 亮; 木村 準; 牧野 洋知; 小野 秀高; 秋山 浩利; 田栗 正隆; 森田 智視; 遠藤 格
        癌の臨床, 2011年09月
      • Phase I Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
        Takahiro Nakayama; Satoshi Morita; Tsutomu Takashima; Shunji Kamigaki; Katsuhide Yoshidome; Toshikazu Ito; Tetsuya Taguchi; Junichi Sakamoto; Shinzaburo Noguchi
        ANTICANCER RESEARCH, 2011年09月, 査読有り
      • Prediction of the Pathogens That Are the Cause of Pneumonia by the Battlefield Hypothesis
        Takashi Hirama; Takefumi Yamaguchi; Hitoshi Miyazawa; Tomoaki Tanaka; Giichi Hashikita; Etsuko Kishi; Yoshimi Tachi; Shun Takahashi; Keiji Kodama; Hiroshi Egashira; Akemi Yokote; Kunihiko Kobayashi; Makoto Nagata; Toshiaki Ishii; Manabu Nemoto; Masahiko Tanaka; Koichi Fukunaga; Satoshi Morita; Minoru Kanazawa; Koichi Hagiwara
        PLOS ONE, 2011年09月, 査読有り
      • Recurrence Pattern and Prognosis of Pancreatic Cancer After Pancreatic Fistula
        Shunji Nagai; Tsutomu Fujii; Yasuhiro Kodera; Mitsuro Kanda; Tevfik T. Sahin; Akiyuki Kanzaki; Masamichi Hayashi; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
        ANNALS OF SURGICAL ONCOLOGY, 2011年08月, 査読有り
      • Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer
        Mitsuro Kanda; Tsutomu Fujii; Shunji Nagai; Yasuhiro Kodera; Akiyuki Kanzaki; Tevfik T. Sahin; Masamichi Hayashi; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
        PANCREAS, 2011年08月, 査読有り
      • PREOPERATIVE INNER SEGMENT/OUTER SEGMENT JUNCTION IN SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS A PROGNOSTIC FACTOR IN EPIRETINAL MEMBRANE SURGERY
        Maiko Inoue; Satoshi Morita; Yoichiro Watanabe; Tetsuji Kaneko; Shin Yamane; Satoshi Kobayashi; Akira Arakawa; Kazuaki Kadonosono
        RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011年07月, 査読有り
      • Placental Growth Factor and Soluble c-Kit Receptor Dynamics Characterize the Cytokine Signature of Imatinib in Prostate Cancer and Bone Metastases
        Paul Mathew; Sijin Wen; Satoshi Morita; Peter F. Thall
        JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011年07月, 査読有り
      • Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer
        H. Makino; C. Kunisaki; T. Kosaka; H. Akiyama; S. Morita; I. Endo
        BRITISH JOURNAL OF SURGERY, 2011年07月, 査読有り
      • Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West
        Satoshi Morita
        STATISTICS IN MEDICINE, 2011年07月, 査読有り
      • Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer
        Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi Fujii; Ryo Takagawa; Jun Kimura; Takashi Kosaka; Hidetaka A. Ono; Hirotoshi Akiyama; Kunio Kameda; Fumihiko Kito; Satoshi Morita; Itaru Endo
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011年06月, 査読有り
      • Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan
        Makiko Nakagawa; Chiaki Kawanishi; Tomoki Yamada; Kanna Sugiura; Yoko Iwamoto; Ryoko Sato; Satoshi Morita; Toshinari Odawara; Yoshio Hirayasu
        PSYCHIATRY RESEARCH, 2011年06月, 査読有り
      • Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects
        Kengo Tsukahara; Kazuo Kimura; Satoshi Morita; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Noriaki Iwahashi; Mitsuaki Endo; Nobuhiko Maejima; Teruyasu Sugano; Satoshi Umemura
        JOURNAL OF CARDIOLOGY, 2011年05月, 査読有り
      • Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
        Takashi Ishikawa; Daisuke Shimizu; Takashi Sasaki; Satoshi Morita; Mikiko Tanabe; Ikuko Ota; Kae Kawachi; Takashi Chishima; Yasushi Ichikawa; Itaru Endo
        CANCER RESEARCH, 2011年04月, 査読有り
      • Relation Between Hyperinsulinemia and Nonculprit Plaque Characteristics in Nondiabetic Patients With Acute Coronary Syndromes
        Takayuki Mitsuhashi; Kiyoshi Hibi; Masami Kosuge; Satoshi Morita; Naohiro Komura; Ikuyoshi Kusama; Fumiyuki Otsuka; Mitsuaki Endo; Noriaki Iwahashi; Jun Okuda; Kengo Tsukahara; Toshiaki Ebina; Satoshi Umemura; Kazuo Kimura
        JACC-CARDIOVASCULAR IMAGING, 2011年04月, 査読有り
      • Application of the transorally inserted anvil (OrVil™) after laparoscopy-assisted total gastrectomy
        C. Kunisaki; H. Makino; T. Oshima; S. Fujii; J. Kimura; R. Takagawa; T. Kosaka; H. Akiyama; S. Morita; I. Endo
        Surgical Endoscopy and Other Interventional Techniques, 2011年04月, 査読有り
      • Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma
        Chigusa Morizane; Takuji Okusaka; Satoshi Morita; Katsuaki Tanaka; Hideki Ueno; Shunsuke Kondo; Masafumi Ikeda; Kohei Nakachi; Shuichi Mitsunaga
        PANCREAS, 2011年04月, 査読有り
      • Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib
        Manabu Morimoto; Kazushi Numata; Masaaki Kondo; Hisashi Hidaka; Juichi Takada; Akitaka Shibuya; Satoshi Kobayashi; Shinichi Ohkawa; Chiaki Okuse; Satoshi Morita; Masataka Taguri; Katsuaki Tanaka
        HEPATOLOGY RESEARCH, 2011年04月, 査読有り
      • Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis.
        Masakatsu Yanagimachi; Takako Miyamae; Takuya Naruto; Takuma Hara; Masako Kikuchi; Ryoki Hara; Tomoyuki Imagawa; Masaaki Mori; Tetsuji Kaneko; Hiroaki Goto; Satoshi Morita; Nobuhisa Mizuki; Akinori Kimura; Shumpei Yokota
        J. Hum. Genet., 2011年03月, 査読有り
      • Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia
        Tadashi Yamakawa; Takeshi Kaneko; Erina Shigematu; Junko Kawaguchi; Kazuaki Kadonosono; Satoshi Morita; Yasuo Terauchi
        ENDOCRINE JOURNAL, 2011年03月, 査読有り
      • Association of HLA- A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis
        Masakatsu Yanagimachi; Takako Miyamae; Takuya Naruto; Takuma Hara; Masako Kikuchi; Ryoki Hara; Tomoyuki Imagawa; Masaaki Mori; Tetsuji Kaneko; Hiroaki Goto; Satoshi Morita; Nobuhisa Mizuki; Akinori Kimura; Shumpei Yokota
        JOURNAL OF HUMAN GENETICS, 2011年03月, 査読有り
      • Rectal Content and Intrafractional Prostate Gland Motion Assessed by Magnetic Resonance Imaging
        Ichiro Ogino; Tetsuji Kaneko; Ryoko Suzuki; Tonika Matsui; Shigeo Takebayashi; Tomio Inoue; Satoshi Morita
        JOURNAL OF RADIATION RESEARCH, 2011年03月, 査読有り
      • Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer.
        Haruhiko Imamoto; Koji Oba; Junichi Sakamoto; Hiroyasu Iishi; Hiroyuki Narahara; Takeyoshi Yumiba; Takashi Morimoto; Masaki Nakamura; Noboru Oriuchi; Chieko Kakutani; Satoshi Morita; Hitoshi Shiozaki
        Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2011年03月, 査読有り
      • Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
        Masakatsu Yanagimachi; Takuya Naruto; Takuma Hara; Masako Kikuchi; Ryoki Hara; Takako Miyamae; Tomoyuki Imagawa; Masaaki Mori; Tetsuji Kaneko; Satoshi Morita; Hiroaki Goto; Shumpei Yokota
        Br J Clin Pharmacol, 2011年02月, 査読有り
      • A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor
        S. Kako; S. Morita; H. Sakamaki; H. Ogawa; T. Fukuda; S. Takahashi; H. Kanamori; M. Onizuka; K. Iwato; R. Suzuki; Y. Atsuta; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda
        LEUKEMIA, 2011年02月, 査読有り
      • An Early and Simple Predictor of Severe Left Main and/or Three-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Mitsuaki Endo; Nobuhiki Maejima; Noriaki Iwahashi; Kozo Okada; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        AMERICAN JOURNAL OF CARDIOLOGY, 2011年02月, 査読有り
      • A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial)
        Yasuhiro Kodera; Motohiro Imano; Takaki Yoshikawa; Naoto Takahashi; Akira Tsuburaya; Yumi Miyashita; Satoshi Morita; Akimasa Nakao; Junichi Sakamoto; Mitsuru Sasako
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011年02月, 査読有り
      • Effect of feedback in promoting adherence to an exercise programme: a randomized controlled trial
        Masaaki Shakudo; Misa Takegami; Ai Shibata; Miki Kuzumaki; Takahiro Higashi; Yasuaki Hayashino; Yoshimi Suzukamo; Satoshi Morita; Michio Katsuki; Shunichi Fukuhara
        JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2011年02月, 査読有り
      • Extensive Reconstruction of the Left Anterior Descending Coronary Artery With an Internal Thoracic Artery Graft
        Toshihiro Fukui; Minoru Tabata; Masataka Taguri; Susumu Manabe; Satoshi Morita; Shuichiro Takanashi
        ANNALS OF THORACIC SURGERY, 2011年02月, 査読有り
      • Evaluation of the Pentax-AWS ® and the Macintosh laryngoscope in difficult intubation: A manikin study
        T. Kariya; G. Inagawa; K. Nakamura; J. Fujimoto; Y. Aoi; S. Morita; T. Goto
        Acta Anaesthesiologica Scandinavica, 2011年02月, 査読有り
      • Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis
        Masakatsu Yanagimachi; Takuya Naruto; Takuma Hara; Masako Kikuchi; Ryoki Hara; Takako Miyamae; Tomoyuki Imagawa; Masaaki Mori; Tetsuji Kaneko; Satoshi Morita; Hiroaki Goto; Shumpei Yokota
        BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011年02月, 査読有り
      • Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study
        Satoshi Inoue; Yuji Watanuki; Tetsuji Kaneko; Takashi Sato; Naoki Miyazawa; Takeshi Kaneko; Yoshiaki Ishigatsubo; Satoshi Morita; Yutaka Natsumeda; Shunsaku Mizushima
        BMJ OPEN, 2011年, 査読有り
      • Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia
        H. Kuwabara; H. Takahashi; Y. Hattori; R. Ohshima; M. Hagihara; R. Sakai; T. Kaneko; S. Morita; Y. Ishigatsubo; S. Fujisawa
        Yokohama Medical Journal, 2011年, 査読有り
      • Prognostic Implications of Intraoperative Radiotherapy for Unresectable Pancreatic Cancer
        Shunji Nagai; Tsutomu Fujii; Yasuhiro Kodera; Mitsuro Kanda; Tevfik T. Sahin; Akiyuki Kanzaki; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
        PANCREATOLOGY, 2011年, 査読有り
      • Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas
        Shunji Nagai; Tsutomu Fujii; Yasuhiro Kodera; Mitsuro Kanda; Tevfik T. Sahin; Akiyuki Kanzaki; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
        PANCREAS, 2011年01月, 査読有り
      • Association between Breast Cancer Risk and the Wild-type Allele of Human ABC Transporter ABCC11
        Ikuko Ota; Aki Sakurai; Yu Toyoda; Satoshi Morita; Takeshi Sasaki; Takashi Chishima; Minoru Yamakado; Yuki Kawai; Takefumi Ishidao; Alexander Lezhava; Koh-Ichiro Yoshiura; Shinji Togo; Yoshihide Hayashizaki; Takashi Ishikawa; Toshihisa Ishikawa; Itaru Endo; Hiroshi Shimada
        ANTICANCER RESEARCH, 2010年12月, 査読有り
      • Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: Results of a west Japan oncology group study
        I. Okamoto; H. Yoshioka; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; K. Asami; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; M. Miyazaki; K. Tamura; T. Kurata; M. Fukuoka; K. Nakagawa
        Journal of Clinical Oncology, 2010年12月, 査読有り
      • Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma
        Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; Katsuaki Tanaka
        CANCER, 2010年12月, 査読有り
      • Inner Segment/Outer Segment Junction Assessed by Spectral-Domain Optical Coherence Tomography in Patients with Idiopathic Epiretinal Membrane
        Maiko Inoue; Satoshi Morita; Yoichiro Watanabe; Tetsuji Kaneko; Shin Yamane; Satoshi Kobayashi; Akira Arakawa; Kazuaki Kadonosono
        AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010年12月, 査読有り
      • Arterial graft deterioration one year after coronary artery bypass grafting
        Susumu Manabe; Toshihiro Fukui; Minoru Tabata; Tomoki Shimokawa; Satoshi Morita; Shuichiro Takanashi
        JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010年12月, 査読有り
      • FIRST-LINE GEFITINIB VS CARBOPLATIN/PACLITAXEL IN NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION: PHASE III STUDY NEJ002
        Ishimoto Osamu; Kunihiko Kobayashi; Akira Inoue; Makoto Maemondo; Shunichi Sugawara; Satoshi Oizumi; Yasuo Saijo; Akihiko Gemma; Satoshi Morita; Koichi Hagiwara; Toshihiro Nukiwa
        ANNALS OF ONCOLOGY, 2010年11月, 査読有り
      • Laparoscopic Surgery for Gastric Cancer: A Collective Review with Meta-Analysis of Randomized Trials
        Yasuhiro Kodera; Michitaka Fujiwara; Norifumi Ohashi; Goro Nakayama; Masahiko Koike; Satoshi Morita; Akimasa Nakao
        JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010年11月, 査読有り
      • Off-pump bilateral internal thoracic artery grafting in patients with left main disease
        Toshihiro Fukui; Minoru Tabata; Susumu Manabe; Tomoki Shimokawa; Jun Shimizu; Satoshi Morita; Shuichiro Takanashi
        JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010年11月, 査読有り
      • 18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with 18F-FDG PET and immunohistochemistry
        Go Miyashita; Tetsuya Higuchi; Noboru Oriuchi; Yukiko Arisaka; Hirofumi Hanaoka; Hideyuki Tominaga; Satoshi Morita; Mitsuyuki Miyakubo; Tomohiro Ishikita; Yoshiki Nakasone; Akihide Negishi; Satoshi Yokoo; Keigo Endo
        Annals of Nuclear Medicine, 2010年10月, 査読有り
      • F-18-FAMT uptake correlates tumor proliferative activity in oral squamous cell carcinoma; Comparative study with F-18-FDG PET and immunohistochemistry
        G. Miyashita; T. Higuchi; N. Oriuch; Y. Arisaka; T. Ishikita; H. Hanaoka; H. Tominaga; M. Miyakubo; A. Negishi; S. Yokoo; K. Endo
        EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010年10月, 査読有り
      • WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient
        Yusuke Oji; Yoshihiro Oka; Sumiyuki Nishida; Akihiro Tsuboi; Manabu Kawakami; Toshiaki Shirakata; Kazuko Takahashi; Ayako Murao; Hiroko Nakajima; Miwako Narita; Masuhiro Takahashi; Satoshi Morita; Junichi Sakamoto; Toshio Tanaka; Ichiro Kawase; Naoki Hosen; Haruo Sugiyama
        EUROPEAN JOURNAL OF HAEMATOLOGY, 2010年10月, 査読有り
      • Silent Brain Infarction and Rapid Decline of Kidney Function in Patients With CKD: A Prospective Cohort Study
        Mayumi Kobayashi; Nobuhito Hirawa; Satoshi Morita; Keisuke Yatsu; Yusuke Kobayashi; Yuichiro Yamamoto; Sanae Saka; Yoshiyuki Toya; Gen Yasuda; Satoshi Umemura
        AMERICAN JOURNAL OF KIDNEY DISEASES, 2010年09月, 査読有り
      • Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
        Kei Muro; Narikazu Boku; Yasuhiro Shimada; Akihito Tsuji; Shinichi Sameshima; Hideo Baba; Taroh Satoh; Tadamichi Denda; Kenji Ina; Tomohiro Nishina; Kensei Yamaguchi; Hiroya Takiuchi; Taito Esaki; Shinya Tokunaga; Hiroyuki Kuwano; Yoshito Komatsu; Masahiko Watanabe; Ichinosuke Hyodo; Satoshi Morita; Kenichi Sugihara
        LANCET ONCOLOGY, 2010年09月, 査読有り
      • Observations of Chromospheric Anemone Jets with Hinode Ca II Broadband Filtergraph and Hida Ca II Spectroheliograph
        Satoshi Morita; Kazunari Shibata; Satoru UeNo; Kiyoshi Ichimoto; Reizaburo Kitai; Ken-ichi Otsuji
        PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, 2010年08月, 査読有り
      • A meta-analysis of F-18-Fluoride positron emission tomography for assessment of metastatic bone tumor
        Ukihide Tateishi; Satoshi Morita; Masataka Taguri; Kazuya Shizukuishi; Ryogo Minamimoto; Masashi Kawaguchi; Takeshi Murano; Takashi Terauchi; Tomio Inoue; E. Edmund Kim
        ANNALS OF NUCLEAR MEDICINE, 2010年08月, 査読有り
      • Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer
        Yuji Ueda; Hisakazu Yamagishi; Daisuke Ichikawa; Kazuma Okamoto; Eigo Otsuji; Jun Morii; Kinya Koizumi; Naoki Kakihara; Masataka Shimotsuma; Tetsuro Yamashita; Fumihiro Taniguchi; Hideki Aragane; Hiroshi Nishi; Yoshiki Itokawa; Satoshi Morita; Junichi Sakamoto
        GASTRIC CANCER, 2010年08月, 査読有り
      • Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas
        Tsutomu Fujii; Koichi Kato; Yasuhiro Kodera; Mitsuro Kanda; Shunji Nagai; Suguru Yamada; Akiyuki Kanzaki; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Shigeo Nakamura; Akimasa Nakao
        SURGERY, 2010年08月, 査読有り
      • A Human Epidermal Growth Factor Receptor 2 Expression-based Approach to Neoadjuvant Chemotherapy for Operable Breast Cancer
        Takashi Ishikawa; Daisuke Shimizu; Takeshi Sasaki; Satoshi Morita; Mikiko Tanabe; Ikuko Ota; Kae Kawachi; Akinori Nozawa; Takashi Chishima; Yasushi Ichikawa; Itaru Endo; Hiroshi Shimada
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010年07月, 査読有り
      • Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
        Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
        NEW ENGLAND JOURNAL OF MEDICINE, 2010年06月, 査読有り
      • Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Jun Okuda; Noriaki Iwahashi; Kengo Tsukahara; Tatsuya Nakachi; Masayoshi Kiyokuni; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010年06月, 査読有り
      • Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies
        Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Michio Ueda; Masaaki Kondo; Satoshi Morita; Katsuaki Tanaka
        WORLD JOURNAL OF GASTROENTEROLOGY, 2010年05月, 査読有り
      • Identification of Occult Parechymal Disease Such as Emphysema or Airway Disease Using Screening Computed Tomography
        Kenji Tsushima; Shusuke Sone; Keisaku Fujimoto; Keishi Kubo; Satoshi Morita; Misa Takegami; Shunichi Fukuhara
        COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010年04月, 査読有り
      • A Comparison of Multimodality Treatment: Two or Four Courses of Paclitaxel plus Cisplatin or S-1 plus Cisplatin Followed by Surgery for Locally Advanced Gastric Cancer, a Randomized Phase II Trial (COMPASS)
        Takaki Yoshikawa; Akira Tsuburaya; Satoshi Morita; Yasuhiro Kodera; Seiji Ito; Haruhiko Cho; Yumi Miyashita; Junichi Sakamoto
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010年04月, 査読有り
      • Impact of High-Responsiveness to Dual Antiplatelet Therapy on Bleeding Complications in Patients Receiving Drug-Eluting Stents
        Kengo Tsukahara; Kazuo Kimura; Satoshi Morita; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Jun Okuda; Noriaki Iwahashi; Nobuhiko Maejima; Tatsuya Nakachi; Fumiyuki Ohtsuka; Katsutaka Hashiba; Yoshio Tahara; Teruyasu Sugano; Satoshi Umemura
        CIRCULATION JOURNAL, 2010年04月, 査読有り
      • Hydroxyurea as an inhibitor of hepatitis C virus RNA replication
        Akito Nozaki; Manabu Morimoto; Masaaki Kondo; Takashi Oshima; Kazushi Numata; Shin Fujisawa; Takeshi Kaneko; Eiji Miyajima; Satoshi Morita; Kyoko Mori; Masanori Ikeda; Nobuyuki Kato; Katsuaki Tanaka
        ARCHIVES OF VIROLOGY, 2010年04月, 査読有り
      • Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting
        Toshihiro Fukui; Minoru Tabata; Susumu Manabe; Tomoki Shimokawa; Satoshi Morita; Shuichiro Takanashi
        JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010年04月, 査読有り
      • Invasion of the Splenic Artery Is a Crucial Prognostic Factor in Carcinoma of the Body and Tail of the Pancreas
        Mitsuro Kanda; Tsutomu Fujii; Tevfik T. Sahin; Akiyuki Kanzaki; Shunji Nagai; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Yasuhiro Kodera; Satoshi Morita; Akimasa Nakao
        ANNALS OF SURGERY, 2010年03月, 査読有り
      • Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels
        Susumu Manabe; Toshihiro Fukui; Tomoki Shimokawa; Minoru Tabata; Yuzo Katayama; Satoshi Morita; Shuichiro Takanashi
        ANNALS OF THORACIC SURGERY, 2010年03月, 査読有り
      • Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients
        Hideki Hirakata; Yoshiharu Tsubakihara; Fumitake Gejyo; Shinichi Nishi; Yasuhiko Iino; Yuzou Watanabe; Masashi Suzuki; Akira Saito; Takashi Akiba; Daijo Inaguma; Shunichi Fukuhara; Satoshi Morita; Michiaki Hiroe; Yoshiyuki Hada; Makoto Suzuki; Makoto Akaishi; Kazutaka Aonuma; Tadao Akizawa
        CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010年02月, 査読有り
      • Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
        Masakazu Toi; Jeff Sperinde; Weidong Huang; Shigehira Saji; John Winslow; Xueguang Jin; Yuping Tan; Shinji Ohno; Seigo Nakamura; Hiroji Iwata; Norikazu Masuda; Kenjiro Aogi; Satoshi Morita; Christos Petropoulos; Michael Bates
        BMC CANCER, 2010年02月, 査読有り
      • Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
        Tetsuya Mitsudomi; Satoshi Morita; Yasushi Yatabe; Shunichi Negoro; Isamu Okamoto; Junji Tsurutani; Takashi Seto; Miyako Satouchi; Hirohito Tada; Tomonori Hirashima; Kazuhiro Asami; Nobuyuki Katakami; Minoru Takada; Hiroshige Yoshioka; Kazuhiko Shibata; Shinzoh Kudoh; Eiji Shimizu; Hiroshi Saito; Shinichi Toyooka; Kazuhiko Nakagawa; Masahiro Fukuoka
        LANCET ONCOLOGY, 2010年02月, 査読有り
      • Frequency of and variables associated with the EGFR mutation and its subtypes
        Tomoaki Tanaka; Masaru Matsuoka; Akihisa Sutani; Akihiko Gemma; Makoto Maemondo; Akira Inoue; Shoji Okinaga; Makoto Nagashima; Satoshi Oizumi; Kazutsugu Uematsu; Yoshiaki Nagai; Gaku Moriyama; Hitoshi Miyazawa; Kenji Ikebuchi; Satoshi Morita; Kunihiko Kobayashi; Koichi Hagiwara
        INTERNATIONAL JOURNAL OF CANCER, 2010年02月, 査読有り
      • Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)
        Bunzo Nakata; Akihito Tsuji; Yasushi Mitachi; Naoyuki Taenaka; Toshiki Kamano; Keisuke Oikawa; Naoyoshi Onoda; Mariko Kambe; Masahiro Takahashi; Tetsuhiko Shirasaka; Satoshi Morita; Junichi Sakamoto; Yukari Tanaka; Shigetoyo Saji; Kosei Hirakawa
        ONCOLOGY, 2010年, 査読有り
      • Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients
        Akito Nozaki; Kazushi Numata; Manabu Morimoto; Masaaki Kondo; Kazuya Sugimori; Satoshi Morita; Eiji Miyajima; Masanori Ikeda; Nobuyuki Kato; Shin Maeda; Katsuaki Tanaka
        ANTIVIRAL THERAPY, 2010年, 査読有り
      • Evaluating the impact of prior assumptions in Bayesian biostatistics
        Satoshi Morita; Peter F. Thall; Peter Müller
        Statistics in Biosciences, 2010年, 査読有り
      • Vaginal Douching in Cambodian Women: Its Prevalence and Association With Vaginal Candidiasis
        Lon Say Heng; Hiroshi Yatsuya; Satoshi Morita; Junichi Sakamoto
        JOURNAL OF EPIDEMIOLOGY, 2010年01月, 査読有り
      • A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer
        Satoshi Morita; Peter F. Thall; B. Nebiyou Bekele; Paul Mathew
        JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2010年, 査読有り
      • Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
        Kojiro Shimozuma; Yasuo Ohashi; Ayano Takeuchi; Toshihiko Aranishi; Satoshi Morita; Katsumasa Kuroi; Shozo Ohsumi; Haruhiko Makino; Hirohumi Mukai; Noriyuki Katsumata; Yoshihide Sunada; Toru Watanabe; Frederick H. Hausheer
        SUPPORTIVE CARE IN CANCER, 2009年12月, 査読有り
      • Preventive Effect of Goshajinkigan on Peripheral Neurotoxicity of FOLFOX Therapy: A Placebo-controlled Double-blind Randomized Phase II Study (the GONE Study)
        Toru Kono; Hideyuki Mishima; Mitsuo Shimada; Satoshi Morita; Junichi Sakamoto
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009年12月, 査読有り
      • Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction
        Masami Kosuge; Toshiyuki Ishikawa; Satoshi Morita; Toshiaki Ebina; Kiyoshi Hibi; Nobuhiko Maejima; Satoshi Umemura; Kazuo Kimura
        JOURNAL OF CARDIOLOGY, 2009年12月, 査読有り
      • Wilms' Tumor 1 (WT1) Peptide Immunotherapy for Gynecological Malignancy
        Satoshi Ohno; Satoru Kyo; Subaru Myojo; Satoshi Dohi; Junko Ishizaki; Ken-Ichi Miyamoto; Satoshi Morita; Jun-Ichi Sakamoto; Takayuki Enomoto; Tadashi Kimura; Yoshihiro Oka; Akihiro Tsuboi; Haruo Sugiyama; Masaki Inoue
        ANTICANCER RESEARCH, 2009年11月, 査読有り
      • Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial
        Tadao Akizawa; Yasushi Asano; Satoshi Morita; Takafumi Wakita; Yoshihiro Onishi; Shunichi Fukuhara; Fumitake Gejyo; Seiichi Matsuo; Noriaki Yorioka; Kiyoshi Kurokawa
        AMERICAN JOURNAL OF KIDNEY DISEASES, 2009年09月, 査読有り
      • Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis
        Tomoki Shimokawa; Hitoshi Kasegawa; Shigefumi Matsuyama; Hiroshi Seki; Susumu Manabe; Toshihiro Fukui; Satoshi Morita; Shuichiro Takanashi
        ANNALS OF THORACIC SURGERY, 2009年09月, 査読有り
      • Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)
        Katsumasa Kuroi; Kojiro Shimozuma; Yasuo Ohashi; Kazufumi Hisamatsu; Norikazu Masuda; Ayano Takeuchi; Toshihiko Aranishi; Satoshi Morita; Shozo Ohsumi; Frederick H. Hausheer
        SUPPORTIVE CARE IN CANCER, 2009年08月, 査読有り
      • A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia
        M. Kanai; S. Morita; S. Matsumoto; T. Nishimura; E. Hatano; S. Yazumi; T. Sasaki; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yanagihara; I. Ikai; R. Doi; M. Fukushima
        ANNALS OF ONCOLOGY, 2009年08月, 査読有り
      • Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer Influence of Resection Margin Status on Survival
        Koichi Kato; Suguru Yamada; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Shin Takeda; Yasuhiro Kodera; Satoshi Morita; Akimasa Nakao
        PANCREAS, 2009年08月, 査読有り
      • Factors Associated with Health-related Quality-of-life in Breast Cancer Survivors: Influence of the Type of Surgery
        Shozo Ohsumi; Kojiro Shimozuma; Satoshi Morita; Fumikata Hara; Daisuke Takabatake; Seiki Takashima; Naruto Taira; Kenjiro Aogi; Shigemitsu Takashima
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009年08月, 査読有り
      • Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non-Small Cell Lung Cancer with EGFR Mutations
        Satoshi Morita; Isamu Okamoto; Kunihiko Kobayashi; Koichi Yamazaki; Hajime Asahina; Akira Inoue; Koichi Hagiwara; Noriaki Sunaga; Noriko Yanagitani; Toyoaki Hida; Kimihide Yoshida; Tomonori Hirashima; Kosei Yasumoto; Kenji Sugio; Tetsuya Mitsudomi; Masahiro Fukuoka; Toshihiro Nukiwa
        CLINICAL CANCER RESEARCH, 2009年07月, 査読有り
      • Characteristics of suicide attempters with family history of suicide attempt: a retrospective chart review
        Makiko Nakagawa; Chiaki Kawanishi; Tomoki Yamada; Yoko Iwamoto; Ryoko Sato; Hana Hasegawa; Satoshi Morita; Toshinari Odawara; Yoshio Hirayasu
        BMC PSYCHIATRY, 2009年06月, 査読有り
      • Early, Accurate, Non-Invasive Predictors of Left Main or 3-Vessel Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Naohiro Komura; Katsutaka Hashiba; Masayoshi Kiyokuni; Naoki Nakayama; Satoshi Umemura; Kazuo Kimura
        CIRCULATION JOURNAL, 2009年06月, 査読有り
      • Feasibility of AC/EC Followed by Weekly Paclitaxel in Node-positive Breast Cancer in Japan
        Takashi Ishikawa; Satoru Shimizu; Kiyofumi Katayama; Takashi Chishima; Yohei Hamaguchi; Takako Doi; Mikiko Tanabe; Akio Kasahara; Naotaka Yamaguchi; Kazutaka Narui; Ikuko Ohta; Chizuru Matsumoto; Daisuke Shimizu; Ayako Kito; Takashi Suda; Masaaki Inaba; Taro Asaga; Nobuyoshi Momiyama; Yasushi Ichikawa; Masataka Yoshimoto; Satoshi Morita; Hiroshi Shimada
        ANTICANCER RESEARCH, 2009年05月, 査読有り
      • Lidocaine Concentration in Cerebrospinal Fluid after Epidural Administration A Comparison between Epidural and Combined Spinal-Epidural Anesthesia
        Yoshinori Kamiya; Tatsuaki Kikuchi; Gaku Inagawa; Hiroshi Miyazaki; Masashi Miura; Satoshi Morita; Takahisa Goto
        ANESTHESIOLOGY, 2009年05月, 査読有り
      • Augmentation Index Is Elevated in Aortic Aneurysm and Dissection
        Yasushige Shingu; Norihiko Shiiya; Tomonori Ooka; Tsuyoshi Tachibana; Suguru Kubota; Satoshi Morita; Yoshiro Matsui
        ANNALS OF THORACIC SURGERY, 2009年05月, 査読有り
      • Focal Liver Tumors: Characterization with 3D Perflubutane Microbubble Contrast Agent-enhanced US versus 3D Contrast-enhanced Multidetector CT
        Wen Luo; Kazushi Numata; Manabu Morimoto; Masaaki Kondo; Shigeo Takebayashi; Masahiro Okada; Satoshi Morita; Katsuaki Tanaka
        RADIOLOGY, 2009年04月, 査読有り
      • The CHAIN-project and installation of flare monitoring telescopes in developing countries
        S. Ueno; K. Shibata; R. Kitai; K. Ichimoto; S. Nagata; H. Isobe; G. Kimura; Y. Nakatani; M. Kadota; H. Komori; T. T. Ishii; S. Morita; K. Otsuji
        Data Science Journal, 2009年03月30日, 査読有り
      • First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.
        Inoue Akira; Kobayashi Kunihiko; Usui Kazuhiro; Maemondo Makoto; Okinaga Shoji; Mikami Iwao; Ando Masahiro; Yamazaki Koichi; Saijo Yasuo; Gemma Akihiko; Miyazawa Hitoshi; Tanaka Tomoaki; Ikebuchi Kenji; Nukiwa Toshihiro; Morita Satoshi; Hagiwara Koichi
        J Clin Oncol, 2009年03月20日, 査読有り
      • IRON AND IODINE DEFICIENCIES AMONG UNDER-2 CHILDREN, ADOLESCENT GIRLS, AND PREGNANT WOMEN OF BANGLADESH: ASSOCIATION WITH COMMON DISEASES
        Md Harun-Or-Rashid; Uh Farida Khatun; Yoshitoku Yoshida; Satoshi Morita; Nuruddin Chowdhury; Junichi Sakamoto
        NAGOYA JOURNAL OF MEDICAL SCIENCE, 2009年02月, 査読有り
      • KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING DENGUE AMONG PEOPLE IN PAKSE, LAOS
        Soodsada Nalongsack; Yoshitoku Yoshida; Satoshi Morita; Keo Sosouphanh; Junichi Sakamoto
        NAGOYA JOURNAL OF MEDICAL SCIENCE, 2009年02月, 査読有り
      • Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction
        Masami Kosuge; Kazuo Kimura; Satoshi Morita; Sunao Kojima; Tomohiro Sakamoto; Masaharu Ishihara; Yujiro Asada; Chuwa Tei; Shunichi Miyazaki; Masahiro Sonoda; Kazufumi Tsuchihashi; Masakazu Yamagishi; Mutsunori Shirai; Hisatoyo Hiraoka; Takashi Honda; Yasuhiro Ogata; Hisao Ogawa
        AMERICAN JOURNAL OF CARDIOLOGY, 2009年02月, 査読有り
      • Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction
        Toshihiro Fukui; Tomoki Shimokawa; Susumu Manabe; Satoshi Morita; Shuichiro Takanashi
        ANNALS OF THORACIC SURGERY, 2009年02月, 査読有り
      • Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer - ECRIN group studies
        J. Sakamoto; Y. Kodera; M. Kobayashi; K. Kondo; M. Ninomiya; N. Nagata; Y. Ueda; T. Matsui; S. Morita; A. Tsuburaya
        IGCC: PROCEEDINGS OF THE 8TH INTERNATIONAL GASTRIC CANCER CONGRESS, 2009年, 査読有り
      • The tandem fabry-perot filter imagaing spectro-polarimeter for the Solar Magnetic Activity Research Telescope(SMART)
        S. Nagata; K. Otsuji; T.T. Ishii; K. Ichimoto; S. UeNo; R. Kitai; G. Kimura; K. Shibata; Y. Nakatani; S. Morita
        Proceedings of SPIE - The International Society for Optical Engineering, 2009年, 査読有り
      • β-Blocker prescription and outcomes in hemodialysis patients from the japan dialysis outcomes and practice patterns study
        K. Nakao; H. Makino; S. Morita; Y. Takahashi; T. Akizawa; A. Saito; Y. Asano; K. Kurokawa; S. Fukuhara; T. Akiba
        Nephron - Clinical Practice, 2009年, 査読有り
      • Response shift in a randomized controlled trial of low vision care for patients with age-related maculopathy.
        Shimozuma K; Yamaguchi T; Fujita K; Yuzawa M; Suzukamo Y; Takahashi N; Takahashi K; Morita S; Fukuhara S
        Value in Health, 2008年11月, 査読有り
      • A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer
        Katsumasa Kuroi; Kojiro Shimozuma; Yasuo Ohashi; Ayano Takeuchi; Toshihiko Aranishi; Satoshi Morita; Shozo Ohsumi; Toru Watanabe; Stacey Bain; Frederick H. Hausheer
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008年11月, 査読有り
      • A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
        Akihiro Nakajo; Shuichi Hokita; Sumiya Ishigami; Futoshi Miyazono; Tadaaki Etoh; Masahiro Hamanoue; Shigeho Maenohara; Toshimitsu Iwashita; Hideaki Komatsu; Kiyoharu Satoh; Kuniaki Aridome; Satoshi Morita; Shoji Natsugoe; Hiroya Takiuchi; Shyuji Nakano; Yoshihiko Maehara; Junichi Sakamoto; Takashi Aikou; Kyushu Taxol
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008年11月, 査読有り
      • Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment
        Ken-ichi Takahashi; Kazuo Chin; Takashi Akamizu; Satoshi Morita; Kensuke Sumi; Toru Oga; Hisako Matsumoto; Akio Niimi; Tomomasa Tsuboi; Shunichi Fukuhara; Kenji Kangawa; Michiaki Mishima
        RESPIROLOGY, 2008年09月, 査読有り
      • Injury and pre-hospital trauma care in Hanoi, Vietnam
        Nguyen Thi Lien Huong; Nguyen Thi Hong Tu; Satoshi Morita; Junichi Sakamoto
        INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2008年09月, 査読有り
      • Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP
        Noriko Handa; Eiichi Mizohata; Seiichiro Kishishita; Mitsutoshi Toyama; Satoshi Morita; Tomomi Uchikubo-Kamo; Ryogo Akasaka; Kenji Omori; Jun Kotera; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
        Journal of Biological Chemistry, 2008年07月11日, 査読有り
      • Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) in Japan
        K. Kobayashi; S. Morita; M. Shimonagayoshi; M. Kobayashi; Y. Fujiki; Y. Uchida; K. Yamaguchi
        PSYCHO-ONCOLOGY, 2008年06月, 査読有り
      • Determining the effective sample size of a parametric prior
        Satoshi Morita; Peter F. Thall; Peter Mueller
        BIOMETRICS, 2008年06月, 査読有り
      • The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data.
        Satoshi Morita; Adrian A Kaptein; Koji Oba; Junichi Sakamoto
        Psycho-oncology, 2008年05月, 査読有り
      • Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
        Shuichi Izumoto; Akihiro Tsuboi; Yoshihiro Oka; Tsuyoshi Suzuki; Tetsuo Hashiba; Naoki Kagawa; Naoya Hashimoto; Motohiko Maruno; Olga A. Elisseeva; Toshiaki Shirakata; Manabu Kawakami; Yusuke Oji; Sumiyuki Nishida; Satoshi Ohno; Ichiro Kawase; Jun Hatazawa; Shin-icih Nakatsuka; Katsuyuki Aozasa; Satoshi Morita; Junichi Sakamoto; Haruo Sugiyama; Toshiki Yosihmine
        JOURNAL OF NEUROSURGERY, 2008年05月, 査読有り
      • Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure
        Ken-Ichi Takahashi; Kazuo Chin; Hajime Nakamura; Satoshi Morita; Kensuke Sumi; Toru Oga; Hisako Matsumoto; Akio Niimi; Shunichi Fukuhara; Junji Yodoi; Michiaki Mishima
        ANTIOXIDANTS & REDOX SIGNALING, 2008年04月, 査読有り
      • Quality of life improvements in dialysis patients receiving darbepoetin alfa
        Shunichi Fukuhara; Tadao Akizawa; Satoshi Morita; Shozo Koshikawa
        THERAPEUTIC APHERESIS AND DIALYSIS, 2008年02月, 査読有り
      • Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN
        Y. Asano; T. Akizawa; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; S. Morita; T. Wakita; Y. Onishi; K. Kurokawa
        Japanese Journal of Nephrology, 2008年, 査読有り
      • A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group.
        Haruhiko Cho; Akira Tsuburaya; Junichi Sakamoto; Satoshi Morita; Koji Oba; Takaki Yoshikawa; Naomi Miyajima
        Japanese journal of clinical oncology, 2008年01月, 査読有り
      • A phase I study of combination therapy of the oral fluorinated pyrimidine compound s-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 step2) in patients with advanced gastric cancer using a continual reassessment method
        Satoshi Morita; Bunzo Nakata; Akihito Tsuji; Yasushi Mitachi; Tetsuhiko Shirasaka; Shigetoyo Saji; Yasuo Ohashi; Junichi Sakamoto; Kosei Hirakawa
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007年12月, 査読有り
      • Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma
        Akihiro Tsuboi; Yoshihiro Oka; Hiroko Nakajima; Yoko Fukuda; Olga A. Elisseeva; Satoshi Yoshihara; Naoki Hosen; Atsushi Ogata; Katsuyuki Kito; Fumihiro Fujiki; Sumiyuki Nishida; Toshiaki Shirakata; Satoshi Ohno; Masaki Yasukawa; Yusuke Oji; Manabu Kawakami; Satoshi Morita; Junichi Sakamoto; Keiko Udaka; Ichiro Kawase; Haruo Sugiyama
        INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007年12月, 査読有り
      • Structure of the human Tim44 C-terminal domain in complex with pentaethylene glycol: Ligand-bound form
        Noriko Handa; Seiichiro Kishishita; Satoshi Morita; Ryogo Akasaka; Zhongmin Jin; John Chrzas; Lirong Chen; Zhi-Jie Liu; Bi-Cheng Wang; Sumio Sugano; Akiko Tanaka; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
        Acta Crystallographica Section D: Biological Crystallography, 2007年11月16日, 査読有り
      • Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma
        M. Ninomiya; K. Kondo; K. Matsuo; N. Hirabayashi; H. Kojima; M. Kobayashi; S. Kawamura; T. Ando; N. Musha; H. Konno; N. Nagata; H. Usuki; Y. Miyashita; K. Oba; S. Morita; J. Sakamoto
        JOURNAL OF CHEMOTHERAPY, 2007年08月, 査読有り
      • Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer - Positive peritoneal cytology may not confer an adverse prognosis
        Suguru Yamada; Shin Takeda; Tsutomu Fujii; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Hideki Kasuya; Yasuhiro Kodera; Tetsuro Nagasaka; Satoshi Morita; Akimasa Nakao
        ANNALS OF SURGERY, 2007年08月, 査読有り
      • Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement
        Hisashi Urushihara; Shunichi Fukuhara; Shigeru Tai; Satoshi Morita; Kazuo Chihara
        EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007年06月, 査読有り
      • Lifestyle and work predictors of fatigue in Japanese manufacturing workers.
        Yamazaki S; Fukuhara S; Suzukamo Y; Morita S; Okamura T; Tanaka T; Ueshima H
        Occup Med (Lond), 2007年06月, 査読有り
      • Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 μg/body) in a patient with chronic myelomonocytic leukemia
        M. Kawakami; Y. Oka; A. Tsuboi; Y. Harada; O.A. Elisseeva; Y. Furukawa; M. Tsukaguchi; T. Shirakata; S. Nishida; H. Nakajima; S. Morita; J. Sakamoto; I. Kawase; Y. Oji; H. Sugiyama
        International Journal of Hematology, 2007年06月, 査読有り
      • A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC)
        Satoshi Morita; Hideo Baba; Akira Tsuburaya; Hiroya Takiuchi; Takanori Matsui; Yoshihiko Maehara; Junichi Sakamoto
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007年06月, 査読有り
      • Crystal structure of the human BRD2 bromodomain: Insights into dimerization and recognition of acetylated histone H4
        Yoshihiro Nakamura; Takashi Umehara; Kazumi Nakano; Kyoo Jang Moon; Mikako Shirouzu; Satoshi Morita; Hiroko Uda-Tochio; Hiroaki Hamana; Takaho Terada; Naruhiko Adachi; Takehisa Matsumoto; Akiko Tanaka; Masami Horikoshi; Keiko Ozato; Balasundaram Padmanabhan; Shigeyuki Yokoyama
        Journal of Biological Chemistry, 2007年01月09日, 査読有り
      • Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer
        Shigehira Saji; Masakazu Toi; Satoshi Morita; Hiroji Iwata; Yoshinori Ito; Shinji Ohno; Tadashi Kobayashi; Yasuo Hozumi; Junichi Sakamoto
        ONCOLOGY, 2007年, 査読有り
      • HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia.
        S. Enkhbold; S. Tugsdelger; S. Morita; J. Sakamoto; N. Hamajima
        Nagoya journal of medical science, 2007年, 査読有り
      • Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer
        Satoshi Morita; Masakazu Toi; Shigehira Saji; Hiroji Iwata; Shinji Ohno; Yoshinori Ito; Tadashi Kobayashi; Yasuo Hozumi; Junichi Sakamoto
        DRUG INFORMATION JOURNAL, 2007年, 査読有り
      • From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside.
        J. Sakamoto; S. Morita
        Nagoya journal of medical science, 2007年, 査読有り
      • Clinical validity of the japanese version of the functional assessment of cancer therapy-anemia scale
        Maya Kurita; Kojiro Shimozuma; Satoshi Morita; Yuki Fujiki; Kenichi Ishizawa; Hisae Eguchi; Yuko Saito; Nobuko Ushirozawa; Izumi Wasada; Yasuo Ohashi; Kenji Eguchi
        SUPPORTIVE CARE IN CANCER, 2007年01月, 査読有り
      • Health-related quality of life among Japanese women with iron-deficiency anemia
        Kiyoshi Ando; Satoshi Morita; Takahiro Higashi; Shunichi Fukuhara; Shigeki Watanabe; Jaeon Park; Masao Kikuchi; Koichi Kawano; Izumi Wasada; Tomomitsu Hotta
        QUALITY OF LIFE RESEARCH, 2006年12月, 査読有り
      • Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer
        Takanori Matsui; Kenji Omura; Kazuyuki Kawakami; Satoshi Morita; Junichi Sakamoto
        ONCOLOGY REPORTS, 2006年11月, 査読有り
      • Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments
        Satoshi Morita; Adrian A. Kaptein; Akira Tsuburaya; Yasuhiro Kodera; Takanori Matsui; Junichi Sakamoto
        Gastric Cancer, 2006年11月, 査読有り
      • Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial.
        Koji Oba; Satoshi Morita; Mahbubur Rahman; Junichi Sakamoto
        Trials, 2006年08月21日, 査読有り
      • Informed consent in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial: A survey of collaborating physicians
        Tsuguya Fukui; Mahbubur Rahman; Satoshi Morita; Junichi Sakamoto
        HYPERTENSION RESEARCH, 2006年07月, 査読有り
      • Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: Rationale and design of the carvedilol or metoprolol post-revascularization atrial fibrillation controlled trial (COMPACT)
        Masataka Kamei; Satoshi Morita; Yukio Hayashi; Yuichi Kanmura; Masakazu Kuro
        Cardiovascular Drugs and Therapy, 2006年06月, 査読有り
      • Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan
        K. Oba; S. Morita; A. Tsuburaya; Y. Kodera; M. Kobayashi; J. Sakamoto
        JOURNAL OF CHEMOTHERAPY, 2006年06月, 査読有り
      • A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma
        K Kobayashi; A Tsuji; S Morita; T Horimi; T Shirasaka; T Kanematsu
        BMC CANCER, 2006年05月, 査読有り
      • A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data
        S Morita; Y Oka; A Tsuboi; M Kawakami; M Maruno; S Izumoto; T Osaki; T Taguchi; T Ueda; A Myoui; S Nishida; T Shirakata; S Ohno; Y Oji; K Aozasa; J Hatazawa; K Udaka; H Yoshikawa; T Yoshimine; S Noguchi; Kawase, I; SI Nakatsuka; H Sugiyama; J Sakamoto
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006年04月, 査読有り
      • Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design
        S Morita; J Sakamoto
        PHARMACEUTICAL STATISTICS, 2006年04月, 査読有り
      • Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors
        N Takahashi; S Kikuchi; S Konno; S Morita; Y Suzukamo; J Green; S Fukuhara
        SPINE, 2006年04月, 査読有り
      • Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials.
        Junichi Sakamoto; Satoshi Morita; Koji Oba; Takanori Matsui; Michiya Kobayashi; Hiroaki Nakazato; Yasuo Ohashi
        Cancer immunology, immunotherapy : CII, 2006年04月, 査読有り
      • Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease
        S Morita; S Fukuhara; T Akizawa; Y Asano; S Koshikawa; K Koide; K Kurokawa
        THERAPEUTIC APHERESIS AND DIALYSIS, 2006年02月, 査読有り
      • Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan
        Satoshi Morita; Michiya Kobayashi; Koji Oba; Toru Ichihara; Akimasa Nakao; Junichi Sakamoto
        Annals of Cancer Research and Therapy, 2006年, 査読有り
      • Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side
        Tsuguya Fukui; Mahbubur Rahman; Takuro Shimbo; Satoshi Morita; Junichi Sakamoto
        INTERNAL MEDICINE, 2006年, 査読有り
      • Estimation of the average causal effect among subgroups defined by post-treatment variables
        Y Matsuyama; S Morita
        CLINICAL TRIALS, 2006年, 査読有り
      • Spiritual needs in cancer patients and spiritual care based on logotherapy
        W Noguchi; S Morita; T Ohno; O Aihara; H Tsujii; K Shimozuma; E Matsushima
        SUPPORTIVE CARE IN CANCER, 2006年01月, 査読有り
      • "Point of no return (PNR)" in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR
        Hiroyuki Komatsu; Shouichi Fujimoto; Yuji Sato; Seiichiro Hara; Kazuhiro Yamada; Satoshi Morita; Tanenao Eto
        Journal of Nephrology, 2005年11月, 査読有り
      • A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial
        A Tsuburaya; J Sakamoto; S Morita; Y Kodera; M Kobayashi; Y Miyashita; JS Macdonald
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005年11月, 査読有り
      • Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD)
        Satoshi Morita; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Kiyoshi Kurokawa
        Clinical and Experimental Nephrology, 2005年09月, 査読有り
      • Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation
        S Morita; K Kobayashi; K Eguchi; T Matsumoto; M Shibuya; Y Yamaji; Y Ohashi
        QUALITY OF LIFE RESEARCH, 2005年08月, 査読有り
      • Crystal structure of an enhancer of rudimentary homolog (ERH) at 2.1 Å resolution
        Ryoichi Arai; Mutsuko Kukimoto-Niino; Hiroko Uda-Tochio; Satoshi Morita; Tomomi Uchikubo-Kamo; Ryogo Akasaka; Yuuka Etou; Yoshihide Hayashizaki; Takanori Kigawa; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
        Protein Science, 2005年07月, 査読有り
      • Quality of life in gastric cancer
        Ad A. Kaptein; Satoshi Morita; Junichi Sakamoto
        WORLD JOURNAL OF GASTROENTEROLOGY, 2005年06月, 査読有り
      • Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma
        H Matsumoto; A Niimi; M Takemura; T Ueda; M Minakuchi; R Tabuena; K Chin; T Mio; Y Ito; S Muro; T Hirai; S Morita; S Fukuhara; M Mishima
        THORAX, 2005年04月, 査読有り
      • Physicians' attitudes towards and reasons for participation in the Candesartan Anti Hypertensive Survival Evaluation in Japan (CASE-J) trial
        M Rahman; S Morita; T Fukui; J Sakamoto
        JOURNAL OF EPIDEMIOLOGY, 2005年03月, 査読有り
      • Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
        Y Ueda; H Yamagishi; D Ichikawa; J Morii; K Koizumi; N Kakihara; M Shimotsuma; A Takenaka; T Yamashita; H Kurioka; M Nishiyama; S Morita; K Nakamura; J Sakamoto
        ONCOLOGY, 2005年, 査読有り
      • Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives
        J Sakamoto; S Morita; Y Kodera; M Rahman; A Nakao
        CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004年09月, 査読有り
      • Physicians' reasons for not entering their patients in a randomized controlled trial in Japan
        M Rahman; S Morita; T Fukui; J Sakamoto
        TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2004年06月, 査読有り
      • Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer
        W Noguchi; T Ohno; S Morita; O Aihara; H Tsujii; K Shimozuma; E Matsushima
        SUPPORTIVE CARE IN CANCER, 2004年04月, 査読有り
      • 腰痛特異的QOL尺度 Roland-Morris Disability Questionnaireの性・年齢階層別基準値の測定
        高橋奈津子; 菊地臣一; 福原俊一; 鈴鴨よしみ; 紺野愼一; 森田智視; 岩本幸英; 中村孝志
        臨床整形外科, 2004年03月, 査読有り
      • Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: a novel study design to evaluate safety and efficacy
        S Morita; Y Ohashi; K Hirakawa; B Nakata; S Saji; J Sakamoto
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004年03月, 査読有り
      • Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer
        S Morita; M Toi; T Kobayashi; Y Ito; Y Hozumi; S Ohno; H Iwata; J Sakamoto
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004年02月, 査読有り
      • Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial
        S. Morita; K. Kobayashi; Y. Ohashi; K. Eguchi; M. Shibuya; T. Matsumoto; Y. Yamaji; K. Nagao; J. Sakamoto; H. Niitani
        Annals of Cancer Research and Therapy, 2004年, 査読有り
      • Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module
        S. Morita; K. Shimozuma; A. Sato; M. Nakamachi; J. Blazeby; K. West; S. Fukuhara; J. Sakamoto
        Gan to kagaku ryoho. Cancer & chemotherapy, 2004年, 査読有り
      • Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence?
        Junichi Sakamoto; Satoshi Morita
        Japanese Journal of Allergology, 2004年, 査読有り
      • Physicians' choice in using internet and fax for patient recruitment and follow-up in a randomized controlled trial
        M Rahman; S Morita; T Fukui; J Sakamoto
        METHODS OF INFORMATION IN MEDICINE, 2004年, 査読有り
      • Candesartan antihypertensive survival evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods
        T Fukui; M Rahman; K Hayashi; K Takeda; J Higaki; T Sato; M Fukushima; J Sakamoto; S Morita; T Ogihara; K Fukiyama
        HYPERTENSION RESEARCH, 2003年12月, 査読有り
      • Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model
        S Morita; K Kobayashi; K Eguchi; T Matsumoto; M Shibuya; Y Yamaji; J Sakamoto; Y Ohashi
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003年09月, 査読有り
      • Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer
        S Morita; Y Ohashi; K Kobayashi; T Matsumoto; K Eguchi; M Shibuya; Y Yamaji; M Fukuoka; K Nagao; H Niitani
        JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003年08月, 査読有り
      • A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer
        J Sakamoto; S Morita; T Yumiba; H Narahara; K Kinoshita; Y Nakane; H Imamoto; H Shiozaki
        JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003年05月, 査読有り
      • The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): Validity and reliability in Japanese patients with advanced non-small-cell lung cancer
        T Matsumoto; Y Ohashi; S Morita; K Kobayashi; M Shibuya; Y Yamaji; K Eguchi; M Fukuoka; K Nagao; Y Nishiwaki; H Niitani
        QUALITY OF LIFE RESEARCH, 2002年08月, 査読有り
      • Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy
        Y Suzuki; T Nakano; T Ohno; A Abe; S Morita; H Tsujii
        JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000年06月, 査読有り
      • Dose-volume histogram analysis of high dose rate intracavitary brachytherapy for uterine cervix cancer
        A Terahara; T Nakano; A Ishikawa; S Morita; H Tsujii
        INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996年06月, 査読有り
      • Preoperative autologous blood donations in pediatric cardiac surgery
        M Masuda; Y Kawachi; S Inaba; K Matsuzaki; F Fukumura; S Morita; R Tominaga; H Yasui
        ANNALS OF THORACIC SURGERY, 1995年12月, 査読有り
      • Hepatic arterial infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II for the treatment of malignant liver tumors
        S. Morita; S. Matsumoto; R. Odani
        Japanese Journal of Cancer and Chemotherapy, 1988年, 査読有り
      • BOUNDED COHOMOLOGY OF CERTAIN GROUPS OF HOMEOMORPHISMS
        S MATSUMOTO; S MORITA
        PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY, 1985年, 査読有り
      • Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study)
        Masahiro Takada; Hiroshi Ishiguro; Shigenori Nagai; Shoichiro Ohtani; Hidetaka Kawabata; Yasuhiro Yanagita; Yasuo Hozumi; Chikako Shimizu; Shintaro Takao; Nobuaki Sato; Yoshimasa Kosaka; Yasuaki Sagara; Hiroji Iwata; Shinji Ohno; Katsumasa Kuroi; Norikazu Masuda; Hiroyasu Yamashiro; Masahiro Sugimoto; Masahide Kondo; Yasuhiro Naito; Hironobu Sasano; Takashi Inamoto; Satoshi Morita; Masakazu Toi
        San Antonio Breast Cancer Symposium 2013, 査読有り

      MISC

      • 臨床研究における紙とアプリでの患者報告アウトカム(PRO)の検証:CIPN多施設共同観察研究(KBCRNA004)から
        川口展子; 川口展子; 露木茂; 露木茂; 木川雄一郎; 木川雄一郎; 太良哲彦; 太良哲彦; 相良安昭; 相良安昭; 諏訪裕文; 諏訪裕文; 山城大泰; 山城大泰; 山城大泰; 石黒洋; 石黒洋; 杉江知治; 杉江知治; 片岡裕貴; 工藤紀子; 荒牧英治; 森田智視; 池田隆文; 戸井雅和; 戸井雅和
        日本乳癌学会学術総会(CD-ROM), 2024年
      • The 2020 edition of the clinical guidelines for lung cancer: Challenges and future perspectives
        Yuichi Takiguchi; Takashi Seto; Kaname Nosaki; Kazuo Hasegawa; Satoshi Morita; Ryo Morita; Kiichiro Ninomiya; Toyoaki Hida
        Japanese Journal of Lung Cancer, 2021年
      • 持続陽圧(CPAP,ASV)治療管理開始時からの治療状況確認と自己学習を含めた患者・医療機関相互方向の遠隔医療の試み 3.持続気道陽圧(CPAP)療法中の睡眠時無呼吸患者の肥満に対する遠隔モニタリングシステムを利用した減量指導の検証
        巽浩一郎; 平井豊博; 森田智視; 大平徹郎; 坪井知正; 富井啓介; 葛西隆敏; 千葉伸太郎; 黒田知宏; 中山健夫; 吉嶺裕之; 權寧博; 吉川雅則; 小川浩正; 百村伸一; 小賀徹; 陳和夫
        持続陽圧(CPAP、ASV)治療管理開始時からの治療状況確認と自己学習を含めた患者・医療機関相互方向の遠隔医療の試み 平成31(令和元)年度 研究報告書(Web), 2020年
      • Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma
        Kazushi Numata; Hiroyuki Fukuda; Haruo Miwa; Tomohiro Ishii; Satoshi Moriya; Masaaki Kondo; Akito Nozaki; Manabu Morimoto; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Akinori Nozawa; Masayuki Nakano; Katsuaki Tanaka
        European Journal of Radiology, 2014年01月01日
      • Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma
        Kenichi Takizawa; Kazushi Numata; Manabu Morimoto; Masaaki Kondo; Akito Nozaki; Satoshi Moriya; Tomohiro Ishii; Takashi Oshima; Hiroyuki Fukuda; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Katsuaki Tanaka
        European Journal of Radiology, 2013年09月01日
      • LONG-TERM OUTCOME IN PATIENTS WITH INTERMEDIATE-SIZED HEPATOCELLULAR CARCINOMA: A RANDOMIZED CONTROLLED TRIAL TO DETERMINE THE EFFICACY OF RADIOFREQUENCY ABLATION COMBINED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
        Manabu Morimoto; Kazushi Numata; Masaaki Kondo; Akito Nozaki; Satoshi Moriya; Kenichi Takizawa; Shin Maeda; Katsuaki Tanaka
        HEPATOLOGY, 2011年10月
      • 睡眠呼吸障害のバイオマーカーとしての血清尿酸値の有用性の検討 ながはまスタディ
        砂留 広伸; 村瀬 公彦; 田原 康玄; 南 卓馬; 武山 博文; 高橋 順美; 松本 健; 濱田 哲; 長崎 忠雄; 谷澤 公伸; 半田 知宏; 松本 久子; 若村 智子; 森田 智視; 平井 豊博; 松田 文彦; 陳 和夫
        日本呼吸器学会誌, 2021年04月
      • Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation in the Real-world: The Fushimi AF Registry
        Yugo Yamashita; Ryuji Uozumi; Masahiro Esato; Yeong-Hwa Chun; Hiromichi Wada; Koji Hasegawa; Hisashi Ogawa; Mitsuru Abe; Satoshi Morita; Masaharu Akao
        CIRCULATION, 2016年11月
      • Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation in the Real-world: The Fushimi AF Registry
        Yugo Yamashita; Ryuji Uozumi; Masahiro Esato; Yeong-Hwa Chun; Hiromichi Wada; Koji Hasegawa; Hisashi Ogawa; Mitsuru Abe; Satoshi Morita; Masaharu Akao
        CIRCULATION, 2016年11月
      • 「それぞれの癌」難治性癌に対する治療戦略 乳腺 HER2陽性転移性乳癌に対するtrastuzumab、pertuzumab、eribulin併用療法(JBCRG-M03)
        北田 正博; 山下 年成; 川口 英俊; 成井 一隆; 服部 正也; 吉波 哲大; 松並 展輝; 柳原 一広; 長谷川 善枝; 中村 力也; 増田 慎三; 森田 智視; 大野 真司; 戸井 雅和
        日本癌治療学会学術集会抄録集, 2017年10月
      • 高齢者進行非小細胞肺癌に対するpemetrexed/bevacizumab併用療法の検討 忍容性試験 (TORG1015)
        堺田 惠美子; 滝口 裕一; 上月 稔幸; 野上 尚之; 北島 寛元; 新海 哲; 榎本 泰典; 加藤 晃史; 小倉 高志; 宮本 信吾; 森田 智視; 渡邉 古志郎
        肺癌, 2013年10月
      • 高齢者進行NSCLCに対するpemetrexed/bevacizumab併用療法 忍容性試験 (TORG1015)
        宮本 信吾; 上月 稔幸; 野上 尚之; 北島 寛元; 新海 哲; 堺田 恵美子; 滝口 裕一; 榎本 泰典; 加藤 晃史; 小倉 高志; 森田 智視; 渡邉 古志郎
        日本癌治療学会誌, 2013年09月
      • Prospective analysis of UGT1A1 genotyping for predicting toxicities in advanced colorectal cancer (ACRC) treated with irinotecan (IRI)-based regimens: The development of nomogram predicting severe neutropenia
        W. Ichikawa; I. Hyodo; K. Fujita; M. Nakamura; A. Tsuji; S. Morita; Y. Ando; T. Sugiyama; Y. Ohashi; Y. Sakata
        EUROPEAN JOURNAL OF CANCER, 2013年09月
      • FINAL ANALYSIS OF RANDOMIZED PHASE III STUDY WJOG4007 COMPARING IRINOTECAN (CPT-11) WITH WEEKLY PACLITAXEL (WPTX) IN ADVANCED GASTRIC CANCER (AGC) REFRACTORY TO CHEMOTHERAPY (CT) OF FLUOROPYRIMIDINE PLUS PLATINUM (FP)
        T. Nishina; S. Hironaka; A. Tsuji; K. Suzuki; T. Otsuji; T. Shibata; S. Morita; I. Okamoto; N. Boku; I. Hyodo
        ANNALS OF ONCOLOGY, 2012年09月
      • 進行・再発胃癌に対する標準化学療法のコンセンサスは得られたか 切除不能・再発胃がんに対する少量Cisplatin(週2回投与)+TS-1療法(JFMC27-9902 Step2)の第I/II相臨床試験成績
        辻 晃仁; 三田地 泰司; 仲田 文造; 及川 圭介; 片見 厚夫; 妙中 直之; 高橋 昌宏; 神部 眞理子; 小野田 尚佳; 森田 智視; 坂本 純一; 佐治 重豊; 白坂 哲彦; 平川 弘聖
        日本癌治療学会誌, 2008年10月
      • Phase II study of CDOP + S-1 combination chemotherapy for advanced and recurrent gastric cancer
        A Tsuji; S Morita; Y Shima; Y Nishioka; T Horimi; T Shirasaka
        JOURNAL OF CLINICAL ONCOLOGY, 2004年07月
      • A pilot pharmacological study of twice-weekly paclitaxel therapy in advanced and recurrent gastric cancer.
        Y Shima; A Tsuji; S Morita; T Horimi
        JOURNAL OF CLINICAL ONCOLOGY, 2004年07月
      • Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
        A. Tsuji; S. Morita; T. Horimi; M. Takasaki; I. Takahashi; T. Shirasaka
        Gan to kagaku ryoho. Cancer & chemotherapy, 2000年01月01日
      • Preliminary clinical evaluation of low-dose CDDP and continuous 5-FU therapy for advanced gallbladder cancer
        A. Tsuji; S. Morita; T. Horimi; M. Takasaki; M. Takamatsu; I. Takahashi; T. Shirasaka
        Gan to kagaku ryoho. Cancer & chemotherapy, 2000年01月01日
      • Ambulatory and domiciliary cancer chemotherapy with forearm implant catheter system and low-dose CDDP + 5-FU therapy
        A. Tsuji; S. Morita; T. Horimi; M. Takasaki; I. Takahashi; T. Shirasaka
        Gan to kagaku ryoho. Cancer & chemotherapy, 1999年01月01日
      • Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers
        A. Tsuji; S. Morita; T. Horimi; M. Takasaki; I. Takahashi; T. Shirasaka
        Gan to kagaku ryoho. Cancer & chemotherapy, 1999年01月01日
      • Chemotherapy with low dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers
        A Tsuji; S Morita; T Horimi; M Takasaki; Takahashi, I; T Shirasaka
        ANNALS OF ONCOLOGY, 1998年
      • Low-dose CDDP and continuous 5-FU treatment of advanced gastric cancer with peritoneal dissemination: a case with long disease-free survival
        A. Tsuji; M. Takasaki; S. Morita; M. Takamatsu; T. Horimi; I. Takahashi
        Gan to kagaku ryoho. Cancer & chemotherapy, 1998年01月01日
      • Superficial esophageal carcinoma detected on extensive esophageal varices before endoscopic injection sclerotherapy
        M Takasaki; T Horimi; Takahashi, I; M Takamatsu; A Hirano; A Tsuji; Y Yorimitsu; S Morita
        GASTROINTESTINAL ENDOSCOPY, 1997年01月
      • 切除不能大腸癌に対するFOLFOX+bevacizumab(Bev)とFOLFIRI+Bevの第III相試験WJOG4407G
        田村 孝雄; 山崎 健太郎; 奥野 達哉; 仁科 智裕; 大石 達郎; 栗本 拓也; 高山 哲治; 根来 裕二; 吉田 元樹; 杉山 敏郎; 柴田 義宏; 安藤 昌彦; 森田 智視; 朴 成和; 兵頭 一之介
        日本癌治療学会誌, 2014年06月
      • Treatment Responses and Their Predictors Of Abatacept In Biologic naive Patients With Rheumatoid Arthritis; Data Form Abroad Study.
        Yutaka Kawahito; Takao Fujii; Akira Yokota; Hideo Hashimoto; Kiyoshi Matsui; Kenji Miki; Masayasu Kitano; Naoki Shinmyo; Aihiro Yamamoto; Koichiro Ohmura; Takanori Kuroiwa; Toshihiko Hidaka; Ichiro Yoshii; Hideko Nakahara; Takashi Fujimoto; Kosaku Murakami; Satoshi Morita; Masahiro Sekiguchi; Norihiro Nishimoto; Tsuneyo Mimori; Hajime Sano
        ARTHRITIS AND RHEUMATISM, 2013年10月
      • ER陽性の閉経後乳癌に対するANA+UFT併用療法の無作為化第II相臨床試験(Neo-ACET BC)
        中山 貴寛; 相良 安昭; 高島 勉; 松並 展輝; 増田 慎三; 三好 康雄; 田口 哲也; 青野 豊一; 位藤 俊一; 戸井 雅和; 森田 智視; 野口 慎三郎
        日本乳癌学会総会プログラム抄録集, 2016年06月
      • 気管支喘息(成人) 管理:合併症,COVID-19 中高年発症喘息と睡眠呼吸障害の関係 ながはまスタディ
        砂留 広伸; 松本 久子; 村瀬 公彦; 田原 康玄; 西 健太; 寺田 悟; 野村 奈都子; 古郷 摩利子; 田嶋 範之; 森本 千絵; 高橋 順美; 松本 健; 濱田 哲; 長崎 忠雄; 小熊 毅; 谷澤 公伸; 半田 知宏; 佐藤 晋; 森田 智視; 平井 豊博; 松田 文彦; 陳 和夫
        アレルギー, 2021年08月
      • 気管支喘息(成人) 管理:合併症,COVID-19 中高年発症喘息と睡眠呼吸障害の関係 ながはまスタディ
        砂留 広伸; 松本 久子; 村瀬 公彦; 田原 康玄; 西 健太; 寺田 悟; 野村 奈都子; 古郷 摩利子; 田嶋 範之; 森本 千絵; 高橋 順美; 松本 健; 濱田 哲; 長崎 忠雄; 小熊 毅; 谷澤 公伸; 半田 知宏; 佐藤 晋; 森田 智視; 平井 豊博; 松田 文彦; 陳 和夫
        アレルギー, 2021年08月
      • Association of Peripheral Regulatory T Cells with Achievement of Deep Molecular Response in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Treated with Dasatinib - the Final Results of D-First Study
        Chikashi Yoshida; Noriyoshi Iriyama; Yuho Najima; Shin Fujisawa; Hisashi Wakita; Shigeru Chiba; Shinichiro Okamoto; Kimihiro Kawakami; Naoki Takezako; Takashi Kumagai; Kazuma Ohyashiki; Jun Taguchi; Shingo Yano; Tadahiko Igarashi; Yasuji Kouzai; Satoshi Morita; Junichi Sakamoto; Hisashi Sakamaki; Koiti Inokuchi
        BLOOD, 2016年12月
      • HER2陽性乳癌の術前化学療法におけるトポイソメラーゼIIα遺伝子増幅と病理学的所見についての検討
        太田 郁子; 石川 孝; 田辺 美樹子; 森田 智視; 大場 真梨; 藤; 成井 一隆; 喜多 久美子; 嶋田 和博; 山田 顕光; 佐々木 毅; 市川 靖史; 遠藤 格
        日本乳癌学会総会プログラム抄録集, 2014年07月
      • IB〜IIIA期肺癌切除例に対するCBDCA/PTXとUFTによる術後補助療法のランダム化比較試験(SLCG0401試験)の病期・組織型別のサブ解析
        宗 淳一; 豊岡 伸一; 奥村 典仁; 中村 廣繁; 中田 昌男; 山下 素弘; 青江 基; 堀田 勝幸; 吉岡 弘鎮; 伊達 洋至; 森田 智視
        肺癌, 2019年08月
      • 非小細胞肺癌完全切除例に対する術後補助化学療法におけるERCC1の効果予測因子としての意義
        中田 昌男; 最相 晋輔; 宗 淳一; 奥村 典仁; 中村 廣繁; 山下 素弘; 多田 弘人; 森田 智視; 豊岡 伸一; 伊達 洋至; 瀬戸内肺癌研究会
        肺癌, 2018年10月
      • LAZAROID (U74500A) PREVENTS ENDOTHELIAL AND MYOCARDIAL STUNNING AFTER 24-HOUR RABBIT HEART PRESERVATION
        T NISHIDA; S MORITA; K MIYAMOTO; M MASUDA; R TOMINAGA; H YASUI
        CIRCULATION, 1995年10月
      • A MULTICENTER PHASE II STUDY OF SALVAGE PHOTODYNAMIC THERAPY USING TALAPORFIN SODIUM AND A DIODE LASER FOR LOCAL FAILURE OF ESOPHAGEAL CANCER AFTER CHEMORADIOTHERAPY
        N. Kakushima; T. Yano; R. Ishihara; Y. Yamamoto; H. Kataoka; H. Isomoto; T. Horimatsu; H. Kasai; S. Morita; M. Muto
        ANNALS OF ONCOLOGY, 2014年09月
      • 睡眠時無呼吸患者に対する遠隔モニタリングシステムを利用した体重減量指導の効果:多施設共同無作為化比較試験
        村瀬公彦; 陳和夫; 赤星俊樹; 津田徹; 大井元晴; 外山善朗; 成井浩司; 富田康弘; 大平徹郎; 葛西隆敏; 坪井知正; 權寧博; 山城義広; 安藤眞一; 吉嶺裕之; 高田佳史; 義久精臣; 巽浩一郎; 百村伸一; 森田智視; 黒田知宏; 平井豊博
        日本呼吸器学会誌(Web), 2021年
      • 睡眠時無呼吸患者に対する遠隔モニタリングシステムを利用した体重減量指導の効果 多施設共同無作為化比較試験
        村瀬 公彦; 陳 和夫; 赤星 俊樹; 津田 徹; 大井 元晴; 外山 善朗; 成井 浩司; 富田 康弘; 大平 徹郎; 葛西 隆敏; 坪井 知正; 權 寧博; 山城 義広; 安藤 眞一; 吉嶺 裕之; 高田 佳史; 義久 精臣; 巽 浩一郎; 百村 伸一; 森田 智視; 黒田 知宏; 平井 豊博; 厚生労働科学研究遠隔モニタリング研究班
        日本呼吸器学会誌, 2021年04月
      • EGFR遺伝子変異陽性NSCLCのゲフィチニブ/化学療法併用の第二相試験(NEJ005/TCOG0902) 最新アップデート解析
        宮林 貴大; 大泉 聡史; 菅原 俊一; 湊 浩一; 原田 敏之; 井上 彰; 藤田 結花; 前門戸 任; 渡部 聡; 弦間 昭彦; 出村 芳樹; 原田 眞雄; 磯部 宏; 木下 一郎; 森田 智視; 小林 国彦; 萩原 弘一; 相羽 惠介; 貫和 敏博
        日本呼吸器学会誌, 2018年03月
      • EGFR遺伝子変異陽性NSCLCのゲフィチニブ/化学療法併用の第II相試験(NEJ005/TCOG0902)最新アップデート結果
        渡部 聡; 大泉 聡史; 菅原 俊一; 湊 浩一; 原田 敏之; 井上 彰; 藤田 結花; 前門戸 任; 伊藤 和彦; 弦間 昭彦; 出村 芳樹; 原田 眞雄; 磯部 宏; 木下 一郎; 森田 智視; 小林 国彦; 萩原 弘一; 栗原 稔; 貫和 敏博
        肺癌, 2017年09月
      • Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma
        H Tanioka; A Tsuji; S Morita; T Horimi; M Takamatsu; T Shirasaka; T Mizushima; K Ochi; K Kiura; M Tanimoto
        ANTICANCER RESEARCH, 2003年03月
      • The outcomes of elderly ED patients intubated because of community acquired pneumonia: Why not give noninvasive ventilation a chance? Response
        Toru Hifumi; Ippei Jinbo; Ichiro Okada; Nobuaki Kiriu; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Kenya Kawakita; Satoshi Morita; Yasuhiro Kuroda
        AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015年08月
      • 外来化学療法の今後 (特集 外来がん化学療法と外科)
        坂本 純一; 森田 智視
        臨床外科, 2007年05月
      • 術後長期健存乳癌患者でのQOLの予測因子の検討 : 特に術式との関連について
        大住 省三; 下妻 晃二郎; 森田 智視; 高嶋 成光; 青儀 健二郎; 平 成人; 栗田 啓; 棚田 稔; 久保 義郎; 山下 素弘
        日本外科学会雑誌, 2006年03月05日
      • NEJ026: Phase III study comparing bevacizumab plus erlotinib to erlotinib in patients with untreated NSCLC harboring activating EGFR mutations
        M. Maemondo; T. Fukuhara; S. Sugawara; Y. Takiguchi; A. Inoue; S. Oizumi; Y. Ishii; H. Yoshizawa; T. Isobe; A. Gemma; S. Morita; K. Hagiwara; K. Kobayashi; T. Nukiwa
        ANNALS OF ONCOLOGY, 2016年10月
      • HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究
        服部 正也; 相良 安昭; 高田 正泰; 大井 恭代; 黒住 昌史; 大谷 彰一郎; 井上 賢一; 高尾 信太郎; 佐藤 信昭; 山下 年成; 小坂 愉賢; 黒住 献; 森田 智視; 岩田 広治; 戸井 雅和
        日本乳癌学会総会プログラム抄録集, 2018年05月
      • the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload
        Takayoshi Tachibana; Junya Kanda; Shinichiro Machida; Takeshi Saitou; Masatsugu Tanaka; Yuho Najima; Satoshi Koyama; Takuya Miyazaki; Eri Yamamoto; Masahiro Takeuchi; Satoshi Morita; Yoshinobu Kanda; Heiwa Kanamori; Shinichiro Okamoto
        BLOOD, 2016年12月
      • ベイズ流試験デザインの紹介
        森田 智視
        臨床薬理 = Japanese journal of clinical pharmacology, 2009年05月31日
      • Prognostic factors in patients with advanced thymic carcinoma treated with chemotherapy: A retrospective analysis of 289 patients from NEJ023 Study.
        Yusuke Okuma; Ryo Ko; Takehito Shukuya; Kazunari Tateishi; Hisao Imai; Eisaku Miyauchi; Akiko Fujiwara; Tomohide Sugiyama; Keisuke Azuma; Keiko Muraki; Masahiro Yamasaki; Hisashi Tanaka; Yuta Takashima; Sayo Soda; Osamu Ishimoto; Nobuyuki Koyama; Shoichi Kuyama; Kyoko Murase; Satoshi Morita; Kazuhisa Takahashi
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Antitumor activity of ASP8273, an irreversible mutant selective EGFR-TKI, in NSCLC patients with tumors harboring EGFR activating mutations and T790M resistance mutation
        H. Murakami; H. Nokihara; T. Shimizu; T. Seto; A. Keating; A. Krivoshik; K. Uegaki; S. Morita; K. Nakagawa; M. Fukuoka
        EUROPEAN JOURNAL OF CANCER, 2014年11月
      • FEASIBILITY STUDY OF PEMETREXED (PEM) PLUS BEVACIZUMAB (BV) AS THE FIRST-LINE TREATMENT FOR ELDERLY ADVANCED OR RECURRENT NON-SQUAMOUS (NON-SQ) NON-SMALL CELL LUNG CANCER (NSCLC): TORG1015.
        Toshiyuki Kozuki; Naoyuki Nogami; Hiromoto Kitajima; Tetsu Shinkai; Fumiaki Kato; Emiko Sakaida; Yuichi Takiguchi; Satoshi Ikeda; Masahiro Yoshida; Yasunori Enomoto; Terufumi Kato; Takashi Ogura; Shingo Miyamato; Satoshi Morita; Koshiro Watanabe
        JOURNAL OF THORACIC ONCOLOGY, 2013年11月
      • ER陽性HER2陰性再発・進行乳癌の治療戦略 HER2陰性進行・再発乳癌に対するベバシズマブとパクリタキセル併用療法の前向き観察研究(JBCRG-C05試験)
        唐 宇飛; 山本 豊; 山城 大泰; 近藤 直人; 中村 力也; 柏葉 匡寛; 高橋 將人; 津川 浩一郎; 石川 孝; 中山 貴寛; 大谷 彰一郎; 高野 利実; 藤澤 知巳; 遠山 竜也; 川口 英俊; 増野 浩二郎; 谷野 裕一; 森田 智視; 戸井 雅和; 大野 真司
        日本乳癌学会総会プログラム抄録集, 2018年05月
      • 「それぞれの生」安全なレジメン管理 閉経後HR乳癌患者に対するレスポンスガイド下術前内分泌療法(JBCRG-11CPA)
        森本 卓; 佐藤 信昭; 増田 慎三; 上野 貴之; 神林 智寿子; 金子 耕司; 八十島 宏行; 佐藤 友威; 新宮 聖士; 田邊 匡; 尾崎 慎治; 笹野 公伸; 森田 智視; 大野 真司; 戸井 雅和
        日本癌治療学会学術集会抄録集, 2017年10月
      • Randomized phase II study of preoperative docetaxel and cyclophosphamide-containing chemotherapy for luminal-type breast cancer
        N. Sato; N. Masuda; K. Higaki; T. Morimoto; Y. Yanagita; M. Mizutani; S. Ohtani; K. Kaneko; T. Fujisawa; M. Takahashi; T. Kadoya; N. Matsunami; Y. Yamamoto; S. Ohno; T. Takano; S. Morita; S. Tanaka; M. Toi
        CANCER RESEARCH, 2013年12月
      • A prospective multicenter randomized phase II neo-adjuvant study of 5-fluorouracil, epirubicin and cyclophosphamide (FEC) followed by docetaxel, cyclophosphamide and trastuzumab (TCH) versus TCH followed by FEC versus TCH alone, in patients (pts) with operable HER2 positive breast cancer: JBCRG-10 study
        N. Masuda; N. Sato; K. Higaki; M. Kashiwaba; N. Matsunami; T. Takano; J. Yamamura; K. Kaneko; M. Takahashi; S. Ohno; T. Fujisawa; S. Tsuyuki; Y. Miyoshi; S. Ohtani; Y. Yamamoto; H. Bando; T. Onoda; H. Kawabata; S. Morita; T. Ueno; M. Toi
        CANCER RESEARCH, 2012年12月
      • Early Hemoglobin Decrease in Heart Failure With Acute Pulmonary Edema
        Masaaki Konishi; Yasushi Matsuzawa; Hiroyuki Suzuki; Eiichi Akiyama; Noriaki Iwahashi; Kiyoshi Hibi; Masami Kosuge; Toshiaki Ebina; Kentaro Sakamaki; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2013年11月
      • 【臨床腫瘍学におけるQOL研究の意義】がん医療におけるQOL研究の世界的動向 肺癌を中心に
        小林 国彦; 手良向 聡; 森田 智視
        血液・腫瘍科, 2000年12月
      • Predicting the efficacy of nivolumab combined with radiation therapy by longitudinal liquid biopsy with artificial intelligence for patients with metastatic breast cancer (translational research of the KBCRN-B-002 trial).
        Kosuke Kawaguchi; Masahiro Takada; Takeshi Kotake; Michio Yoshimura; Ryuji Uozumi; Masako Kataoka; Takahiko Koyama; Reitaro Tokumasu; Hironori Kato; Hiroshi Yoshibayashi; Hirofumi Suwa; Wakako Tsuji; Hiroyasu Yamashiro; Tatsuki R. Kataoka; Hiroshi Ishiguro; Laxmi Parida; Satoshi Morita; Masakazu Toi
        JOURNAL OF CLINICAL ONCOLOGY, 2020年05月
      • Alteration of the tumor immune microenvironment signatures by nivolumab combined with radiation therapy for patients with metastatic breast cancer (Translational Research of the KBCRN-B-002 trial)
        Kosuke Kawaguchi; Masahiro Takada; Takeshi Kotake; Michio Yoshimura; Ryuji Uozumi; Masako Kataoka; Takahiko Koyama; Reitaro Tokumasu; Maya Honda; Rikiya Yamashita; Atsushi Yonezawa; Yuki Himoto; Natsuko Onishi; Hironori Kato; Hiroshi Yoshibayashi; Hirofumi Suwa; Wakako Tsuji; Hiroyasu Yamashiro; Tatsuki Kataoka; Hiroshi Ishiguro; Laxmi Parida; Satoshi Morita; Masakazu Toi
        CANCER RESEARCH, 2020年02月
      • 抗PD-1抗体(Nivolumab)を用いた卵巣癌に対する第II相医師主導治験
        濱西 潤三; 万代 昌紀; 池田 隆文; 川口 淳; 金井 雅史; 森 由希子; 松本 繁巳; 松村 謙臣; 安彦 郁; 山口 建; 植田 彰彦; 森田 智視; 清水 章; 本庶 佑; 小西 郁生
        日本癌治療学会誌, 2014年06月, 査読有り
      • A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study
        Yutaka Yamamoto; Hiroji Iwata; Taira Naruto; Norikazu Masuda; Masato Takahashi; Tetsuhiro Yoshinami; Takayuki Ueno; Tatsuya Toyama; Takashi Yamanaka; Toshimi Takano; Masahiro Kashiwaba; Koichiro Tsugawa; Yoshie Hasegawa; Kenji Tamura; Hiroshi Tada; Fumikata Hara; Shigehira Saji; Satoshi Morita; Masakazu Toi; Shinji Ohno
        CANCER RESEARCH, 2021年02月
      • 臨床試験デザインの紹介 (特集 臨床試験デザイン)
        森田 智視
        日本外科学会雑誌 = Journal of Japan Surgical Society, 2016年
      • SY-4-3 SAMIT試験のデザイン・現況および将来展望(シンポジウム(4)わが国における消化器癌補助療法に関する臨床試験によるエビデンス,シンポジウム,第110回日本外科学会定期学術集会)
        円谷 彰; 吉田 和弘; 森田 智視; 坂本 純一
        日本外科学会雑誌, 2010年03月05日
      • Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.
        Nahomi Tokudome; Yasuhiro Koh; Hiroaki Akamatsu; Daichi Fujimoto; Isamu Okamoto; Kazuhiko Nakagawa; Toyoaki Hida; Fumio Imamura; Satoshi Morita; Nobuyuki Yamamoto
        BMC cancer, 2020年02月06日
      • Addition of capecitabine to maintenance endocrine therapy after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)
        Tetsuhiro Yoshinami; Takahiro Nakayama; Masahiko Ikeda; Makiko Mizutani; Miki Yamaguchi; Yoshifumi Komoike; Tsutomu Takashima; Katsuhide Yoshidome; Junji Tsurutani; Mitsuhiko Iwamoto; Fumie Fujisawa; Hiroyuki Yasojima; Jun Yamamura; Hirotaka Morishima; Fuminori Aki; Tomomi Yamada; Satoshi Morita; Norikazu Masuda
        CANCER RESEARCH, 2020年02月
      • A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial)
        Masahiro Takada; Michio Yoshimura; Kosuke Kawaguchi; Takeshi Kotake; Ryuji Uozumi; Masako Kataoka; Takahiko Koyama; Hironori Kato; Hiroshi Yoshibayashi; Hirofumi Suwa; Wakako Tsuji; Hiroyasu Yamashiro; Tatsuki Kataoka; Hiroshi Ishiguro; Reitaro Tokumasu; Maya Honda; Rikiya Yamashita; Atsushi Yonezawa; Yuki Himoto; Natsuko Onishi; Laxmi Parida; Satoshi Morita; Masakazu Toi
        CANCER RESEARCH, 2020年02月
      • 動脈硬化リスク因子が睡眠時無呼吸症候群と動脈硬化の関連性に及ぼす影響についての検討~ながはまスタディ~
        中塚賀也; 村瀬公彦; 濱田哲; 武山博文; 松本健; 高橋順美; 谷澤公伸; 半田知宏; 田原康玄; 平井豊博; 森田智視; 中山健夫; 松田文彦; 陳和夫
        日本呼吸器学会誌(Web), 2020年
      • Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
        Keiko Imamura; Yuishin Izumi; Haruhiko Banno; Ryuji Uozumi; Satoshi Morita; Naohiro Egawa; Takashi Ayaki; Makiko Nagai; Kazutoshi Nishiyama; Yasuhiro Watanabe; Ritsuko Hanajima; Ryosuke Oki; Koji Fujita; Naoto Takahashi; Takafumi Ikeda; Akira Shimizu; Akiko Morinaga; Tomoko Hirohashi; Yosuke Fujii; Ryosuke Takahashi; Haruhisa Inoue
        BMJ open, 2019年12月02日
      • 進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer)
        西田 純幸; 白方 俊章; 森本 創世子; 榎本 隆之; 吉野 潔; 冨松 拓治; 藤木 文博; 尾路 祐介; 上田 豊; 坪井 昭博; 森田 智視; 岡 芳弘; 熊ノ郷 淳; 木村 正; 杉山 治夫
        日本がん免疫学会総会プログラム・抄録集, 2019年07月
      • 持続陽圧(CPAP,ASV)治療管理開始時からの治療状況確認と自己学習を含めた患者・医療機関相互方向の遠隔医療の試み 持続気道陽圧(CPAP)療法中の睡眠時無呼吸患者の肥満に対する遠隔モニタリングシステムを利用した減量指導の検証
        巽浩一郎; 平井豊博; 森田智視; 大平徹郎; 坪井知正; 富井啓介; 葛西隆敏; 千葉伸太郎; 黒田知宏; 中山健夫; 吉嶺裕之; 權寧博; 吉川雅則; 小川浩正; 小川浩正; 百村伸一; 小賀徹; 陳和夫
        持続陽圧(CPAP、ASV)治療管理開始時からの治療状況確認と自己学習を含めた患者・医療機関相互方向の遠隔医療の試み 平成30年度 研究報告書(Web), 2019年
      • Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer.
        Takaki Yoshikawa; Toru Aoyama; Kentaro Sakamaki; Takasi Oshima; Joyce Lin; Shenli Zhang; Nur Sabrina Sapari; Richie Soong; Iain Tan; Xiu Bin Chan; Dan Bottomley; Lindsay C Hewitt; Tomio Arai; Bin Tean Teh; David Epstein; Takashi Ogata; Yoichi Kameda; Yohei Miyagi; Akira Tsuburaya; Satoshi Morita; Heike I Grabsch; Patrick Tan
        Journal of Cancer, 2019年
      • Global phase III trial of comparing mXELIRI plus BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis
        Takeshi Kato; Yoshinori Kagawa; Mitsuyoshi Ota; Akitaka Makiyama; Tadamichi Denda; Chu Matsuda; Yasuhide Yamada; Satoru Iwasa; Tae Won Kim; Rui-hua Xu; Young Suk Park; Satoshi Morita; Junichi Sakamoto; Kei Muro
        ANNALS OF ONCOLOGY, 2018年10月
      • Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.
        Shuichi Mizuta; Masashi Sawa; Hisashi Tsurumi; Kana Matsumoto; Kotaro Miyao; Takeshi Hara; Takeshi Takahashi; Reona Sakemura; Hiroshi Kojima; Akio Kohno; Mari S Oba; Satoshi Morita; Junichi Sakamoto; Nobuhiko Emi
        International journal of clinical oncology, 2018年10月
      • HER2陽性原発性乳癌の治療最適化 ER陰性HER2陽性乳癌におけるbasal markerの有用性に関する研究
        服部 正也; 相良 安昭; 高田 正泰; 大井 恭代; 黒住 昌史; 大谷 彰一郎; 井上 賢一; 高尾 信太郎; 佐藤 信昭; 山下 年成; 小坂 愉賢; 黒住 献; 森田 智視; 岩田 広治; 戸井 雅和
        日本乳癌学会総会プログラム抄録集, 2018年05月
      • 遠隔モニタリングシステム導入によるCPAPアドヒアランスの変化:多施設共同無作為化比較試験
        村瀬公彦; 谷澤公伸; 津田徹; 大井元晴; 赤星俊樹; 成井浩司; 名嘉村博; 大平徹郎; 吉嶺裕之; 坪井知正; 山城義広; 安藤眞一; 葛西隆敏; 北英夫; 巽浩一郎; 鰤岡直人; 富井啓介; 近藤康博; 小賀徹; 酒巻哲夫; 森田智視; 平井豊博; 黒田知宏; 陳和夫
        日本呼吸器学会誌(Web), 2018年03月10日
      • A randomized phase II study of maintenance hormone therapy with or without capecitabine after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)
        Miki Yamaguchi; Takahiro Nakayama; Tetsuhiro Yoshinami; Masahiko Ikeda; Mitsuhiko Iwamoto; Yoshifumi Komoike; Tsutomu Takashima; Junji Tsurutani; Katsuhide Yoshidome; Tomomi Yamada; Satoshi Morita; Norikazu Masuda
        CANCER RESEARCH, 2018年02月
      • CDISC標準導入の経験から
        江口直樹; 多田春江; 上山華栄; 青山正典; 森田智視
        日本臨床試験学会第9回学術集会総会, 2018年02月
      • CDISC標準導入のメリットと効率化の検討
        上山華栄; 多田春江; 江口直樹; 青山正典; 竹川遼子; 森田智視
        日本臨床試験学会第9回学術集会総会, 2018年02月
      • データレビュー情報を品質管理活動の指標として定量化するためのツールの開発と運用
        多田春江; 上山華栄; 木下明美; 白川知佐; 徳田彩華; 森麻子; 船越千尋; 川口恭子; 榎本佳代子; 渡邊美惠子; 前尾裕子; 塚田紗佑里; 森田智視
        日本臨床試験学会第9回学術集会総会, 2018年02月
      • 「それぞれの癌」難治性癌に対する治療戦略 乳腺 閉経後進行再発乳癌におけるフルベストラントの長期TTFに関わる検討 Safari試験
        藤澤 知巳; 川口 英俊; 増田 慎三; 中山 貴寛; 青儀 健二郎; 伊藤 良則; 大谷 彰一郎; 佐治 重衛; 長谷川 善枝; 服部 正也; 山下 年成; 山本 豊; 森田 智視; 戸井 雅和; 大野 真司
        日本癌治療学会学術集会抄録集, 2017年10月
      • 「それぞれの癌」難治性癌に対する治療戦略 大腸・虫垂 進行下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同研究結果と追加調査
        肥田侯矢; 岡村亮輔; 西崎大輔; 坂井義治; 小西 毅; 赤木智徳; 山口智弘; 秋吉高志; 福田 明輝; 山本聖一郎; 山本倫生; 森田智視; 有薗茂樹; 田村 寛; 渡邊昌彦; 腹腔鏡下大腸切除研究会
        第55回日本癌治療学会学術集会抄録集, 2017年10月, 査読有り
      • Treatment outcome according to tumor RAS mutation status in TRICOLORE trial: A randomized phase 3 trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer
        Y. Komatsu; A. Takashima; T. Denda; M. Gamoh; I. Iwanaga; H. Shimodaira; M. Nakamura; T. Yamaguchi; H. Takahashi; K. Kobayashi; M. Tsuda; Y. Kobayashi; H. Baba; M. Kotake; C. Ishioka; A. Sato; S. Yuki; S. Morita; S. Takahashi; K. Shimada
        ANNALS OF ONCOLOGY, 2017年09月
      • Neoadjuvant therapy with trastuzumab emtansine and pertuzumab in patients with HER2-positive primary breast cancer (A randomized, phase 2 study; JBCRG-20)
        N. Masuda; S. Ohtani; T. Takano; K. Inoue; E. Suzuki; R. Nakamura; H. Bando; Y. Ito; K. Ishida; T. Yamanaka; K. Kuroi; H. Yasojima; H. Kasai; T. Takasuka; T. Sakurai; T. R. Kataoka; S. Morita; S. Ohno; M. Toi
        ANNALS OF ONCOLOGY, 2017年09月
      • Frequent Self-Weighing Delays or Prevents the Development of Type 2 Diabetes in a Real-World Setting: A Subanalysis of Japan Diabetes Outcome Trial-1
        Naoki Sakane; Yoshitake Oshima; Shinsuke Nirengi; Kazuhiko Kotani; Kentaro Okazaki; Juichi Sato; Sadao Suzuki; Satoshi Morita; Kazuo Izumi; Masayuki Kato; Naoki Ishizuka; Mitsuhiko Noda; Hideshi Kuzuya
        DIABETES, 2017年06月
      • Predictive impact of complete molecular response in plasma: A phase II, liquid biopsy study in EGFR mutated NSCLC patients treated with afatinib (WJOG 8114LTR).
        Kohei Otsubo; Hiroaki Akamatsu; Yasuhiro Koh; Satoshi Morita; Daichi Fujimoto; Akihiro Bessho; Koichi Azuma; Kazuhiko Nakagawa; Nobuyuki Yamamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2017年05月
      • Afatinib (Afa) plus bevacizumab (Bev) combination after acquired resistance (AR) to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small cell lung cancer (NSCLC): Multicenter single arm phase II trial (ABC-study).
        Akito Hata; Nobuyuki Katakami; Reiko Kaji; Toshihide Yokoyama; Toshihiko Kaneda; Motohiro Tamiya; Takako Inoue; Hiromi Kimura; Yukihiro Yano; Daisuke Tamura; Satoshi Morita; Shunichi Negoro
        JOURNAL OF CLINICAL ONCOLOGY, 2017年05月
      • Eribulin in combination with pertuzumab plus trastuzumab for HER2-positive advanced or recurrent breast cancer (JBCRG-M03).
        Kazutaka Narui; Toshinari Yamashita; Masahiro Kitada; Hidetoshi Kawaguchi; Masaya Hattori; Tetsuhiro Yoshinami; Nobuki Matsunami; Kazuhiro Yanagihara; Teru Kawasoe; Takeshi Nagashima; Hiroko Bando; Hiroshi Yano; Yoshie Hasegawa; Rikiya Nakamura; Masahiro Kashiwaba; Norikazu Masuda; Satoshi Morita; Shinji Ohno; Masakazu Toi
        JOURNAL OF CLINICAL ONCOLOGY, 2017年05月
      • Phase II study on radiofrequency ablation in stage 0 and I breast cancer without extensive intraductal components.
        Shigeru Imoto; Shinji Nagamine; Toshikazu Ito; Hitoshi Tsuda; Mitsuhiro Tozaki; Satoshi Morita; Takayuki Ueno
        JOURNAL OF CLINICAL ONCOLOGY, 2017年05月
      • Tolerability and antitumor activity of ASP8273 in TKI-naive Japanese subjects with EGFR mutation positive non-small cell lung cancer.
        Shunichi Sugawara; Koichi Azuma; Makoto Nishio; Hidetoshi Hayashi; Katsuyuki Kiura; Miyako Satouchi; Toyoaki Hida; Atsushi Nakamura; Yasuo Iwamoto; Akira Inoue; Koji Takeda; Satoshi Ikeda; Tomoki Nakagawa; Seitaro Asahina; Kanji Komatsu; Satoshi Morita; Masahiro Fukuoka; Kazuhiko Nakagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2017年05月
      • Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH
        M. Tsuda; H. Ishiguro; N. Toriguchi; N. Masuda; H. Bando; M. Ohgami; M. Homma; S. Morita; N. Yamamoto; K. Kuroi; T. Takano; S. Shimizu; M. Toi
        CANCER RESEARCH, 2017年02月
      • 同種移植後鉄過剰症に対するdeferasiroxの安全性と有効性:第1相臨床試験
        立花崇孝; 立花崇孝; 諫田淳也; 町田真一郎; 斉藤健; 田中正嗣; 名島悠峰; 小山哲; 宮崎拓也; 山本恵理; 武内正博; 森田智視; 神田善伸; 金森平和; 岡本真一郎
        日本造血細胞移植学会総会プログラム・抄録集, 2017年
      • Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients
        Kazushi Yoshida; Yuichiro Ohe; Akira Inoue; Toru Kumagai; Masayuki Takeda; Nobuyuki Yamamoto; Takashi Seto; Isamu Okamoto; Naoki Tashiro; Satoshi Morita; Masahiro Fukuoka
        JOURNAL OF THORACIC ONCOLOGY, 2017年01月
      • ASP8273 Tolerability and Antitumor Activity in TKI-Naive Japanese Subjects with EGFRmut plus NSCLC: Preliminary Results
        Makoto Nishio; Koichi Azuma; Hidetoshi Hayashi; Toyoaki Hida; Akira Inoue; Yasuo Iwamoto; Satoshi Ikeda; Katsuyuki Kiura; Miyako Satouchi; Shunichi Sugawara; Koji Takeda; Desai Bhardwaj; Anne Keating; Kanji Komatsu; Maiko Morishita; Kentaro Takeda; Satoshi Morita; Masahiro Fulmoka; Kazuhiko Nakagawa
        JOURNAL OF THORACIC ONCOLOGY, 2017年01月
      • A Phase II, Liquid Biopsy Study Using Digital PCR in EGFR Mutated, Lung Cancer Patients Treated with Afatinib (WJOG 8114LTR)
        Hiroaki Akamatsu; Yasuhiro Koh; Satoshi Morita; Daichi Fujimoto; Isamu Okamoto; Akihiro Bessho; Koichi Azuma; Kazuhiko Nakagawa; Nobuyuki Yamamoto
        JOURNAL OF THORACIC ONCOLOGY, 2017年01月
      • 切除不能大腸癌に対するmFOLFOX6/CapeOX+BmabとS‐1/CPT‐11+Bmabとの第3相試験:TRICOLORE試験
        蒲生真紀夫; 沖田南都子; 傳田忠道; 岩永一郎; 小松嘉人; 下平秀樹; 中村将人; 山口達郎; 大堀久詔; 小林功治; 飛松和俊; 宮城島拓人; 馬場秀夫; 小竹優範; 嶋田顕; 佐藤温; 結城敏志; 森田智視; 高橋信; 石岡千加史
        日本臨床腫瘍学会学術集会(CD-ROM), 2017年
      • Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial)
        Takashi Kumagai; Chiaki Nakaseko; Kaichi Nishiwaki; Chikashi Yoshida; Kazuteru Ohashi; Naoki Takezako; Hina Takano; Yasuji Kouzai; Tadashi Murase; Kosei Matsue; Satoshi Morita; Junichi Sakamoto; Hisashi Wakita; Hisashi Sakamaki; Koiti Inokuchi
        BLOOD, 2016年12月
      • Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: an exploratory study of the randomized phase II COMPASS trial
        K. Tanabe; T. Yoshikawa; T. Oshima; Y. Miyagi; S. Morita; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; T. Aoyama; T. Hayashi; T. Ogata; H. Cho; A. Tuburaya; J. Sakamoto
        ANNALS OF ONCOLOGY, 2016年10月
      • 膵臓 進行膵がんに対する治療戦略 進行膵癌に対するゲムシタビン併用WT1ペプチドワクチン療法ランダム化第II相臨床試験
        小井戸 薫雄; 西田 純幸; 石川 剛; 江川 新一; 石井 淳; 菅野 良秀; 柳本 泰明; 古倉 聡; 森本 創世子; 大庭 真梨; 江口 英利; 島田 英昭; 本間 定; 森田 智視; 杉山 治夫
        日本癌治療学会学術集会抄録集, 2016年10月
      • Best of Cancer Investigation(Clinical Research)from Japan '15-'16 卵巣がんに対する抗PD-1抗体(ニボルマブ)免疫療法の安全性と有効性(Best of Cancer Investigation (Clinical Research) from Japan '15-'16)
        濱西 潤三; 万代 昌紀; 池田 隆文; 南 学; 川口 淳; 村山 敏典; 金井 雅史; 森 由希子; 松本 繁; 松村 謙臣; 森田 智視; 清水 章; 本庶 佑; 小西 郁生
        日本癌治療学会学術集会抄録集, 2016年10月
      • Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果
        肥田 侯矢; 岡村 亮輔; 坂井 義治; 小西 毅; 赤木 智徳; 山口 智弘; 秋吉 高志; 福田 明輝; 山本 聖一郎; 山本 倫生; 森田 智視; 長谷川 順一; 堀江 久永; 山口 高史; 渡邊 昌彦; 腹腔鏡下大腸切除研究会
        日本癌治療学会学術集会抄録集, 2016年10月
      • Stage II/III下部直腸癌に対する腹腔鏡下手術と開腹手術 多施設共同観察研究結果
        肥田 侯矢; 岡村 亮輔; 坂井 義治; 小西 毅; 赤木 智徳; 山口 智弘; 秋吉 高志; 福田 明輝; 山本 聖一郎; 山本 倫生; 森田 智視; 長谷川 順一; 堀江 久永; 山口 高史; 渡邊 昌彦; 腹腔鏡下大腸切除研究会
        日本癌治療学会学術集会抄録集, 2016年10月
      • Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101) (vol 19, pg 839, 2016)
        Satoshi Matsusaka; Atsushi Nashimoto; Kazuhiro Nishikawa; Akira Miki; Hiroto Miwa; Kazuya Yamaguchi; Takaki Yoshikawa; Atsushi Ochiai; Satoshi Morita; Takeshi Sano; Yasuhiro Kodera; Yoshihiro Kakeji; Junichi Sakamoto; Shigetoyo Saji; Kazuhiro Yoshida
        GASTRIC CANCER, 2016年07月
      • A prospective biomarker study using digital PCR method in EGFR-mutated, advanced lung adenocarcinoma patients treated with afatinib (West Japan Oncology Group 8114LTR)
        Hiroaki Akamatsu; Yasuhiro Koh; Satoshi Morita; Nobuyuki Yamamoto; Kazuhiko Nakagawa
        CANCER RESEARCH, 2016年07月
      • Overall survival (OS) of EGFR mutation-positive nonsmall cell lung cancer (NSCLC): 1,660 Japanese patients (pts)
        Hiroshige Yoshioka; Shunichi Sugawara; Kazushi Yoshida; Shuji Murakami; Young Hak Kim; Shinji Atagi; Fumio Imamura; Koji Takeda; Takashi Seto; Satoshi Morita; Yuichiro Ohe
        ANNALS OF ONCOLOGY, 2016年07月
      • Validation of Functional Assessment of Cancer Therapy-Gastric (FACT-Ga) and its sensitivity to ascites volume change: an analysis of two Japanese clinical trials
        H. Maeda; M. Sato; M. Kobayashi; N. Takiguchi; T. Yoshikawa; S. Yoshino; K. Yoshida; A. Tsuburaya; J. Sakamoto; S. Morita
        ANNALS OF ONCOLOGY, 2016年06月
      • 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価
        西田 純幸; 石川 剛; 江川 新一; 小井戸 薫雄; 森本 創世子; 石井 淳; 菅野 良秀; 柳本 泰明; 大庭 真梨; 古倉 聡; 本間 定; 島田 英昭; 森田 智視; 岡 芳弘; 杉山 治夫
        日本がん免疫学会総会プログラム・抄録集, 2016年06月
      • 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験 臨床効果と抗原特異的免疫反応の評価
        西田 純幸; 石川 剛; 江川 新一; 小井戸 薫雄; 森本 創世子; 石井 淳; 菅野 良秀; 柳本 泰明; 大庭 真梨; 古倉 聡; 本間 定; 島田 英昭; 森田 智視; 岡 芳弘; 杉山 治夫
        日本がん免疫学会総会プログラム・抄録集, 2016年06月
      • Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-lioxaliplatin (SOX) versus UFT/LV as adjuvant chemotherapy for high-risk stage III colon cancer
        Takuya Miura; Eiji Sunami; Tetsuya Kusumoto; Mitsuyoshi Ota; Kazuhiro Yoshida; Naohiro Tomita; Atsuyuki Maeda; Izumi Mochizuki; Michio Okabe; Katsuyuki Kunieda; Junichiro Yamauchi; Michio Itabashi; Kenjiro Kotake; Keiichi Takahashi; Hideo Baba; Narikazu Boku; Keisuke Aiba; Megumi Ishiguro; Satoshi Morita; Kenichi Sugihara
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study.
        Shunichiro Iwasawa; Ryo Ko; Takehito Shukuya; Satoshi Watanabe; Yoko Tsukita; Hironori Ashinuma; Taku Nakagawa; Ryo Ito; Kazutsugu Uematsu; Mika Nakao; Yoshiaki Mori; Kyoichi Kaira; Atsuto Moun; Takao Miyabayashi; Hiroyuki Sakashita; Yoko Matsumoto; Tomoyuki Tanigawa; Satoshi Morita; Kazuhisa Takahashi
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy.
        Yutaka Yamamoto; Hiroji Iwata; Takayuki Ueno; Masahiro Kashiwaba; Naruto Taira; Masato Takahashi; Hiroshi Tada; Koichiro Tsugawa; Tatsuya Toyama; Naoki Niikura; Fumikata Hara; Tomomi Fujisawa; Tetsuhiro Yoshinami; Shigehira Saji; Toshimi Takano; Norikazu Masuda; Satoshi Morita; Masakazu Toi; Shinji Ohno
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Open versus laparoscopic surgery for low rectal cancer: a large multicenter cohort study in Japan
        Koya Hida; Ryosuke Okamura; Yoshiharu Sakai; Tsuyoshi Konishi; Tomonori Akagi; Tomohiro Yamaguchi; Takashi Akiyoshi; Meiki Fukuda; Seiichiro Yamamoto; Michio Yamamoto; Tatsuto Nishigori; Kenji Kawada; Suguru Hasegawa; Satoshi Morita; Masahiko Watanabe
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Impact of UGT1A1 genotype on overall survival in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens.
        Wataru Ichikawa; Keisuke Uehara; Keisuke Minamimura; Chihiro Tanaka; Yasumasa Takii; Hideaki Miyauchi; Sotaro Sadahiro; Katsunori Shinozaki; Kanehisa Fukumoto; Toshio Otsuji; Takeshi Kambara; Satoshi Morita; Yuichi Ando; Miyuki Arai; Masahiro Sugihara; Toru Sugiyama; Yasuo Ohashi; Yuh Sakata
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Overall survival (OS) of EGFR mutation-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns of 1,660 Japanese patients (pts).
        Yoshida Kazushi; Akira Inoue; Shunichi Sugawara; Shuji Murakami; Hideo Saka; Satoshi Morita; Young Hak Kim; Fumio Imamura; Koji Takeda; Kazuhiko Nakagawa; Masayuki Takeda; Shinji Atagi; Yoshikazu Hasegawa; Nobuyuki Yamamoto; Nobuyuki Katakami; Hiroshige Yoshioka; Yasuo Iwamoto; Isamu Okamoto; Takashi Seto; Yuichiro Ohe
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17).
        Naoto Kondo; Yoshinori Ito; Ippei Fukada; Shoichiro Ohtani; Masaya Hattori; Eriko Tokunaga; Nobuki Matsunami; Kohjiro Mashino; Taijiro Kosaka; Masahiko Tanabe; Daisuke Yotsumoto; Kosho Yamanouchi; Masataka Sawaki; Masahiro Kashiwaba; Hidetaka Kawabata; Katsumasa Kuroi; Satoshi Morita; Shinji Ohno; Masakazu Toi; Norikazu Masuda
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Phase II study on radiofrequency ablation in early breast cancer
        Shigeru Imoto; Takayuki Ueno; Hirotsugu Isaka; Hiroki Ito; Kaisuke Miyamoto; Satoshi Morita
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response
        Sumiyuki Nishida; Takeshi Ishikawa; Satoshi Kokura; Shinichi Egawa; Shigeo Koido; Hiroaki Yasuda; Hiroaki Yanagimoto; Jun Ishii; Yoshihide Kanno; Mari Saito Oba; Maho Sato; Soyoko Morimoto; Hidetoshi Eguchi; Hiroaki Nagano; Sadamu Homma; Yoshihiro Oka; Satoshi Morita; Haruo Sugiyama
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16).
        Kosuke Kawaguchi; Eiji Suzuki; Tatsuki R. Kataoka; Masahiro Hirata; Shinji Ohno; Hiroko Bando; Hiroshi Ishiguro; Kenichi Inoue; Naohito Yamamoto; Katsumasa Kuroi; Satoshi Morita; Norikazu Masuda; Masakazu Toi
        JOURNAL OF CLINICAL ONCOLOGY, 2016年05月
      • Prospective observational cohort study of bevacizumab combined with paclitaxel as the first-or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE)
        N. Kondo; Y. Yamamoto; H. Yamashiro; M. Kashiwaba; R. Nakamura; M. Takahashi; U. Toh; K. Tsugawa; K. Narui; K. Tamaki; T. Yoshinami; S. Ohtani; Y. Kai; T. Takano; Y. Yanagita; S. Morita; M. Toi; S. Ohno
        EUROPEAN JOURNAL OF CANCER, 2016年04月
      • A multinational, randomized, phase III trial of XELIRI ( plus bevacizumab) versus FOLFIRI ( plus bevacizumab) as the second-line chemotherapy for metastatic colorectal cancer: Asian XELIRI project (AXEPT).
        Kei Muro; Tae Won Kim; Young Suk Park; Hiroyuki Uetake; Tomohiro Nishina; Hiroaki Nozawa; Hiroshi Matsumoto; Kentaro Yamazaki; Sae-Won Han; Keun-Wook Lee; Yanhong Deng; Marc E. Buyse; Taroh Satoh; Baek-Yeol Ryoo; Lin Shen; Satoru Iwasa; Satoshi Morita; Junichi Sakamoto; Rui-hua Xu
        JOURNAL OF CLINICAL ONCOLOGY, 2016年02月
      • 物性調整した食品別の嚥下動態の相違と適切な嚥下調整食選択への応用
        永見慎輔; 永見慎輔; 八木直美; 魚住龍史; 山縣誉志江; 田中信吾; 伊藤圭子; 平位知久; 延原浩; 森田智視; 高橋良輔; 栢下淳; 越久仁敬
        嚥下医学, 2016年
      • 物性調整した食品別の嚥下動態の相違と適切な嚥下調整食選択への応用
        永見慎輔; 永見慎輔; 永見慎輔; 八木直美; 八木直美; 魚住龍史; 山縣誉志江; 延原浩; 平位知久; 伊藤圭子; 田中信吾; 森田智視; 高橋良輔; 栢下淳; 越久仁敬
        嚥下医学, 2016年
      • Molecular biomarker study in randomized phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: XParTS IIb
        A. Tsuburaya; K. Nishikawa; M. Kobayashi; J. Kawada; T. Namikawa; R. Fukushima; H. Kojima; K. Tanabe; K. Yamaguchi; S. Yoshino; M. Takahashi; N. Hirabayashi; S. Sato; H. Nemoto; Y. Rino; T. Yoshikawa; J. Nakajima; P. Tan; S. Morita; J. Sakamoto
        ANNALS OF ONCOLOGY, 2015年12月
      • Reply
        Masatsugu Hamaji; Fengshi Chen; Atsushi Kawaguchi; Satoshi Morita; Hiroshi Date
        Annals of Thoracic Surgery, 2015年11月01日
      • Surgery Versus Radiation Therapy in Stage I Lung Cancer Reply
        Masatsugu Hamaji; Fengshi Chen; Atsushi Kawaguchi; Satoshi Morita; Hiroshi Date
        ANNALS OF THORACIC SURGERY, 2015年11月
      • Garenoxacin (GRNX) for secondary prophylaxis against febrile neutropenia (FN) in chemotherapies for advanced lung cancer
        Akito Hata; Nobuyuki Katakami; Shiro Fujita; Reiko Kaji; Jumpei Takeshita; Satoshi Morita; Daichi Fujimoto; Kazuma Nagata; Kojiro Otsuka; Keisuke Tomii
        ANNALS OF ONCOLOGY, 2015年11月
      • Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations
        Toshio Shimizu; Hiroshi Nokihara; Haruyasu Murakami; Takashi Seto; Makoto Nishio; Koji Takeda; Akira Inoue; Katsuyuki Kiura; Koichi Azuma; Anne Keating; Andrew Krivoshik; Koichi Uegaki; Kentaro Takeda; Kanji Komatsu; Satoshi Morita; Masahiro Fukuoka; Kazuhiko Nakagawa
        ANNALS OF ONCOLOGY, 2015年11月
      • Feasibility of weekly intraperitoneal versus intravenous paclitaxel delivered from the day of radical surgery for gastric cancer: A preliminary safety analysis of INPACT study, a randomized controlled trial
        N. Takiguchi; Y. Kodera; N. Takahashi; T. Yoshikawa; K. Fujitani; S. Ito; K. Miyamoto; O. Takayama; M. Imano; D. Kobayashi; Y. Miyashita; S. Morita; J. Sakamoto
        EUROPEAN JOURNAL OF CANCER, 2015年09月
      • Bevacizumab with Docetaxel or S-1 in Non-Squamous NSCLC (HANSHIN 0110)
        Motoko Tachihara; Kazumi Nishino; Daisuke Tamura; Toru Kumagai; Fumio Imamura; Chiyuki Okuda; Akito Hata; Nobuyuki Katakami; Yoshiko Urata; Yoshihiro Hattori; Miyako Satouchi; Tsutomu Yoneda; Soichiro Yokota; Takashi Nishimura; Toshihiko Kaneda; Yoshihiro Nishimura; Satoshi Morita; Shunichi Negoro
        JOURNAL OF THORACIC ONCOLOGY, 2015年09月
      • 下部進行直腸癌に対する腹腔鏡下手術の意義
        肥田 侯矢; 岡村 亮輔; 林 佑里子; 森田 智視; 小西 毅; 秋吉 高志; 山口 智弘; 福田 明輝; 山本 聖一郎; 坂井 義治; 渡邊 昌彦
        日本癌治療学会誌, 2015年09月
      • 基礎研究 基礎研究の臨床応用 わが国初の網羅的遺伝子変異パネルを用いたクリニカルシーケンスの臨床導入
        金井 雅史; 佐久間 朋寛; 柳澤 宏次; 松島 健太郎; 小柳 智義; 松本 繁巳; 黒田 知宏; 森田 智視; 小杉 眞司; 奥野 恭史; 武藤 学
        日本癌治療学会誌, 2015年09月
      • 京大病院におけるバイオバンク、クリニカルシークエンス、ビッグデータ解析の取組
        武藤 学; 金井 雅史; 森 由希子; 松本 繁巳; 佐久間 朋寛; 小柳 智義; 岡本 和也; 加藤 源太; 黒田 知宏; 森田 智視; 小杉 眞司; 多門 啓子; 種石 慶; 奥野 恭史; 高折 晃史
        日本癌治療学会誌, 2015年09月
      • The authors respond
        Toru Hifumi; Ippei Jinbo; Ichiro Okada; Nobuaki Kiriu; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Kenya Kawakita; Satoshi Morita; Yasuhiro Kuroda
        American Journal of Emergency Medicine, 2015年08月01日
      • pCRの意義を問う HER2陽性乳癌における術前Dual-HER2 blockage療法±ホルモン療法の検討(Neo-LaTH、JBCRG-16試験)
        山本 尚人; 増田 慎三; 近藤 直人; 坂東 裕子; 黒井 克昌; 大野 真司; 宮本 健志; 檜垣 健二; 高野 利実; 井上 賢一; 中村 力也; 清水 哲; 石黒 洋; 青儀 健二郎; 天野 定雄; 山城 大泰; 笠井 宏委; 森田 智視; 桜井 孝規; 戸井 雅和
        日本乳癌学会総会プログラム抄録集23回 シンポジウムSY-2-11-04, 2015年07月
      • がん臨床試験における統計のあり方(第1部 外科臨床研究のあり方,日本外科学会・日本臨床外科学会共催(第76回日本臨床外科学会総会開催時)第13回臨床研究セミナー)
        森田 智視
        日本外科学会雑誌, 2015年05月01日
      • Multicenter phase II study of oral care program for head and neck cancer patients treated with chemoradiotherapy.
        Tomoya Yokota; Tetsuhito Konishi; Hiroyuki Tachibana; Takashi Yurikusa; Satoshi Hamauchi; Kensuke Sakai; Masaya Nishikawa; Maho Sato; Masataka Taguri; Satoshi Morita; Toru Eguchi; Kaoru Kubota; Sadamoto Zenda
        JOURNAL OF CLINICAL ONCOLOGY, 2015年05月
      • The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY)
        Tetsuhiro Yoshinami; Norikazu Masuda; Takahiro Nakayama; Fumikata Hara; Yasuaki Sagara; Hidetoshi Kawaguchi; Ken-ichi Watanabe; Masako Sato; Kenjiro Aogi; Kenji Higaki; Takashi Morimoto; Yasushi Shigeoka; Shinya Tokunaga; Hirotaka Morishima; Yasuhiro Yanagita; Junji Tsurutani; Shinichi Baba; Kazuhisa Katayama; Satoshi Morita; Shoichiro Ohtani
        JOURNAL OF CLINICAL ONCOLOGY, 2015年05月
      • Subset analysis of COMPASS: A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally advanced gastric cancer.
        Takaki Yoshikawa; Kazuaki Tanabe; Yuichi Ito; Kazuhiro Nishikawa; Kazumasa Fujitani; Takanori Matsui; Tsutomu Hayashi; Toru Aoyama; Haruhiko Cho; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2015年05月
      • Impact of UGT1A1 genotype on prognosis in Japanese advanced colorectal cancer patients treated by irinotecan-based regimens.
        Wataru Ichikawa; Keisuke Uehara; Keisuke Minamimura; Chihiro Tanaka; Yasumasa Takii; Hideaki Miyauchi; Sotaro Sadahiro; Katsunori Shinozaki; Kanehisa Fukumoto; Toshio Otsuji; Takeshi Kambara; Satoshi Morita; Yuichi Ando; Yukihiro Okutani; Masahiro Sugihara; Toru Sugiyama; Yasuo Ohashi; Yuh Sakata
        JOURNAL OF CLINICAL ONCOLOGY, 2015年05月
      • ASP8273, a mutant-selective irreversible EGFR inhibitor in patients (pts) with NSCLC harboring EGFR activating mutations: Preliminary results of first-in-human phase I study in Japan.
        Yasushi Goto; Hiroshi Nokihara; Haruyasu Murakami; Toshio Shimizu; Takashi Seto; Andrew P. Krivoshik; Anne Therese Keating; Koichi Uegaki; Kentaro Takeda; Kanji Komatsu; Satoshi Morita; Masahiro Fukuoka; Kazuhiko Nakagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2015年05月
      • ANDROGEN DEPRIVATION THERAPY PREVENTS RECURRENCE OF BLADDER CANCER
        Koji Izumi; Mastaka Taguri; Hiroshi Miyamoto; Yusuke Ito; Yasuhide Miyoshi; Masatoshi Moriyama; Tetsuo Murai; Hiroyuki Hayashi; Yoshiaki Inayama; Yoji Nagashima; Satoshi Morita; Hiroji Uemura
        JOURNAL OF UROLOGY, 2015年04月
      • Androgen deprivation therapy to prevent bladder cancer recurrence.
        Hiroji Uemura; Koji Izumi; Masataka Taguri; Hiroshi Miyamoto; Satoshi Morita; Yasuhide Miyoshi; Yoshinori Hara; Takeshi Kishida; Kimio Chiba; Tetsuo Murai; Kotaro Hirai; Kotaro Suzuki; Kiyoshi Fujinami; Teiichiro Ueki; Koichi Udagawa; Kazuo Kitami; Masatoshi Moriyama; Futoshi Tsuchiya; Ichiro Ikeda; Kazuki Kobayashi
        JOURNAL OF CLINICAL ONCOLOGY, 2015年03月
      • Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer
        H. Iwata; N. Yamamoto; N. Masuda; H. Bando; K. Kuroi; S. Ohno; H. Kasai; S. Morita; T. Sakurai; M. Toi
        BREAST, 2015年03月
      • 医師主導型の介入および侵襲を伴う臨床研究のデータの質保証体制の構築に向けた京大病院での取り組み
        森田智視; 多田春江; 渡邊美恵子; 山本倫生; 上山華栄; 柏木直子; 川口淳; 町田優子; 榎本佳代子
        日本臨床試験学会第6回学術集会総会, 2015年02月
      • A randomized 2X2 phase II trial comparing two and four courses of S-1/cisplatin (SC) and paclitaxel/cisplatin (PC) as neoadjuvant chemotherapy for locally resectable advanced gastric cancer: Survival results of COMPASS.
        Takaki Yoshikawa; Kazuaki Tanabe; Kazuhiro Nishikawa; Kazumasa Fujitani; Yuichi Ito; Takanori Matsui; Tsutomu Hayashi; Toru Aoyama; Haruhiko Cho; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2015年01月
      • A randomized phase II trial of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment versus SP randomized PII trial (XParTS II).
        Michiya Kobayashi; Akira Tsuburaya; Kazuhiro Nishikawa; Junji Kawada; Tsutomu Namikawa; Ryoji Fukushima; Hiroshi Kojima; Kazuaki Tanabe; Kazuya Yamaguchi; Shigefumi Yoshino; Masazumi x Takahashi; Naoki Hirabayashi; Seiji Sato; Hiroshi Nemoto; Yasushi Rino; Takaki Yoshikawa; Junta Nakajima; Satoshi Morita; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2015年01月
      • The impact of early tumor shrinkage on survival in WJOG4407G trial, a randomized phase III trial of mFOLFOX6 plus bevacizumab versus FOLFIRI plus bevacizumab in first-line treatment for metastatic colorectal cancer.
        Michitaka Nagase; Kentaro Yamazaki; Hiroshi Tamagawa; Shinya Ueda; Takao Tamura; Kohei Murata; Takashi Tsuda; Eishi Baba; Masahiro Tsuda; Toshikazu Moriwaki; Taito Esaki; Yasushi Tsuji; Kei Muro; Koichi Taira; Tadamichi Denda; Masahiko Ando; Satoshi Morita; Narikazu Boku; Ichinosuke Hyodo
        JOURNAL OF CLINICAL ONCOLOGY, 2015年01月
      • Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer
        Ichiro Tateya; Shuko Morita; Manabu Muto; Shin'Ichi Miyamoto; Tomomasa Hayashi; Makiko Funakoshi; Ikuo Aoyama; Shigeru Hirano; Morimasa Kitamura; Seiji Ishikawa; Yo Kishimoto; Mami Morita; Patnarin Mahattanasakul; Satoshi Morita; Juichi Ito
        Laryngoscope, 2015年01月01日
      • 網羅的がん関連遺伝子変異パネル(OncoPrime)を用いたクリニカルシークエンスの臨床導入
        金井雅史; 佐久間朋寛; 柳澤宏次; 小柳智義; 松本繁巳; 黒田知宏; 森田智視; 小杉眞司; 奥野恭史
        日本臨床腫瘍学会学術集会(CD-ROM), 2015年
      • 京大病院がんセンターにおけるバイオバンクとメディカルバイオインフォマティクスプロジェクト
        武藤学; 釆野優; 西川佳孝; 森由希子; 金井雅史; 松本繁巳; 加藤源太; 黒田知宏; 森田智視; 奥野恭史
        日本臨床腫瘍学会学術集会(CD-ROM), 2015年
      • Comparison of Long-term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score-Match Analysis
        Y. Matsuo; F. Chen; M. Hamaji; A. Kawaguchi; N. Ueki; Y. Nagata; M. Sonobe; S. Morita; H. Date; M. Hiraoka
        INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014年11月
      • TUMOR GENOMIC PROFILING OF NSCLC FROM THE PHASE III TRIAL OF FIRST-LINE S-1/CBDCA VERSUS PACLITAXEL/CBDCA (WJOG6611LTR)
        Hiroyasu Kaneda; Isamu Okamoto; Kazuko Sakai; Satoshi Morita; Koichi Takayama; Keisuke Tomii; Tadashi Maeda; Kazuhiko Nakagawa; Yoichi Nakanishi; Kazuto Nishio
        ANNALS OF ONCOLOGY, 2014年10月
      • High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.
        Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota
        BMC cancer, 2014年09月26日
      • Comparison of Long-Term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sub lobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score Match Analysis
        Y. Matsuo; F. Chen; M. Hamaji; A. Kawaguchi; N. Ueki; Y. Nagata; M. Sonobe; S. Morita; H. Date; M. Hiraoka
        INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014年09月
      • 医師主導型介入臨床試験のデータの質保証体制の構築に向けた京大病院での取り組み
        渡邊美惠子; 多田春江; 山本倫生; 上山華栄; 川口淳; 町田優子; 榎本佳代子; 森田智視
        ARO協議会第2回学術集会, 2014年09月
      • PRESPECIFIED SUBGROUP ANALYSES IN WJOG4407G TRIAL, A RANDOMIZED PHASE III TRIAL OF MFOLFOX6 PLUS BEVACIZUMAB VERSUS FOLFIRI PLUS BEVACIZUMAB IN FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER
        Tamagawa Hiroshi; Yamazaki Kentaro; Suyama Koichi; Okabe Michio; Suzuki Kazuya; Seki Nobuhiko; Kawakami Kentaro; Sato Mikio; Takahashi Yasuo; Hirashima Tomonori; Ebi Masahide; Taku Keisei; Otsuji Toshio; Tamura Fumio; Shinozaki Eiji; Nakashima Koji; Yamaguchi Kensei; Ando Masahiko; Morita Satoshi; Boku Narikazu; Hyodo Ichinosuke
        ANNALS OF ONCOLOGY, 2014年06月
      • Effects of Telephone-delivered Lifestyle Support on the Development of Diabetes in Subjects at High Risk of Type 2 Diabetes: J-DOIT1, a Pragmatic Cluster Randomized Trial in the Primary Health Care Setting
        Naoki Sakane; Kazuhiko Kotani; Kaoru Takahashi; Yoshiko Sano; Kokoro Tsuzaki; Kentaro Okazaki; Juichi Sato; Sadao Suzuki; Satoshi Morita; Yoshitake Oshima; Kazuo Izumi; Masayuki Kato; Naoki Ishizuka; Mitsuhiko Noda; Hideshi Kuzuya
        DIABETES, 2014年06月
      • 進行性膵癌に対するgemcitabine療法と併用したWT1ペプチドを用いる癌ワクチン療法(WT1 peptide-based cancer vaccine in combination with gemcitabine for advanced pancreatic cancer)
        西田 純幸; 小井戸 薫雄; 本間 定; 武田 裕; 石川 剛; 古倉 聡; 江川 新一; 森本 創世子; 江口 英利; 森田 智視; 岡 芳弘; 杉山 治夫
        日本がん免疫学会総会プログラム・抄録集, 2014年06月
      • Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L.
        Nobuyuki Katakami; Satoshi Morita; Hiroshige Yoshioka; Takashi Seto; Yoshiko Urata; Miyako Satouchi; Yasuo Iwamoto; Kojiro Otsuka; Norihiko Ikeda; Toshiaki Takahashi; Haruko Daga; Tetsuya Oguri; Isao Goto; Junji Uchida; Shunichi Sugawara; Chiyoe Kitagawa; Toshiyuki Kozuki; Junya Inata; Kazuhiko Nakagawa; Yoichi Nakanishi
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • Subgroup analyses of randomized phase II study on gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer.
        Makoto Ueno; Shinichi Ohkawa; Satoshi Kobayashi; Kazuya Sugimori; Taku Kaneko; Ryo Kameda; Tomoko Andou; Haruo Miwa; Ryonho Ko; Katsuaki Tanaka; Manabu Morimoto; Masataka Taguri; Satoshi Morita
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • Final overall survival results of WJTOG 3405, a randomized phase 3 trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer (NSCLC) harboring mutations of the epidermal growth factor receptor (EGFR).
        Hiroshige Yoshioka; Tetsuya Mitsudomi; Satoshi Morita; Yasushi Yatabe; Shunichi Negoro; Isamu Okamoto; Takashi Seto; Miyako Satouchi; Hirohito Tada; Tomonori Hirashima; Kazuhiro Asami; Nobuyuki Katakami; Minoru Takada; Kazuhiko Shibata; Shinzoh Kudoh; Eiji Shimizu; Hiroshi Saito; Shinichi Toyooka; Kazuhiko Nakagawa; Masahiro Fukuoka
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • NEJ009 trial: A randomized phase III study of gefitinib (G) on combination with carboplatin (C) plus pemetrexed (P) versus G alone in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) with EGFR mutation
        Akira Inoue; Yukio Hosomi; Makoto Maemondo; Shunichi Sugawara; Terufumi Kato; Kazuhlsa Takahashi; Yuka Fujita; Aklhlko Gamma; Toshiyuki Harada; Satoshi Oizumi; Koichi Minato; Satoshi Morita; Toshihiro Nukiwa
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • Multiplex genomic profiling of non-small cell lung cancer patients enrolled in the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin (WJOG6611LTR)
        Hiroshige Yoshioka; Isamu Okamoto; Kazuko Sakai; Satoshi Morita; Hiroyasu Kaneda; Koji Takeda; Tomonori Hirashima; Yoshihito Kogure; Tatsuo Kimura; Toshiaki Takahashi; Shinji Atagi; Takashi Seto; Toshiyuki Sawa; Masashi Yamamoto; Miyako Satouchi; Motoyasu Okuno; Seisuke Nagase; Kazuhiko Nakagawa; Yoichi Nakanishi; Kazuto Nishio
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • Updated results of the SOFT study: A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/I-LV/oxaliplatin (mFOLFOX6) plus bevacizumab in patients with metastatic colorectal cancer (mCRC).
        Masato Nakamura; Yasuhide Yamada; Daisuke Takahari; Hiroshi Matsumoto; Hideo Baba; Kazuhiro Yoshida; Motoki Yoshida; Shigeyoshi Iwamoto; Ken Shimada; Yoshito Komatsu; Yasutsuna Sasaki; Taroh Satoh; Keiichi Takahashi; Hideyuki Mishima; Kei Muro; Masahiko Watanabe; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Kenichi Sugihara
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • A prospective, multicenter phase II trial of low-dose erlotinib monotherapy for patients with previously treated non-small cell lung cancer (NSCLC) with activating mutation of epidermal growth factor receptor (EGFR): Thoracic Oncology 1 Research Group (TORG) 0911
        Yoshiro Nakahara; Yukio Hosomi; Kazuhiko Yamada; Hiroaki Okamoto; Terufumi Kato; Yuko Komase; Masanori Nishikawa; Satoshi Morita; Hideo Kunitoh; Koshiro Watanabe
        JOURNAL OF CLINICAL ONCOLOGY, 2014年05月
      • ゼラチンハイドロゲルを用いたbFGF徐放投与による血管新生療法の可能性
        熊谷基之; 丸井晃; 田畑泰彦; 吉川英治; 武田崇秀; 山本雅哉; 米澤淳; 池田隆文; 松原和夫; 川上浩司; 森田智視; 横出正之; 清水章; 坂田隆造
        再生医療, 2014年01月27日
      • Web-based recruiting for a survey on knowledge and awareness of Cervical cancer prevention among young women living in Kanagawa prefecture, Japan
        Etsuko Miyagi; Yoko Motoki; Mikiko Asai-Sato; Masataka Taguri; Satoshi Morita; Fumiki Hirahara; John D. Wark; Suzanne M. Garland
        International Journal of Gynecological Cancer, 2014年
      • Handling of missing data in clinical trials: From the academic viewpoint
        Satoshi Morita
        Japanese Journal of Clinical Pharmacology and Therapeutics, 2014年
      • Efficacy and safety result of trastuzumab (T-mab) and paclitaxel for T-mab naive patients with HER2-positive previously treated advanced or recurrent gastric cancer (JFMC45-1102): Final report
        Tsunehiro Takahashi; Kazuhiro Nishikawa; Akira Miki; Hirokazu Noshiro; Takaki Yoshikawa; Yasunori Nishida; Satoru Iwasa; Hiroto Miwa; Toshiki Masuishi; Kazuhiro Yoshida; Yasuhiro Kodera; Narikazu Boku; Yasuhide Yamada; Satoshi Morita; Mitsuru Sasako; Yoshihiko Maehara; Masaki Kitajima; Junichi Sakamoto; Shigetoyo Saji; Yuko Kitagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2014年01月
      • Potential predictive markers of chemotherapy for advanced gastric cancer: Biomarker study in GC0301/TOP-002, randomized phase III study of irinotecan plus S-1 versus S-1
        Naotoshi Sugimoto; Akira Tsuburaya; Ryohei Kawabata; Kazuhiro Nishikawa; Haruhiko Imamoto; Toshimasa Tsujinaka; Taito Esaki; Yosuke Horita; Yutaka Kimura; Tsuneaki Fujiya; Osamu Takayama; Ryo Oono; Hiroshi Yabusaki; Masataka Taguri; Satoshi Morita; Wasaburo Koizumi; Patrick Tan; Motoki Ninomiya; Hiroshi Furukawa; Mitsuru Sasako
        JOURNAL OF CLINICAL ONCOLOGY, 2014年01月
      • Harvesting lymph nodes in gastric cancer surgery: A prospective randomized controlled study
        Toru Aoyama; Hirohito Fujikawa; Junya Shirai; Kameda Yoichi; Haruhiko Cho; Tsutomu Hayashi; Yasushi Rino; Shinichi Hasegawa; Takashi Oshima; Munetaka Masuda; Mari Saito Oba; Satoshi Morita; Takaki Yoshikawa
        JOURNAL OF CLINICAL ONCOLOGY, 2014年01月
      • Risk factors for surgical complications after D2 gastrectomy following neoadjuvant chemotherapy for gastric cancer.
        Takaki Yoshikawa; Toru Aoyama; Tsutomu Hayashi; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Haruhiko Cho; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2014年01月
      • A PROSPECTIVE, MULTI-CENTER PHASE II TRIAL ON THE EFFICACY AND SAFETY OF LOW-DOSE ERLOTINIB MONOTHERAPY FOR PATIENTS WITH EGFR MUTATION-POSITIVE, PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER: RESULTS OF THORACIC ONCOLOGY RESEARCH GROUP (TORG) TRIAL 0911
        Kazuhiko Yamada; Hideo Kunitoh; Yukio Hosomi; Hiroaki Okamoto; Terufumi Kato; Yuko Komase; Masanori Nishikawa; Satoshi Morita; Koshiro Watanabe
        JOURNAL OF THORACIC ONCOLOGY, 2013年11月
      • Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery Disease (OPERA) Study
        Masato Nakamura; Masaki Awata; Takaaki Isshiki; Ken Kozuma; Miyahara Masatoshi; Satoshi Morita; Shinsuke Nanto; Nobuhiro Omura
        JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013年10月
      • Effect of virtual bronchoscopic navigation in combination with ultrathin bronchoscopy for diagnosing peripheral pulmonary lesions
        Naofumi Shinagawa; Fumihiro Asano; Takashi Ishida; Joe Shindoh; Masaki Anzai; Akifumi Tsuzuku; Satoshi Oizumi; Satoshi Morita
        EUROPEAN RESPIRATORY JOURNAL, 2013年09月
      • Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1): A Cluster Randomized Controlled Trial of Type 2 Diabetes (T2DM) Prevention by Telephone-Delivered Lifestyle Support for High-Risk Subjects
        Naoki Sakane; Kentaro Okazaki; Kazuhiko Kotani; Kaoru Takahashi; Yoshiko Sano; Kokoro Tsuzaki; Juichi Sato; Sadao Suzuki; Satoshi Morita; Yoshitake Oshima; Kazuo Izumi; Masayuki Kato; Naoki Ishizuka; Mitsuhiko Noda; Hideshi Kuzuya
        DIABETES, 2013年07月
      • Multicenter, phase II study of trastuzumab and paclitaxel to treat HER2-positive, metastatic gastric cancer patients naive to trastuzumab (JFMC45-1102).
        Satoru Iwasa; Kazuhiro Nishikawa; Akira Miki; Hirokazu Noshiro; Akira Tsuburaya; Yasunori Nishida; Hiroto Miwa; Toshiki Masuishi; Kazuhiro Yoshida; Yasuhiro Kodera; Narikazu Boku; Yasuhide Yamada; Satoshi Morita; Junichi Sakamoto; Shigetoyo Saji; Yuko Kitagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/l-LV/oxaliplatin (mFOLFOX6) plus bevacizmab in patients with metastatic colorectal cancer: The SOFT study.
        Daisuke Takahari; Yasuhide Yamada; Hiroshi Matsumoto; Hideo Baba; Kazuhiro Yoshida; Masato Nakamura; Motoki Yoshida; Shigeyoshi Iwamoto; Yasutaka Takinishi; Yuh Sakata; Satoshi Morita; Yasuhiro Shimada; Yoshito Komatsu; Yasutsuna Sasaki; Taroh Satoh; Keiichi Takahashi; Hideyuki Mishima; Kei Muro; Masahiko Watanabe; Kenichi Sugihara
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • A prospective cohort study to reduce operative risk in stage I gastric cancer patients with metabolic syndrome: Preoperative exercise versus surgery alone.
        Haruhiko Cho; Akira Tsuburaya; Naoki Hirabayashi; Junya Shirai; Toru Aoyama; Tsutomu Hayashi; Takanobu Yamada; Takaki Yoshikawa; Satoshi Morita; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Dynamic treatment regimen analysis to determine which treatment sequence can prolong survival of NSCLC patients.
        Taro Koba; Fumio Imamura; Satoshi Morita; Masahide Mori; Kiyoshi Komuta; Takashi Kijima; Yoshinobu Namba; Kazumi Nishino; Suguru Yamamoto; Ryo Takahashi; Yukie Nakazawa; Seigo Minami; Yoshitaka Ogata; Atsushi Kumanogoh
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Phase II study of neoadjuvant chemotherapy with a metronomic regimen of paclitaxel plus cyclophosphamide plus capecitabine followed by 5-fluorouracil plus epirubicin plus cyclophosphamide in operable triple-negative breast cancer (JBCRG-13 study)
        Kenji Higaki; Norikazu Masuda; Toshimi Takano; Nobuki Matsunami; Takashi Morimoto; Shoichiro Ohtani; Makiko Mizutani; Takeshi Miyamoto; Katsumasa Kuroi; Shinji Ohno; Satoshi Morita; Masakazu Toi
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Feasibility study of pemetrexed (PEM) plus bevacizumab (BV) as the first-line treatment for elderly advanced or recurrent non-squamous (non-Sq) non-small cell lung cancer (NSCLC): TORG1015
        Toshiyuki Kozuki; Naoyuki Nogami; Hiromoto Kitajima; Tetsu Shinkai; Fumiaki Kato; Emiko Sakaida; Yuichi Takiguchi; Satoshi Ikeda; Masahiro Yoshida; Yasunori Enomoto; Terufumi Kato; Takashi Ogura; Shingo Miyamoto; Satoshi Morita; Koshiro Watanabe
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Pathologic complete response to cisplatin with dose-dense paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: Preliminary results of a multicenter phase II study with additional mutation analysis of adeno/adenosquamous carcinoma
        Maki Tanioka; Satoshi Yamaguchi; Shinya Sato; Shoji Nagao; Kazuhiro Takehara; Masato Nishimura; Tamotsu Sudo; Satoshi Morita; Hironobu Minami; Shunichi Negoro; Muneaki Shimada; Junzo Kigawa; Kiyoshi Fujiwara
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Safety of trastuzumab in HER2-positive primary breast cancer in Japan: Initial safety report for the large-scale cohort study (JBCRG C-01).
        Naohito Yamamoto; Hiroyasu Yamashiro; Hiroji Iwata; Norikazu Masuda; Shoichiro Ohtani; Masata Takahashi; Kosuke Yamazaki; Makota Kato; Shinji Ohno; Katsumasa Kuroi; Kazuhiko Yamagami; Takashi Morimoto; Yoshie Hasegawa; Toshimi Takano; Takayuki Kadoya; Mitsuchika Hosoda; Hajime Abe; Satoshi Morita; Shinji Yasuna; Mairakazu Toi
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Prospective analysis of UGT1A1 genotyping for predicting toxicities in advanced colorectal cancer (aCRC) treated with irinotecan (IRI)-based regimens: Interim safety analysis of a Japanese observational study.
        Wataru Ichikawa; Keisuke Uehara; Keisuke Minamimura; Chihiro Tanaka; Yasumasa Takii; Sotaro Sadahiro; Hideaki Miyauchi; Katsunori Shinozaki; Takuya Miyagaki; Toshio Otsuji; Takeshi Kambara; Satoshi Morita; Yuichi Ando; Yukihiro Okutani; Masahiro Sugihara; Toru Sugiyama; Yasuo Ohashi; Yuh Sakata
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Early results of a randomized phase II, compass trial to compare regimen and duration of neoadjuvant chemotherapy for gastric cancer.
        Takaki Yoshikawa; Kazuaki Tanabe; Kazuhiro Nishikawa; Yuichi Ito; Takanori Matsui; Yutaka Kimura; Satoshi Morita; Yumi Miyashita; Akira Tsuburaya; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer.
        Makoto Ueno; Satoshi Kobayashi; Shinichi Ohkawa; Ryo Kameda; Tomoko Andou; Kazuya Sugimori; Haruo Miwa; Ryonho Ko; Katsuaki Tanaka; Masataka Taguri; Satoshi Morita
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Evaluation of UGT1A1 genotyping for predicting individual toxicity of irinotecan plus platinum analog regimens: Interim safety analysis of a prospective observational study.
        Masashi Takano; Kaichiro Yamamoto; Tsutomu Tabata; Yuji Minegishi; Takuma Yokoyama; Eiji Hirata; Takeshi Ikeda; Junzo Kigawa; Kouzo Yamada; Satoshi Morita; Yuichi Ando; Yukihiro Okutani; Masahiro Sugihara; Toru Sugiyama; Yasuo Ohashi; Yuh Sakata
        JOURNAL OF CLINICAL ONCOLOGY, 2013年05月
      • Efficacy and safety of trastuzumab (T-mab) and paclitaxel for T-mab naive patients with HER2 positive previously treated metastatic gastric cancer (JFMC45-1102)
        Akira Miki; Kazuhiro Nishikawa; Hirokazu Noshiro; Akira Tsuburaya; Yasunori Nishida; Yasuhide Yamada; Hiroto Miwa; Yoshinori Sakai; Kazuhiro Yoshida; Yasuhiro Kodera; Narikazu Boku; Satoshi Morita; Junichi Sakamoto; Shigetoyo Saji; Yoko Kitagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2013年02月
      • Efficacy analyses of a randomized phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer refractory to prior S-1 chemotherapy
        Hitoshi Inagaki; Kazuhiro Nishikawa; Kazumasa Fujitani; Naotoshi Sugimoto; Tadashi Shigematsu; Tohru Ishiguro; Akira Tsuburaya; Masato Nakamura; Atsushi Nashimoto; Takao Yamane; Makoto Yamada; Motohiro Imano; Shohei Iijima; Yoshio Oka; Masato Kataoka; Shuichi Hironaka; Hideaki Andoh; Satoshi Morita; Junichi Sakamoto; Toshimasa Tsujinaka
        JOURNAL OF CLINICAL ONCOLOGY, 2013年02月
      • Result of HER2 status in Japanese metastatic gastric cancer: Prospective cohort study (JFMC44-1101)
        Kazuhiro Nishikawa; Keisho Chin; Atsushi Nashimoto; Akira Miki; Hiroto Miwa; Akira Tsuburaya; Tamon Miyanaga; Takuo Hara; Ryoji Fukushima; Makio Gamoh; Norimasa Fukushima; Takeshi Sano; Yasuhiro Kodera; Yoshihiro Kakeji; Satoshi Morita; Junichi Sakamoto; Shigetoyo Saji; Kazuhiro Yoshida
        JOURNAL OF CLINICAL ONCOLOGY, 2013年02月
      • Induction of pathologic complete response by long-term neoadjuvant chemotherapy for gastric cancer: Early results of a randomized phase II study-A COMPASS trial
        Kazuaki Tanabe; Takaki Yoshikawa; Akira Tsuburaya; Kazuhiro Nishikawa; Seiji Ito; Takanori Matsui; Haruhiko Cho; Yuichi Ito; Takahisa Suzuki; Satoshi Morita; Yumi Miyashita; Junichi Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2013年02月
      • Diagnostic accuracy of 18F-fluoride PET and PET/CT in patients with bone metastases: A systematic review and meta-analysis update
        Ukihide Tateishi; Satoshi Morita; Tomio Inoue
        Clinical and Translational Imaging, 2013年
      • RNF213遺伝子のホモ接合性14576多型は、重症型のもやもや病の遺伝マーカーである
        宮武 聡子; 東保 肇; 土井 宏; 三宅 紀子; 田栗 正隆; 児谷野 繁; 森田 智視; 川原 信隆; 黒岩 義之; 松原 洋一; 呉 繁夫; 松本 直通
        臨床神経学, 2012年12月
      • ST-Segment Elevation in Lead aVR Strongly Predicts 3-Year Adverse Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Nobuhiko Maejima; Mitsuaki Endo; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2012年11月
      • ST-Segment Depression in Lead aVR Predicts In-Hospital Adverse Outcomes in Patients With Inferior Wall Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Noriaki Iwahashi; Kengo Tsukahara; Nobuhiko Maejima; Mitsuaki Endo; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2012年11月
      • Simple and Accurate Electrocardiographic Criteria for Differentiation Among Acute Coronary Syndrome, Acute Pulmonary Embolism, and Takotsubo Cardiomyopathy
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Nobuhiko Maejima; Mitsuaki Endo; Satoshi Morita; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2012年11月
      • POSTPROGRESSION SURVIVAL FOR FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
        H. Kawakami; I. Okamoto; H. Hayashi; M. Taguri; S. Morita; K. Nakagawa
        ANNALS OF ONCOLOGY, 2012年10月
      • CORRELATION BETWEEN DOCETAXEL-INDUCED SKIN TOXICITY AND THE USE OF STEROIDS AND H2 BLOCKERS: A MULTI-INSTITUTION SURVEY
        K. Kawaguchi; H. Ishiguro; S. Morita; S. Nakamura; S. Ohno; N. Masuda; H. Iwata; K. Aogi; K. Kuroi; M. Toi
        ANNALS OF ONCOLOGY, 2012年10月
      • Daikenchuto improves functional gastrointestinal disorder after hepatic resection in patients with liver cancer: a multicenter, randomized, double-blind, placebo-controlled phase II trial (JFMC40-1001)
        Etsuro Hatano; Shinji Uemoto; Mitsuo Shimada; Yuji Morine; Hiroaki Nagano; Shogo Kobayashi; Takashi Kaiho; Masaru Miyazaki; Toru Kono; Toshiya Kamiyama; Satoshi Morita; Junichi Sakamoto; Mitsuo Kusano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
        HEPATOLOGY, 2012年10月
      • A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
        Y. Namba; Y. Hattori; M. Edagawa; H. Yoshioka; M. Iwasaku; T. Shimada; M. Satouchi; N. Katagami; S. Fujita; M. Mori; F. Imamura; Y. Kotani; T. Nishimura; S. Morita; S. Negoro
        ANNALS OF ONCOLOGY, 2012年10月
      • THE CLINICAL SIGNIFICANCE OF THE SERUM CROSS-LINKED N-TELOPEPTIDE OF TYPE I COLLAGEN AS A PROGNOSTIC MARKER FOR NON-SMALL-CELL LUNG CANCER
        T. Shiroyama; M. Tamiya; T. Hirashima; S. Morita; O. Morimura; K. Okafuji; N. Morishita; H. Suzuki; N. Okamoto; M. Kobayashi; T. Hirashima; I. Kawase
        ANNALS OF ONCOLOGY, 2012年10月
      • ORAL S-1 AND CARBOPLATIN PLUS BEVACIZUMAB WITH MAINTENANCE S-1 AND BEVACIZUMAB FOR CHEMO-NAIVE PATIENTS WITH NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
        Y. Urata; I. Okamoto; Y. Hattori; K. Okuno; T. Shimada; M. Takeda; T. Kurata; H. Kaneda; M. Miyazaki; M. Terashima; K. Tanaka; S. Morita; K. Nakagawa; S. Negoro; M. Satouchi
        ANNALS OF ONCOLOGY, 2012年10月
      • POSTPROGRESSION SURVIVAL FOR ADVANCED NSCLC
        H. Hayashi; I. Okamoto; M. Taguri; S. Morita; K. Nakagawa
        ANNALS OF ONCOLOGY, 2012年10月
      • RANDOMIZED PHASE II STUDY OF CONCURRENT GEFITINIB PLUS CHEMOTHERAPY VERSUS ALTERNATION OF GEFITINIB AND CHEMOTHERAPY IN PREVIOUSLY UNTREATED NON-SMALL CELL LUNG CANCER (NSCLC) WITH SENSITIVE EGFR MUTATIONS: NEJ005/TCOG0902
        S. Oizumi; J. Sakakibara-Konishi; A. Inoue; K. Kobayashi; A. Gemma; H. Yoshizawa; H. Isobe; Y. Saijyo; Y. Ishii; S. Morita; K. Hagiwara; T. Nukiwa
        ANNALS OF ONCOLOGY, 2012年10月
      • PROGNOSTIC FACTORS IN NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS: DATA FROM THE RANDOMIZED PHASE III STUDY COMPARED GEFITINIB WITH CARBOPLATIN PLUS PACLITAXEL (NEJ002)
        Y. Minegishi; K. Kobayashi; M. Maemondo; A. Inoue; S. Sugawara; S. Ohizumi; H. Isobe; K. Hagiwara; S. Morita; T. Nukiwa; A. Gemma
        ANNALS OF ONCOLOGY, 2012年10月
      • WHAT FACTORS AFFECT LONG-TERM SURVIVAL AFTER RESPONDING TO GEFITINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER? REAL WORLD EVIDENCE
        R. Takahashi; F. Imamura; S. Morita; M. Mori; K. Komuta; T. Kijima; Y. Namba; K. Nishino; S. Yamamoto; H. Hirata; I. Tachibana; A. Kumanogoh
        ANNALS OF ONCOLOGY, 2012年10月
      • LONG-TERM FOLLOW UP OF A FEASIBILITY STUDY OF THE FACTORIAL PHASE III SAMIT TRIAL: ADJUVANT PACLITAXEL FOLLOWED BY S1 FOR GASTRIC CANCER
        S. Yoshino; A. Tsuburaya; M. Kobayashi; N. Hirabayashi; N. Nagata; Y. Miyashita; S. Morita; J. Sakamoto
        ANNALS OF ONCOLOGY, 2012年09月
      • LONG-TERM SURVIVORS IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS: DATA FROM A RANDOMIZED PHASE III STUDY COMPARING GEFITINIB WITH CARBOPLATIN PLUS PACLITAXEL (NEJ002)
        Y. Minegishi; K. Kobayashi; M. Maemondo; A. Inoue; S. Sugawara; S. Oizumi; K. Hagiwara; T. Nukiwa; S. Morita; A. Gemma
        ANNALS OF ONCOLOGY, 2012年09月
      • RETROSPECTIVE EFFICACY AND SAFETY ANALYSIS OF ERLOTINIB (E), PEMETREXED (P) AND DOCETAXEL (D) IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER PATIENTS (NSCLC) WITHOUT EGFR MUTATION
        J. Takeshita; N. Katakami; A. Nishiyama; H. Yoshioka; M. Iwasaku; A. Hata; F. Imamura; K. Nishino; S. Yokota; S. Morita
        ANNALS OF ONCOLOGY, 2012年09月
      • PHASE II TRIAL OF SINGLE-AGENT PEMETREXED IN CHEMONAIVE ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) AND ITS ACCRUAL RATE IN A COMMUNITY-BASED CLINICAL TRIAL GROUP: LCEN1001
        N. Seki; T. Yokoyama; K. Kishi; T. Takao; I. Tsujino; N. Takahashi; H. Yoshifumi; S. Maho; S. Morita; K. Eguchi
        ANNALS OF ONCOLOGY, 2012年09月
      • DOES GEFITINIB RE-CHALLENGE OR TREATMENT BEYOND PROGRESSION (TBP) PROLONG SURVIVAL OF NSCLC PATIENTS? - REAL WORLD EVIDENCE FROM GEFITINIB TREATMENT RESPONDERS
        Y. Namba; F. Imamura; S. Morita; M. Mori; K. Komuta; T. Kijima; Y. Nakazawa; S. Yokota; S. Yamamoto; A. Kumanogoh
        ANNALS OF ONCOLOGY, 2012年09月
      • A PHASE II STUDY OF PEMETREXED IN CHEMOTHERAPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER: HANSHIN ONCOLOGY GROUP 003
        M. Iwasaku; Y. Hattori; S. Morita; H. Yoshioka; K. Otsuka; N. Katakami; S. Fujita; S. Yokota; F. Imamura; S. Negoro
        ANNALS OF ONCOLOGY, 2012年09月
      • 治療抵抗性婦人科悪性腫瘍におけるWT1ペプチドワクチン第II相臨床試験(Phase II trial of WT1 peptide vaccine to gynecologic malignancies which are resistant to conventional therapies)
        森本 晶子; 上田 豊; 宮武 崇; 榎本 隆之; 岡 芳弘; 西田 純幸; 坪井 昭博; 白方 俊章; 尾路 祐介; 森田 智視; 坂本 純一; 杉山 治夫; 木村 正
        日本癌学会総会記事, 2012年08月
      • Prognosis of early breast cancer patients treated with sentinel node biopsy: A prospective study from the Japanese society for sentinel node navigation surgery
        Shigeru Imoto; Takashi Aikou; Hiroyuki Takei; Noriaki Wada; Tomohiko Aihara; Masaaki Inaba; Kazuyoshi Motomura; Norikazu Masuda; Takeshi Nagashima; Hiromitsu Jinno; Daishu Miura; Mari Saito; Satoshi Morita; Junichi Sakamoto; Masaki Kitajima
        JOURNAL OF CLINICAL ONCOLOGY, 2012年05月
      • What factors affect long-term survival after responding to gefitinib in advanced non-small cell lung cancer? Real-world evidence
        Yoshiko Takeuchi; Fumio Imamura; Satoshi Morita; Masahide Mori; Kiyoshi Komuta; Takashi Kijima; Yoshinobu Namba; Kazumi Nishino; Suguru Yamamoto; Ryo Takahashi; Yukie Nakazawa; Seigo Minami; Yoshitaka Ogata; Atsushi Kumanogoh
        JOURNAL OF CLINICAL ONCOLOGY, 2012年05月
      • Randomized phase III study of irinotecan (CPT-11) versus weekly paclitaxel (wPTX) for advanced gastric cancer (AGC) refractory to combination chemotherapy (CT) of fluoropyrimidine plus platinum (FP): WJOG4007 trial
        Shinya Ueda; Shuichi Hironaka; Hirofumi Yasui; Tomohiro Nishina; Masahiro Tsuda; Takehiko Tsumura; Naotoshi Sugimoto; Hideki Shimodaira; Shinya Tokunaga; Toshikazu Moriwaki; Taito Esaki; Michitaka Nagase; Kazumasa Fujitani; Kensei Yamaguchi; Takashi Ura; Yasuo Hamamoto; Satoshi Morita; Isamu Okamoto; Narikazu Boku; Ichinosuke Hyodo
        JOURNAL OF CLINICAL ONCOLOGY, 2012年05月
      • Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR)
        Tetsuya Mitsudomi; Satoshi Morita; Yasushi Yatabe; Shunichi Negoro; Isamu Okamoto; Takashi Seto; Miyako Satouchi; Hirohito Tada; Tomonori Hirashima; Kazuhiro Asami; Nobuyuki Katakami; Minoru Takada; Hiroshige Yoshioka; Kazuhiko Shibata; Shinzoh Kudoh; Eiji Shimizu; Hiroshi Saito; Shinichi Toyooka; Kazuhiko Nakagawa; Masahiro Fukuoka
        JOURNAL OF CLINICAL ONCOLOGY, 2012年05月
      • Current status of acute graft-versus-host disease prophylaxis in Japan. Retrospective comparison of cyclosporine plus methotrexate versus tacrolimus plus methotrexate by donor source
        R. Sakai; M. Taguri; K. Oshima; T. Mori; H. Ago; S. Adachi; S. Morita; S. Taniguchi; T. Fukuda; K. Ohashi; T. Eto; Y. Morishima; T. Nagamura-Inoue; H. Sakamaki; Y. Atsuta; M. Murata
        BONE MARROW TRANSPLANTATION, 2012年04月
      • ST-SEGMENT DEPRESSION IN LEAD AVR STRONGLY PREDICTS ADVERSE OUTCOMES IN PATIENTS WITH ANTEROLATERAL ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Noriaki Iwahashi; Kengo Tsukahara; Nobuhiko Maejima; Mitsuaki Endo; Satoshi Morita; Toshiyuki Ishikawa; Kazuaki Uchino; Satoshi Umemura; Kazuo Kimura
        JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012年03月
      • ST-SEGMENT DEPRESSION IN LEAD AVR COMBINED WITH NO ST-SEGMENT ELEVATION IN LEAD V1 DIFFERENTIATES TAKOTSUBO CARDIOMYOPATHY FROM ANTERIOR ACUTE MYOCARDIAL INFARCTION
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Noriaki Iwahashi; Kengo Tsukahara; Nobuhiko Maejima; Mitsuaki Endo; Satoshi Morita; Toshiyuki Ishikawa; Kazuaki Uchino; Satoshi Umemura; Kazuo Kimura
        JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012年03月
      • Clinical Implications of ST-Segment Elevation in Leads V5-6 in Patients with Reperfused Inferior Wall Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Mitsuaki Endo; Nobuhiko Maejima; Noriaki Iwahashi; Satoshi Morita; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2011年11月
      • Differences in Electrocardiographic Findings Between Takotsubo Cardiomyopathy and Reperfused Non-Q-Wave Anterior Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Mitsuaki Endo; Nobuhiko Maejima; Satoshi Morita; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2011年11月
      • ST-Segment Elevation in Lead aVR Strongly Predicts Adverse Outcomes at 1 Year in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Noriaki Iwahashi; Nobuhiko Maejima; Mitsuaki Endo; Kengo Tsukahara; Satoshi Morita; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2011年11月
      • PROGNOSTIC AND PREDICTIVE FACTORS OF THE RESPONSE TO ADJUVANT CHEMOTHERAPY IN RESECTABLE GASTRIC CANCER: RESULTS FROM THE GASTRIC META-ANALYSIS
        Satoshi Morita; Eric Van Cutsem
        ANNALS OF ONCOLOGY, 2011年06月
      • NEUROPROTECTION WITH GOSHAJINKIGAN (TJ-107) IN THE ADVANCED/RECURRENT COLORECTAL CANCER WITH OXALIPLATIN-BASED CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE II STUDY FROM THE GONE STUDY GROUP
        Junichi Sakamoto; Toru Kono; Taishi Hata; Satoshi Morita; Mitsuo Shimada; Masanori Nishioka; Naoki Nagata; Yoshinori Munemoto; Hiroshi Kojima; Takanori Matsui; Hiroyoshi Takemoto; Mutsumi Fukunaga; Hideyuki Mishima
        ANNALS OF ONCOLOGY, 2011年06月
      • PHASE III TRIAL COMPARING CARBOPLATIN/S-1 TO CARBOPLATIN/PACLITAXEL IN TREATMENT-NAIVE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): SUBGROUP ANALYSIS AND UPDATED RESULTS OF THE LETS STUDY (WJTOG3605).
        Miyako Satouchi; Isamu Okamoto; Satoshi Morita; Hiroshige Yoshioka; Koji Takeda; Takashi Seto; Nobuyuki Yamamoto; Masahiro Fukuoka; Toyoaki Hida; Nobuyuki Katakami; Hiroshi Saito; Hiroshi Senba; Kenji Tamura; Soichiro Yokota; Takashi Nakano; Yoshiro Tanio; Kazuhiko Nakagawa
        JOURNAL OF THORACIC ONCOLOGY, 2011年06月
      • 造血幹細胞移植後患者に対するWT1ワクチン免疫療法
        保仙 直毅; 前田 哲生; 山根 孝久; 日野 雅之; 森本 創世子; 原 一真; 中田 潤; 西田 純幸; 坪井 昭博; 尾路 祐介; 岡 芳弘; 金倉 譲; 森田 智視; 坂本 純一; 杉山 治夫
        日本がん免疫学会総会プログラム・抄録集, 2011年06月
      • SAMIT: Preliminary safety data from a 2x2 factorial randomized phase III trial to investigate weekly paclitaxel (PTX) followed by oral fluoropyrimidines (FPs) versus FPs alone as adjuvant chemotherapy in patients (pts) with gastric cancer.
        A. Tsuburaya; K. Yoshida; M. Kobayashi; S. Yoshino; Y. Miyashita; S. Morita; K. Oba; M. E. Buyse; J. S. Macdonald; J. Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2011年05月
      • Phase III study comparing the effects of carboplatin plus S-1 and carboplatin plus paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancer: An updated report of the LETS study (WJTOG3605)
        T. Hirashima; I. Okamoto; H. Yoshioka; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; K. Asami; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; M. Miyazaki; K. Tamura; T. Kurata; M. Fukuoka; K. Nakagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2011年05月
      • Neuroprotective effects of goshajinkigan (TJ-107) in colorectal cancer patients receiving oxaliplatin-based chemotherapy: A double-blind, placebo-controlled, randomized phase II trial from the GONE Study Group.
        T. Matsui; T. Kono; T. Hata; Y. Munemoto; M. Fukunaga; N. Nagata; M. Nishioka; J. Hasegawa; K. Kunieda; S. Morita; J. Sakamoto; H. Mishima
        JOURNAL OF CLINICAL ONCOLOGY, 2011年05月
      • Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001).
        M. Ueno; S. Ohkawa; K. Sugimori; S. Kobayashi; T. Kaneko; M. Taguri; S. Morita
        JOURNAL OF CLINICAL ONCOLOGY, 2011年05月
      • Final overall survival results of NEJ002, a phase III trial comparing gefitinib to carboplatin (CBDCA) plus paclitaxel (TXL) as the first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations
        A. Inoue; K. Kobayashi; M. Maemondo; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; Y. Saijo; H. Yoshizawa; S. Morita; K. Hagiwara; T. Nukiwa
        JOURNAL OF CLINICAL ONCOLOGY, 2011年05月
      • GREATER ST-SEGMENT ELEVATION IN LEAD AVR IS ASSOCIATED WITH WORSE OUTCOMES IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Mitsuaki Endo; Nobuhiko Maejima; Noriaki Iwahashi; Kengo Tsukahara; Toshiyuki Ishikawa; Kazuaki Iwahashi; Satoshi Umemura; Kazuo Kimura
        JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011年04月
      • Prognostic implication of intraoperative radiotherapy for unresectable pancreatic cancer.
        T. Fujii; S. Nagai; Y. Kodera; M. Kanda; T. T. Sahin; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao
        JOURNAL OF CLINICAL ONCOLOGY, 2011年02月
      • Progression-free Survival as Surrogate Endpoint of Overall Survival in Patients with Advanced/Recurrent Gastric Cancer: Individual Patient Data Analysis on 4102 patients from 20 Randomized Trials
        FUSE Nozomu; FUSE Nozomu; OBA Koji; OBA Koji; SHITARA Kohei; SHITARA Kohei; OHASHI Yasuo; OHASHI Yasuo; KOIZUMI Wasaburo; KOIZUMI Wasaburo; SAKAMOTO Junichi; SAKAMOTO Junichi; SASAKO Mitsuru; SASAKO Mitsuru; TSUBURAYA Akira; TSUBURAYA Akira; NAKAMURA Kenichi; NAKAMURA Kenichi; NIO Yoshinori; NIO Yoshinori; BOKU Narikazu; BOKU Narikazu; MORITA Satoshi; MORITA Satoshi; YAMAMOTO Seiichiro; YAMAMOTO Seiichiro; OHTSU Atsushi; OHTSU Atsushi
        日本臨床腫瘍学会学術集会プログラム・抄録集, 2011年
      • Randomized Phase III Study of Carboplatin Plus S-1 Compared with Carboplatin Plus Paclitaxel as First-Line Treatment in Advanced Non-Small-Cell Lung Cancer (WJTOG3605)
        Chiyoe Kitagawa; Satoshi Morita; Hiroshige Yoshioka; Koji Takedea; Fumihiko Hirai; Nobuyuki Yamamoto; Masahiko Ando; Isamu Okamoto; Masahiro Fukuoka; Kazuhiko Nakagawa
        JOURNAL OF THORACIC ONCOLOGY, 2010年12月
      • ST-Segment Elevation in Lead aVR is the Strongest Predictor of Severe Left Main or 3-Vessel Disease in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Noriaki Iwahashi; Nobuhiki Maejima; Mitsuaki Endo; Kengo Tsukahara; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2010年11月
      • A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling.
        Shinichi Kako; Satoshi Morita; Hisashi Sakamaki; Hiromitsu Iida; Mineo Kurokawa; Koichi Miyamura; Heiwa Kanamori; Masamichi Hara; Naoki Kobayashi; Yasuo Morishima; Keisei Kawa; Taiichi Kyo; Toru Sakura; Itsuro Jinnai; Jin Takeuchi; Yasushi Miyazaki; Shuichi Miyawaki; Kazunori Ohnishi; Tomoki Naoe; Yoshinobu Kanda
        BLOOD, 2010年11月
      • The Development of Negative T Waves After Initial ST-Segment Elevation Differs Between Takotsubo Cardiomyopathy and Reperfused Anterior Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Noriaki Iwahashi; Mitsuaki Endo; Nobuhiko Maejima; Kengo Tsukahara; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2010年11月
      • High QRS Score on Admission Strongly Predicts Impaired Myocardial Reperfusion in Patients With a First Anterior Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Noriaki Iwahashi; Mitsuaki Endo; Nobuhiko Maejima; Kengo Tsukahara; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2010年11月
      • QOL ANALYSIS FROM NEJ 002 STUDY COMPARING GEFITINIB TO CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER WITH MUTATED EGFR
        H. Yoshizawa; K. Kobayashi; A. Inoue; M. Maemondo; S. Sugawara; S. Oizumi; A. Gemma; S. Morita; K. Hagiwara; T. Nukiwa
        ANNALS OF ONCOLOGY, 2010年10月
      • PHASE I STUDY OF S-1 PLUS TRASTUZUMAB COMBINATION THERAPY IN HUMAN EPIDERMAL-GROWTH RECEPTOR 2-POSITIVE METASTATIC BREAST CANCER
        T. Takashima; T. Nakayama; S. Kamigaki; K. Yoshidome; H. Kusumoto; S. Morita; J. Sakamoto; T. Taguchi; K. Morimoto; S. Noguchi
        ANNALS OF ONCOLOGY, 2010年10月
      • S-1 PLUS CARBOPLATIN HAS BECOME ONE OF THE STANDARD REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER: RESULTS OF A RANDOMIZED PHASE III STUDY CONDUCTED BY THE WEST JAPAN ONCOLOGY GROUP (WJTOG 3605)
        T. Seto; S. Morita; M. Ando; H. Saka; T. Hirashima; K. Asami; S. Kudoh; M. Satouchi; M. Fukuoka; K. Nakagawa
        ANNALS OF ONCOLOGY, 2010年10月
      • PROGNOSTIC IMPLICATION OF GEMCITABINE-BASED CHEMOTHERAPY AND INTRAOPERATIVE RADIATION THERAPY IN UNRESECTABLE PANCREATIC CANCER
        T. Fujii; S. Nagai; M. Kanda; Y. Kodera; T. T. Sahin; H. Sugimoto; S. Nomoto; S. Takeda; A. Nakao; S. Morita
        ANNALS OF ONCOLOGY, 2010年10月
      • 肺癌に対する分子標的治療 WJOG3405 EGFR遺伝子変異を持つNSCLCに対するゲフィチニブ(G)とCDDP+DOC(CD)のランダム化第三相比較試験
        中嶋 隆; 光冨 徹哉; 森田 智視; 谷田部 恭; 清水 英治; 岩本 康男; 谷尾 吉郎; 片上 信之; 工藤 新三; 豊岡 伸一; 吉岡 弘鎮; 高田 実; 中川 和彦
        肺癌, 2010年10月
      • Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis
        Xavier Paoletti; The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group; Koji Oba; Tomasz Burzykowski; Stefan Michiels; Yasuo Ohashi; Jean-Pierre Pignon; Philippe Rougier; Junichi Sakamoto; Daniel Sargent; Mitsuru Sasako; Eric Van Cutsem; Marc Buyse; Seiichiro Yamamoto; Kenichi Yoshimura; Yung-Jue Bang; Harry Bleiberg; Catherine Delbaldo; Satoshi Morita; Carmelo Pozzo; Steven Alberts; Emilio Bajetta; Jacqueline Benedetti; Franck Bonnetain; Olivier Bouche; R. Charles Coombes; Maria Di Bartolomeo; Juan J. Grau; Juan C. Garcia-Valdecasas; Josep Fuster; James E. Krook; Florian Lordick; Mario Lise; John S. Macdonald; Pierre Michel; Toshifusa Nakajima; Atsushi Nashimoto; Garth D. Nelson; Donato Nitti; Tadeusz Popiela; Nicolas Tsavaris
        Journal of the American Medical Association, 2010年05月05日
      • Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
        Koji Oba; Seiichiro Yamamoto; Kenichi Nakamura; Yung Jue Bang; Harry Bleiberg; Tomasz Burzykowski; Marc Buyse; Catherine Delbaldo; Stefan Michiels; Satoshi Morita; Yasuo Ohashi; Xavier Paoletti; Jean Pierre Pignon; Philippe Rougier; Junichi Sakamoto; Daniel Sargent; Mitsuru Sasako; Eric Van Cutsem; Nozomu Fuse; Kohei Shitara; Akira Tsuburaya; J. Ajani; N. Boku; C. Barone; M. Borner; O. Bouche; R. Bugat; C. Coombes; S. Cullinan; M. Dank; H. Douglass; B. Glimelius; R. Hawkins; S. Kanzler; W. Koizumi; T. W. Kim; F. Lordick; M. Moehler; Y. Nio; A. Ohtsu; C. Pozzo; P. Reichardt; A. Roth; C. Schumacher; P. Thuss-Patience; U. Vanhoefer; J. Wils; Y. Yamamura
        JAMA - Journal of the American Medical Association, 2010年05月05日
      • The efficacy of low-dose gefitinib for advanced non-small cell lung cancer (NSCLC) with sensitive epidermal growth factor receptor (EGFR) mutations: A post-hoc analysis from NEJ002
        A. Inoue; M. Maemondo; K. Kobayashi; S. Oizumi; H. Isobe; A. Gamma; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa
        JOURNAL OF CLINICAL ONCOLOGY, 2010年05月
      • Randomized phase III study of carboplatin plus S-1 compared with carboplatin plus paclitaxel as first-line chemotherapy in advanced non-small cell lung cancer (WJTOG3605)
        H. Yoshioka; I. Okamoto; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; S. Nakamura; M. Fukuoka; K. Nakagawa
        JOURNAL OF CLINICAL ONCOLOGY, 2010年05月
      • Clinical trials of WT1 peptide vaccine to gynecologic malignancies that are resistant to conventional therapies.
        T. Miyatake; T. Enomoto; Y. Oka; S. Nishida; A. Tsuboi; T. Shirakata; S. Morita; J. Sakamoto; H. Sugiyama; T. Kimura
        JOURNAL OF CLINICAL ONCOLOGY, 2010年05月
      • A decision analysis of allogeneic haematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia in first remission
        S. Kako; S. Morita; H. Sakamaki; H. Iida; M. Kurokawa; K. Miyamura; H. Ogawa; T. Fukuda; S. Takahashi; H. Kanamori; Y. Atsuta; Y. Morishima; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Onishi; T. Naoe; Y. Kanda
        BONE MARROW TRANSPLANTATION, 2010年03月
      • Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial (vol 54, pg 459, 2009)
        T. Akizawa; Y. Asano; S. Morita; T. Wakita; Y. Onishi; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; K. Kurokawa
        AMERICAN JOURNAL OF KIDNEY DISEASES, 2010年03月
      • 腫瘍 EGFR変異陽性の進行非小細胞肺癌におけるゲフィチニブと化学療法の比較第3相試験(NEJ002)
        原田眞雄; 井上彰; 小林国彦; 前門戸任; 菅原俊一; 大泉聡史; 西條康夫; 弦間昭彦; 磯部宏; 森田智視; 萩原弘一; 貫和敏博
        日本呼吸器学会雑誌, 2010年
      • 臨床評価法 DFSとOSの相関:大腸がん補助化学療法―surrogate endpointの探索と留意点―
        坂本純一; 森田智視; 大庭幸治
        月刊腫瘍内科, 2009年11月28日
      • Prolonged QRS Duration is a Strong Predictor of Adverse Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
        Masami Kosuge; Kazuo Kimura; Satoshi Morita; Toshiyuki Ishikawa; Toshiaki Ebina; Kiyoshi Hibi; Jyun Okuda; Noriaki Iwahashi; Kengo Tsukahara; Kazuaki Uchino; Satoshi Umemura
        CIRCULATION, 2009年11月
      • Positive T Wave in Lead aVR and No Negative T Wave in Lead V1 Distinguishes Tako-tsubo Cardiomyopathy From Recanalized Anterior Acute Myocardial Infarction
        Masami Kosuge; Kazuo Kimura; Satoshi Morita; Toshiaki Ebina; Kiyoshi Hibi; Jyun Okuda; Noriaki Iwahashi; Kengo Tsukahara; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura
        CIRCULATION, 2009年11月
      • A Simple Electrocardiographic Criterion for Differentiating Tako-tsubo Cardiomyopathy From Anterior Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Noriaki Iwahashi; Jyun Okuda; Kengo Tsukahara; Kazuaki Uchino; Toshiyuki Ishikawa; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2009年11月
      • ST-Segment Depression in Lead aVR: A Useful Predictor of Impaired Myocardial Reperfusion in Patients With Anterolateral ST-Segment Elevation Acute Myocardial Infarction
        Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Toshiyuki Ishikawa; Kazuaki Uchino; Kengo Tsukahara; Noriaki Iwahashi; Jyun Okuda; Satoshi Umemura; Kazuo Kimura
        CIRCULATION, 2009年11月
      • First line gefitinib versus first line chemotherapy by carboplatin plus paclitaxel in non-small cell lung cancer patients with EGFR mutations: a phase III study (002) by North East Japan Gefitinib Study Group
        Y. Minegishi; A. Inoue; K. Kobayashi; A. Gemma; M. Maemondo; S. Oizumi; Y. Saijo; S. Morita; K. Hagiwara; T. Nukiwa
        EJC SUPPLEMENTS, 2009年10月
      • A randomized phase III study comparing gefitinib with carboplatin (CBDCA) plus paclitaxel (TXL) for the first-line treatment of non-small cell lung cancer (NSCLC) with sensitive EGFR mutations: NEJ002 study
        A. Inoue; K. Kobayashi; M. Maemondo; S. Sugawara; S. Oizumi; Y. Saijo; A. Genma; S. Morita; K. Hagiwara; T. Nukiwa
        EJC SUPPLEMENTS, 2009年09月
      • 治療抵抗性婦人科癌を対象としたWT1ペプチドワクチン療法の有用性の検討
        宮武 崇; 榎本 隆之; 白方 俊章; 岡 芳弘; 西田 純幸; 尾路 祐介; 保仙 直毅; 坪井 昭博; 上田 豊; 藤田 征巳; 青笹 克之; 森田 智視; 坂本 純一; 杉山 哲夫; 木村 正
        日本癌治療学会誌, 2009年09月
      • 分子標的薬 呼吸器 上皮成長因子受容体(EGFR)遺伝子変異を伴う未治療進行・再発非小細胞肺癌(NSCLC)におけるゲフィチニブとシスプラチン+ドセタキセルの無作為比較第III相試験 WJTOG3405のプレリミナリーな結果報告
        瀬戸 貴司; 光冨 徹哉; 森田 智視; 岡本 勇; 一瀬 幸人; 野崎 要; 根来 俊一; 谷田部 恭; 福岡 正博; 中川 和彦
        日本癌治療学会誌, 2009年09月
      • WT1ペプチドワクチンと塩酸ゲムシタビンを併用した進行膵臓癌に対する新たな治療戦略
        西田純幸; 武田裕; 岡芳弘; 小井戸薫雄; 本間定; 込田英夫; 伊藤壽記; 北川透; 坪井昭博; 尾路祐介; 中野晶子; 田中敏郎; 川瀬一郎; 森田智視; 坂本純一; 土岐祐一郎; 森正樹; 大草敏史; 田尻久雄; 杉山治夫
        日本がん免疫学会総会プログラム・抄録集, 2009年05月20日
      • Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: A multi-institution survey
        K. Kawaguchi; H. Ishiguro; S. Morita; S. Nakamura; S. Ohno; N. Masuda; H. Iwata; K. Aogi; K. Kuroi; M. Toi
        JOURNAL OF CLINICAL ONCOLOGY, 2009年05月
      • HER2 expression-based approach of neoadjuvant chemotherapy with doxorubicin plus cyclophosphamide or docetaxel plus cyclophosphamide for operable breast cancer
        Takashi Ishikawa; Daisuke Shimizu; Sasaki Takeshi; Mikiko Tanabe; Ikuko Ota; Ayako Kito; Akinori Nozawa; Kae Kawachi; Satoshi Morita; Takashi Chishima; Yasushi Ichikawa
        CANCER RESEARCH, 2009年05月
      • First-line gefitinib versus first-line chemotherapy by carboplatin (CBDCA) plus paclitaxel (TXL) in non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations: A phase III study (002) by North East Japan Gefitinib Study Group
        K. Kobayashi; A. Inoue; M. Maemondo; S. Sugawara; H. Isobe; S. Oizumi; Y. Saijo; A. Gemma; S. Morita; K. Hagiwara; T. Nukiwa
        JOURNAL OF CLINICAL ONCOLOGY, 2009年05月
      • Prospective Study of Platelet Aggregation in Antiplatelet Therapy.
        Takeo Abumiya; Kiyohiro Houkin; Satoshi Morita; Shunichi Fukuhara
        STROKE, 2009年04月
      • 分子標的治療の基礎と臨床 Star Trials from Japan 1 EGFR遺伝子変異陽性の進行非小細胞肺癌における第三相試験(NEJ002)の中間解析結果
        磯部宏; 井上彰; 小林国彦; 前門戸任; 菅原俊一; 大泉聡史; 西條康夫; 弦間昭彦; 森田智視; 萩原弘一; 貫和敏博
        肺癌, 2009年
      • EGFR遺伝子変異陽性NSCLC症例に対するゲフィチニブ治療の第II相試験統合解析(I-CAMP study group)
        杉尾賢二; 平島智徳; 樋田豊明; 萩原弘一; 砂長則明; 井上彰; 朝比奈肇; 森田智視; 光冨徹哉; 福岡正博; 貫和敏博; 安元公正
        日本呼吸器学会雑誌, 2009年
      • がんワクチン療法標準化への提言 大腸癌、膵癌に対するWT1ペプチドワクチン療法
        岡 芳弘; 西田 純幸; 武田 裕; 坪井 昭博; 尾路 祐介; 伊藤 壽記; 森田 智視; 坂本 純一; 関本 貢嗣; 杉山 治夫
        Biotherapy, 2008年11月
      • WS4-2 EGFR遺伝子変異を有する進行非小細胞肺癌患者を対象としたgefitinib治療prospective試験統合解析(分子標的治療2(臨床),第49回日本肺癌学会総会号)
        砂長 則明; 柳谷 典子; 山崎 浩一; 朝比奈 肇; 井上 彰; 西條 康夫; 萩原 弘一; 小林 国彦; 森田 智視; 樋田 豊明; 吉田 公秀; 光富 徹哉; 岡本 勇; 平島 智徳; 杉尾 賢二; 貫和 敏博; 福岡 正博
        肺癌, 2008年10月05日
      • 進行・術後胃癌におけるランダム化比較試験を対象としたメタアナリシス(GASTRIC研究)
        大庭幸治; 大津敦; 大橋靖雄; 小泉和三郎; 坂本純一; 笹子三津留; 中島聰聰; 仁尾義則; 朴成和; 森田智視; 山村義孝; 山本精一郎; 吉村健一
        日本癌治療学会誌, 2008年10月01日
      • COMPARISON OF THE EFFICACY BETWEEN CHEMOTHERAPY AND GEFITINIB AS 1ST LINE SETTING IN PATIENTS WITH EGFR MUTATION POSITIVE NSCLC
        K. Yoshida; I. Okamoto; K. Kobayashi; N. Sunaga; K. Sugio; A. Inoue; K. Yamazaki; S. Morita; T. Nukiwa; M. Fukuoka
        ANNALS OF ONCOLOGY, 2008年09月
      • GEFITINIB PROVIDES AN BENEFICIAL TREATMENT TO POOR PS OR SUPER-ELDERLY PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC (NORTH-EAST JAPAN GEFITINIB STUDY GROUP)
        A. Inoue; K. Kobayashi; K. Usui; M. Maemondo; M. Ando; A. Gemma; S. Morita; T. Nukiwa; S. Okinaga; K. Hagiwara
        ANNALS OF ONCOLOGY, 2008年09月
      • First-line gefitinib for poor PS patients with EGFR mutations
        K. Kobayashi; A. Inoue; K. Usui; M. Maemondo; S. Okinaga; I. Mikami; M. Ando; A. Gemma; S. Morita; K. Hagiwara
        JOURNAL OF CLINICAL ONCOLOGY, 2008年05月
      • Gefitinib combined survival analysis of the mutation positives from the prospective phase II trials (I-CAMP)
        S. Morita; T. Hirashima; K. Hagiwara; T. Hida; N. Sunaga; K. Sugio; A. Inoue; K. Yamazaki; T. Mitsudomi; T. Nukiwa
        JOURNAL OF CLINICAL ONCOLOGY, 2008年05月
      • CASE‐Jにおける評価判定 医療統計家の役割
        佐藤俊哉; 森田智視; 大庭幸冶
        日本臨床, 2008年04月08日
      • 悪性脳腫瘍に対するWT1ペプチド免疫療法
        杉山 治夫; 泉本 修一; 坪井 昭博; 香川 尚己; 鈴木 強; 橋本 直哉; 丸野 元彦; 尾路 祐介; 西田 純幸; 白方 俊章; 保仙 直毅; 川上 学; 森田 智視; 坂本 純一; 川瀬 一郎; 岡 芳弘; 吉峰 俊樹
        Biotherapy, 2007年09月
      • 進行胃癌患者に対するレンチナン併用化学療法の個人データを用いたメタアナリシス
        坂本純一; 大庭幸治; 森田智視; 松井隆則; 小寺泰弘; 小林道也; 近藤建
        日本消化器外科学会雑誌, 2007年07月01日
      • Quality of life of patients receiving adjuvant chemotherapies for breast cancer in Japan
        T. Fukuda; K. Shimozuma; S. Ohsumi; H. Mukai; S. Morita; H. Imai; T. Watanabe; Y. Ohashi
        VALUE IN HEALTH, 2006年11月
      • WT1ペプチドワクチンによる膠芽腫に対する癌免疫療法
        岡 芳弘; 泉本 修一; 坪井 昭博; 香川 尚己; 鈴木 強; 橋本 直哉; 丸野 元彦; 川上 学; 西田 純幸; 白方 俊章; 中島 博子; エリセーバ・オリガ; 原田 ゆきえ; 藤木 文博; 李 哲雨; 尾路 祐介; 森田 智視; 坂本 純一; 吉峰 俊樹; 杉山 治夫
        Biotherapy, 2006年09月
      • 大規模臨床試験の実践(計画・運営・実施)上の諸問題 高血圧に対する大規模臨床試験(CASE-J)の実践における諸問題
        坂本 純一; 森田 智視; 大庭 幸治; 佐藤 俊哉; 福井 次矢; 荻原 俊男; 北 徹; 中尾 一和; 猿田 亨男
        臨床薬理, 2006年07月
      • Adjuvant chemotherapy with tegafur/uracil (UFT) for gastric cancer. A meta-analysis of centrally randomized clinical trials.
        J. Sakamoto; A. Tsuburaya; S. Morita; T. Matsui; K. Oba; Y. Kodera; M. Kobayashi; K. Yoshida; A. Nakao
        JOURNAL OF CLINICAL ONCOLOGY, 2006年06月
      • Assessment and quantification of taxane-induced neurotoxicity in a phase III randomized trial of breast cancer (AC followed by PAC/DOC vs. PAC/DOC alone): N-SAS BC 02.
        K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; T. Watanabe; F. H. Hausheer
        JOURNAL OF CLINICAL ONCOLOGY, 2006年06月
      • WT1ペプチド癌ワクチンを用いた膠芽腫に対する免疫療法
        岡 芳弘; 泉本 修一; 坪井 昭博; 香川 尚己; 鈴木 強; 橋本 直哉; 丸野 元彦; 川上 学; 西田 純幸; 白方 俊章; 中島 博子; オリガ・エリセーバ; 原田 ゆきえ; 藤木 文博; 李 哲雨; 尾路 祐介; 森田 智視; 坂本 純一; 吉峰 俊樹; 杉山 治夫
        基盤的癌免疫研究会総会抄録, 2006年06月
      • UFTを用いた胃癌術後補助化学療法の有用性
        坂本 純一; 森田 智視; 大庭 幸治; 円谷 彰; 小林 道也; 小寺 泰弘; 大橋 靖雄; 中尾 昭公
        日本外科学会雑誌, 2006年03月05日
      • 進行・再発胃癌に対する逐次併用または同時併用のRandomized Phase II Trial: Trial for Advanced Stomach Cancer (TASC)
        馬場 秀夫; 坂本純一; 森田智視; 前原喜彦
        Taxol for Gastric Cancer 第78回日本胃癌学会総会 記録集, 2006年
      • THE PRACTICAL PROBLEMS IN A LARGE-SCALE RANDOMIZED CLINICAL TRIAL FOR HYPERTENSIVE PATIENTS (CASE-J)
        SAKAMOTO Junichi; SAKAMOTO Junichi; MORITA Satoshi; MORITA Satoshi; OBA Koji; OBA Koji; SATO Toshiya; SATO Toshiya; FUKUI Tsuguya; OGIHARA Toshio; NAKAO Kazuwa; NAKAO Kazuwa; SARUTA Takao
        Abstr 21st Sci Meet Int Soc Hypertens 2006, 2006年
      • COMPLIANCE AND NON-COMPLIANCE BY PHYSICIANS IN A LARGE-SCALE RANDOMIZED CLINICAL TRIAL (CASE-J)
        OBA Koji; MORITA Satoshi; RAHMAN Mahbubur; SAKAMOTO Junichi
        Abstr 21st Sci Meet Int Soc Hypertens 2006, 2006年
      • 高血圧:CASE‐J(Candesartan Antihypertensive Survival Evaluation in Japan)
        坂本純一; 森田智視; 大庭幸治; 佐藤俊哉; 福井次矢; 荻原俊男; 北徹; 猿田享男
        臨床薬理, 2005年11月15日
      • エビデンスに基づいたバイオセラピィ バイオセラピィに関する世界におけるエビデンス
        坂本 純一; 大庭 幸治; 小林 道也; 手良向 聡; 森田 智視
        Biotherapy, 2005年10月
      • 大腸癌治癒切除例に対するPSK術後補助免疫化学療法の効果―メタアナリシスによる評価―
        坂本純一; 森田智視; 大庭幸治; 小林道也; 松井隆則; 中里博昭; 大橋靖雄
        日本癌治療学会誌, 2005年09月22日
      • 京都大学社会健康医学系専攻における臨床研究者養成コース(MCR)の概要
        中山 健夫; 福原 俊一; 今中 雄一; 白川 太郎; 小杉 眞司; 川村 孝; 石崎 達郎; 森田 智視; 東 尚弘; 安藤 昌彦
        医学教育, 2005年07月
      • Efficacy of adjuvant chemotherapy with oral fluorinated pyrimidines for patients with curatively resected gastric cancer. A meta-analysis of centrally randomized controlled clinical trials
        J Sakamoto; S Morita; A Tsuburaya; Y Kodera; T Matsui; O Kobayashi
        JOURNAL OF CLINICAL ONCOLOGY, 2005年06月
      • IMPACT OF EXCESSIVE DAYTIME SLEEPINESS ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
        Misa Takegami; Satoshi Morita; Kazuo Chin; Tsuneto Akashiba; Hiroshi Kimura; Yoshimi Suzukamo; Shunichi Fukuhara
        QUALITY OF LIFE RESEARCH, 2004年11月
      • Possible aids to remove the burdens during informed consent process in clinical trials: A case of National Surgical Adjuvant Study of Breast Cancer 02 (N-SAS BC 02).
        M Yamauchi; Y Ohashi; S Morita; T Watanabe
        JOURNAL OF CLINICAL ONCOLOGY, 2004年07月
      • Relationship among socioeconomic factors, distress, and quality of life (QOL) in cancer outpatients.
        K Kobayashi; M Shimonagayoshi; M Kobayashi; M Uno; K Yamaguchi; S Morita
        JOURNAL OF CLINICAL ONCOLOGY, 2004年07月
      • Truth-telling to patients with advanced cancer in Japan: A comparison between major centers and local hospitals.
        S Morita; M Kobayashi; T Ichihara; A Nakao; M Rahman; M Yamauchi; J Sakamoto
        JOURNAL OF CLINICAL ONCOLOGY, 2004年07月
      • Perceived barriers and reasons behind the participation in a randomized controlled trial in Japan: Collaborating physicians' view.
        M Rahman; S Morita; T Fukui; J Sakamoto
        AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004年06月
      • Validation of the patient neurotoxicity questionnaire (PNQ) during taxane chemotherapy in a phase III randomized trial of breast cancer: N-SAS BC 02
        K Shimozuma; Y Ohashi; A Takeuchi; S Morita; S Ohsumi; Y Sunada; K Kuroi; H Makino; T Watanabe; FH Hausheer
        BREAST CANCER RESEARCH AND TREATMENT, 2004年
      • Care-seeking behavior for low back pain in Japan: A population survey.
        S Fukuhara; N Takahashi; S Konno; S Morita; Y Suzukamo; S Kikuchi
        JOURNAL OF GENERAL INTERNAL MEDICINE, 2003年04月
      • The prevalence and burden of low back pain in Japan: A population-based survey
        S Fukuhara; N Takahashi; S Konno; S Morita; Y Suzukamo; S Kikuchi
        JOURNAL OF GENERAL INTERNAL MEDICINE, 2003年04月
      • The cuffed oropharyngeal airway and management of the difficult airway - Reply
        S Uezono; T Goto; S Morita
        ANESTHESIOLOGY, 1999年03月

      講演・口頭発表等

      • Bayesian Population Finding (BaPoFi) with Biomarkers in a Randomized Clinical Trial.
        森田 智視
        CEN-ISBS Conference, 2017年08月
      • Incorporating historical data in Bayesian phase I trial design: The Caucasian-to-Asian toxicity tolerability problem
        森田 智視
        The Ninth ICSA International Conference, 2013年12月
      • Bridging dose-finding for a multinational cancer phase I trial
        森田 智視
        Society for Clinical Trials 34th Annual Meeting, 2013年05月
      • Bayesian study designs for new drug development
        森田 智視
        ISBA 2012 World Meeting, 2012年
      • Sequential dose-finding in phase I clinical trials in Japan: East meets West
        森田 智視
        The 2011 Society for Clinical Trials Meeting, 2011年
      • Bridging dose-finding studies from West to East.
        森田 智視
        The 2nd CRM Workshop, 2011年
      • Practical Application of the Continual Reassessment Method to a Phase I Dose-Finding Trial in Japan: East meets West
        森田 智視
        The 1st CRM Workshop, 2009年10月

      書籍等出版物

      • Encyclopedia of Biopharmaceutical Statistics, 3rd Edition
        森田 智視, 分担執筆, Prior Effective Sample Size of a Bayesian Model.
        Informa Healthcare, 2010年, 査読無し
      • 消火器癌化学療法
        森田 智視, 分担執筆, 抗癌剤の臨床第Ⅱ,Ⅲ相試験
        南山堂, 2009年, 査読無し
      • QOL評価学‐測定, 解析, 解釈のすべて
        森田 智視, 共訳
        中山書店, 2005年, 査読無し
      • 癌治療の新たな試み 新編III
        森田 智視, 分担執筆, QOL評価
        医薬ジャーナル社, 2005年, 査読無し
      • 腎臓病: 先端医療シリーズ
        森田 智視, 分担執筆, 予後予測因子としての健康関連QOL
        先端医療技術研究所, 2005年, 査読無し
      • Handbook of Statistics in Clinical Oncology, Second Edition.
        森田 智視, 分担執筆, Practical Implementation of the Continual Reassessment Method.
        CRC Press, 2005年, 査読無し
      • 実践医学統計学
        森田 智視, 共訳
        朝倉書店, 2004年, 査読無し
      • 医学統計のための線型混合効果モデル-SASによるアプローチ-
        森田 智視, 共訳
        サイエンティスト社, 2001年, 査読無し
      • 新QOL調査票と評価の手引き
        森田 智視, 分担執筆, 臨床比較試験におけるQOLデータの解析
        メディカルレビュー社, 2001年, 査読無し
      • 臨床のためのQOL評価ハンドブック
        森田 智視, 分担執筆, QOLの統計学的評価
        医学書院, 2001年, 査読無し
      • シナリオで学ぶ医療経済学入門
        森田 智視, 共訳
        サイエンティスト社, 2000年, 査読無し

      受賞

      • 2004年08月
        SAS Forumユーザー会, 学術総会優秀論文賞

      外部資金:科学研究費補助金

      • 肺機能低下と睡眠呼吸障害の横断・縦断的解析と病態生理解明のためのメタボローム解析
        基盤研究(B)
        小区分53030:呼吸器内科学関連
        京都大学
        陳 和夫
        自 2020年04月01日, 至 2023年03月31日, 完了
        睡眠呼吸障害;睡眠時無呼吸;慢性閉塞性肺疾患;メタボローム;前向き検討;生活習慣病;糖尿病;高血圧;糖尿病家族歴
      • ベイズ流アプローチによる探索的がん臨床試験デザインの開発
        基盤研究(C)
        京都大学;横浜市立大学
        森田 智視
        自 2012年04月01日, 至 2015年03月31日, 完了
        バイオマーカー;個別化医療;ベイズ流統計学;臨床腫瘍学
      • 先端医療技術の開発における臨床試験の計画と統計解析に関する研究
        基盤研究(A)
        名古屋大学;統計数理研究所
        松井 茂之
        自 2012年04月01日, 至 2016年03月31日, 完了
        臨床試験;統計的デザイン;データ解析;個別化医療;先端医療技術;臨床試験の計画と解析;先端医療技術の開発;診断法開発;ゲノムデータの解析;ゲノムデータ解析;統計解析;バイオマーカー;予測解析
      • 胃全摘後の普遍的な再建法を確立するランダム化比較試験
        基盤研究(C)
        名古屋大学
        小寺 泰弘
        自 2011年04月01日, 至 2014年03月31日, 完了
        胃全摘術;再建法;胃癌;空腸パウチ;胃全摘術後再建法
      • 個別化医療実現のための臨床研究のデザインと統計解析に関する研究
        基盤研究(C)
        統計数理研究所
        松井 茂之
        自 2008年04月01日, 至 2011年03月31日, 完了
        医学統計;ゲノム薬理学;個別化医療;ゲノムワイド研究;分子診断法の開発;マイクロアレー;臨床研究の計画と解析;階層混合モデル;遺伝子スクリーニング;体外診断法の開発;ベイズ流階層混合モデル

      外部資金:その他

      • バイオマーカーに基づいた肺癌個別化治療における分子標的治療薬の至適治療法を検証するランダム化第Ⅲ相試験
        がん臨床研究事業
        自 2011年, 至 2011年
        分担
      • HLA不適合血縁者間移植の安全性および有効性向上のための包括的研究
        免疫アレルギー疾患等予防・治療研究事業
        自 2011年, 至 2011年
        分担
      • ゲノムワイド関連解析を用いた革新的な肝移植後肝炎ウィルス再感染予防・治療法の確立
        肝炎等克服緊急対策研究事業
        自 2011年, 至 2011年
        分担
      list
        Last Updated :2025/04/24

        教育

        担当科目

        • 自 2024年04月01日, 至 2025年03月31日
          臨床研究・臨床開発概論
          3233, 後期後半, 医学部, 1
        • 自 2024年04月01日, 至 2025年03月31日
          橋渡し研究・臨床研究マネジメント
          E068, 通年集中, 医学研究科, 2
        • 自 2024年04月01日, 至 2025年03月31日
          保健医療統計学
          M022, 前期, 医学研究科, 2
        • 自 2024年04月01日, 至 2025年03月31日
          臨床研究実地研修II
          H147, 通年集中, 医学研究科, 2
        • 自 2024年04月01日, 至 2025年03月31日
          臨床研究実地研修 I
          H140, 通年集中, 医学研究科, 2
        • 自 2023年04月01日, 至 2024年03月31日
          臨床研究・臨床開発概論
          3233, 後期後半, 医学部, 1
        • 自 2023年04月01日, 至 2024年03月31日
          臨床研究実地研修 I
          H140, 通年集中, 医学研究科, 2
        • 自 2023年04月01日, 至 2024年03月31日
          橋渡し研究・臨床研究マネジメント
          E068, 通年集中, 医学研究科, 2
        • 自 2023年04月01日, 至 2024年03月31日
          保健医療統計学
          M022, 前期, 医学研究科, 2
        • 自 2023年04月01日, 至 2024年03月31日
          臨床研究実地研修II
          H147, 通年集中, 医学研究科, 2
        • 自 2022年04月01日, 至 2023年03月31日
          臨床研究・臨床開発概論
          3233, 後期前半, 医学部, 1
        • 自 2022年04月01日, 至 2023年03月31日
          臨床研究実地研修 I
          H140, 通年集中, 医学研究科, 2
        • 自 2022年04月01日, 至 2023年03月31日
          橋渡し研究・臨床研究マネジメント
          E068, 通年集中, 医学研究科, 2
        • 自 2022年04月01日, 至 2023年03月31日
          保健医療統計学
          M022, 前期, 医学研究科, 2
        • 自 2022年04月01日, 至 2023年03月31日
          臨床研究実地研修II
          H147, 通年集中, 医学研究科, 2
        • 自 2015年04月, 至 2016年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2016年04月, 至 2017年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2017年04月, 至 2018年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2018年04月, 至 2019年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2018年04月, 至 2019年03月
          臨床研究実地研修 I
          前期集中, 医学研究科
        • 自 2018年04月, 至 2019年03月
          高度医療看護論
          前期前半, 医学部(人間健康科学科)
        • 自 2019年04月, 至 2020年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2019年04月, 至 2020年03月
          臨床研究実地研修 I
          通年集中, 医学研究科
        • 自 2019年04月, 至 2020年03月
          臨床研究実地研修II
          通年集中, 医学研究科
        • 自 2019年04月, 至 2020年03月
          高度医療看護論
          前期前半, 医学部(人間健康科学科)
        • 自 2020年04月, 至 2021年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2020年04月, 至 2021年03月
          臨床研究実地研修 I  (CB限定)
          通年集中, 医学研究科
        • 自 2020年04月, 至 2021年03月
          臨床研究実地研修II (CB限定)
          通年集中, 医学研究科
        • 自 2021年04月, 至 2022年03月
          保健医療統計学
          前期, 医学研究科(人間健康科学系専攻)
        • 自 2021年04月, 至 2022年03月
          臨床研究実地研修 I  (CB限定)
          通年集中, 医学研究科
        • 自 2021年04月, 至 2022年03月
          臨床研究実地研修II (CB限定)
          通年集中, 医学研究科
        • 自 2021年04月, 至 2022年03月
          臨床研究・臨床開発概論
          後期前半, 医学部(人間健康科学科)

        博士学位審査

        • Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy:A Propensity Score Analysis(慢性中心性漿液性網脈絡膜症に対する低線量光線力学療法の有効性:傾向スコア解析)
          愛須 奈央, 医学研究科, 副査
          2024年03月25日
        • Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NETR in Japan(ベースライン共変量として用いる臨床検査値が欠測している場合の対処:データベースシステムMID-NETR内の複数施設データを用いたコホート研究事例)
          櫻井 真希, 医学研究科, 主査
          2024年03月25日
        • Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NETR in Japan(ベースライン共変量として用いる臨床検査値が欠測している場合の対処:データベースシステムMID-NETR内の複数施設データを用いたコホート研究事例)
          櫻井 真希, 医学研究科, 主査
          2024年03月25日
        • Impact of the cefazolin shortage on the selection and cost of parenteral antibiotics during the supply disruption period in Japan: A controlled interrupted time series analysis(日本における供給停止期間中のセファゾリン不足が注射抗菌薬の選択と費用に与えた影響: 対照群を置いた分割時系列解析)
          長野 広之, 医学研究科, 副査
          2024年03月25日
        • Stronger Associations of Centrilobular Than Paraseptal Emphysema With Longitudinal Changes in Diffusing Capacity and Mortality in COPD(COPDにおける肺拡散能低下と予後は、傍隔壁性肺気腫よりも小葉中心性肺気腫が強く関連する)
          白石 祐介, 医学研究科, 副査
          2024年03月25日
        • Improved genetic prediction of the risk of knee osteoarthritis using the risk factor-based polygenic score(ポリジェニックスコアに基づくリスクファクター形質を使用した変形性膝関節症の予測モデルの改善)
          森田 悠吾, 医学研究科, 副査
          2024年01月23日
        • Clinical Relevance of Parafoveal Intercapillary Spaces and Foveal Avascular Zone in Diabetic Retinopathy Without Macular Edema(黄斑浮腫を伴わない糖尿病網膜症における傍中心窩の毛細血管間隙と中心窩無血管域の臨床的意義)
          寺田 紀子, 医学研究科, 副査
          2023年09月25日
        • Multiply Robust Weighted Generalized Estimating Equations for Incomplete Longitudinal Binary Data Using Empirical Likelihood(欠測を含む二値の経時データにおける経験尤度法を用いた多重頑健重み付き一般化推定方程式)
          駒嵜 弘, 医学研究科, 主査
          2024年03月25日
        • Efficacy of Integrated Online Mindfulness and Self-compassion Training for Adults With Atopic Dermatitis: A Randomized Clinical Trial(成人アトピー性皮膚炎患者に対するオンラインマインドフルネス及びセルフコンパッションの有効性 -ランダム化比較試験)
          岸本 早苗, 医学研究科, 主査
          2024年03月25日
        • Predicting the efficacy of monoclonal antibodies against multiple myeloma(多発性骨髄腫に対する抗体療法の有効性の予測)
          島津 裕, 医学研究科, 主査
          2024年03月25日
        • Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers(ラミン遺伝子変異キャリアにおける遺伝子型を用いた心疾患リスクの層別化)
          西内 英, 医学研究科, 主査
          2023年09月25日
        • Two-Minute Quantitative Susceptibility Mapping From Three-Dimensional Echo-Planar Imaging Accuracy, Reliability, and Detection Performance in Patients With Cerebral Microbleeds(脳微小出血患者における三次元エコープラナー法を用いた二分間撮影定量的磁化率マッピングの正確性、信頼性、検出能)
          Krishna Pandu Wicaksono, 医学研究科, 副査
          2023年03月23日
        • Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning(アンサンブル学習を用いた造血幹細胞移植後予後予測モデルの開発)
          岩﨑 惇, 医学研究科, 主査
          2023年01月23日
        • A proof-of-concept study to construct Bayesian network decision models for supporting the categorization of sudden unexpected infant death(乳幼児の予期せぬ突然死の分類を支援するベイジアンネットワークモデルの構築についての概念実証研究)
          濱保 英樹, 医学研究科, 副査
          2022年09月26日
        • Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer(I期非小細胞肺癌に対する体幹部定位放射線治療、肺葉切除術および縮小切除術の傾向スコアに基づく解析)
          岸 徳子, 医学研究科, 副査
          2022年11月24日
        • Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer(下部直腸癌における側方リンパ節転移予測モデルの作成と評価)
          住井 敦彦, 医学研究科, 主査
          2022年11月24日
        • Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types(相同組換え修復欠損のがん横断的バイオマーカーとしての有用性)
          高松 士朗, 医学研究科, 主査
          2022年11月24日
        • Relationship between Intraocular Pressure and Coffee Consumption in a Japanese Population without Glaucoma: The Nagahama Study (緑内障を有さない日本人における、コーヒー摂取量と眼圧の関係:ながはまスタディ―)
          中野 絵梨, 医学研究科, 副査
          2022年03月23日
        • Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice (実臨床における重症大動脈弁狭窄症に対する経カテーテル大動脈弁置換術と保存的治療の比較)
          竹治 泰明, 医学研究科, 副査
          2022年03月23日
        • Immediate effect of neuromuscular electrical stimulation on the abductor hallucis muscle: A randomized controlled trial (母趾外転筋への神経筋電気刺激の即時効果:ランダム化比較試験)
          下浦 佳南子, 医学研究科, 副査
          2022年03月23日
        • A Geometry-Based Multiple Testing Correction for Contingency Tables by Truncated Normal Distribution (切断正規分布を用いた分割表の幾何学的マルチプルテスティング補正法)
          Basak Tapati, 医学研究科, 主査
          2021年05月24日
        • Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer, a retrospective study (ダイナミック造影MRIによる血行動態解析はトリプルネガティブ乳癌の残存腫瘍量と予後の予測を可能にする;後方視的研究)
          山口 絢音, 医学研究科, 副査
          2021年09月24日
        • Clinical Characteristics and Outcomes of Heart Failure Patients With Long-Term Care Insurance -Insights From the Kitakawachi Clinical Background and Outcome of Heart Failure Registry- (介護保険と心不全患者の臨床的特徴と予後 ‐北河内心不全レジストリより‐)
          髙林 健介, 医学研究科, 副査
          2021年07月26日

        学外学位論文審査

        • Bayesian adaptive methods for phase I clinical trials
          Ruitao Lin, University of Hong Kong, Hong Kong, 副査
          2016年04月

        指導学生の業績:受賞

        • Poster Prize Award
          Kentaro Takeda, 34th Annual conference of the International Society for Clinical Biostatistics, 2013年08月
        list
          Last Updated :2025/04/24

          大学運営

          全学運営(役職等)

          • 自 2024年04月01日, 至 2025年03月31日
            病院協議会
          • 自 2014年01月01日, 至 2014年12月31日
            オープンキャンパス委員会 委員

          部局運営(役職等)

          • 自 2022年04月01日, 至 2023年03月31日
            病院協議会 委員
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構協議会 委員
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構執行部会議 委員
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構財務委員会 委員
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構人事委員会 委員
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構推進委員会 委員
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構ACTION-K推進委員会
          • 自 2022年04月01日, 至 2023年03月31日
            先端医療研究開発機構支援研究検討・管理会議 委員
          • 自 2022年04月01日, 至 2023年03月31日
            特定臨床研究等実施管理委員会
          • 自 2022年04月01日, 至 2023年03月31日
            シーズ選定評価委員会 委員
          • 自 2013年06月02日
            医学部附属病院 臨床研究総合センター データサイエンス部長
          • 自 2013年06月02日, 至 2020年03月31日
            病院協議会 委員
          • 至 2018年03月31日
            iPS等臨床試験センター整備専門委員会
          • 至 2020年03月31日
            特定臨床研究実施管理委員会
          • 至 2019年03月31日
            臨床研究総合センター協議会
          • 至 2020年03月31日
            臨床研究総合センター運営会議
          • 至 2020年03月31日
            臨床研究総合センター推進委員会
          • 至 2017年03月31日
            臨床研究総合センター医療開発委員会
          • 自 2018年04月01日, 至 2020年03月31日
            iPS等臨床試験センター設置準備委員会
          • 自 2018年04月01日, 至 2023年03月31日
            研究開発戦略推進委員会
          • 自 2018年04月01日, 至 2020年03月31日
            シーズ選定委員会
          • 自 2014年10月01日, 至 2020年09月30日
            管理体制委員会
          • 自 2017年04月01日, 至 2020年03月31日
            寄附講座運営委員会(臨床システム腫瘍学講座)
          • 自 2019年04月01日, 至 2020年03月31日
            臨床研究総合センター財務委員会 委員
          • 自 2019年04月01日, 至 2020年03月31日
            臨床研究総合センター人事委員会 委員
          • 自 2019年04月01日, 至 2020年03月31日
            iPS等臨床試験センター設置準備室ミーティング 委員
          • 自 2019年04月01日, 至 2020年03月31日
            シーズ評価委員会 委員
          • 自 2019年04月01日, 至 2020年03月31日
            臨床試験データ等の移転規程化に向けたワーキンググループ 委員
          • 自 2019年04月01日, 至 2020年03月31日
            特定臨床研究実施管理委員会事務局ワーキング 委員
          • 自 2019年04月01日
            ゲノム医学センター運営委員会
          • 自 2019年03月01日, 至 2024年03月31日
            学術情報システム・情報セキュリティ委員会 委員
          • 自 2020年10月01日, 至 2022年09月30日
            管理体制委員会委員

          ページ上部へ戻る